Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
EUROPEAN COMMISSION
Directorate-General for Communications Networks, Content and
Technology
Digital Society, Trust and Cybersecurity
eHealth, Well-Being and Ageing
GRANT AGREEMENT
NUMBER 951938 — X-eHealth
This Agreement (‘the Agreement’) is between the following parties:
on the one part,
the European Union (‘the EU’), represented by the European Commission ('the Commission'),
represented for the purposes of signature of this Agreement by Head of Unit, Directorate-General
for Communications Networks, Content and Technology, Data, Administration and Finance, Mikaela
FARR-DAVID,
and
on the other part,
1. ‘the coordinator’:
SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE (SPMS), established
in AVENIDA DA REPUBLICA, 61, LISBOA 1050 189, Portugal, VAT number: PT509540716,
represented for the purposes of signing the Agreement by Member of the Board of Directors,
Domingos Pereira
and the following other beneficiaries, if they sign their ‘Accession Form’ (see Annex 3 and Article 56):
2. BUNDESMINISTERIUM FUER ARBEIT, SOZIALES, GESUNDHEIT UND
KONSUMENTENSCHUTZ (ATNA), established in Radetzkystrasse 2, WIEN 1030, Austria,
3. GESUNDHEIT OSTERREICH GMBH (GÖG), established in STUBENRING 6, WIEN 1010,
Austria, VAT number: ATU62777178,
4. SERVICE PUBLIC FEDERAL SANTE PUBLIQUE, SECURITE DE LA CHAINE
ALIMENTAIRE ET ENVIRONNEMENT (FPS Health Be), established in SQUARE VICTOR
HORTA 40 BUR 1D 1G, BRUSSELS 1060, Belgium, VAT number: N/A,
5. INTEGRATING THE HEALTHCARE ENTERPRISE-EUROPE AISBL (IHE-EUR),
established in BOULEVARD AUGUSTE REYERS 80, BRUXELLES 1030, Belgium,
6. HL7 INTERNATIONAL FONDATION (HL7 Europe), established in SQUARE DE MEEUS
38-40, BRUSSELS 1000, Belgium,
1
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
7. STICHTING KONINKLIJK NEDERLANDS NORMALISATIE INSTITUUT (NEN),
established in VLINDERWEG 6, DELFT 2623 AX, Netherlands, VAT number: NL002814237B01,
8. HRVATSKI ZAVOD ZA ZDRAVSTVENO OSIGURANJE (HZZO), established in
MARGARETSKA 3, ZAGREB 10000, Croatia, VAT number: HR3580261,
9. UNIVERSITY OF CYPRUS (UCY), established in KALLIPOLEOS STREET 75, NICOSIA
1678, Cyprus, VAT number: CY90001673W,
10. MINISTERSTVO ZDRAVOTNICTVI CESKE REPUBLIKY (MZCR), established in
PALACKEHO NAMESTI 375/4, PRAHA 12801, Czech Republic,
11. VYSOCINA KRAJ (Kraj Vysočina), established in ZIZKOVA 57, JIHLAVA 587 33, Czech
Republic, VAT number: CZ70890749,
12. SOTSIAALMINISTEERIUM (MSAE), established in Suur-Ameerika 1, TALLINN 10122,
Estonia,
13. AGENCE DU NUMÉRIQUE EN SANTÉ (ANS), established in RUE GEORGES PITARD 9,
PARIS 75015, France,
14. MINISTERE DES AFFAIRES SOCIALES ET DE LA SANTE (MoH-FR), established in
AVENUE DUQUESNE 14, PARIS CEDEX 75350, France, VAT number: N/A,
15. DEUTSCHES INSTITUT FUR MEDIZINISCHE DOKUMENTATION UND
INFORMATION (DIMDI) (DIMDI), established in WAISENHAUSGASSE 36-38A, KOLN
50676, Germany, VAT number: DE123052538,
16. GEMATIK GMBH (GEMATIK), established in FRIEDRICHSTRASSE 136, BERLIN 10117,
Germany, VAT number: DE241843684,
17. TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE
MEDIZINISCHE FORSCHUNG EV (TMF), established in CHARLOTTENSTRASSE 42 ECKE
DOROTHEENSTRASSE, BERLIN 10117, Germany, VAT number: DE244871253,
18. MINISTRY OF HEALTH (MoHGR), established in ARISTOTELOUS STREET 17, ATHINA,
Greece,
19. ALLAMI EGESZSEGUGYI ELLATO KOZPONT (AEEK), established in DIOS AROK 3,
BUDAPEST 1125, Hungary, VAT number: HU15324683,
20. SEMMELWEIS EGYETEM (SE), established in ULLOI UTCA 26, BUDAPEST 1085,
Hungary, VAT number: HU15329808,
21. DEPARTMENT OF HEALTH (DoH), established in Block 1, Miesian Plaza, 50 – 58 Lower
Baggot Street, Dublin D02 XW14, Ireland,
22. AGENZIA PER L'ITALIA DIGITALE (AGID), established in VIA LISZT 21, ROMA 00144,
Italy,
23. AZIENDA REGIONALE PER L'INNOVAZIONEE GLI ACQUISTI S.P.A. (ARIA),
established in VIA TORQUATO TARAMELLI 26, MILANO 20124, Italy, VAT number:
IT05017630152,
2
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
24. MINISTERO DELLA SALUTE (MIN SAL), established in Via Giorgio Ribotta 5, ROMA
00144, Italy, VAT number: N/A,
25. REGIONE LOMBARDIA (REGLOMB), established in PIAZZA CITTA DI LOMBARDIA 1,
MILANO 20124, Italy, VAT number: IT12874720159,
26. NACIONALAIS VESELIBAS DIENESTS (NVD), established in 31 Cēsu str., k-3, 6.entrance,
Riga LV-1012, Latvia, VAT number: 90009649337,
27. LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (SAM), established
in VILNIAUS G 33, VILNIUS LT 01506, Lithuania,
28. STICHTING NATIONAAL ICT INSTITUUT IN DE ZORG (NICTIZ), established in Oude
Middenweg 55, Den Haag 2491AC, Netherlands,
29. NARODNE CENTRUM ZDRAVOTNICKYCH INFORMACII (NCZI), established in
LAZARETSKA 26, BRATISLAVA 811 09, Slovakia, VAT number: SK2020830119,
30. NACIONALNI INSTITUT ZA JAVNO ZDRAVJE (NIJZ), established in TRUBARJEVA
CESTA 2, LJUBLJANA 1000, Slovenia, VAT number: SI44724535,
31. FUNDACIO TICSALUT (TICSALUT), established in C ERNEST LLUCH 32 Planta 6 Porta 4
TECNOCAMPUS MATARO MARESME TORRE TCM 3, MATARO BARCELONA 08302, Spain,
VAT number: ESG64350374,
32. EQUALIS AB (Equalis AB), established in KUNGSGATAN 113, UPPSALA 751 09, Sweden,
VAT number: SE556515280701,
33. E-HALSOMYNDIGHETEN (SEHA), established in SANK ERIKSGATAN 117,
STOCKHOLM 118 60, Sweden, VAT number: SE202100655201,
34. INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
(INSERM), established in RUE DE TOLBIAC 101, PARIS 75654, France, VAT number:
FR31180036048,
Unless otherwise specified, references to ‘beneficiary’ or ‘beneficiaries’ include the coordinator.
The parties referred to above have agreed to enter into the Agreement under the terms and conditions
below.
By signing the Agreement or the Accession Form, the beneficiaries accept the grant and agree to
implement it under their own responsibility and in accordance with the Agreement, with all the
obligations and conditions it sets out.
3
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
The Agreement is composed of:
Terms and Conditions
Annex 1 Description of the action
Annex 2 Estimated budget for the action
2a Additional information on the estimated budget
Annex 3 Accession Forms
Annex 4 Model for the financial statements
Annex 5 Model for the certificate on the financial statements
Annex 6 Model for the certificate on the methodology
4
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
TERMS AND CONDITIONS
TABLE OF CONTENTS
CHAPTER 1 GENERAL..............................................................................................................................................13
ARTICLE 1 — SUBJECT OF THE AGREEMENT.......................................................................................13
CHAPTER 2 ACTION................................................................................................................................................. 13
ARTICLE 2 — ACTION TO BE IMPLEMENTED ......................................................................................13
ARTICLE 3 — DURATION AND STARTING DATE OF THE ACTION....................................................13
ARTICLE 4 — ESTIMATED BUDGET AND BUDGET TRANSFERS.......................................................13
4.1 Estimated budget................................................................................................................................ 13
4.2 Budget transfers..................................................................................................................................13
CHAPTER 3 GRANT...................................................................................................................................................13
ARTICLE 5 — GRANT AMOUNT, FORM OF GRANT, REIMBURSEMENT RATES AND FORMS OF
COSTS............................................................................................................................................13
5.1 Maximum grant amount..................................................................................................................... 13
5.2 Form of grant, reimbursement rates and forms of costs....................................................................13
5.3 Final grant amount — Calculation.....................................................................................................14
5.4 Revised final grant amount — Calculation....................................................................................... 16
ARTICLE 6 — ELIGIBLE AND INELIGIBLE COSTS................................................................................16
6.1 General conditions for costs to be eligible........................................................................................ 16
6.2 Specific conditions for costs to be eligible........................................................................................17
6.3 Conditions for costs of linked third parties to be eligible................................................................. 23
6.4 Conditions for in-kind contributions provided by third parties free of charge to be eligible............. 24
6.5 Ineligible costs....................................................................................................................................24
6.6 Consequences of declaration of ineligible costs................................................................................ 24
CHAPTER 4 RIGHTS AND OBLIGATIONS OF THE PARTIES........................................................................ 24
SECTION 1 RIGHTS AND OBLIGATIONS RELATED TO IMPLEMENTING THE ACTION................ 25
ARTICLE 7 — GENERAL OBLIGATION TO PROPERLY IMPLEMENT THE ACTION.........................25
7.1 General obligation to properly implement the action........................................................................ 25
7.2 Consequences of non-compliance...................................................................................................... 25
ARTICLE 8 — RESOURCES TO IMPLEMENT THE ACTION — THIRD PARTIES INVOLVED IN THE
ACTION.........................................................................................................................................25
ARTICLE 9 — IMPLEMENTATION OF ACTION TASKS BY BENEFICIARIES NOT RECEIVING EU
FUNDING...................................................................................................................................... 25
ARTICLE 10 — PURCHASE OF GOODS, WORKS OR SERVICES..........................................................25
5
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
10.1 Rules for purchasing goods, works or services............................................................................... 25
10.2 Consequences of non-compliance.................................................................................................... 26
ARTICLE 11 — USE OF IN-KIND CONTRIBUTIONS PROVIDED BY THIRD PARTIES AGAINST
PAYMENT..................................................................................................................................... 26
11.1 Rules for the use of in-kind contributions against payment............................................................ 26
11.2 Consequences of non-compliance.................................................................................................... 27
ARTICLE 12 — USE OF IN-KIND CONTRIBUTIONS PROVIDED BY THIRD PARTIES FREE OF
CHARGE........................................................................................................................................27
12.1 Rules for the use of in-kind contributions free of charge................................................................27
12.2 Consequences of non-compliance.................................................................................................... 27
ARTICLE 13 — IMPLEMENTATION OF ACTION TASKS BY SUBCONTRACTORS............................27
13.1 Rules for subcontracting action tasks.............................................................................................. 27
13.2 Consequences of non-compliance.................................................................................................... 28
ARTICLE 14 — IMPLEMENTATION OF ACTION TASKS BY LINKED THIRD PARTIES.................... 28
14.1 Rules for calling upon linked third parties to implement part of the action.................................... 28
14.2 Consequences of non-compliance.................................................................................................... 29
ARTICLE 14a — IMPLEMENTATION OF ACTION TASKS BY INTERNATIONAL PARTNERS........... 29
ARTICLE 15 — FINANCIAL SUPPORT TO THIRD PARTIES.................................................................. 29
15.1 Rules for providing financial support to third parties......................................................................29
15.2 Financial support in the form of prizes........................................................................................... 29
15.3 Consequences of non-compliance.................................................................................................... 29
ARTICLE 16 — PROVISION OF TRANS-NATIONAL OR VIRTUAL ACCESS TO RESEARCH
INFRASTRUCTURE.....................................................................................................................29
16.1 Rules for providing trans-national access to research infrastructure............................................... 29
16.2 Rules for providing virtual access to research infrastructure.......................................................... 30
16.3 Consequences of non-compliance.................................................................................................... 30
SECTION 2 RIGHTS AND OBLIGATIONS RELATED TO THE GRANT ADMINISTRATION.............. 30
ARTICLE 17 — GENERAL OBLIGATION TO INFORM............................................................................30
17.1 General obligation to provide information upon request.................................................................30
17.2 Obligation to keep information up to date and to inform about events and circumstances likely to
affect the Agreement........................................................................................................................30
17.3 Consequences of non-compliance.................................................................................................... 30
ARTICLE 18 — KEEPING RECORDS — SUPPORTING DOCUMENTATION.........................................30
18.1 Obligation to keep records and other supporting documentation.................................................... 31
18.2 Consequences of non-compliance.................................................................................................... 32
ARTICLE 19 — SUBMISSION OF DELIVERABLES................................................................................. 32
6
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
19.1 Obligation to submit deliverables.................................................................................................... 32
19.2 Consequences of non-compliance.................................................................................................... 32
ARTICLE 20 — REPORTING — PAYMENT REQUESTS.......................................................................... 32
20.1 Obligation to submit reports............................................................................................................ 32
20.2 Reporting periods............................................................................................................................. 32
20.3 Periodic reports — Requests for interim payments.........................................................................33
20.4 Final report — Request for payment of the balance....................................................................... 34
20.5 Information on cumulative expenditure incurred.............................................................................34
20.6 Currency for financial statements and conversion into euro........................................................... 34
20.7 Language of reports..........................................................................................................................35
20.8 Consequences of non-compliance.................................................................................................... 35
ARTICLE 21 — PAYMENTS AND PAYMENT ARRANGEMENTS...........................................................35
21.1 Payments to be made....................................................................................................................... 35
21.2 Pre-financing payment — Amount — Amount retained for the Guarantee Fund........................... 35
21.3 Interim payments — Amount — Calculation..................................................................................36
21.4 Payment of the balance — Amount — Calculation — Release of the amount retained for the
Guarantee Fund................................................................................................................................ 36
21.5 Notification of amounts due.............................................................................................................37
21.6 Currency for payments..................................................................................................................... 37
21.7 Payments to the coordinator — Distribution to the beneficiaries....................................................37
21.8 Bank account for payments..............................................................................................................38
21.9 Costs of payment transfers...............................................................................................................38
21.10 Date of payment............................................................................................................................. 38
21.11 Consequences of non-compliance.................................................................................................. 38
ARTICLE 22 — CHECKS, REVIEWS, AUDITS AND INVESTIGATIONS — EXTENSION OF
FINDINGS..................................................................................................................................... 39
22.1 Checks, reviews and audits by the Commission..............................................................................39
22.2 Investigations by the European Anti-Fraud Office (OLAF)............................................................41
22.3 Checks and audits by the European Court of Auditors (ECA)........................................................41
22.4 Checks, reviews, audits and investigations for international organisations..................................... 41
22.5 Consequences of findings in checks, reviews, audits and investigations — Extension of
findings............................................................................................................................................. 41
22.6 Consequences of non-compliance.................................................................................................... 43
ARTICLE 23 — EVALUATION OF THE IMPACT OF THE ACTION....................................................... 43
23.1 Right to evaluate the impact of the action.......................................................................................43
23.2 Consequences of non-compliance.................................................................................................... 43
7
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
SECTION 3 RIGHTS AND OBLIGATIONS RELATED TO BACKGROUND AND RESULTS................. 44
SUBSECTION 1 GENERAL............................................................................................................................ 44
ARTICLE 23a — MANAGEMENT OF INTELLECTUAL PROPERTY...................................................... 44
23a.1 Obligation to take measures to implement the Commission Recommendation on the management
of intellectual property in knowledge transfer activities................................................................. 44
23a.2 Consequences of non-compliance.................................................................................................. 44
SUBSECTION 2 RIGHTS AND OBLIGATIONS RELATED TO BACKGROUND................................ 44
ARTICLE 24 — AGREEMENT ON BACKGROUND..................................................................................44
24.1 Agreement on background............................................................................................................... 44
24.2 Consequences of non-compliance.................................................................................................... 44
ARTICLE 25 — ACCESS RIGHTS TO BACKGROUND............................................................................ 45
25.1 Exercise of access rights — Waiving of access rights — No sub-licensing....................................45
25.2 Access rights for other beneficiaries, for implementing their own tasks under the action...............45
25.3 Access rights for other beneficiaries, for exploiting their own results............................................ 45
25.4 Access rights for affiliated entities.................................................................................................. 45
25.5 Access rights for third parties.......................................................................................................... 46
25.6 Consequences of non-compliance.................................................................................................... 46
SUBSECTION 3 RIGHTS AND OBLIGATIONS RELATED TO RESULTS............................................46
ARTICLE 26 — OWNERSHIP OF RESULTS...............................................................................................46
26.1 Ownership by the beneficiary that generates the results................................................................. 46
26.2 Joint ownership by several beneficiaries......................................................................................... 46
26.3 Rights of third parties (including personnel)................................................................................... 47
26.4 EU ownership, to protect results......................................................................................................47
26.5 Consequences of non-compliance.................................................................................................... 48
ARTICLE 27 — PROTECTION OF RESULTS — VISIBILITY OF EU FUNDING................................... 48
27.1 Obligation to protect the results.......................................................................................................48
27.2 EU ownership, to protect the results................................................................................................48
27.3 Information on EU funding..............................................................................................................48
27.4 Consequences of non-compliance.................................................................................................... 49
ARTICLE 28 — EXPLOITATION OF RESULTS..........................................................................................49
28.1 Obligation to exploit the results.......................................................................................................49
28.2 Results that could contribute to European or international standards — Information on EU
funding..............................................................................................................................................49
28.3 Consequences of non-compliance.................................................................................................... 49
ARTICLE 29 — DISSEMINATION OF RESULTS — OPEN ACCESS — VISIBILITY OF EU
FUNDING...................................................................................................................................... 49
8
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
29.1 Obligation to disseminate results..................................................................................................... 49
29.2 Open access to scientific publications............................................................................................. 50
29.3 Open access to research data........................................................................................................... 51
29.4 Information on EU funding — Obligation and right to use the EU emblem ..................................51
29.5 Disclaimer excluding Commission responsibility............................................................................51
29.6 Consequences of non-compliance.................................................................................................... 51
ARTICLE 30 — TRANSFER AND LICENSING OF RESULTS.................................................................. 51
30.1 Transfer of ownership...................................................................................................................... 51
30.2 Granting licenses.............................................................................................................................. 52
30.3 Commission right to object to transfers or licensing.......................................................................52
30.4 Consequences of non-compliance.................................................................................................... 52
ARTICLE 31 — ACCESS RIGHTS TO RESULTS....................................................................................... 52
31.1 Exercise of access rights — Waiving of access rights — No sub-licensing....................................52
31.2 Access rights for other beneficiaries, for implementing their own tasks under the action...............52
31.3 Access rights for other beneficiaries, for exploiting their own results............................................ 52
31.4 Access rights of affiliated entities....................................................................................................53
31.5 Access rights for the EU institutions, bodies, offices or agencies and EU Member States..............53
31.6 Access rights for third parties.......................................................................................................... 53
31.7 Consequences of non-compliance.................................................................................................... 53
SECTION 4 OTHER RIGHTS AND OBLIGATIONS.......................................................................................53
ARTICLE 32 — RECRUITMENT AND WORKING CONDITIONS FOR RESEARCHERS..................... 53
32.1 Obligation to take measures to implement the European Charter for Researchers and Code of
Conduct for the Recruitment of Researchers...................................................................................53
32.2 Consequences of non-compliance.................................................................................................... 54
ARTICLE 33 — GENDER EQUALITY.........................................................................................................54
33.1 Obligation to aim for gender equality..............................................................................................54
33.2 Consequences of non-compliance.................................................................................................... 54
ARTICLE 34 — ETHICS AND RESEARCH INTEGRITY.......................................................................... 54
34.1 Obligation to comply with ethical and research integrity principles............................................... 54
34.2 Activities raising ethical issues........................................................................................................ 55
34.3 Activities involving human embryos or human embryonic stem cells............................................55
34.4 Consequences of non-compliance.................................................................................................... 56
ARTICLE 35 — CONFLICT OF INTERESTS.............................................................................................. 56
35.1 Obligation to avoid a conflict of interests....................................................................................... 56
35.2 Consequences of non-compliance.................................................................................................... 56
9
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
ARTICLE 36 — CONFIDENTIALITY...........................................................................................................56
36.1 General obligation to maintain confidentiality................................................................................ 56
36.2 Consequences of non-compliance.................................................................................................... 57
ARTICLE 37 — SECURITY-RELATED OBLIGATIONS............................................................................. 57
37.1 Results with a security recommendation......................................................................................... 57
37.2 Classified information...................................................................................................................... 57
37.3 Activities involving dual-use goods or dangerous materials and substances...................................58
37.4 Consequences of non-compliance.................................................................................................... 58
ARTICLE 38 — PROMOTING THE ACTION — VISIBILITY OF EU FUNDING....................................58
38.1 Communication activities by beneficiaries...................................................................................... 58
38.2 Communication activities by the Commission................................................................................ 59
38.3 Consequences of non-compliance.................................................................................................... 60
ARTICLE 39 — PROCESSING OF PERSONAL DATA...............................................................................60
39.1 Processing of personal data by the Commission............................................................................. 60
39.2 Processing of personal data by the beneficiaries............................................................................. 60
39.3 Consequences of non-compliance.................................................................................................... 61
ARTICLE 40 — ASSIGNMENTS OF CLAIMS FOR PAYMENT AGAINST THE COMMISSION........... 61
CHAPTER 5 DIVISION OF BENEFICIARIES’ ROLES AND RESPONSIBILITIES — RELATIONSHIP
WITH COMPLEMENTARY BENEFICIARIES — RELATIONSHIP WITH PARTNERS OF A
JOINT ACTION........................................................................................................................................ 61
ARTICLE 41 — DIVISION OF BENEFICIARIES’ ROLES AND RESPONSIBILITIES —
RELATIONSHIP WITH COMPLEMENTARY BENEFICIARIES — RELATIONSHIP WITH
PARTNERS OF A JOINT ACTION.............................................................................................61
41.1 Roles and responsibility towards the Commission.......................................................................... 61
41.2 Internal division of roles and responsibilities.................................................................................. 61
41.3 Internal arrangements between beneficiaries — Consortium agreement.........................................62
41.4 Relationship with complementary beneficiaries — Collaboration agreement.................................63
41.5 Relationship with partners of a joint action — Coordination agreement........................................ 63
CHAPTER 6 REJECTION OF COSTS — REDUCTION OF THE GRANT — RECOVERY — SANCTIONS
— DAMAGES — SUSPENSION — TERMINATION — FORCE MAJEURE................................ 63
SECTION 1 REJECTION OF COSTS — REDUCTION OF THE GRANT — RECOVERY —
SANCTIONS.............................................................................................................................................. 63
ARTICLE 42 — REJECTION OF INELIGIBLE COSTS.............................................................................. 63
42.1 Conditions......................................................................................................................................... 63
42.2 Ineligible costs to be rejected — Calculation — Procedure............................................................63
42.3 Effects............................................................................................................................................... 63
ARTICLE 43 — REDUCTION OF THE GRANT......................................................................................... 64
10
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
43.1 Conditions......................................................................................................................................... 64
43.2 Amount to be reduced — Calculation — Procedure.......................................................................64
43.3 Effects............................................................................................................................................... 65
ARTICLE 44 — RECOVERY OF UNDUE AMOUNTS............................................................................... 65
44.1 Amount to be recovered — Calculation — Procedure....................................................................65
ARTICLE 45 — ADMINISTRATIVE SANCTIONS..................................................................................... 69
SECTION 2 LIABILITY FOR DAMAGES.........................................................................................................69
ARTICLE 46 — LIABILITY FOR DAMAGES.............................................................................................69
46.1 Liability of the Commission............................................................................................................ 69
46.2 Liability of the beneficiaries............................................................................................................ 69
SECTION 3 SUSPENSION AND TERMINATION............................................................................................69
ARTICLE 47 — SUSPENSION OF PAYMENT DEADLINE....................................................................... 69
47.1 Conditions......................................................................................................................................... 69
47.2 Procedure.......................................................................................................................................... 70
ARTICLE 48 — SUSPENSION OF PAYMENTS.......................................................................................... 70
48.1 Conditions......................................................................................................................................... 70
48.2 Procedure.......................................................................................................................................... 71
ARTICLE 49 — SUSPENSION OF THE ACTION IMPLEMENTATION................................................... 71
49.1 Suspension of the action implementation, by the beneficiaries.......................................................71
49.2 Suspension of the action implementation, by the Commission....................................................... 72
ARTICLE 50 — TERMINATION OF THE AGREEMENT OR OF THE PARTICIPATION OF ONE OR
MORE BENEFICIARIES..............................................................................................................73
50.1 Termination of the Agreement, by the beneficiaries........................................................................73
50.2 Termination of the participation of one or more beneficiaries, by the beneficiaries........................74
50.3 Termination of the Agreement or the participation of one or more beneficiaries, by the
Commission...................................................................................................................................... 76
SECTION 4 FORCE MAJEURE.......................................................................................................................... 80
ARTICLE 51 — FORCE MAJEURE.............................................................................................................. 80
CHAPTER 7 FINAL PROVISIONS...........................................................................................................................81
ARTICLE 52 — COMMUNICATION BETWEEN THE PARTIES...............................................................81
52.1 Form and means of communication.................................................................................................81
52.2 Date of communication.................................................................................................................... 81
52.3 Addresses for communication.......................................................................................................... 82
ARTICLE 53 — INTERPRETATION OF THE AGREEMENT.....................................................................82
53.1 Precedence of the Terms and Conditions over the Annexes............................................................82
53.2 Privileges and immunities................................................................................................................ 82
11
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
ARTICLE 54 — CALCULATION OF PERIODS, DATES AND DEADLINES........................................... 82
ARTICLE 55 — AMENDMENTS TO THE AGREEMENT......................................................................... 82
55.1 Conditions......................................................................................................................................... 82
55.2 Procedure.......................................................................................................................................... 83
ARTICLE 56 — ACCESSION TO THE AGREEMENT............................................................................... 83
56.1 Accession of the beneficiaries mentioned in the Preamble............................................................. 83
56.2 Addition of new beneficiaries.......................................................................................................... 84
ARTICLE 57 — APPLICABLE LAW AND SETTLEMENT OF DISPUTES.............................................. 84
57.1 Applicable law..................................................................................................................................84
57.2 Dispute settlement............................................................................................................................ 84
ARTICLE 58 — ENTRY INTO FORCE OF THE AGREEMENT................................................................ 84
12
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
CHAPTER 1 GENERAL
ARTICLE 1 — SUBJECT OF THE AGREEMENT
This Agreement sets out the rights and obligations and the terms and conditions applicable to the grant
awarded to the beneficiaries for implementing the action set out in Chapter 2.
CHAPTER 2 ACTION
ARTICLE 2 — ACTION TO BE IMPLEMENTED
The grant is awarded for the action entitled ‘X-eHealth: eXchanging electronic Health Records in
a commom framework’ — ‘X-eHealth’ (‘action’), as described in Annex 1.
ARTICLE 3 — DURATION AND STARTING DATE OF THE ACTION
The duration of the action will be 24 months as of 1 September 2020 (‘starting date of the action’).
ARTICLE 4 — ESTIMATED BUDGET AND BUDGET TRANSFERS
4.1 Estimated budget
The ‘estimated budget’ for the action is set out in Annex 2.
It contains the estimated eligible costs and the forms of costs, broken down by beneficiary (and linked
third party) and budget category (see Articles 5, 6, and 14).
4.2 Budget transfers
The estimated budget breakdown indicated in Annex 2 may be adjusted — without an amendment
(see Article 55) — by transfers of amounts between beneficiaries, budget categories and/or forms of
costs set out in Annex 2, if the action is implemented as described in Annex 1.
However, the beneficiaries may not add costs relating to subcontracts not provided for in Annex 1,
unless such additional subcontracts are approved by an amendment or in accordance with Article 13.
CHAPTER 3 GRANT
ARTICLE 5 — GRANT AMOUNT, FORM OF GRANT, REIMBURSEMENT RATES AND
FORMS OF COSTS
5.1 Maximum grant amount
The ‘maximum grant amount’ is EUR 2 999 980.00 (two million nine hundred and ninety nine
thousand nine hundred and eighty EURO).
5.2 Form of grant, reimbursement rates and forms of costs
13
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
The grant reimburses 100% of the action's eligible costs (see Article 6) (‘reimbursement of eligible
costs grant’) (see Annex 2).
The estimated eligible costs of the action are EUR 2 999 980.00 (two million nine hundred and ninety
nine thousand nine hundred and eighty EURO).
Eligible costs (see Article 6) must be declared under the following forms ('forms of costs'):
(a) for direct personnel costs:
- as actually incurred costs (‘actual costs’) or
- on the basis of an amount per unit calculated by the beneficiary in accordance with its
usual cost accounting practices (‘unit costs’).
Personnel costs for SME owners or beneficiaries that are natural persons not receiving a
salary (see Article 6.2, Points A.4 and A.5) must be declared on the basis of the amount per
unit set out in Annex 2a (unit costs);
(b) for direct costs for subcontracting: as actually incurred costs (actual costs);
(c) for direct costs of providing financial support to third parties: not applicable;
(d) for other direct costs:
- for costs of internally invoiced goods and services: on the basis of an amount per unit
calculated by the beneficiary in accordance with its usual cost accounting practices (‘unit
costs’);
- for all other costs: as actually incurred costs (actual costs);
(e) for indirect costs: on the basis of a flat-rate applied as set out in Article 6.2, Point E (‘flat-rate
costs’);
(f) specific cost category(ies): not applicable.
5.3 Final grant amount — Calculation
The ‘final grant amount’ depends on the actual extent to which the action is implemented in
accordance with the Agreement’s terms and conditions.
This amount is calculated by the Commission — when the payment of the balance is made (see
Article 21.4) — in the following steps:
Step 1 — Application of the reimbursement rates to the eligible costs
Step 2 — Limit to the maximum grant amount
Step 3 — Reduction due to the no-profit rule
Step 4 — Reduction due to substantial errors, irregularities or fraud or serious breach of
obligations
14
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
5.3.1 Step 1 — Application of the reimbursement rates to the eligible costs
The reimbursement rate(s) (see Article 5.2) are applied to the eligible costs (actual costs, unit costs
and flat-rate costs; see Article 6) declared by the beneficiaries and linked third parties (see Article 20)
and approved by the Commission (see Article 21).
5.3.2 Step 2 — Limit to the maximum grant amount
If the amount obtained following Step 1 is higher than the maximum grant amount set out in
Article 5.1, it will be limited to the latter.
5.3.3 Step 3 — Reduction due to the no-profit rule
The grant must not produce a profit.
‘Profit’ means the surplus of the amount obtained following Steps 1 and 2 plus the action’s total
receipts, over the action’s total eligible costs.
The ‘action’s total eligible costs’ are the consolidated total eligible costs approved by the
Commission.
The ‘action’s total receipts’ are the consolidated total receipts generated during its duration (see
Article 3).
The following are considered receipts:
(a) income generated by the action; if the income is generated from selling equipment or other
assets purchased under the Agreement, the receipt is up to the amount declared as eligible under
the Agreement;
(b) financial contributions given by third parties to the beneficiary or to a linked third party
specifically to be used for the action, and
(c) in-kind contributions provided by third parties free of charge and specifically to be used for the
action, if they have been declared as eligible costs.
The following are however not considered receipts:
(a) income generated by exploiting the action’s results (see Article 28);
(b) financial contributions by third parties, if they may be used to cover costs other than the eligible
costs (see Article 6);
(c) financial contributions by third parties with no obligation to repay any amount unused at the
end of the period set out in Article 3.
If there is a profit, it will be deducted from the amount obtained following Steps 1 and 2.
5.3.4 Step 4 — Reduction due to substantial errors, irregularities or fraud or serious breach
of obligations — Reduced grant amount — Calculation
If the grant is reduced (see Article 43), the Commission will calculate the reduced grant amount
by deducting the amount of the reduction (calculated in proportion to the seriousness of the errors,
15
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
irregularities or fraud or breach of obligations, in accordance with Article 43.2) from the maximum
grant amount set out in Article 5.1.
The final grant amount will be the lower of the following two:
- the amount obtained following Steps 1 to 3 or
- the reduced grant amount following Step 4.
5.4 Revised final grant amount — Calculation
If — after the payment of the balance (in particular, after checks, reviews, audits or investigations;
see Article 22) — the Commission rejects costs (see Article 42) or reduces the grant (see Article 43),
it will calculate the ‘revised final grant amount’ for the beneficiary concerned by the findings.
This amount is calculated by the Commission on the basis of the findings, as follows:
- in case of rejection of costs: by applying the reimbursement rate to the revised eligible costs
approved by the Commission for the beneficiary concerned;
- in case of reduction of the grant: by calculating the concerned beneficiary’s share in the grant
amount reduced in proportion to the seriousness of the errors, irregularities or fraud or breach
of obligations (see Article 43.2).
In case of rejection of costs and reduction of the grant, the revised final grant amount for the
beneficiary concerned will be the lower of the two amounts above.
ARTICLE 6 — ELIGIBLE AND INELIGIBLE COSTS
6.1 General conditions for costs to be eligible
‘Eligible costs’ are costs that meet the following criteria:
(a) for actual costs:
(i) they must be actually incurred by the beneficiary;
(ii) they must be incurred in the period set out in Article 3, with the exception of costs relating
to the submission of the periodic report for the last reporting period and the final report
(see Article 20);
(iii) they must be indicated in the estimated budget set out in Annex 2;
(iv) they must be incurred in connection with the action as described in Annex 1 and necessary
for its implementation;
(v) they must be identifiable and verifiable, in particular recorded in the beneficiary’s accounts
in accordance with the accounting standards applicable in the country where the beneficiary
is established and with the beneficiary’s usual cost accounting practices;
(vi) they must comply with the applicable national law on taxes, labour and social security, and
16
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
(vii) they must be reasonable, justified and must comply with the principle of sound financial
management, in particular regarding economy and efficiency;
(b) for unit costs:
(i) they must be calculated as follows:
{amounts per unit set out in Annex 2a or calculated by the beneficiary in accordance with its usual
cost accounting practices (see Article 6.2, Point A and Article 6.2.D.5)
multiplied by
the number of actual units};
(ii) the number of actual units must comply with the following conditions:
- the units must be actually used or produced in the period set out in Article 3;
- the units must be necessary for implementing the action or produced by it, and
- the number of units must be identifiable and verifiable, in particular supported by
records and documentation (see Article 18);
(c) for flat-rate costs:
(i) they must be calculated by applying the flat-rate set out in Annex 2, and
(ii) the costs (actual costs or unit costs) to which the flat-rate is applied must comply with the
conditions for eligibility set out in this Article.
6.2 Specific conditions for costs to be eligible
Costs are eligible if they comply with the general conditions (see above) and the specific conditions
set out below for each of the following budget categories:
A. direct personnel costs;
B. direct costs of subcontracting;
C. not applicable;
D. other direct costs;
E. indirect costs;
F. not applicable.
‘Direct costs’ are costs that are directly linked to the action implementation and can therefore be
attributed to it directly. They must not include any indirect costs (see Point E below).
‘Indirect costs’ are costs that are not directly linked to the action implementation and therefore cannot
be attributed directly to it.
A. Direct personnel costs
Types of eligible personnel costs
17
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
A.1 Personnel costs are eligible, if they are related to personnel working for the beneficiary under an
employment contract (or equivalent appointing act) and assigned to the action (‘costs for employees
(or equivalent)’). They must be limited to salaries (including during parental leave), social security
contributions, taxes and other costs included in the remuneration, if they arise from national law or
the employment contract (or equivalent appointing act).
Beneficiaries that are non-profit legal entities1 may also declare as personnel costs additional
remuneration for personnel assigned to the action (including payments on the basis of supplementary
contracts regardless of their nature), if:
(a) it is part of the beneficiary’s usual remuneration practices and is paid in a consistent manner
whenever the same kind of work or expertise is required;
(b) the criteria used to calculate the supplementary payments are objective and generally applied
by the beneficiary, regardless of the source of funding used.
‘Additional remuneration’ means any part of the remuneration which exceeds what the person would
be paid for time worked in projects funded by national schemes.
Additional remuneration for personnel assigned to the action is eligible up to the following amount:
(a) if the person works full time and exclusively on the action during the full year: up to EUR 8 000;
(b) if the person works exclusively on the action but not full-time or not for the full year: up to the
corresponding pro-rata amount of EUR 8 000, or
(c) if the person does not work exclusively on the action: up to a pro-rata amount calculated as
follows:
{{EUR 8 000
divided by
the number of annual productive hours (see below)},
multiplied by
the number of hours that the person has worked on the action during the year}.
A.2 The costs for natural persons working under a direct contract with the beneficiary other than
an employment contract are eligible personnel costs, if:
(a) the person works under conditions similar to those of an employee (in particular regarding
the way the work is organised, the tasks that are performed and the premises where they are
performed);
(b) the result of the work carried out belongs to the beneficiary (unless exceptionally agreed
otherwise), and
1 For the definition, see Article 2.1(14) of the Rules for Participation Regulation No 1290/2013: ‘non-profit legal entity’
means a legal entity which by its legal form is non-profit-making or which has a legal or statutory obligation not to
distribute profits to its shareholders or individual members.
18
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
(c) the costs are not significantly different from those for personnel performing similar tasks under
an employment contract with the beneficiary.
A.3 The costs of personnel seconded by a third party against payment are eligible personnel costs,
if the conditions in Article 11.1 are met.
A.4 Costs of owners of beneficiaries that are small and medium-sized enterprises (‘SME owners’)
who are working on the action and who do not receive a salary are eligible personnel costs, if they
correspond to the amount per unit set out in Annex 2a multiplied by the number of actual hours worked
on the action.
A.5 Costs of ‘beneficiaries that are natural persons’ not receiving a salary are eligible personnel
costs, if they correspond to the amount per unit set out in Annex 2a multiplied by the number of actual
hours worked on the action.
Calculation
Personnel costs must be calculated by the beneficiaries as follows:
{{hourly rate
multiplied by
the number of actual hours worked on the action},
plus
for non-profit legal entities: additional remuneration to personnel assigned to the action under the
conditions set out above (Point A.1)}.
The number of actual hours declared for a person must be identifiable and verifiable (see Article 18).
The total number of hours declared in EU or Euratom grants, for a person for a year, cannot be higher
than the annual productive hours used for the calculations of the hourly rate. Therefore, the maximum
number of hours that can be declared for the grant are:
{number of annual productive hours for the year (see below)
minus
total number of hours declared by the beneficiary, for that person in that year, for other EU or Euratom
grants}.
The ‘hourly rate’ is one of the following:
(a) for personnel costs declared as actual costs (i.e. budget categories A.1, A.2, A.3): the hourly rate
is calculated per full financial year, as follows:
{actual annual personnel costs (excluding additional remuneration) for the person
divided by
number of annual productive hours}.
using the personnel costs and the number of productive hours for each full financial year
covered by the reporting period concerned. If a financial year is not closed at the end of the
19
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
reporting period, the beneficiaries must use the hourly rate of the last closed financial year
available.
For the ‘number of annual productive hours’, the beneficiaries may choose one of the following:
(i) ‘fixed number of hours’: 1 720 hours for persons working full time (or corresponding
pro-rata for persons not working full time);
(ii) ‘individual annual productive hours’: the total number of hours worked by the person in
the year for the beneficiary, calculated as follows:
{annual workable hours of the person (according to the employment contract, applicable
collective labour agreement or national law)
plus
overtime worked
minus
absences (such as sick leave and special leave)}.
‘Annual workable hours’ means the period during which the personnel must be
working, at the employer’s disposal and carrying out his/her activity or duties under the
employment contract, applicable collective labour agreement or national working time
legislation.
If the contract (or applicable collective labour agreement or national working time
legislation) does not allow to determine the annual workable hours, this option cannot
be used;
(iii) ‘standard annual productive hours’: the ‘standard number of annual hours’ generally
applied by the beneficiary for its personnel in accordance with its usual cost accounting
practices. This number must be at least 90% of the ‘standard annual workable hours’.
If there is no applicable reference for the standard annual workable hours, this option
cannot be used.
For all options, the actual time spent on parental leave by a person assigned to the action
may be deducted from the number of annual productive hours.
As an alternative, beneficiaries may calculate the hourly rate per month, as follows:
{actual monthly personnel cost (excluding additional remuneration) for the person
divided by
{number of annual productive hours / 12}}
using the personnel costs for each month and (one twelfth of) the annual productive hours
calculated according to either option (i) or (iii) above, i.e.:
- fixed number of hours or
- standard annual productive hours.
20
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
Time spent on parental leave may not be deducted when calculating the hourly rate per month.
However, beneficiaries may declare personnel costs incurred in periods of parental leave in
proportion to the time the person worked on the action in that financial year.
If parts of a basic remuneration are generated over a period longer than a month, the
beneficiaries may include only the share which is generated in the month (irrespective of the
amount actually paid for that month).
Each beneficiary must use only one option (per full financial year or per month) for each full
financial year;
(b) for personnel costs declared on the basis of unit costs (i.e. budget categories A.1, A.2, A.4, A.5):
the hourly rate is one of the following:
(i) for SME owners or beneficiaries that are natural persons: the hourly rate set out in Annex 2a
(see Points A.4 and A.5 above), or
(ii) for personnel costs declared on the basis of the beneficiary’s usual cost accounting practices:
the hourly rate calculated by the beneficiary in accordance with its usual cost accounting
practices, if:
- the cost accounting practices used are applied in a consistent manner, based on objective
criteria, regardless of the source of funding;
- the hourly rate is calculated using the actual personnel costs recorded in the beneficiary’s
accounts, excluding any ineligible cost or costs included in other budget categories.
The actual personnel costs may be adjusted by the beneficiary on the basis of budgeted
or estimated elements. Those elements must be relevant for calculating the personnel
costs, reasonable and correspond to objective and verifiable information;
and
- the hourly rate is calculated using the number of annual productive hours (see above).
B. Direct costs of subcontracting (including related duties, taxes and charges such as non-
deductible value added tax (VAT) paid by the beneficiary) are eligible if the conditions in Article 13.1.1
are met.
C. Direct costs of providing financial support to third parties
Not applicable
D. Other direct costs
D.1 Travel costs and related subsistence allowances (including related duties, taxes and charges
such as non-deductible value added tax (VAT) paid by the beneficiary) are eligible if they are in line
with the beneficiary’s usual practices on travel.
D.2 The depreciation costs of equipment, infrastructure or other assets (new or second-hand)
as recorded in the beneficiary’s accounts are eligible, if they were purchased in accordance with
21
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
Article 10.1.1 and written off in accordance with international accounting standards and the
beneficiary’s usual accounting practices.
The costs of renting or leasing equipment, infrastructure or other assets (including related duties,
taxes and charges such as non-deductible value added tax (VAT) paid by the beneficiary) are also
eligible, if they do not exceed the depreciation costs of similar equipment, infrastructure or assets and
do not include any financing fees.
The costs of equipment, infrastructure or other assets contributed in-kind against payment are
eligible, if they do not exceed the depreciation costs of similar equipment, infrastructure or assets, do
not include any financing fees and if the conditions in Article 11.1 are met.
The only portion of the costs that will be taken into account is that which corresponds to the duration
of the action and rate of actual use for the purposes of the action.
D.3 Costs of other goods and services (including related duties, taxes and charges such as
non-deductible value added tax (VAT) paid by the beneficiary) are eligible, if they are:
(a) purchased specifically for the action and in accordance with Article 10.1.1 or
(b) contributed in kind against payment and in accordance with Article 11.1.
Such goods and services include, for instance, consumables and supplies, dissemination (including
open access), protection of results, certificates on the financial statements (if they are required by the
Agreement), certificates on the methodology, translations and publications.
D.4 Capitalised and operating costs of ‘large research infrastructure’2 directly used for the action
are eligible, if:
(a) the value of the large research infrastructure represents at least 75% of the total fixed assets (at
historical value in its last closed balance sheet before the date of the signature of the Agreement
or as determined on the basis of the rental and leasing costs of the research infrastructure3);
(b) the beneficiary’s methodology for declaring the costs for large research infrastructure has been
positively assessed by the Commission (‘ex-ante assessment’);
(c) the beneficiary declares as direct eligible costs only the portion which corresponds to the
duration of the action and the rate of actual use for the purposes of the action, and
(d) they comply with the conditions as further detailed in the annotations to the H2020 grant
agreements.
2 ‘Large research infrastructure’ means research infrastructure of a total value of at least EUR 20 million, for a
beneficiary, calculated as the sum of historical asset values of each individual research infrastructure of that beneficiary,
as they appear in its last closed balance sheet before the date of the signature of the Agreement or as determined on the
basis of the rental and leasing costs of the research infrastructure.
3 For the definition, see Article 2(6) of the H2020 Framework Programme Regulation No 1291/2013: ‘Research
infrastructure’ are facilities, resources and services that are used by the research communities to conduct research and
foster innovation in their fields. Where relevant, they may be used beyond research, e.g. for education or public services.
They include: major scientific equipment (or sets of instruments); knowledge-based resources such as collections,
archives or scientific data; e-infrastructures such as data and computing systems and communication networks; and any
other infrastructure of a unique nature essential to achieve excellence in research and innovation. Such infrastructures
may be ‘single-sited’, ‘virtual’ or ‘distributed’.
22
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
D.5 Costs of internally invoiced goods and services directly used for the action are eligible, if:
(a) they are declared on the basis of a unit cost calculated in accordance with the beneficiary’s
usual cost accounting practices;
(b) the cost accounting practices used are applied in a consistent manner, based on objective
criteria, regardless of the source of funding;
(c) the unit cost is calculated using the actual costs for the good or service recorded in the
beneficiary’s accounts, excluding any ineligible cost or costs included in other budget
categories.
The actual costs may be adjusted by the beneficiary on the basis of budgeted or estimated
elements. Those elements must be relevant for calculating the costs, reasonable and correspond
to objective and verifiable information;
(d) the unit cost excludes any costs of items which are not directly linked to the production of the
invoiced goods or service.
‘Internally invoiced goods and services’ means goods or services which are provided by the
beneficiary directly for the action and which the beneficiary values on the basis of its usual cost
accounting practices.
E. Indirect costs
Indirect costs are eligible if they are declared on the basis of the flat-rate of 25% of the eligible direct
costs (see Article 5.2 and Points A to D above), from which are excluded:
(a) costs of subcontracting and
(b) costs of in-kind contributions provided by third parties which are not used on the beneficiary’s
premises;
(c) not applicable;
(d) not applicable.
Beneficiaries receiving an operating grant4 financed by the EU or Euratom budget cannot declare
indirect costs for the period covered by the operating grant, unless they can demonstrate that the
operating grant does not cover any costs of the action.
F. Specific cost category(ies)
Not applicable
6.3 Conditions for costs of linked third parties to be eligible
4 For the definition, see Article 121(1)(b) of Regulation (EU, Euratom) No 966/2012 of the European Parliament and
of the Council of 25 October 2012 on the financial rules applicable to the general budget of the Union and repealing
Council Regulation (EC, Euratom) No 1605/2002 (‘Financial Regulation No 966/2012’)(OJ L 218, 26.10.2012, p.1):
‘operating grant’ means direct financial contribution, by way of donation, from the budget in order to finance the
functioning of a body which pursues an aim of general EU interest or has an objective forming part of and supporting
an EU policy.
23
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
Costs incurred by linked third parties are eligible if they fulfil — mutatis mutandis — the general
and specific conditions for eligibility set out in this Article (Article 6.1 and 6.2) and Article 14.1.1.
6.4 Conditions for in-kind contributions provided by third parties free of charge to be
eligible
In-kind contributions provided free of charge are eligible direct costs (for the beneficiary or linked
third party), if the costs incurred by the third party fulfil — mutatis mutandis — the general and
specific conditions for eligibility set out in this Article (Article 6.1 and 6.2) and Article 12.1.
6.5 Ineligible costs
‘Ineligible costs’ are:
(a) costs that do not comply with the conditions set out above (Article 6.1 to 6.4), in particular:
(i) costs related to return on capital;
(ii) debt and debt service charges;
(iii) provisions for future losses or debts;
(iv) interest owed;
(v) doubtful debts;
(vi) currency exchange losses;
(vii) bank costs charged by the beneficiary’s bank for transfers from the Commission;
(viii) excessive or reckless expenditure;
(ix) deductible VAT;
(x) costs incurred during suspension of the implementation of the action (see Article 49);
(b) costs declared under another EU or Euratom grant (including grants awarded by a Member
State and financed by the EU or Euratom budget and grants awarded by bodies other than the
Commission for the purpose of implementing the EU or Euratom budget); in particular, indirect
costs if the beneficiary is already receiving an operating grant financed by the EU or Euratom
budget in the same period, unless it can demonstrate that the operating grant does not cover
any costs of the action.
6.6 Consequences of declaration of ineligible costs
Declared costs that are ineligible will be rejected (see Article 42).
This may also lead to any of the other measures described in Chapter 6.
CHAPTER 4 RIGHTS AND OBLIGATIONS OF THE PARTIES
24
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
SECTION 1 RIGHTS AND OBLIGATIONS RELATED TO IMPLEMENTING THE
ACTION
ARTICLE 7 — GENERAL OBLIGATION TO PROPERLY IMPLEMENT THE ACTION
7.1 General obligation to properly implement the action
The beneficiaries must implement the action as described in Annex 1 and in compliance with the
provisions of the Agreement and all legal obligations under applicable EU, international and national
law.
7.2 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 43).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 8 — RESOURCES TO IMPLEMENT THE ACTION — THIRD PARTIES
INVOLVED IN THE ACTION
The beneficiaries must have the appropriate resources to implement the action.
If it is necessary to implement the action, the beneficiaries may:
- purchase goods, works and services (see Article 10);
- use in-kind contributions provided by third parties against payment (see Article 11);
- use in-kind contributions provided by third parties free of charge (see Article 12);
- call upon subcontractors to implement action tasks described in Annex 1 (see Article 13);
- call upon linked third parties to implement action tasks described in Annex 1 (see Article 14);
- call upon international partners to implement action tasks described in Annex 1 (see
Article 14a).
In these cases, the beneficiaries retain sole responsibility towards the Commission and the other
beneficiaries for implementing the action.
ARTICLE 9 — IMPLEMENTATION OF ACTION TASKS BY BENEFICIARIES NOT
RECEIVING EU FUNDING
Not applicable
ARTICLE 10 — PURCHASE OF GOODS, WORKS OR SERVICES
10.1 Rules for purchasing goods, works or services
10.1.1 If necessary to implement the action, the beneficiaries may purchase goods, works or services.
25
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
The beneficiaries must make such purchases ensuring the best value for money or, if appropriate, the
lowest price. In doing so, they must avoid any conflict of interests (see Article 35).
The beneficiaries must ensure that the Commission, the European Court of Auditors (ECA) and the
European Anti-Fraud Office (OLAF) can exercise their rights under Articles 22 and 23 also towards
their contractors.
10.1.2 Beneficiaries that are ‘contracting authorities’ within the meaning of Directive 2004/18/EC5 (or
2014/24/EU6) or ‘contracting entities’ within the meaning of Directive 2004/17/EC7 (or 2014/25/EU8)
must comply with the applicable national law on public procurement.
10.2 Consequences of non-compliance
If a beneficiary breaches any of its obligations under Article 10.1.1, the costs related to the contract
concerned will be ineligible (see Article 6) and will be rejected (see Article 42).
If a beneficiary breaches any of its obligations under Article 10.1.2, the grant may be reduced (see
Article 43).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 11 — USE OF IN-KIND CONTRIBUTIONS PROVIDED BY THIRD PARTIES
AGAINST PAYMENT
11.1 Rules for the use of in-kind contributions against payment
If necessary to implement the action, the beneficiaries may use in-kind contributions provided by third
parties against payment.
The beneficiaries may declare costs related to the payment of in-kind contributions as eligible (see
Article 6.1 and 6.2), up to the third parties’ costs for the seconded persons, contributed equipment,
infrastructure or other assets or other contributed goods and services.
The third parties and their contributions must be set out in Annex 1. The Commission may however
approve in-kind contributions not set out in Annex 1 without amendment (see Article 55), if:
- they are specifically justified in the periodic technical report and
- their use does not entail changes to the Agreement which would call into question the decision
awarding the grant or breach the principle of equal treatment of applicants.
The beneficiaries must ensure that the Commission, the European Court of Auditors (ECA) and the
5 Directive 2004/18/EC of the European Parliament and of the Council of 31 March 2004 on the coordination of
procedures for the award of public work contracts, public supply contracts and public service contracts (OJ L 134,
30.04.2004, p. 114).
6 Directive 2014/24/EU of the European Parliament and of the Council of 26 February 2014 on public procurement and
repealing Directive 2004/18/EC. (OJ L 94, 28.03.2014, p. 65).
7 Directive 2004/17/EC of the European Parliament and of the Council of 31 March 2004 coordinating the procurement
procedures of entities operating in the water, energy, transport and postal services sectors (OJ L 134, 30.04.2004, p. 1)
8 Directive 2014/25/EU of the European Parliament and of the Council of 26 February 2014 on procurement by entities
operating in the water, energy, transport and postal services sectors and repealing Directive 2004/17/EC (OJ L 94,
28.03.2014, p. 243).
26
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
European Anti-Fraud Office (OLAF) can exercise their rights under Articles 22 and 23 also towards
the third parties.
11.2 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the costs related to the payment of
the in-kind contribution will be ineligible (see Article 6) and will be rejected (see Article 42).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 12 — USE OF IN-KIND CONTRIBUTIONS PROVIDED BY THIRD PARTIES
FREE OF CHARGE
12.1 Rules for the use of in-kind contributions free of charge
If necessary to implement the action, the beneficiaries may use in-kind contributions provided by third
parties free of charge.
The beneficiaries may declare costs incurred by the third parties for the seconded persons, contributed
equipment, infrastructure or other assets or other contributed goods and services as eligible in
accordance with Article 6.4.
The third parties and their contributions must be set out in Annex 1. The Commission may however
approve in-kind contributions not set out in Annex 1 without amendment (see Article 55), if:
- they are specifically justified in the periodic technical report and
- their use does not entail changes to the Agreement which would call into question the decision
awarding the grant or breach the principle of equal treatment of applicants.
The beneficiaries must ensure that the Commission, the European Court of Auditors (ECA) and the
European Anti-Fraud Office (OLAF) can exercise their rights under Articles 22 and 23 also towards
the third parties.
12.2 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the costs incurred by the third parties
related to the in-kind contribution will be ineligible (see Article 6) and will be rejected (see Article 42).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 13 — IMPLEMENTATION OF ACTION TASKS BY SUBCONTRACTORS
13.1 Rules for subcontracting action tasks
13.1.1 If necessary to implement the action, the beneficiaries may award subcontracts covering the
implementation of certain action tasks described in Annex 1.
Subcontracting may cover only a limited part of the action.
The beneficiaries must award the subcontracts ensuring the best value for money or, if appropriate,
the lowest price. In doing so, they must avoid any conflict of interests (see Article 35).
27
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
The tasks to be implemented and the estimated cost for each subcontract must be set out in Annex 1 and
the total estimated costs of subcontracting per beneficiary must be set out in Annex 2. The Commission
may however approve subcontracts not set out in Annex 1 and 2 without amendment (see Article 55),
if:
- they are specifically justified in the periodic technical report and
- they do not entail changes to the Agreement which would call into question the decision
awarding the grant or breach the principle of equal treatment of applicants.
The beneficiaries must ensure that the Commission, the European Court of Auditors (ECA) and the
European Anti-Fraud Office (OLAF) can exercise their rights under Articles 22 and 23 also towards
their subcontractors.
13.1.2 The beneficiaries must ensure that their obligations under Articles 35, 36, 38 and 46 also apply
to the subcontractors.
Beneficiaries that are ‘contracting authorities’ within the meaning of Directive 2004/18/EC (or
2014/24/EU) or ‘contracting entities’ within the meaning of Directive 2004/17/EC (or 2014/25/EU)
must comply with the applicable national law on public procurement.
13.2 Consequences of non-compliance
If a beneficiary breaches any of its obligations under Article 13.1.1, the costs related to the subcontract
concerned will be ineligible (see Article 6) and will be rejected (see Article 42).
If a beneficiary breaches any of its obligations under Article 13.1.2, the grant may be reduced (see
Article 43).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 14 — IMPLEMENTATION OF ACTION TASKS BY LINKED THIRD PARTIES
14.1 Rules for calling upon linked third parties to implement part of the action
14.1.1 The following affiliated entities10 and third parties with a legal link to a beneficiary11
(‘linked third parties’) may implement the action tasks attributed to them in Annex 1:
10 For the definition see Article 2.1(2) Rules for Participation Regulation No 1290/2013: ‘affiliated entity’ means any
legal entity that is:
- under the direct or indirect control of a participant, or
- under the same direct or indirect control as the participant, or
- directly or indirectly controlling a participant.
‘Control’ may take any of the following forms:
(a) the direct or indirect holding of more than 50% of the nominal value of the issued share capital in the legal entity
concerned, or of a majority of the voting rights of the shareholders or associates of that entity;
(b) the direct or indirect holding, in fact or in law, of decision-making powers in the legal entity concerned.
However the following relationships between legal entities shall not in themselves be deemed to constitute controlling
relationships:
(a) the same public investment corporation, institutional investor or venture-capital company has a direct or indirect
holding of more than 50% of the nominal value of the issued share capital or a majority of voting rights of the
shareholders or associates;
(b) the legal entities concerned are owned or supervised by the same public body.
28
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
- FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI (INT), affiliated or linked to
REGLOMB
The linked third parties may declare as eligible the costs they incur for implementing the action tasks
in accordance with Article 6.3.
The beneficiaries must ensure that the Commission, the European Court of Auditors (ECA) and the
European Anti-Fraud Office (OLAF) can exercise their rights under Articles 22 and 23 also towards
their linked third parties.
14.1.2 The beneficiaries must ensure that their obligations under Articles 18, 20, 35, 36 and 38 also
apply to their linked third parties.
14.2 Consequences of non-compliance
If any obligation under Article 14.1.1 is breached, the costs of the linked third party will be ineligible
(see Article 6) and will be rejected (see Article 42).
If any obligation under Article 14.1.2 is breached, the grant may be reduced (see Article 43).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 14a — IMPLEMENTATION OF ACTION TASKS BY INTERNATIONAL
PARTNERS
Not applicable
ARTICLE 15 — FINANCIAL SUPPORT TO THIRD PARTIES
15.1 Rules for providing financial support to third parties
Not applicable
15.2 Financial support in the form of prizes
Not applicable
15.3 Consequences of non-compliance
Not applicable
ARTICLE 16 — PROVISION OF TRANS-NATIONAL OR VIRTUAL ACCESS TO
RESEARCH INFRASTRUCTURE
16.1 Rules for providing trans-national access to research infrastructure
Not applicable
11 ‘Third party with a legal link to a beneficiary’ is any legal entity which has a legal link to the beneficiary implying
collaboration that is not limited to the action.
29
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
16.2 Rules for providing virtual access to research infrastructure
Not applicable
16.3 Consequences of non-compliance
Not applicable
SECTION 2 RIGHTS AND OBLIGATIONS RELATED TO THE GRANT
ADMINISTRATION
ARTICLE 17 — GENERAL OBLIGATION TO INFORM
17.1 General obligation to provide information upon request
The beneficiaries must provide — during implementation of the action or afterwards and in accordance
with Article 41.2 — any information requested in order to verify eligibility of the costs, proper
implementation of the action and compliance with any other obligation under the Agreement.
17.2 Obligation to keep information up to date and to inform about events and
circumstances likely to affect the Agreement
Each beneficiary must keep information stored in the Participant Portal Beneficiary Register (via
the electronic exchange system; see Article 52) up to date, in particular, its name, address, legal
representatives, legal form and organisation type.
Each beneficiary must immediately inform the coordinator — which must immediately inform the
Commission and the other beneficiaries — of any of the following:
(a) events which are likely to affect significantly or delay the implementation of the action or the
EU's financial interests, in particular:
(i) changes in its legal, financial, technical, organisational or ownership situation or those
of its linked third parties and
(ii) changes in the name, address, legal form, organisation type of its linked third parties;
(b) circumstances affecting:
(i) the decision to award the grant or
(ii) compliance with requirements under the Agreement.
17.3 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 43).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 18 — KEEPING RECORDS — SUPPORTING DOCUMENTATION
30
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
18.1 Obligation to keep records and other supporting documentation
The beneficiaries must — for a period of five years after the payment of the balance — keep records
and other supporting documentation in order to prove the proper implementation of the action and
the costs they declare as eligible.
They must make them available upon request (see Article 17) or in the context of checks, reviews,
audits or investigations (see Article 22).
If there are on-going checks, reviews, audits, investigations, litigation or other pursuits of claims under
the Agreement (including the extension of findings; see Article 22), the beneficiaries must keep the
records and other supporting documentation until the end of these procedures.
The beneficiaries must keep the original documents. Digital and digitalised documents are considered
originals if they are authorised by the applicable national law. The Commission may accept non-
original documents if it considers that they offer a comparable level of assurance.
18.1.1 Records and other supporting documentation on the scientific and technical
implementation
The beneficiaries must keep records and other supporting documentation on scientific and technical
implementation of the action in line with the accepted standards in the respective field.
18.1.2 Records and other documentation to support the costs declared
The beneficiaries must keep the records and documentation supporting the costs declared, in particular
the following:
(a) for actual costs: adequate records and other supporting documentation to prove the costs
declared, such as contracts, subcontracts, invoices and accounting records. In addition, the
beneficiaries' usual cost accounting practices and internal control procedures must enable direct
reconciliation between the amounts declared, the amounts recorded in their accounts and the
amounts stated in the supporting documentation;
(b) for unit costs: adequate records and other supporting documentation to prove the number of
units declared. Beneficiaries do not need to identify the actual eligible costs covered or to keep
or provide supporting documentation (such as accounting statements) to prove the amount per
unit.
In addition, for unit costs calculated in accordance with the beneficiary's usual cost
accounting practices, the beneficiaries must keep adequate records and documentation to
prove that the cost accounting practices used comply with the conditions set out in Article 6.2.
The beneficiaries and linked third parties may submit to the Commission, for approval, a
certificate (drawn up in accordance with Annex 6) stating that their usual cost accounting
practices comply with these conditions (‘certificate on the methodology’). If the certificate
is approved, costs declared in line with this methodology will not be challenged subsequently,
unless the beneficiaries have concealed information for the purpose of the approval.
(c) for flat-rate costs: adequate records and other supporting documentation to prove the eligibility
of the costs to which the flat-rate is applied. The beneficiaries do not need to identify the costs
31
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
covered or provide supporting documentation (such as accounting statements) to prove the
amount declared at a flat-rate.
In addition, for personnel costs (declared as actual costs or on the basis of unit costs), the beneficiaries
must keep time records for the number of hours declared. The time records must be in writing and
approved by the persons working on the action and their supervisors, at least monthly. In the absence
of reliable time records of the hours worked on the action, the Commission may accept alternative
evidence supporting the number of hours declared, if it considers that it offers an adequate level of
assurance.
As an exception, for persons working exclusively on the action, there is no need to keep time records,
if the beneficiary signs a declaration confirming that the persons concerned have worked exclusively
on the action.
For costs declared by linked third parties (see Article 14), it is the beneficiary that must keep the
originals of the financial statements and the certificates on the financial statements of the linked third
parties.
18.2 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, costs insufficiently substantiated
will be ineligible (see Article 6) and will be rejected (see Article 42), and the grant may be reduced
(see Article 43).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 19 — SUBMISSION OF DELIVERABLES
19.1 Obligation to submit deliverables
The coordinator must submit the ‘deliverables’ identified in Annex 1, in accordance with the timing
and conditions set out in it.
19.2 Consequences of non-compliance
If the coordinator breaches any of its obligations under this Article, the Commission may apply any
of the measures described in Chapter 6.
ARTICLE 20 — REPORTING — PAYMENT REQUESTS
20.1 Obligation to submit reports
The coordinator must submit to the Commission (see Article 52) the technical and financial reports
set out in this Article. These reports include requests for payment and must be drawn up using the
forms and templates provided in the electronic exchange system (see Article 52).
20.2 Reporting periods
The action is divided into the following ‘reporting periods’:
32
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
- RP1: from month 1 to month 12
- RP2: from month 13 to month 24
20.3 Periodic reports — Requests for interim payments
The coordinator must submit a periodic report within 60 days following the end of each reporting
period.
The periodic report must include the following:
(a) a ‘periodic technical report’ containing:
(i) an explanation of the work carried out by the beneficiaries;
(ii) an overview of the progress towards the objectives of the action, including milestones
and deliverables identified in Annex 1.
This report must include explanations justifying the differences between work expected
to be carried out in accordance with Annex 1 and that actually carried out.
The report must detail the exploitation and dissemination of the results and — if required
in Annex 1 — an updated ‘plan for the exploitation and dissemination of the results’.
The report must indicate the communication activities;
(iii) a summary for publication by the Commission;
(iv) the answers to the ‘questionnaire’, covering issues related to the action implementation
and the economic and societal impact, notably in the context of the Horizon 2020 key
performance indicators and the Horizon 2020 monitoring requirements;
(b) a ‘periodic financial report’ containing:
(i) an ‘individual financial statement’ (see Annex 4) from each beneficiary and from each
linked third party, for the reporting period concerned.
The individual financial statement must detail the eligible costs (actual costs, unit costs
and flat-rate costs; see Article 6) for each budget category (see Annex 2).
The beneficiaries and linked third parties must declare all eligible costs, even if —
for actual costs, unit costs and flat-rate costs — they exceed the amounts indicated in
the estimated budget (see Annex 2). Amounts which are not declared in the individual
financial statement will not be taken into account by the Commission.
If an individual financial statement is not submitted for a reporting period, it may be
included in the periodic financial report for the next reporting period.
The individual financial statements of the last reporting period must also detail the
receipts of the action (see Article 5.3.3).
Each beneficiary and each linked third party must certify that:
- the information provided is full, reliable and true;
33
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
- the costs declared are eligible (see Article 6);
- the costs can be substantiated by adequate records and supporting documentation
(see Article 18) that will be produced upon request (see Article 17) or in the context
of checks, reviews, audits and investigations (see Article 22), and
- for the last reporting period: that all the receipts have been declared (see
Article 5.3.3);
(ii) an explanation of the use of resources and the information on subcontracting (see
Article 13) and in-kind contributions provided by third parties (see Articles 11 and
12) from each beneficiary and from each linked third party, for the reporting period
concerned;
(iii) not applicable;
(iv) a ‘periodic summary financial statement’, created automatically by the electronic
exchange system, consolidating the individual financial statements for the reporting
period concerned and including — except for the last reporting period — the request
for interim payment.
20.4 Final report — Request for payment of the balance
In addition to the periodic report for the last reporting period, the coordinator must submit the final
report within 60 days following the end of the last reporting period.
The final report must include the following:
(a) a ‘final technical report’ with a summary for publication containing:
(i) an overview of the results and their exploitation and dissemination;
(ii) the conclusions on the action, and
(iii) the socio-economic impact of the action;
(b) a ‘final financial report’ containing:
(i) a ‘final summary financial statement’, created automatically by the electronic
exchange system, consolidating the individual financial statements for all reporting
periods and including the request for payment of the balance and
(ii) a ‘certificate on the financial statements’ (drawn up in accordance with Annex 5) for
each beneficiary and for each linked third party, if it requests a total contribution of
EUR 325 000 or more, as reimbursement of actual costs and unit costs calculated on the
basis of its usual cost accounting practices (see Article 5.2 and Article 6.2).
20.5 Information on cumulative expenditure incurred
Not applicable
20.6 Currency for financial statements and conversion into euro
34
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
Financial statements must be drafted in euro.
Beneficiaries and linked third parties with accounting established in a currency other than the euro
must convert the costs recorded in their accounts into euro, at the average of the daily exchange
rates published in the C series of the Official Journal of the European Union, calculated over the
corresponding reporting period.
If no daily euro exchange rate is published in the Official Journal of the European Union for the
currency in question, they must be converted at the average of the monthly accounting rates published
on the Commission’s website, calculated over the corresponding reporting period.
Beneficiaries and linked third parties with accounting established in euro must convert costs incurred
in another currency into euro according to their usual accounting practices.
20.7 Language of reports
All reports (technical and financial reports, including financial statements) must be submitted in the
language of the Agreement.
20.8 Consequences of non-compliance
If the reports submitted do not comply with this Article, the Commission may suspend the payment
deadline (see Article 47) and apply any of the other measures described in Chapter 6.
If the coordinator breaches its obligation to submit the reports and if it fails to comply with this
obligation within 30 days following a written reminder, the Commission may terminate the Agreement
(see Article 50) or apply any of the other measures described in Chapter 6.
ARTICLE 21 — PAYMENTS AND PAYMENT ARRANGEMENTS
21.1 Payments to be made
The following payments will be made to the coordinator:
- one pre-financing payment;
- one or more interim payments, on the basis of the request(s) for interim payment (see
Article 20), and
- one payment of the balance, on the basis of the request for payment of the balance (see
Article 20).
21.2 Pre-financing payment — Amount — Amount retained for the Guarantee Fund
The aim of the pre-financing is to provide the beneficiaries with a float.
It remains the property of the EU until the payment of the balance.
The amount of the pre-financing payment will be EUR 2 399 984.00 (two million three hundred and
ninety nine thousand nine hundred and eighty four EURO).
The Commission will — except if Article 48 applies — make the pre-financing payment to the
35
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
coordinator within 30 days, either from the entry into force of the Agreement (see Article 58) or from
10 days before the starting date of the action (see Article 3), whichever is the latest.
An amount of EUR 149 999.00 (one hundred and forty nine thousand nine hundred and ninety nine
EURO), corresponding to 5% of the maximum grant amount (see Article 5.1), is retained by the
Commission from the pre-financing payment and transferred into the ‘Guarantee Fund’.
21.3 Interim payments — Amount — Calculation
Interim payments reimburse the eligible costs incurred for the implementation of the action during
the corresponding reporting periods.
The Commission will pay to the coordinator the amount due as interim payment within 90 days from
receiving the periodic report (see Article 20.3), except if Articles 47 or 48 apply.
Payment is subject to the approval of the periodic report. Its approval does not imply recognition of
the compliance, authenticity, completeness or correctness of its content.
The amount due as interim payment is calculated by the Commission in the following steps:
Step 1 — Application of the reimbursement rates
Step 2 — Limit to 90% of the maximum grant amount
21.3.1 Step 1 — Application of the reimbursement rates
The reimbursement rate(s) (see Article 5.2) are applied to the eligible costs (actual costs, unit costs and
flat-rate costs; see Article 6) declared by the beneficiaries and the linked third parties (see Article 20)
and approved by the Commission (see above) for the concerned reporting period.
21.3.2 Step 2 — Limit to 90% of the maximum grant amount
The total amount of pre-financing and interim payments must not exceed 90% of the maximum grant
amount set out in Article 5.1. The maximum amount for the interim payment will be calculated as
follows:
{90% of the maximum grant amount (see Article 5.1)
minus
{pre-financing and previous interim payments}}.
21.4 Payment of the balance — Amount — Calculation — Release of the amount retained
for the Guarantee Fund
The payment of the balance reimburses the remaining part of the eligible costs incurred by the
beneficiaries for the implementation of the action.
If the total amount of earlier payments is greater than the final grant amount (see Article 5.3), the
payment of the balance takes the form of a recovery (see Article 44).
If the total amount of earlier payments is lower than the final grant amount, the Commission will
36
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
pay the balance within 90 days from receiving the final report (see Article 20.4), except if Articles
47 or 48 apply.
Payment is subject to the approval of the final report. Its approval does not imply recognition of the
compliance, authenticity, completeness or correctness of its content.
The amount due as the balance is calculated by the Commission by deducting the total amount of
pre-financing and interim payments (if any) already made, from the final grant amount determined
in accordance with Article 5.3:
{final grant amount (see Article 5.3)
minus
{pre-financing and interim payments (if any) made}}.
At the payment of the balance, the amount retained for the Guarantee Fund (see above) will be released
and:
- if the balance is positive: the amount released will be paid in full to the coordinator together
with the amount due as the balance;
- if the balance is negative (payment of the balance taking the form of recovery): it will be
deducted from the amount released (see Article 44.1.2). If the resulting amount:
- is positive, it will be paid to the coordinator
- is negative, it will be recovered.
The amount to be paid may however be offset — without the beneficiaries' consent — against any
other amount owed by a beneficiary to the Commission or an executive agency (under the EU or
Euratom budget), up to the maximum EU contribution indicated, for that beneficiary, in the estimated
budget (see Annex 2).
21.5 Notification of amounts due
When making payments, the Commission will formally notify to the coordinator the amount due,
specifying whether it concerns an interim payment or the payment of the balance.
For the payment of the balance, the notification will also specify the final grant amount.
In the case of reduction of the grant or recovery of undue amounts, the notification will be preceded
by the contradictory procedure set out in Articles 43 and 44.
21.6 Currency for payments
The Commission will make all payments in euro.
21.7 Payments to the coordinator — Distribution to the beneficiaries
Payments will be made to the coordinator.
Payments to the coordinator will discharge the Commission from its payment obligation.
37
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
The coordinator must distribute the payments between the beneficiaries without unjustified delay.
Pre-financing may however be distributed only:
(a) if the minimum number of beneficiaries set out in the call for proposals has acceded to the
Agreement (see Article 56) and
(b) to beneficiaries that have acceded to the Agreement (see Article 56).
21.8 Bank account for payments
All payments will be made to the following bank account:
Name of bank: AGENCIA GESTAO DA TESOURARIA E DIV. PUBLICA, IGCP EPE
Full name of the account holder: SERVICOS PARTILHADOS DO MINISTERIODA SAUDE
EPE
IBAN code: PT50078101120112001528863
21.9 Costs of payment transfers
The cost of the payment transfers is borne as follows:
- the Commission bears the cost of transfers charged by its bank;
- the beneficiary bears the cost of transfers charged by its bank;
- the party causing a repetition of a transfer bears all costs of the repeated transfer.
21.10 Date of payment
Payments by the Commission are considered to have been carried out on the date when they are
debited to its account.
21.11 Consequences of non-compliance
21.11.1 If the Commission does not pay within the payment deadlines (see above), the beneficiaries
are entitled to late-payment interest at the rate applied by the European Central Bank (ECB) for its
main refinancing operations in euros (‘reference rate’), plus three and a half points. The reference rate
is the rate in force on the first day of the month in which the payment deadline expires, as published
in the C series of the Official Journal of the European Union.
If the late-payment interest is lower than or equal to EUR 200, it will be paid to the coordinator only
upon request submitted within two months of receiving the late payment.
Late-payment interest is not due if all beneficiaries are EU Member States (including regional and
local government authorities or other public bodies acting on behalf of a Member State for the purpose
of this Agreement).
Suspension of the payment deadline or payments (see Articles 47 and 48) will not be considered as
late payment.
38
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
Late-payment interest covers the period running from the day following the due date for payment (see
above), up to and including the date of payment.
Late-payment interest is not considered for the purposes of calculating the final grant amount.
21.11.2 If the coordinator breaches any of its obligations under this Article, the grant may be reduced
(see Article 43) and the Agreement or the participation of the coordinator may be terminated (see
Article 50).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 22 — CHECKS, REVIEWS, AUDITS AND INVESTIGATIONS — EXTENSION
OF FINDINGS
22.1 Checks, reviews and audits by the Commission
22.1.1 Right to carry out checks
The Commission will — during the implementation of the action or afterwards — check the proper
implementation of the action and compliance with the obligations under the Agreement, including
assessing deliverables and reports.
For this purpose the Commission may be assisted by external persons or bodies.
The Commission may also request additional information in accordance with Article 17. The
Commission may request beneficiaries to provide such information to it directly.
Information provided must be accurate, precise and complete and in the format requested, including
electronic format.
22.1.2 Right to carry out reviews
The Commission may — during the implementation of the action or afterwards — carry out reviews
on the proper implementation of the action (including assessment of deliverables and reports),
compliance with the obligations under the Agreement and continued scientific or technological
relevance of the action.
Reviews may be started up to two years after the payment of the balance. They will be formally
notified to the coordinator or beneficiary concerned and will be considered to have started on the date
of the formal notification.
If the review is carried out on a third party (see Articles 10 to 16), the beneficiary concerned must
inform the third party.
The Commission may carry out reviews directly (using its own staff) or indirectly (using external
persons or bodies appointed to do so). It will inform the coordinator or beneficiary concerned of the
identity of the external persons or bodies. They have the right to object to the appointment on grounds
of commercial confidentiality.
The coordinator or beneficiary concerned must provide — within the deadline requested — any
information and data in addition to deliverables and reports already submitted (including information
39
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
on the use of resources). The Commission may request beneficiaries to provide such information to
it directly.
The coordinator or beneficiary concerned may be requested to participate in meetings, including with
external experts.
For on-the-spot reviews, the beneficiaries must allow access to their sites and premises, including to
external persons or bodies, and must ensure that information requested is readily available.
Information provided must be accurate, precise and complete and in the format requested, including
electronic format.
On the basis of the review findings, a ‘review report’ will be drawn up.
The Commission will formally notify the review report to the coordinator or beneficiary concerned,
which has 30 days to formally notify observations (‘contradictory review procedure’).
Reviews (including review reports) are in the language of the Agreement.
22.1.3 Right to carry out audits
The Commission may — during the implementation of the action or afterwards — carry out audits on
the proper implementation of the action and compliance with the obligations under the Agreement.
Audits may be started up to two years after the payment of the balance. They will be formally notified
to the coordinator or beneficiary concerned and will be considered to have started on the date of the
formal notification.
If the audit is carried out on a third party (see Articles 10 to 16), the beneficiary concerned must
inform the third party.
The Commission may carry out audits directly (using its own staff) or indirectly (using external
persons or bodies appointed to do so). It will inform the coordinator or beneficiary concerned of the
identity of the external persons or bodies. They have the right to object to the appointment on grounds
of commercial confidentiality.
The coordinator or beneficiary concerned must provide — within the deadline requested — any
information (including complete accounts, individual salary statements or other personal data) to
verify compliance with the Agreement. The Commission may request beneficiaries to provide such
information to it directly.
For on-the-spot audits, the beneficiaries must allow access to their sites and premises, including to
external persons or bodies, and must ensure that information requested is readily available.
Information provided must be accurate, precise and complete and in the format requested, including
electronic format.
On the basis of the audit findings, a ‘draft audit report’ will be drawn up.
The Commission will formally notify the draft audit report to the coordinator or beneficiary concerned,
which has 30 days to formally notify observations (‘contradictory audit procedure’). This period
may be extended by the Commission in justified cases.
40
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
The ‘final audit report’ will take into account observations by the coordinator or beneficiary
concerned. The report will be formally notified to it.
Audits (including audit reports) are in the language of the Agreement.
The Commission may also access the beneficiaries’ statutory records for the periodical assessment
of unit costs or flat-rate amounts.
22.2 Investigations by the European Anti-Fraud Office (OLAF)
Under Regulations No 883/201316 and No 2185/9617 (and in accordance with their provisions and
procedures), the European Anti-Fraud Office (OLAF) may — at any moment during implementation
of the action or afterwards — carry out investigations, including on-the-spot checks and inspections,
to establish whether there has been fraud, corruption or any other illegal activity affecting the financial
interests of the EU.
22.3 Checks and audits by the European Court of Auditors (ECA)
Under Article 287 of the Treaty on the Functioning of the European Union (TFEU) and Article 161
of the Financial Regulation No 966/201218, the European Court of Auditors (ECA) may — at any
moment during implementation of the action or afterwards — carry out audits.
The ECA has the right of access for the purpose of checks and audits.
22.4 Checks, reviews, audits and investigations for international organisations
Not applicable
22.5 Consequences of findings in checks, reviews, audits and investigations — Extension of
findings
22.5.1 Findings in this grant
Findings in checks, reviews, audits or investigations carried out in the context of this grant may lead
to the rejection of ineligible costs (see Article 42), reduction of the grant (see Article 43), recovery of
undue amounts (see Article 44) or to any of the other measures described in Chapter 6.
Rejection of costs or reduction of the grant after the payment of the balance will lead to a revised final
grant amount (see Article 5.4).
Findings in checks, reviews, audits or investigations may lead to a request for amendment for the
modification of Annex 1 (see Article 55).
16 Regulation (EU, Euratom) No 883/2013 of the European Parliament and of the Council of 11 September 2013
concerning investigations conducted by the European Anti-Fraud Office (OLAF) and repealing Regulation (EC) No
1073/1999 of the European Parliament and of the Council and Council Regulation (Euratom) No 1074/1999 (OJ L 248,
18.09.2013, p. 1).
17 Council Regulation (Euratom, EC) No 2185/1996 of 11 November 1996 concerning on-the-spot checks and inspections
carried out by the Commission in order to protect the European Communities' financial interests against fraud and other
irregularities (OJ L 292, 15.11.1996, p. 2).
18 Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of 25 October 2012 on the
financial rules applicable to the general budget of the Union and repealing Council Regulation (EC, Euratom) No
1605/2002 (OJ L 298, 26.10.2012, p. 1).
41
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
Checks, reviews, audits or investigations that find systemic or recurrent errors, irregularities, fraud or
breach of obligations may also lead to consequences in other EU or Euratom grants awarded under
similar conditions (‘extension of findings from this grant to other grants’).
Moreover, findings arising from an OLAF investigation may lead to criminal prosecution under
national law.
22.5.2 Findings in other grants
The Commission may extend findings from other grants to this grant (‘extension of findings from
other grants to this grant’), if:
(a) the beneficiary concerned is found, in other EU or Euratom grants awarded under similar
conditions, to have committed systemic or recurrent errors, irregularities, fraud or breach of
obligations that have a material impact on this grant and
(b) those findings are formally notified to the beneficiary concerned — together with the list of
grants affected by the findings — no later than two years after the payment of the balance of
this grant.
The extension of findings may lead to the rejection of costs (see Article 42), reduction of the grant
(see Article 43), recovery of undue amounts (see Article 44), suspension of payments (see Article 48),
suspension of the action implementation (see Article 49) or termination (see Article 50).
22.5.3 Procedure
The Commission will formally notify the beneficiary concerned the systemic or recurrent errors and
its intention to extend these audit findings, together with the list of grants affected.
22.5.3.1 If the findings concern eligibility of costs: the formal notification will include:
(a) an invitation to submit observations on the list of grants affected by the findings;
(b) the request to submit revised financial statements for all grants affected;
(c) the correction rate for extrapolation established by the Commission on the basis of the
systemic or recurrent errors, to calculate the amounts to be rejected if the beneficiary concerned:
(i) considers that the submission of revised financial statements is not possible or practicable
or
(ii) does not submit revised financial statements.
The beneficiary concerned has 90 days from receiving notification to submit observations, revised
financial statements or to propose a duly substantiated alternative correction method. This period
may be extended by the Commission in justified cases.
The Commission may then start a rejection procedure in accordance with Article 42, on the basis of:
- the revised financial statements, if approved;
- the proposed alternative correction method, if accepted
42
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
or
- the initially notified correction rate for extrapolation, if it does not receive any observations
or revised financial statements, does not accept the observations or the proposed alternative
correction method or does not approve the revised financial statements.
22.5.3.2 If the findings concern substantial errors, irregularities or fraud or serious breach of
obligations: the formal notification will include:
(a) an invitation to submit observations on the list of grants affected by the findings and
(b) the flat-rate the Commission intends to apply according to the principle of proportionality.
The beneficiary concerned has 90 days from receiving notification to submit observations or to
propose a duly substantiated alternative flat-rate.
The Commission may then start a reduction procedure in accordance with Article 43, on the basis of:
- the proposed alternative flat-rate, if accepted
or
- the initially notified flat-rate, if it does not receive any observations or does not accept the
observations or the proposed alternative flat-rate.
22.6 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, any insufficiently substantiated costs
will be ineligible (see Article 6) and will be rejected (see Article 42).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 23 — EVALUATION OF THE IMPACT OF THE ACTION
23.1 Right to evaluate the impact of the action
The Commission may carry out interim and final evaluations of the impact of the action measured
against the objective of the EU programme.
Evaluations may be started during implementation of the action and up to five years after the payment
of the balance. The evaluation is considered to start on the date of the formal notification to the
coordinator or beneficiaries.
The Commission may make these evaluations directly (using its own staff) or indirectly (using external
bodies or persons it has authorised to do so).
The coordinator or beneficiaries must provide any information relevant to evaluate the impact of the
action, including information in electronic format.
23.2 Consequences of non-compliance
43
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
If a beneficiary breaches any of its obligations under this Article, the Commission may apply the
measures described in Chapter 6.
SECTION 3 RIGHTS AND OBLIGATIONS RELATED TO BACKGROUND AND
RESULTS
SUBSECTION 1 GENERAL
ARTICLE 23a — MANAGEMENT OF INTELLECTUAL PROPERTY
23a.1 Obligation to take measures to implement the Commission Recommendation on the
management of intellectual property in knowledge transfer activities
Beneficiaries that are universities or other public research organisations must take measures to
implement the principles set out in Points 1 and 2 of the Code of Practice annexed to the Commission
Recommendation on the management of intellectual property in knowledge transfer activities19.
This does not change the obligations set out in Subsections 2 and 3 of this Section.
The beneficiaries must ensure that researchers and third parties involved in the action are aware of
them.
23a.2 Consequences of non-compliance
If a beneficiary breaches its obligations under this Article, the Commission may apply any of the
measures described in Chapter 6.
SUBSECTION 2 RIGHTS AND OBLIGATIONS RELATED TO BACKGROUND
ARTICLE 24 — AGREEMENT ON BACKGROUND
24.1 Agreement on background
The beneficiaries must identify and agree (in writing) on the background for the action (‘agreement
on background’).
‘Background’ means any data, know-how or information — whatever its form or nature (tangible or
intangible), including any rights such as intellectual property rights — that:
(a) is held by the beneficiaries before they acceded to the Agreement, and
(b) is needed to implement the action or exploit the results.
24.2 Consequences of non-compliance
19 Commission Recommendation C(2008) 1329 of 10.4.2008 on the management of intellectual property in knowledge
transfer activities and the Code of Practice for universities and other public research institutions attached to this
recommendation.
44
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 43).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 25 — ACCESS RIGHTS TO BACKGROUND
25.1 Exercise of access rights — Waiving of access rights — No sub-licensing
To exercise access rights, this must first be requested in writing (‘request for access’).
‘Access rights’ means rights to use results or background under the terms and conditions laid down
in this Agreement.
Waivers of access rights are not valid unless in writing.
Unless agreed otherwise, access rights do not include the right to sub-license.
25.2 Access rights for other beneficiaries, for implementing their own tasks under the action
The beneficiaries must give each other access — on a royalty-free basis — to background needed to
implement their own tasks under the action, unless the beneficiary that holds the background has —
before acceding to the Agreement —:
(a) informed the other beneficiaries that access to its background is subject to legal restrictions or
limits, including those imposed by the rights of third parties (including personnel), or
(b) agreed with the other beneficiaries that access would not be on a royalty-free basis.
25.3 Access rights for other beneficiaries, for exploiting their own results
The beneficiaries must give each other access — under fair and reasonable conditions — to
background needed for exploiting their own results, unless the beneficiary that holds the background
has — before acceding to the Agreement — informed the other beneficiaries that access to its
background is subject to legal restrictions or limits, including those imposed by the rights of third
parties (including personnel).
‘Fair and reasonable conditions’ means appropriate conditions, including possible financial terms
or royalty-free conditions, taking into account the specific circumstances of the request for access, for
example the actual or potential value of the results or background to which access is requested and/or
the scope, duration or other characteristics of the exploitation envisaged.
Requests for access may be made — unless agreed otherwise — up to one year after the period set
out in Article 3.
25.4 Access rights for affiliated entities
Unless otherwise agreed in the consortium agreement, access to background must also be given
— under fair and reasonable conditions (see above; Article 25.3) and unless it is subject to legal
restrictions or limits, including those imposed by the rights of third parties (including personnel) —
45
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
to affiliated entities20 established in an EU Member State or ‘associated country’21, if this is needed
to exploit the results generated by the beneficiaries to which they are affiliated.
Unless agreed otherwise (see above; Article 25.1), the affiliated entity concerned must make the
request directly to the beneficiary that holds the background.
Requests for access may be made — unless agreed otherwise — up to one year after the period set
out in Article 3.
25.5 Access rights for third parties
Not applicable
25.6 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 43).
Such breaches may also lead to any of the other measures described in Chapter 6.
SUBSECTION 3 RIGHTS AND OBLIGATIONS RELATED TO RESULTS
ARTICLE 26 — OWNERSHIP OF RESULTS
26.1 Ownership by the beneficiary that generates the results
Results are owned by the beneficiary that generates them.
‘Results’ means any (tangible or intangible) output of the action such as data, knowledge or
information — whatever its form or nature, whether it can be protected or not — that is generated in
the action, as well as any rights attached to it, including intellectual property rights.
26.2 Joint ownership by several beneficiaries
Two or more beneficiaries own results jointly if:
(a) they have jointly generated them and
(b) it is not possible to:
(i) establish the respective contribution of each beneficiary, or
(ii) separate them for the purpose of applying for, obtaining or maintaining their protection
(see Article 27).
20 For the definition, see ‘affiliated entity’ footnote (Article 14.1).
21 For the definition, see Article 2.1(3) of the Rules for Participation Regulation No 1290/2013: ‘associated country’
means a third country which is party to an international agreement with the Union, as identified in Article 7 of
Horizon 2020 Framework Programme Regulation No 1291/2013. Article 7 sets out the conditions for association of
non-EU countries to Horizon 2020.
46
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
The joint owners must agree (in writing) on the allocation and terms of exercise of their joint ownership
(‘joint ownership agreement’), to ensure compliance with their obligations under this Agreement.
Unless otherwise agreed in the joint ownership agreement, each joint owner may grant non-exclusive
licences to third parties to exploit jointly-owned results (without any right to sub-license), if the other
joint owners are given:
(a) at least 45 days advance notice and
(b) fair and reasonable compensation.
Once the results have been generated, joint owners may agree (in writing) to apply another regime
than joint ownership (such as, for instance, transfer to a single owner (see Article 30) with access
rights for the others).
26.3 Rights of third parties (including personnel)
If third parties (including personnel) may claim rights to the results, the beneficiary concerned must
ensure that it complies with its obligations under the Agreement.
If a third party generates results, the beneficiary concerned must obtain all necessary rights (transfer,
licences or other) from the third party, in order to be able to respect its obligations as if those results
were generated by the beneficiary itself.
If obtaining the rights is impossible, the beneficiary must refrain from using the third party to generate
the results.
26.4 EU ownership, to protect results
26.4.1 The EU may — with the consent of the beneficiary concerned — assume ownership of results
to protect them, if a beneficiary intends — up to four years after the period set out in Article 3 — to
disseminate its results without protecting them, except in any of the following cases:
(a) the lack of protection is because protecting the results is not possible, reasonable or justified
(given the circumstances);
(b) the lack of protection is because there is a lack of potential for commercial or industrial
exploitation, or
(c) the beneficiary intends to transfer the results to another beneficiary or third party established
in an EU Member State or associated country, which will protect them.
Before the results are disseminated and unless any of the cases above under Points (a), (b) or (c)
applies, the beneficiary must formally notify the Commission and at the same time inform it of any
reasons for refusing consent. The beneficiary may refuse consent only if it can show that its legitimate
interests would suffer significant harm.
If the Commission decides to assume ownership, it will formally notify the beneficiary concerned
within 45 days of receiving notification.
No dissemination relating to these results may take place before the end of this period or, if the
Commission takes a positive decision, until it has taken the necessary steps to protect the results.
47
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
26.4.2 The EU may — with the consent of the beneficiary concerned — assume ownership of results
to protect them, if a beneficiary intends — up to four years after the period set out in Article 3 — to
stop protecting them or not to seek an extension of protection, except in any of the following cases:
(a) the protection is stopped because of a lack of potential for commercial or industrial exploitation;
(b) an extension would not be justified given the circumstances.
A beneficiary that intends to stop protecting results or not seek an extension must — unless any of
the cases above under Points (a) or (b) applies — formally notify the Commission at least 60 days
before the protection lapses or its extension is no longer possible and at the same time inform it of any
reasons for refusing consent. The beneficiary may refuse consent only if it can show that its legitimate
interests would suffer significant harm.
If the Commission decides to assume ownership, it will formally notify the beneficiary concerned
within 45 days of receiving notification.
26.5 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 43).
Such breaches may also lead to the any of the other measures described in Chapter 6.
ARTICLE 27 — PROTECTION OF RESULTS — VISIBILITY OF EU FUNDING
27.1 Obligation to protect the results
Each beneficiary must examine the possibility of protecting its results and must adequately protect
them — for an appropriate period and with appropriate territorial coverage — if:
(a) the results can reasonably be expected to be commercially or industrially exploited and
(b) protecting them is possible, reasonable and justified (given the circumstances).
When deciding on protection, the beneficiary must consider its own legitimate interests and the
legitimate interests (especially commercial) of the other beneficiaries.
27.2 EU ownership, to protect the results
If a beneficiary intends not to protect its results, to stop protecting them or not seek an extension of
protection, the EU may — under certain conditions (see Article 26.4) — assume ownership to ensure
their (continued) protection.
27.3 Information on EU funding
Applications for protection of results (including patent applications) filed by or on behalf of a
beneficiary must — unless the Commission requests or agrees otherwise or unless it is impossible
— include the following:
“The project leading to this application has received funding from the European Union’s Horizon 2020
research and innovation programme under grant agreement No 951938”.
48
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
27.4 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 43).
Such a breach may also lead to any of the other measures described in Chapter 6.
ARTICLE 28 — EXPLOITATION OF RESULTS
28.1 Obligation to exploit the results
Each beneficiary must — up to four years after the period set out in Article 3 — take measures aiming
to ensure ‘exploitation’ of its results (either directly or indirectly, in particular through transfer or
licensing; see Article 30) by:
(a) using them in further research activities (outside the action);
(b) developing, creating or marketing a product or process;
(c) creating and providing a service, or
(d) using them in standardisation activities.
This does not change the security obligations in Article 37, which still apply.
28.2 Results that could contribute to European or international standards — Information on
EU funding
If results could reasonably be expected to contribute to European or international standards, the
beneficiary concerned must — up to four years after the period set out in Article 3 — inform the
Commission.
If results are incorporated in a standard, the beneficiary concerned must — unless the Commission
requests or agrees otherwise or unless it is impossible — ask the standardisation body to include the
following statement in (information related to) the standard:
“Results incorporated in this standard received funding from the European Union’s Horizon 2020 research
and innovation programme under grant agreement No 951938”.
28.3 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced in
accordance with Article 43.
Such a breach may also lead to any of the other measures described in Chapter 6.
ARTICLE 29 — DISSEMINATION OF RESULTS — OPEN ACCESS — VISIBILITY OF
EU FUNDING
29.1 Obligation to disseminate results
Unless it goes against their legitimate interests, each beneficiary must — as soon as possible —
49
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
‘disseminate’ its results by disclosing them to the public by appropriate means (other than those
resulting from protecting or exploiting the results), including in scientific publications (in any
medium).
This does not change the obligation to protect results in Article 27, the confidentiality obligations in
Article 36, the security obligations in Article 37 or the obligations to protect personal data in Article 39,
all of which still apply.
A beneficiary that intends to disseminate its results must give advance notice to the other beneficiaries
of — unless agreed otherwise — at least 45 days, together with sufficient information on the results
it will disseminate.
Any other beneficiary may object within — unless agreed otherwise — 30 days of receiving
notification, if it can show that its legitimate interests in relation to the results or background would
be significantly harmed. In such cases, the dissemination may not take place unless appropriate steps
are taken to safeguard these legitimate interests.
If a beneficiary intends not to protect its results, it may — under certain conditions (see Article 26.4.1)
— need to formally notify the Commission before dissemination takes place.
29.2 Open access to scientific publications
Each beneficiary must ensure open access (free of charge online access for any user) to all
peer-reviewed scientific publications relating to its results.
In particular, it must:
(a) as soon as possible and at the latest on publication, deposit a machine-readable electronic
copy of the published version or final peer-reviewed manuscript accepted for publication in a
repository for scientific publications;
Moreover, the beneficiary must aim to deposit at the same time the research data needed to
validate the results presented in the deposited scientific publications.
(b) ensure open access to the deposited publication — via the repository — at the latest:
(i) on publication, if an electronic version is available for free via the publisher, or
(ii) within six months of publication (twelve months for publications in the social sciences
and humanities) in any other case.
(c) ensure open access — via the repository — to the bibliographic metadata that identify the
deposited publication.
The bibliographic metadata must be in a standard format and must include all of the following:
- the terms “European Union (EU)” and “Horizon 2020”;
- the name of the action, acronym and grant number;
- the publication date, and length of embargo period if applicable, and
- a persistent identifier.
50
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
29.3 Open access to research data
Not applicable;
29.4 Information on EU funding — Obligation and right to use the EU emblem
Unless the Commission requests or agrees otherwise or unless it is impossible, any dissemination of
results (in any form, including electronic) must:
(a) display the EU emblem and
(b) include the following text:
“This project has received funding from the European Union’s Horizon 2020 research and innovation
programme under grant agreement No 951938”.
When displayed together with another logo, the EU emblem must have appropriate prominence.
For the purposes of their obligations under this Article, the beneficiaries may use the EU emblem
without first obtaining approval from the Commission.
This does not however give them the right to exclusive use.
Moreover, they may not appropriate the EU emblem or any similar trademark or logo, either by
registration or by any other means.
29.5 Disclaimer excluding Commission responsibility
Any dissemination of results must indicate that it reflects only the author's view and that the
Commission is not responsible for any use that may be made of the information it contains.
29.6 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 43).
Such a breach may also lead to any of the other measures described in Chapter 6.
ARTICLE 30 — TRANSFER AND LICENSING OF RESULTS
30.1 Transfer of ownership
Each beneficiary may transfer ownership of its results.
It must however ensure that its obligations under Articles 26.2, 26.4, 27, 28, 29, 30 and 31 also apply
to the new owner and that this owner has the obligation to pass them on in any subsequent transfer.
This does not change the security obligations in Article 37, which still apply.
Unless agreed otherwise (in writing) for specifically-identified third parties or unless impossible under
applicable EU and national laws on mergers and acquisitions, a beneficiary that intends to transfer
ownership of results must give at least 45 days advance notice (or less if agreed in writing) to the
other beneficiaries that still have (or still may request) access rights to the results. This notification
51
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
must include sufficient information on the new owner to enable any beneficiary concerned to assess
the effects on its access rights.
Unless agreed otherwise (in writing) for specifically-identified third parties, any other beneficiary
may object within 30 days of receiving notification (or less if agreed in writing), if it can show that
the transfer would adversely affect its access rights. In this case, the transfer may not take place until
agreement has been reached between the beneficiaries concerned.
30.2 Granting licenses
Each beneficiary may grant licences to its results (or otherwise give the right to exploit them), if:
(a) this does not impede the access rights under Article 31 and
(b) not applicable.
In addition to Points (a) and (b), exclusive licences for results may be granted only if all the other
beneficiaries concerned have waived their access rights (see Article 31.1).
This does not change the dissemination obligations in Article 29 or security obligations in Article 37,
which still apply.
30.3 Commission right to object to transfers or licensing
Not applicable
30.4 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 43).
Such a breach may also lead to any of the other measures described in Chapter 6.
ARTICLE 31 — ACCESS RIGHTS TO RESULTS
31.1 Exercise of access rights — Waiving of access rights — No sub-licensing
The conditions set out in Article 25.1 apply.
The obligations set out in this Article do not change the security obligations in Article 37, which still
apply.
31.2 Access rights for other beneficiaries, for implementing their own tasks under the action
The beneficiaries must give each other access — on a royalty-free basis — to results needed for
implementing their own tasks under the action.
31.3 Access rights for other beneficiaries, for exploiting their own results
The beneficiaries must give each other — under fair and reasonable conditions (see Article 25.3) —
access to results needed for exploiting their own results.
52
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
Requests for access may be made — unless agreed otherwise — up to one year after the period set
out in Article 3.
31.4 Access rights of affiliated entities
Unless agreed otherwise in the consortium agreement, access to results must also be given — under
fair and reasonable conditions (Article 25.3) — to affiliated entities established in an EU Member
State or associated country, if this is needed for those entities to exploit the results generated by the
beneficiaries to which they are affiliated.
Unless agreed otherwise (see above; Article 31.1), the affiliated entity concerned must make any such
request directly to the beneficiary that owns the results.
Requests for access may be made — unless agreed otherwise — up to one year after the period set
out in Article 3.
31.5 Access rights for the EU institutions, bodies, offices or agencies and EU Member States
The beneficiaries must give access to their results — on a royalty-free basis — to EU institutions,
bodies, offices or agencies, for developing, implementing or monitoring EU policies or programmes.
Such access rights are limited to non-commercial and non-competitive use.
This does not change the right to use any material, document or information received from the
beneficiaries for communication and publicising activities (see Article 38.2).
31.6 Access rights for third parties
Not applicable
31.7 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 43).
Such breaches may also lead to any of the other measures described in Chapter 6.
SECTION 4 OTHER RIGHTS AND OBLIGATIONS
ARTICLE 32 — RECRUITMENT AND WORKING CONDITIONS FOR RESEARCHERS
32.1 Obligation to take measures to implement the European Charter for Researchers and
Code of Conduct for the Recruitment of Researchers
The beneficiaries must take all measures to implement the principles set out in the Commission
Recommendation on the European Charter for Researchers and the Code of Conduct for the
Recruitment of Researchers23, in particular regarding:
23 Commission Recommendation 2005/251/EC of 11 March 2005 on the European Charter for Researchers and on a Code
of Conduct for the Recruitment of Researchers (OJ L 75, 22.3.2005, p. 67).
53
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
- working conditions;
- transparent recruitment processes based on merit, and
- career development.
The beneficiaries must ensure that researchers and third parties involved in the action are aware of
them.
32.2 Consequences of non-compliance
If a beneficiary breaches its obligations under this Article, the Commission may apply any of the
measures described in Chapter 6.
ARTICLE 33 — GENDER EQUALITY
33.1 Obligation to aim for gender equality
The beneficiaries must take all measures to promote equal opportunities between men and women in
the implementation of the action. They must aim, to the extent possible, for a gender balance at all
levels of personnel assigned to the action, including at supervisory and managerial level.
33.2 Consequences of non-compliance
If a beneficiary breaches its obligations under this Article, the Commission may apply any of the
measures described in Chapter 6.
ARTICLE 34 — ETHICS AND RESEARCH INTEGRITY
34.1 Obligation to comply with ethical and research integrity principles
The beneficiaries must carry out the action in compliance with:
(a) ethical principles (including the highest standards of research integrity)
and
(b) applicable international, EU and national law.
Funding will not be granted for activities carried out outside the EU if they are prohibited in all
Member States or for activities which destroy human embryos (for example, for obtaining stem cells).
The beneficiaries must ensure that the activities under the action have an exclusive focus on civil
applications.
The beneficiaries must ensure that the activities under the action do not:
(a) aim at human cloning for reproductive purposes;
(b) intend to modify the genetic heritage of human beings which could make such changes heritable
(with the exception of research relating to cancer treatment of the gonads, which may be
financed), or
54
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
(c) intend to create human embryos solely for the purpose of research or for the purpose of stem
cell procurement, including by means of somatic cell nuclear transfer.
In addition, the beneficiaries must respect the fundamental principle of research integrity — as set
out, for instance, in the European Code of Conduct for Research Integrity24.
This implies compliance with the following fundamental principles:
- reliability in ensuring the quality of research reflected in the design, the methodology, the
analysis and the use of resources;
- honesty in developing, undertaking, reviewing, reporting and communicating research in a
transparent, fair and unbiased way;
- respect for colleagues, research participants, society, ecosystems, cultural heritage and the
environment;
- accountability for the research from idea to publication, for its management and organisation,
for training, supervision and mentoring, and for its wider impacts
and means that beneficiaries must ensure that persons carrying out research tasks follow the good
research practices and refrain from the research integrity violations described in this Code.
This does not change the other obligations under this Agreement or obligations under applicable
international, EU or national law, all of which still apply.
34.2 Activities raising ethical issues
Activities raising ethical issues must comply with the ‘ethics requirements’ set out as deliverables
in Annex 1.
Before the beginning of an activity raising an ethical issue, each beneficiary must have obtained:
(a) any ethics committee opinion required under national law and
(b) any notification or authorisation for activities raising ethical issues required under national
and/or European law
needed for implementing the action tasks in question.
The documents must be kept on file and be submitted upon request by the coordinator to the
Commission (see Article 52). If they are not in English, they must be submitted together with
an English summary, which shows that the action tasks in question are covered and includes the
conclusions of the committee or authority concerned (if available).
34.3 Activities involving human embryos or human embryonic stem cells
Activities involving research on human embryos or human embryonic stem cells may be carried out,
in addition to Article 34.1, only if:
24 European Code of Conduct for Research Integrity of ALLEA (All European Academies)
http://ec.europa.eu/research/participants/data/ref/h2020/other/hi/h2020-ethics_code-of-conduct_en.pdf
55
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
- they are set out in Annex 1 or
- the coordinator has obtained explicit approval (in writing) from the Commission (see
Article 52).
34.4 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 43) and the Agreement or participation of the beneficiary may be terminated (see Article 50).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 35 — CONFLICT OF INTERESTS
35.1 Obligation to avoid a conflict of interests
The beneficiaries must take all measures to prevent any situation where the impartial and objective
implementation of the action is compromised for reasons involving economic interest, political or
national affinity, family or emotional ties or any other shared interest (‘conflict of interests’).
They must formally notify to the Commission without delay any situation constituting or likely to
lead to a conflict of interests and immediately take all the necessary steps to rectify this situation.
The Commission may verify that the measures taken are appropriate and may require additional
measures to be taken by a specified deadline.
35.2 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 43) and the Agreement or participation of the beneficiary may be terminated (see Article 50).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 36 — CONFIDENTIALITY
36.1 General obligation to maintain confidentiality
During implementation of the action and for four years after the period set out in Article 3, the
parties must keep confidential any data, documents or other material (in any form) that is identified
as confidential at the time it is disclosed (‘confidential information’).
If a beneficiary requests, the Commission may agree to keep such information confidential for an
additional period beyond the initial four years.
If information has been identified as confidential only orally, it will be considered to be confidential
only if this is confirmed in writing within 15 days of the oral disclosure.
Unless otherwise agreed between the parties, they may use confidential information only to implement
the Agreement.
The beneficiaries may disclose confidential information to their personnel or third parties involved
in the action only if they:
56
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
(a) need to know to implement the Agreement and
(b) are bound by an obligation of confidentiality.
This does not change the security obligations in Article 37, which still apply.
The Commission may disclose confidential information to its staff, other EU institutions and bodies.
It may disclose confidential information to third parties, if:
(a) this is necessary to implement the Agreement or safeguard the EU’s financial interests and
(b) the recipients of the information are bound by an obligation of confidentiality.
Under the conditions set out in Article 4 of the Rules for Participation Regulation No 1290/201325,
the Commission must moreover make available information on the results to other EU institutions,
bodies, offices or agencies as well as Member States or associated countries.
The confidentiality obligations no longer apply if:
(a) the disclosing party agrees to release the other party;
(b) the information was already known by the recipient or is given to him without obligation of
confidentiality by a third party that was not bound by any obligation of confidentiality;
(c) the recipient proves that the information was developed without the use of confidential
information;
(d) the information becomes generally and publicly available, without breaching any
confidentiality obligation, or
(e) the disclosure of the information is required by EU or national law.
36.2 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 43).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 37 — SECURITY-RELATED OBLIGATIONS
37.1 Results with a security recommendation
Not applicable
37.2 Classified information
Not applicable
25 Regulation (EU) No 1290/2013 of the European Parliament and of the Council of 11 December 2013 laying down the
rules for participation and dissemination in "Horizon 2020 - the Framework Programme for Research and Innovation
(2014-2020)" (OJ L 347, 20.12.2013 p.81).
57
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
37.3 Activities involving dual-use goods or dangerous materials and substances
Not applicable
37.4 Consequences of non-compliance
Not applicable
ARTICLE 38 — PROMOTING THE ACTION — VISIBILITY OF EU FUNDING
38.1 Communication activities by beneficiaries
38.1.1 Obligation to promote the action and its results
The beneficiaries must promote the action and its results, by providing targeted information to multiple
audiences (including the media and the public) in a strategic and effective manner.
This does not change the dissemination obligations in Article 29, the confidentiality obligations in
Article 36 or the security obligations in Article 37, all of which still apply.
Before engaging in a communication activity expected to have a major media impact, the beneficiaries
must inform the Commission (see Article 52).
38.1.2 Information on EU funding — Obligation and right to use the EU emblem
Unless the Commission requests or agrees otherwise or unless it is impossible, any communication
activity related to the action (including in electronic form, via social media, etc.) and any
infrastructure, equipment and major results funded by the grant must:
(a) display the EU emblem and
(b) include the following text:
For communication activities:
“This project has received funding from the European Union’s Horizon 2020 research and innovation
programme under grant agreement No 951938”.
For infrastructure, equipment and major results:
“This [infrastructure][equipment][insert type of result] is part of a project that has received funding
from the European Union’s Horizon 2020 research and innovation programme under grant agreement
No 951938”.
When displayed together with another logo, the EU emblem must have appropriate prominence.
For the purposes of their obligations under this Article, the beneficiaries may use the EU emblem
without first obtaining approval from the Commission.
This does not, however, give them the right to exclusive use.
Moreover, they may not appropriate the EU emblem or any similar trademark or logo, either by
registration or by any other means.
38.1.3 Disclaimer excluding Commission responsibility
58
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
Any communication activity related to the action must indicate that it reflects only the author's view
and that the Commission is not responsible for any use that may be made of the information it contains.
38.2 Communication activities by the Commission
38.2.1 Right to use beneficiaries’ materials, documents or information
The Commission may use, for its communication and publicising activities, information relating
to the action, documents notably summaries for publication and public deliverables as well as any
other material, such as pictures or audio-visual material received from any beneficiary (including in
electronic form).
This does not change the confidentiality obligations in Article 36 and the security obligations in
Article 37, all of which still apply.
If the Commission’s use of these materials, documents or information would risk compromising
legitimate interests, the beneficiary concerned may request the Commission not to use it (see
Article 52).
The right to use a beneficiary’s materials, documents and information includes:
(a) use for its own purposes (in particular, making them available to persons working for the
Commission or any other EU institution, body, office or agency or body or institutions in EU
Member States; and copying or reproducing them in whole or in part, in unlimited numbers);
(b) distribution to the public (in particular, publication as hard copies and in electronic or digital
format, publication on the internet, as a downloadable or non-downloadable file, broadcasting
by any channel, public display or presentation, communicating through press information
services, or inclusion in widely accessible databases or indexes);
(c) editing or redrafting for communication and publicising activities (including shortening,
summarising, inserting other elements (such as meta-data, legends, other graphic, visual, audio
or text elements), extracting parts (e.g. audio or video files), dividing into parts, use in a
compilation);
(d) translation;
(e) giving access in response to individual requests under Regulation No 1049/200127, without
the right to reproduce or exploit;
(f) storage in paper, electronic or other form;
(g) archiving, in line with applicable document-management rules, and
(h) the right to authorise third parties to act on its behalf or sub-license the modes of use set out
in Points (b), (c), (d) and (f) to third parties if needed for the communication and publicising
activities of the Commission.
If the right of use is subject to rights of a third party (including personnel of the beneficiary), the
27 Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access
to European Parliament, Council and Commission documents, OJ L 145, 31.5.2001, p. 43.
59
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
beneficiary must ensure that it complies with its obligations under this Agreement (in particular, by
obtaining the necessary approval from the third parties concerned).
Where applicable (and if provided by the beneficiaries), the Commission will insert the following
information:
“© – [year] – [name of the copyright owner]. All rights reserved. Licensed to the European Union (EU)
under conditions.”
38.3 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 43).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 39 — PROCESSING OF PERSONAL DATA
39.1 Processing of personal data by the Commission
Any personal data under the Agreement will be processed by the Commission under Regulation
No 45/200128 and according to the ‘notifications of the processing operations’ to the Data Protection
Officer (DPO) of the Commission (publicly accessible in the DPO register).
Such data will be processed by the ‘data controller’ of the Commission for the purposes of
implementing, managing and monitoring the Agreement or protecting the financial interests of the
EU or Euratom (including checks, reviews, audits and investigations; see Article 22).
The persons whose personal data are processed have the right to access and correct their own personal
data. For this purpose, they must send any queries about the processing of their personal data to the
data controller, via the contact point indicated in the privacy statement(s) that are published on the
Commission websites.
They also have the right to have recourse at any time to the European Data Protection Supervisor
(EDPS).
39.2 Processing of personal data by the beneficiaries
The beneficiaries must process personal data under the Agreement in compliance with applicable EU
and national law on data protection (including authorisations or notification requirements).
The beneficiaries may grant their personnel access only to data that is strictly necessary for
implementing, managing and monitoring the Agreement.
The beneficiaries must inform the personnel whose personal data are collected and processed by the
Commission. For this purpose, they must provide them with the privacy statement(s) (see above),
before transmitting their data to the Commission.
28 Regulation (EC) No 45/2001 of the European Parliament and of the Council of 18 December 2000 on the protection
of individuals with regard to the processing of personal data by the Community institutions and bodies and on the free
movement of such data (OJ L 8, 12.01.2001, p. 1).
60
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
39.3 Consequences of non-compliance
If a beneficiary breaches any of its obligations under Article 39.2, the Commission may apply any of
the measures described in Chapter 6.
ARTICLE 40 — ASSIGNMENTS OF CLAIMS FOR PAYMENT AGAINST THE
COMMISSION
The beneficiaries may not assign any of their claims for payment against the Commission to any
third party, except if approved by the Commission on the basis of a reasoned, written request by the
coordinator (on behalf of the beneficiary concerned).
If the Commission has not accepted the assignment or the terms of it are not observed, the assignment
will have no effect on it.
In no circumstances will an assignment release the beneficiaries from their obligations towards the
Commission.
CHAPTER 5 DIVISION OF BENEFICIARIES’ ROLES AND RESPONSIBILITIES
— RELATIONSHIP WITH COMPLEMENTARY BENEFICIARIES —
RELATIONSHIP WITH PARTNERS OF A JOINT ACTION
ARTICLE 41 — DIVISION OF BENEFICIARIES’ ROLES AND RESPONSIBILITIES
— RELATIONSHIP WITH COMPLEMENTARY BENEFICIARIES —
RELATIONSHIP WITH PARTNERS OF A JOINT ACTION
41.1 Roles and responsibility towards the Commission
The beneficiaries have full responsibility for implementing the action and complying with the
Agreement.
The beneficiaries are jointly and severally liable for the technical implementation of the action as
described in Annex 1. If a beneficiary fails to implement its part of the action, the other beneficiaries
become responsible for implementing this part (without being entitled to any additional EU funding
for doing so), unless the Commission expressly relieves them of this obligation.
The financial responsibility of each beneficiary is governed by Article 44.
41.2 Internal division of roles and responsibilities
The internal roles and responsibilities of the beneficiaries are divided as follows:
(a) Each beneficiary must:
(i) keep information stored in the Participant Portal Beneficiary Register (via the electronic
exchange system) up to date (see Article 17);
(ii) inform the coordinator immediately of any events or circumstances likely to affect
significantly or delay the implementation of the action (see Article 17);
61
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
(iii) submit to the coordinator in good time:
- individual financial statements for itself and its linked third parties and, if required,
certificates on the financial statements (see Article 20);
- the data needed to draw up the technical reports (see Article 20);
- ethics committee opinions and notifications or authorisations for activities raising
ethical issues (see Article 34);
- any other documents or information required by the Commission under the Agreement,
unless the Agreement requires the beneficiary to submit this information directly to the
Commission.
(b) The coordinator must:
(i) monitor that the action is implemented properly (see Article 7);
(ii) act as the intermediary for all communications between the beneficiaries and the
Commission (in particular, providing the Commission with the information described in
Article 17), unless the Agreement specifies otherwise;
(iii) request and review any documents or information required by the Commission and verify
their completeness and correctness before passing them on to the Commission;
(iv) submit the deliverables and reports to the Commission (see Articles 19 and 20);
(v) ensure that all payments are made to the other beneficiaries without unjustified delay (see
Article 21);
(vi) inform the Commission of the amounts paid to each beneficiary, when required under the
Agreement (see Articles 44 and 50) or requested by the Commission.
The coordinator may not delegate or subcontract the above-mentioned tasks to any other
beneficiary or third party (including linked third parties).
41.3 Internal arrangements between beneficiaries — Consortium agreement
The beneficiaries must have internal arrangements regarding their operation and co-ordination to
ensure that the action is implemented properly. These internal arrangements must be set out in a written
‘consortium agreement’ between the beneficiaries, which may cover:
- internal organisation of the consortium;
- management of access to the electronic exchange system;
- distribution of EU funding;
- additional rules on rights and obligations related to background and results (including whether
access rights remain or not, if a beneficiary is in breach of its obligations) (see Section 3 of
Chapter 4);
62
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
- settlement of internal disputes;
- liability, indemnification and confidentiality arrangements between the beneficiaries.
The consortium agreement must not contain any provision contrary to the Agreement.
41.4 Relationship with complementary beneficiaries — Collaboration agreement
Not applicable
41.5 Relationship with partners of a joint action — Coordination agreement
Not applicable
CHAPTER 6 REJECTION OF COSTS — REDUCTION OF THE GRANT —
RECOVERY — SANCTIONS — DAMAGES — SUSPENSION —
TERMINATION — FORCE MAJEURE
SECTION 1 REJECTION OF COSTS — REDUCTION OF THE GRANT — RECOVERY
— SANCTIONS
ARTICLE 42 — REJECTION OF INELIGIBLE COSTS
42.1 Conditions
The Commission will — after termination of the participation of a beneficiary, at the time of
an interim payment, at the payment of the balance or afterwards — reject any costs which are
ineligible (see Article 6), in particular following checks, reviews, audits or investigations (see Article
22).
The rejection may also be based on the extension of findings from other grants to this grant (see
Article 22.5.2).
42.2 Ineligible costs to be rejected — Calculation — Procedure
Ineligible costs will be rejected in full.
If the rejection of costs does not lead to a recovery (see Article 44), the Commission will formally
notify the coordinator or beneficiary concerned of the rejection of costs, the amounts and the reasons
why (if applicable, together with the notification of amounts due; see Article 21.5). The coordinator
or beneficiary concerned may — within 30 days of receiving notification — formally notify the
Commission of its disagreement and the reasons why.
If the rejection of costs leads to a recovery, the Commission will follow the contradictory procedure
with pre-information letter set out in Article 44.
42.3 Effects
If the Commission rejects costs at the time of an interim payment or the payment of the balance, it
will deduct them from the total eligible costs declared, for the action, in the periodic or final summary
63
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
financial statement (see Articles 20.3 and 20.4). It will then calculate the interim payment or payment
of the balance as set out in Articles 21.3 or 21.4.
If the Commission rejects costs after termination of the participation of a beneficiary, it will deduct
them from the costs declared by the beneficiary in the termination report and include the rejection in
the calculation after termination (see Article 50.2 and 50.3).
If the Commission — after an interim payment but before the payment of the balance — rejects
costs declared in a periodic summary financial statement, it will deduct them from the total eligible
costs declared, for the action, in the next periodic summary financial statement or in the final summary
financial statement. It will then calculate the interim payment or payment of the balance as set out
in Articles 21.3 or 21.4.
If the Commission rejects costs after the payment of the balance, it will deduct the amount rejected
from the total eligible costs declared, by the beneficiary, in the final summary financial statement. It
will then calculate the revised final grant amount as set out in Article 5.4.
ARTICLE 43 — REDUCTION OF THE GRANT
43.1 Conditions
The Commission may — after termination of the participation of a beneficiary, at the payment
of the balance or afterwards — reduce the grant amount (see Article 5.1), if :
(a) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf)
has committed:
(i) substantial errors, irregularities or fraud or
(ii) serious breach of obligations under the Agreement or during the award procedure
(including improper implementation of the action, submission of false information,
failure to provide required information, breach of ethical principles) or
(b) a beneficiary (or a natural person who has the power to represent or take decision on its behalf)
has committed — in other EU or Euratom grants awarded to it under similar conditions —
systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have a
material impact on this grant (extension of findings from other grants to this grant; see
Article 22.5.2).
43.2 Amount to be reduced — Calculation — Procedure
The amount of the reduction will be proportionate to the seriousness of the errors, irregularities or
fraud or breach of obligations.
Before reduction of the grant, the Commission will formally notify a ‘pre-information letter’ to the
coordinator or beneficiary concerned:
- informing it of its intention to reduce the grant, the amount it intends to reduce and the reasons
why and
- inviting it to submit observations within 30 days of receiving notification.
64
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
If the Commission does not receive any observations or decides to pursue reduction despite the
observations it has received, it will formally notify confirmation of the reduction (if applicable,
together with the notification of amounts due; see Article 21).
43.3 Effects
If the Commission reduces the grant after termination of the participation of a beneficiary, it will
calculate the reduced grant amount for that beneficiary and then determine the amount due to that
beneficiary (see Article 50.2 and 50.3).
If the Commission reduces the grant at the payment of the balance, it will calculate the reduced grant
amount for the action and then determine the amount due as payment of the balance (see Articles 5.3.4
and 21.4).
If the Commission reduces the grant after the payment of the balance, it will calculate the revised
final grant amount for the beneficiary concerned (see Article 5.4). If the revised final grant amount
for the beneficiary concerned is lower than its share of the final grant amount, the Commission will
recover the difference (see Article 44).
ARTICLE 44 — RECOVERY OF UNDUE AMOUNTS
44.1 Amount to be recovered — Calculation — Procedure
The Commission will — after termination of the participation of a beneficiary, at the payment
of the balance or afterwards — claim back any amount that was paid, but is not due under the
Agreement.
Each beneficiary’s financial responsibility in case of recovery is limited to its own debt (including
undue amounts paid by the Commission for costs declared by its linked third parties), except for the
amount retained for the Guarantee Fund (see Article 21.4).
44.1.1 Recovery after termination of a beneficiary’s participation
If recovery takes place after termination of a beneficiary’s participation (including the coordinator), the
Commission will claim back the undue amount from the beneficiary concerned, by formally notifying
it a debit note (see Article 50.2 and 50.3). This note will specify the amount to be recovered, the terms
and the date for payment.
If payment is not made by the date specified in the debit note, the Commission will recover the
amount:
(a) by ‘offsetting’ it — without the beneficiary’s consent — against any amounts owed to the
beneficiary concerned by the Commission or an executive agency (from the EU or Euratom
budget).
In exceptional circumstances, to safeguard the EU’s financial interests, the Commission may
offset before the payment date specified in the debit note;
(b) not applicable;
(c) by taking legal action (see Article 57) or by adopting an enforceable decision under
65
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
Article 299 of the Treaty on the Functioning of the EU (TFEU) and Article 79(2) of the
Financial Regulation No 966/2012.
If payment is not made by the date specified in the debit note, the amount to be recovered (see above)
will be increased by late-payment interest at the rate set out in Article 21.11, from the day following
the payment date in the debit note, up to and including the date the Commission receives full payment
of the amount.
Partial payments will be first credited against expenses, charges and late-payment interest and then
against the principal.
Bank charges incurred in the recovery process will be borne by the beneficiary, unless
Directive 2007/64/EC29 applies.
44.1.2 Recovery at payment of the balance
If the payment of the balance takes the form of a recovery (see Article 21.4), the Commission will
formally notify a ‘pre-information letter’ to the coordinator:
- informing it of its intention to recover, the amount due as the balance and the reasons why;
- specifying that it intends to deduct the amount to be recovered from the amount retained for
the Guarantee Fund;
- requesting the coordinator to submit a report on the distribution of payments to the beneficiaries
within 30 days of receiving notification, and
- inviting the coordinator to submit observations within 30 days of receiving notification.
If no observations are submitted or the Commission decides to pursue recovery despite the
observations it has received, it will confirm recovery (together with the notification of amounts due;
see Article 21.5) and:
- pay the difference between the amount to be recovered and the amount retained for the
Guarantee Fund, if the difference is positive or
- formally notify to the coordinator a debit note for the difference between the amount to be
recovered and the amount retained for the Guarantee Fund, if the difference is negative. This
note will also specify the terms and the date for payment.
If the coordinator does not repay the Commission by the date in the debit note and has not submitted
the report on the distribution of payments: the Commission will recover the amount set out in the
debit note from the coordinator (see below).
If the coordinator does not repay the Commission by the date in the debit note, but has submitted the
report on the distribution of payments: the Commission will:
(a) identify the beneficiaries for which the amount calculated as follows is negative:
29 Directive 2007/64/EC of the European Parliament and of the Council of 13 November 2007 on payment services
in the internal market amending Directives 97/7/EC, 2002/65/EC, 2005/60/EC and 2006/48/EC and repealing
Directive 97/5/EC (OJ L 319, 05.12.2007, p. 1).
66
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
{{{{beneficiary’s costs declared in the final summary financial statement and approved by the
Commission multiplied by the reimbursement rate set out in Article 5.2 for the beneficiary concerned
plus
its linked third parties’ costs declared in the final summary financial statement and approved by the
Commission multiplied by the reimbursement rate set out in Article 5.2 for each linked third party
concerned}
divided by
the EU contribution for the action calculated according to Article 5.3.1}
multiplied by
}
the final grant amount (see Article 5.3) ,
minus
{pre-financing and interim payments received by the beneficiary} . }
(b) formally notify to each beneficiary identified according to point (a) a debit note specifying the
terms and date for payment. The amount of the debit note is calculated as follows:
{{amount calculated according to point (a) for the beneficiary concerned
divided by
the sum of the amounts calculated according to point (a) for all the beneficiaries identified according
to point (a)}
multiplied by
the amount set out in the debit note formally notified to the coordinator}.
If payment is not made by the date specified in the debit note, the Commission will recover the
amount:
(a) by offsetting it — without the beneficiary’s consent — against any amounts owed to the
beneficiary concerned by the Commission or an executive agency (from the EU or Euratom
budget).
In exceptional circumstances, to safeguard the EU’s financial interests, the Commission may
offset before the payment date specified in the debit note;
(b) by drawing on the Guarantee Fund. The Commission will formally notify the beneficiary
concerned the debit note on behalf of the Guarantee Fund and recover the amount:
(i) not applicable;
(ii) by taking legal action (see Article 57) or by adopting an enforceable decision under
Article 299 of the Treaty on the Functioning of the EU (TFEU) and Article 79(2) of the
Financial Regulation No 966/2012.
If payment is not made by the date in the debit note, the amount to be recovered (see above) will be
increased by late-payment interest at the rate set out in Article 21.11, from the day following the
67
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
payment date in the debit note, up to and including the date the Commission receives full payment
of the amount.
Partial payments will be first credited against expenses, charges and late-payment interest and then
against the principal.
Bank charges incurred in the recovery process will be borne by the beneficiary, unless
Directive 2007/64/EC applies.
44.1.3 Recovery of amounts after payment of the balance
If, for a beneficiary, the revised final grant amount (see Article 5.4) is lower than its share of the final
grant amount, it must repay the difference to the Commission.
The beneficiary’s share of the final grant amount is calculated as follows:
{{{beneficiary’s costs declared in the final summary financial statement and approved by the Commission
multiplied by the reimbursement rate set out in Article 5.2 for the beneficiary concerned
plus
its linked third parties’ costs declared in the final summary financial statement and approved by the Commission
multiplied by the reimbursement rate set out in Article 5.2 for each linked third party concerned}
divided by
the EU contribution for the action calculated according to Article 5.3.1}
multiplied by
}
the final grant amount (see Article 5.3) .
If the coordinator has not distributed amounts received (see Article 21.7), the Commission will also
recover these amounts.
The Commission will formally notify a pre-information letter to the beneficiary concerned:
- informing it of its intention to recover, the due amount and the reasons why and
- inviting it to submit observations within 30 days of receiving notification.
If no observations are submitted or the Commission decides to pursue recovery despite the
observations it has received, it will confirm the amount to be recovered and formally notify to the
beneficiary concerned a debit note. This note will also specify the terms and the date for payment.
If payment is not made by the date specified in the debit note, the Commission will recover the
amount:
(a) by offsetting it — without the beneficiary’s consent — against any amounts owed to the
beneficiary concerned by the Commission or an executive agency (from the EU or Euratom
budget).
In exceptional circumstances, to safeguard the EU’s financial interests, the Commission may
offset before the payment date specified in the debit note;
68
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
(b) by drawing on the Guarantee Fund. The Commission will formally notify the beneficiary
concerned the debit note on behalf of the Guarantee Fund and recover the amount:
(i) not applicable;
(ii) by taking legal action (see Article 57) or by adopting an enforceable decision under
Article 299 of the Treaty on the Functioning of the EU (TFEU) and Article 79(2) of the
Financial Regulation No 966/2012.
If payment is not made by the date in the debit note, the amount to be recovered (see above) will be
increased by late-payment interest at the rate set out in Article 21.11, from the day following the
date for payment in the debit note, up to and including the date the Commission receives full payment
of the amount.
Partial payments will be first credited against expenses, charges and late-payment interest and then
against the principal.
Bank charges incurred in the recovery process will be borne by the beneficiary, unless
Directive 2007/64/EC applies.
ARTICLE 45 — ADMINISTRATIVE SANCTIONS
In addition to contractual measures, the Commission may also adopt administrative sanctions under
Articles 106 and 131(4) of the Financial Regulation No 966/2012 (i.e. exclusion from future
procurement contracts, grants, prizes and expert contracts and/or financial penalties).
SECTION 2 LIABILITY FOR DAMAGES
ARTICLE 46 — LIABILITY FOR DAMAGES
46.1 Liability of the Commission
The Commission cannot be held liable for any damage caused to the beneficiaries or to third parties
as a consequence of implementing the Agreement, including for gross negligence.
The Commission cannot be held liable for any damage caused by any of the beneficiaries or third
parties involved in the action, as a consequence of implementing the Agreement.
46.2 Liability of the beneficiaries
Except in case of force majeure (see Article 51), the beneficiaries must compensate the Commission
for any damage it sustains as a result of the implementation of the action or because the action was
not implemented in full compliance with the Agreement.
SECTION 3 SUSPENSION AND TERMINATION
ARTICLE 47 — SUSPENSION OF PAYMENT DEADLINE
47.1 Conditions
69
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
The Commission may — at any moment — suspend the payment deadline (see Article 21.2 to 21.4)
if a request for payment (see Article 20) cannot be approved because:
(a) it does not comply with the provisions of the Agreement (see Article 20);
(b) the technical or financial reports have not been submitted or are not complete or additional
information is needed, or
(c) there is doubt about the eligibility of the costs declared in the financial statements and additional
checks, reviews, audits or investigations are necessary.
47.2 Procedure
The Commission will formally notify the coordinator of the suspension and the reasons why.
The suspension will take effect the day notification is sent by the Commission (see Article 52).
If the conditions for suspending the payment deadline are no longer met, the suspension will be lifted
— and the remaining period will resume.
If the suspension exceeds two months, the coordinator may request the Commission if the suspension
will continue.
If the payment deadline has been suspended due to the non-compliance of the technical or financial
reports (see Article 20) and the revised report or statement is not submitted or was submitted but is also
rejected, the Commission may also terminate the Agreement or the participation of the beneficiary
(see Article 50.3.1(l)).
ARTICLE 48 — SUSPENSION OF PAYMENTS
48.1 Conditions
The Commission may — at any moment — suspend payments, in whole or in part and interim
payments or the payment of the balance for one or more beneficiaries, if:
(a) a beneficiary (or a natural person who has the power to represent or take decision on its behalf)
has committed or is suspected of having committed:
(i) substantial errors, irregularities or fraud or
(ii) serious breach of obligations under the Agreement or during the award procedure
(including improper implementation of the action, submission of false information,
failure to provide required information, breach of ethical principles) or
(b) a beneficiary (or a natural person who has the power to represent or take decision on its behalf)
has committed — in other EU or Euratom grants awarded to it under similar conditions —
systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have a
material impact on this grant (extension of findings from other grants to this grant; see
Article 22.5.2).
If payments are suspended for one or more beneficiaries, the Commission will make partial payment(s)
for the part(s) not suspended. If suspension concerns the payment of the balance, — once suspension
70
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
is lifted — the payment or the recovery of the amount(s) concerned will be considered the payment
of the balance that closes the action.
48.2 Procedure
Before suspending payments, the Commission will formally notify the coordinator or beneficiary
concerned:
- informing it of its intention to suspend payments and the reasons why and
- inviting it to submit observations within 30 days of receiving notification.
If the Commission does not receive observations or decides to pursue the procedure despite the
observations it has received, it will formally notify confirmation of the suspension. Otherwise, it will
formally notify that the suspension procedure is not continued.
The suspension will take effect the day the confirmation notification is sent by the Commission.
If the conditions for resuming payments are met, the suspension will be lifted. The Commission will
formally notify the coordinator or beneficiary concerned.
During the suspension, the periodic report(s) for all reporting periods except the last one (see
Article 20.3), must not contain any individual financial statements from the beneficiary concerned
and its linked third parties. The coordinator must include them in the next periodic report after the
suspension is lifted or — if suspension is not lifted before the end of the action — in the last periodic
report.
The beneficiaries may suspend implementation of the action (see Article 49.1) or terminate the
Agreement or the participation of the beneficiary concerned (see Article 50.1 and 50.2).
ARTICLE 49 — SUSPENSION OF THE ACTION IMPLEMENTATION
49.1 Suspension of the action implementation, by the beneficiaries
49.1.1 Conditions
The beneficiaries may suspend implementation of the action or any part of it, if exceptional
circumstances — in particular force majeure (see Article 51) — make implementation impossible or
excessively difficult.
49.1.2 Procedure
The coordinator must immediately formally notify to the Commission the suspension (see Article 52),
stating:
- the reasons why and
- the expected date of resumption.
The suspension will take effect the day this notification is received by the Commission.
Once circumstances allow for implementation to resume, the coordinator must immediately formally
71
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
notify the Commission and request an amendment of the Agreement to set the date on which the
action will be resumed, extend the duration of the action and make other changes necessary to adapt
the action to the new situation (see Article 55) — unless the Agreement or the participation of a
beneficiary has been terminated (see Article 50).
The suspension will be lifted with effect from the resumption date set out in the amendment. This
date may be before the date on which the amendment enters into force.
Costs incurred during suspension of the action implementation are not eligible (see Article 6).
49.2 Suspension of the action implementation, by the Commission
49.2.1 Conditions
The Commission may suspend implementation of the action or any part of it, if:
(a) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf)
has committed or is suspected of having committed:
(i) substantial errors, irregularities or fraud or
(ii) serious breach of obligations under the Agreement or during the award procedure
(including improper implementation of the action, submission of false information,
failure to provide required information, breach of ethical principles);
(b) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf)
has committed — in other EU or Euratom grants awarded to it under similar conditions —
systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have a
material impact on this grant (extension of findings from other grants to this grant; see
Article 22.5.2), or
(c) the action is suspected of having lost its scientific or technological relevance.
49.2.2 Procedure
Before suspending implementation of the action, the Commission will formally notify the coordinator
or beneficiary concerned:
- informing it of its intention to suspend the implementation and the reasons why and
- inviting it to submit observations within 30 days of receiving notification.
If the Commission does not receive observations or decides to pursue the procedure despite the
observations it has received, it will formally notify confirmation of the suspension. Otherwise, it will
formally notify that the procedure is not continued.
The suspension will take effect five days after confirmation notification is received (or on a later date
specified in the notification).
It will be lifted if the conditions for resuming implementation of the action are met.
The coordinator or beneficiary concerned will be formally notified of the lifting and the Agreement
will be amended to set the date on which the action will be resumed, extend the duration of the action
72
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
and make other changes necessary to adapt the action to the new situation (see Article 55) — unless
the Agreement has already been terminated (see Article 50).
The suspension will be lifted with effect from the resumption date set out in the amendment. This date
may be before the date on which the amendment enters into force.
Costs incurred during suspension are not eligible (see Article 6).
The beneficiaries may not claim damages due to suspension by the Commission (see Article 46).
Suspension of the action implementation does not affect the Commission’s right to terminate the
Agreement or participation of a beneficiary (see Article 50), reduce the grant or recover amounts
unduly paid (see Articles 43 and 44).
ARTICLE 50 — TERMINATION OF THE AGREEMENT OR OF THE PARTICIPATION
OF ONE OR MORE BENEFICIARIES
50.1 Termination of the Agreement, by the beneficiaries
50.1.1 Conditions and procedure
The beneficiaries may terminate the Agreement.
The coordinator must formally notify termination to the Commission (see Article 52), stating:
- the reasons why and
- the date the termination will take effect. This date must be after the notification.
If no reasons are given or if the Commission considers the reasons do not justify termination, the
Agreement will be considered to have been ‘terminated improperly’.
The termination will take effect on the day specified in the notification.
50.1.2 Effects
The coordinator must — within 60 days from when termination takes effect — submit:
(i) a periodic report (for the open reporting period until termination; see Article 20.3) and
(ii) the final report (see Article 20.4).
If the Commission does not receive the reports within the deadline (see above), only costs which are
included in an approved periodic report will be taken into account.
The Commission will calculate the final grant amount (see Article 5.3) and the balance (see
Article 21.4) on the basis of the reports submitted. Only costs incurred until termination are eligible
(see Article 6). Costs relating to contracts due for execution only after termination are not eligible.
Improper termination may lead to a reduction of the grant (see Article 43).
After termination, the beneficiaries’ obligations (in particular Articles 20, 22, 23, Section 3 of
Chapter 4, 36, 37, 38, 40, 42, 43 and 44) continue to apply.
73
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
50.2 Termination of the participation of one or more beneficiaries, by the beneficiaries
50.2.1 Conditions and procedure
The participation of one or more beneficiaries may be terminated by the coordinator, on request of
the beneficiary concerned or on behalf of the other beneficiaries.
The coordinator must formally notify termination to the Commission (see Article 52) and inform the
beneficiary concerned.
If the coordinator’s participation is terminated without its agreement, the formal notification must be
done by another beneficiary (acting on behalf of the other beneficiaries).
The notification must include:
- the reasons why;
- the opinion of the beneficiary concerned (or proof that this opinion has been requested in
writing);
- the date the termination takes effect. This date must be after the notification, and
- a request for amendment (see Article 55), with a proposal for reallocation of the tasks and the
estimated budget of the beneficiary concerned (see Annexes 1 and 2) and, if necessary, the
addition of one or more new beneficiaries (see Article 56). If termination takes effect after the
period set out in Article 3, no request for amendment must be included unless the beneficiary
concerned is the coordinator. In this case, the request for amendment must propose a new
coordinator.
If this information is not given or if the Commission considers that the reasons do not justify
termination, the participation will be considered to have been terminated improperly.
The termination will take effect on the day specified in the notification.
50.2.2 Effects
The coordinator must — within 30 days from when termination takes effect — submit:
(i) a report on the distribution of payments to the beneficiary concerned and
(ii) if termination takes effect during the period set out in Article 3, a ‘termination report’
from the beneficiary concerned, for the open reporting period until termination, containing
an overview of the progress of the work, an overview of the use of resources, the
individual financial statement and, if applicable, the certificate on the financial statement
(see Articles 20.3 and 20.4).
The information in the termination report must also be included in the periodic report for the next
reporting period (see Article 20.3).
If the request for amendment is rejected by the Commission (because it calls into question the decision
awarding the grant or breaches the principle of equal treatment of applicants), the Agreement may be
terminated according to Article 50.3.1(c).
74
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
If the request for amendment is accepted by the Commission, the Agreement is amended to introduce
the necessary changes (see Article 55).
The Commission will — on the basis of the periodic reports, the termination report and the report
on the distribution of payments — calculate the amount which is due to the beneficiary and if the
(pre-financing and interim) payments received by the beneficiary exceed this amount.
The amount which is due is calculated in the following steps:
Step 1 — Application of the reimbursement rate to the eligible costs
The grant amount for the beneficiary is calculated by applying the reimbursement
rate(s) to the total eligible costs declared by the beneficiary and its linked third parties
in the termination report and approved by the Commission.
Only costs incurred by the beneficiary concerned until termination takes effect are
eligible (see Article 6). Costs relating to contracts due for execution only after
termination are not eligible.
Step 2 — Reduction due to substantial errors, irregularities or fraud or serious breach of
obligations
In case of a reduction (see Article 43), the Commission will calculate the reduced
grant amount for the beneficiary by deducting the amount of the reduction (calculated
in proportion to the seriousness of the errors, irregularities or fraud or breach
of obligations, in accordance with Article 43.2) from the grant amount for the
beneficiary.
If the payments received exceed the amounts due:
- if termination takes effect during the period set out in Article 3 and the request for
amendment is accepted, the beneficiary concerned must repay to the coordinator the amount
unduly received. The Commission will formally notify the amount unduly received and
request the beneficiary concerned to repay it to the coordinator within 30 days of receiving
notification. If it does not repay the coordinator, the Commission will draw upon the
Guarantee Fund to pay the coordinator and then notify a debit note on behalf of the
Guarantee Fund to the beneficiary concerned (see Article 44);
- in all other cases, in particular if termination takes effect after the period set out in Article 3,
the Commission will formally notify a debit note to the beneficiary concerned. If payment
is not made by the date in the debit note, the Guarantee Fund will pay to the Commission the
amount due and the Commission will notify a debit note on behalf of the Guarantee Fund
to the beneficiary concerned (see Article 44);
- if the beneficiary concerned is the former coordinator, it must repay the new coordinator
according to the procedure above, unless:
- termination takes effect after an interim payment and
- the former coordinator has not distributed amounts received as pre-financing or
interim payments (see Article 21.7).
75
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
In this case, the Commission will formally notify a debit note to the former coordinator.
If payment is not made by the date in the debit note, the Guarantee Fund will pay to the
Commission the amount due. The Commission will then pay the new coordinator and notify
a debit note on behalf of the Guarantee Fund to the former coordinator (see Article 44).
If the payments received do not exceed the amounts due: amounts owed to the beneficiary
concerned will be included in the next interim or final payment.
If the Commission does not receive the termination report within the deadline (see above), only costs
included in an approved periodic report will be taken into account.
If the Commission does not receive the report on the distribution of payments within the deadline (see
above), it will consider that:
- the coordinator did not distribute any payment to the beneficiary concerned and that
- the beneficiary concerned must not repay any amount to the coordinator.
Improper termination may lead to a reduction of the grant (see Article 43) or termination of the
Agreement (see Article 50).
After termination, the concerned beneficiary’s obligations (in particular Articles 20, 22, 23, Section 3
of Chapter 4, 36, 37, 38, 40, 42, 43 and 44) continue to apply.
50.3 Termination of the Agreement or the participation of one or more beneficiaries, by the
Commission
50.3.1 Conditions
The Commission may terminate the Agreement or the participation of one or more beneficiaries, if:
(a) one or more beneficiaries do not accede to the Agreement (see Article 56);
(b) a change to their legal, financial, technical, organisational or ownership situation (or those
of its linked third parties) is likely to substantially affect or delay the implementation of the
action or calls into question the decision to award the grant;
(c) following termination of participation for one or more beneficiaries (see above), the necessary
changes to the Agreement would call into question the decision awarding the grant or breach
the principle of equal treatment of applicants (see Article 55);
(d) implementation of the action is prevented by force majeure (see Article 51) or suspended by
the coordinator (see Article 49.1) and either:
(i) resumption is impossible, or
(ii) the necessary changes to the Agreement would call into question the decision awarding
the grant or breach the principle of equal treatment of applicants;
(e) a beneficiary is declared bankrupt, being wound up, having its affairs administered by the
courts, has entered into an arrangement with creditors, has suspended business activities, or
is subject to any other similar proceedings or procedures under national law;
76
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
(f) a beneficiary (or a natural person who has the power to represent or take decisions on its
behalf) has been found guilty of professional misconduct, proven by any means;
(g) a beneficiary does not comply with the applicable national law on taxes and social security;
(h) the action has lost scientific or technological relevance;
(i) not applicable;
(j) not applicable;
(k) a beneficiary (or a natural person who has the power to represent or take decisions on its
behalf) has committed fraud, corruption, or is involved in a criminal organisation, money
laundering or any other illegal activity;
(l) a beneficiary (or a natural person who has the power to represent or take decisions on its
behalf) has committed:
(i) substantial errors, irregularities or fraud or
(ii) serious breach of obligations under the Agreement or during the award procedure
(including improper implementation of the action, submission of false information,
failure to provide required information, breach of ethical principles);
(m) a beneficiary (or a natural person who has the power to represent or take decisions on its
behalf) has committed — in other EU or Euratom grants awarded to it under similar conditions
— systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have
a material impact on this grant (extension of findings from other grants to this grant; see
Article 22.5.2);
(n) despite a specific request by the Commission, a beneficiary does not request — through the
coordinator — an amendment to the Agreement to end the participation of one of its linked
third parties or international partners that is in one of the situations under points (e), (f), (g),
(k), (l) or (m) and to reallocate its tasks.
50.3.2 Procedure
Before terminating the Agreement or participation of one or more beneficiaries, the Commission will
formally notify the coordinator or beneficiary concerned:
- informing it of its intention to terminate and the reasons why and
- inviting it, within 30 days of receiving notification, to submit observations and — in case of
Point (l.ii) above — to inform the Commission of the measures to ensure compliance with the
obligations under the Agreement.
If the Commission does not receive observations or decides to pursue the procedure despite the
observations it has received, it will formally notify to the coordinator or beneficiary concerned
confirmation of the termination and the date it will take effect. Otherwise, it will formally notify that
the procedure is not continued.
The termination will take effect:
77
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
- for terminations under Points (b), (c), (e), (g), (h), (j), (l.ii) and (n) above: on the day specified
in the notification of the confirmation (see above);
- for terminations under Points (a), (d), (f), (i), (k), (l.i) and (m) above: on the day after the
notification of the confirmation is received.
50.3.3 Effects
(a) for termination of the Agreement:
The coordinator must — within 60 days from when termination takes effect — submit:
(i) a periodic report (for the last open reporting period until termination; see Article 20.3)
and
(ii) a final report (see Article 20.4).
If the Agreement is terminated for breach of the obligation to submit reports (see Articles 20.8
and 50.3.1(l)), the coordinator may not submit any reports after termination.
If the Commission does not receive the reports within the deadline (see above), only costs
which are included in an approved periodic report will be taken into account.
The Commission will calculate the final grant amount (see Article 5.3) and the balance (see
Article 21.4) on the basis of the reports submitted. Only costs incurred until termination takes
effect are eligible (see Article 6). Costs relating to contracts due for execution only after
termination are not eligible.
This does not affect the Commission’s right to reduce the grant (see Article 43) or to impose
administrative sanctions (Article 45).
The beneficiaries may not claim damages due to termination by the Commission (see
Article 46).
After termination, the beneficiaries’ obligations (in particular Articles 20, 22, 23, Section 3 of
Chapter 4, 36, 37, 38, 40, 42, 43 and 44) continue to apply.
(b) for termination of the participation of one or more beneficiaries:
The coordinator must — within 60 days from when termination takes effect — submit:
(i) a report on the distribution of payments to the beneficiary concerned;
(ii) a request for amendment (see Article 55), with a proposal for reallocation of the tasks and
estimated budget of the beneficiary concerned (see Annexes 1 and 2) and, if necessary,
the addition of one or more new beneficiaries (see Article 56). If termination is notified
after the period set out in Article 3, no request for amendment must be submitted unless
the beneficiary concerned is the coordinator. In this case the request for amendment must
propose a new coordinator, and
(iii) if termination takes effect during the period set out in Article 3, a termination
report from the beneficiary concerned, for the open reporting period until termination,
containing an overview of the progress of the work, an overview of the use of resources,
78
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
the individual financial statement and, if applicable, the certificate on the financial
statement (see Article 20).
The information in the termination report must also be included in the periodic report for the
next reporting period (see Article 20.3).
If the request for amendment is rejected by the Commission (because it calls into question the
decision awarding the grant or breaches the principle of equal treatment of applicants), the
Agreement may be terminated according to Article 50.3.1(c).
If the request for amendment is accepted by the Commission, the Agreement is amended to
introduce the necessary changes (see Article 55).
The Commission will — on the basis of the periodic reports, the termination report and the
report on the distribution of payments — calculate the amount which is due to the beneficiary
and if the (pre-financing and interim) payments received by the beneficiary exceed this amount.
The amount which is due is calculated in the following steps:
Step 1 — Application of the reimbursement rate to the eligible costs
The grant amount for the beneficiary is calculated by applying the
reimbursement rate(s) to the total eligible costs declared by the beneficiary
and its linked third parties in the termination report and approved by the
Commission.
Only costs incurred by the beneficiary concerned until termination takes effect
are eligible (see Article 6). Costs relating to contracts due for execution only
after termination are not eligible.
Step 2 — Reduction due to substantial errors, irregularities or fraud or serious breach
of obligations
In case of a reduction (see Article 43), the Commission will calculate
the reduced grant amount for the beneficiary by deducting the amount of
the reduction (calculated in proportion to the seriousness of the errors,
irregularities or fraud or breach of obligations, in accordance with Article 43.2)
from the grant amount for the beneficiary.
If the payments received exceed the amounts due:
- if termination takes effect during the period set out in Article 3 and the request for
amendment is accepted, the beneficiary concerned must repay to the coordinator the
amount unduly received. The Commission will formally notify the amount unduly
received and request the beneficiary concerned to repay it to the coordinator within
30 days of receiving notification. If it does not repay the coordinator, the Commission
will draw upon the Guarantee Fund to pay the coordinator and then notify a debit
note on behalf of the Guarantee Fund to the beneficiary concerned (see Article 44);
- in all other cases, in particular if termination takes effect after the period set out
in Article 3, the Commission will formally notify a debit note to the beneficiary
concerned. If payment is not made by the date in the debit note, the Guarantee Fund
79
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
will pay to the Commission the amount due and the Commission will notify a debit
note on behalf of the Guarantee Fund to the beneficiary concerned (see Article 44);
- if the beneficiary concerned is the former coordinator, it must repay the new
coordinator according to the procedure above, unless:
- termination takes effect after an interim payment and
- the former coordinator has not distributed amounts received as pre-financing
or interim payments (see Article 21.7).
In this case, the Commission will formally notify a debit note to the former
coordinator. If payment is not made by the date in the debit note, the Guarantee Fund
will pay to the Commission the amount due. The Commission will then pay the new
coordinator and notify a debit note on behalf of the Guarantee Fund to the former
coordinator (see Article 44).
If the payments received do not exceed the amounts due: amounts owed to the beneficiary
concerned will be included in the next interim or final payment.
If the Commission does not receive the termination report within the deadline (see above), only
costs included in an approved periodic report will be taken into account.
If the Commission does not receive the report on the distribution of payments within the
deadline (see above), it will consider that:
- the coordinator did not distribute any payment to the beneficiary concerned and that
- the beneficiary concerned must not repay any amount to the coordinator.
After termination, the concerned beneficiary’s obligations (in particular Articles 20, 22, 23,
Section 3 of Chapter 4, 36, 37, 38, 40, 42, 43 and 44) continue to apply.
SECTION 4 FORCE MAJEURE
ARTICLE 51 — FORCE MAJEURE
‘Force majeure’ means any situation or event that:
- prevents either party from fulfilling their obligations under the Agreement,
- was unforeseeable, exceptional situation and beyond the parties’ control,
- was not due to error or negligence on their part (or on the part of third parties involved in the
action), and
- proves to be inevitable in spite of exercising all due diligence.
The following cannot be invoked as force majeure:
- any default of a service, defect in equipment or material or delays in making them available,
unless they stem directly from a relevant case of force majeure,
80
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
- labour disputes or strikes, or
- financial difficulties.
Any situation constituting force majeure must be formally notified to the other party without delay,
stating the nature, likely duration and foreseeable effects.
The parties must immediately take all the necessary steps to limit any damage due to force majeure
and do their best to resume implementation of the action as soon as possible.
The party prevented by force majeure from fulfilling its obligations under the Agreement cannot be
considered in breach of them.
CHAPTER 7 FINAL PROVISIONS
ARTICLE 52 — COMMUNICATION BETWEEN THE PARTIES
52.1 Form and means of communication
Communication under the Agreement (information, requests, submissions, ‘formal notifications’, etc.)
must:
- be made in writing and
- bear the number of the Agreement.
All communication must be made through the Participant Portal electronic exchange system and using
the forms and templates provided there.
If — after the payment of the balance — the Commission finds that a formal notification was not
accessed, a second formal notification will be made by registered post with proof of delivery (‘formal
notification on paper’). Deadlines will be calculated from the moment of the second notification.
Communications in the electronic exchange system must be made by persons authorised according to
the Participant Portal Terms & Conditions. For naming the authorised persons, each beneficiary must
have designated — before the signature of this Agreement — a ‘legal entity appointed representative
(LEAR)’. The role and tasks of the LEAR are stipulated in his/her appointment letter (see Participant
Portal Terms & Conditions).
If the electronic exchange system is temporarily unavailable, instructions will be given on the
Commission website.
52.2 Date of communication
Communications are considered to have been made when they are sent by the sending party (i.e. on
the date and time they are sent through the electronic exchange system).
Formal notifications through the electronic exchange system are considered to have been made when
they are received by the receiving party (i.e. on the date and time of acceptance by the receiving party,
as indicated by the time stamp). A formal notification that has not been accepted within 10 days after
sending is considered to have been accepted.
81
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
Formal notifications on paper sent by registered post with proof of delivery (only after the payment
of the balance) are considered to have been made on either:
- the delivery date registered by the postal service or
- the deadline for collection at the post office.
If the electronic exchange system is temporarily unavailable, the sending party cannot be considered
in breach of its obligation to send a communication within a specified deadline.
52.3 Addresses for communication
The electronic exchange system must be accessed via the following URL:
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/myarea/projects
The Commission will formally notify the coordinator and beneficiaries in advance any changes to
this URL.
Formal notifications on paper (only after the payment of the balance) addressed to the Commission
must be sent to the official mailing address indicated on the Commission’s website.
Formal notifications on paper (only after the payment of the balance) addressed to the beneficiaries
must be sent to their legal address as specified in the Participant Portal Beneficiary Register.
ARTICLE 53 — INTERPRETATION OF THE AGREEMENT
53.1 Precedence of the Terms and Conditions over the Annexes
The provisions in the Terms and Conditions of the Agreement take precedence over its Annexes.
Annex 2 takes precedence over Annex 1.
53.2 Privileges and immunities
Not applicable
ARTICLE 54 — CALCULATION OF PERIODS, DATES AND DEADLINES
In accordance with Regulation No 1182/7130, periods expressed in days, months or years are calculated
from the moment the triggering event occurs.
The day during which that event occurs is not considered as falling within the period.
ARTICLE 55 — AMENDMENTS TO THE AGREEMENT
55.1 Conditions
The Agreement may be amended, unless the amendment entails changes to the Agreement which
30 Regulation (EEC, Euratom) No 1182/71 of the Council of 3 June 1971 determining the rules applicable to periods, dates
and time-limits (OJ L 124, 8.6.1971, p. 1).
82
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
would call into question the decision awarding the grant or breach the principle of equal treatment
of applicants.
Amendments may be requested by any of the parties.
55.2 Procedure
The party requesting an amendment must submit a request for amendment signed in the electronic
exchange system (see Article 52).
The coordinator submits and receives requests for amendment on behalf of the beneficiaries (see
Annex 3).
If a change of coordinator is requested without its agreement, the submission must be done by another
beneficiary (acting on behalf of the other beneficiaries).
The request for amendment must include:
- the reasons why;
- the appropriate supporting documents, and
- for a change of coordinator without its agreement: the opinion of the coordinator (or proof that
this opinion has been requested in writing).
The Commission may request additional information.
If the party receiving the request agrees, it must sign the amendment in the electronic exchange system
within 45 days of receiving notification (or any additional information the Commission has requested).
If it does not agree, it must formally notify its disagreement within the same deadline. The deadline
may be extended, if necessary for the assessment of the request. If no notification is received within
the deadline, the request is considered to have been rejected.
An amendment enters into force on the day of the signature of the receiving party.
An amendment takes effect on the date agreed by the parties or, in the absence of such an agreement,
on the date on which the amendment enters into force.
ARTICLE 56 — ACCESSION TO THE AGREEMENT
56.1 Accession of the beneficiaries mentioned in the Preamble
The other beneficiaries must accede to the Agreement by signing the Accession Form (see Annex 3) in
the electronic exchange system (see Article 52) within 30 days after its entry into force (see Article 58).
They will assume the rights and obligations under the Agreement with effect from the date of its entry
into force (see Article 58).
If a beneficiary does not accede to the Agreement within the above deadline, the coordinator must
— within 30 days — request an amendment to make any changes necessary to ensure proper
implementation of the action. This does not affect the Commission’s right to terminate the Agreement
(see Article 50).
83
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
H2020Ref.
Associated with document General MGA — Multi:
Ares(2020)2778062 v5
- 28/05/2020
56.2 Addition of new beneficiaries
In justified cases, the beneficiaries may request the addition of a new beneficiary.
For this purpose, the coordinator must submit a request for amendment in accordance with Article 55.
It must include an Accession Form (see Annex 3) signed by the new beneficiary in the electronic
exchange system (see Article 52).
New beneficiaries must assume the rights and obligations under the Agreement with effect from the
date of their accession specified in the Accession Form (see Annex 3).
ARTICLE 57 — APPLICABLE LAW AND SETTLEMENT OF DISPUTES
57.1 Applicable law
The Agreement is governed by the applicable EU law, supplemented if necessary by the law of
Belgium.
57.2 Dispute settlement
If a dispute concerning the interpretation, application or validity of the Agreement cannot be settled
amicably, the General Court — or, on appeal, the Court of Justice of the European Union — has sole
jurisdiction. Such actions must be brought under Article 272 of the Treaty on the Functioning of the
EU (TFEU).
If a dispute concerns administrative sanctions, offsetting or an enforceable decision under Article 299
TFEU (see Articles 44, 45 and 46), the beneficiaries must bring action before the General Court —
or, on appeal, the Court of Justice of the European Union — under Article 263 TFEU.
ARTICLE 58 — ENTRY INTO FORCE OF THE AGREEMENT
The Agreement will enter into force on the day of signature by the Commission or the coordinator,
depending on which is later.
SIGNATURES
For the coordinator For the Commission
[--TGSMark#signature-950932323_75_210--] [--TGSMark#signature-service_75_210--]
Domingos Pereira with ECAS id n003a89o signed in the Signed by Mikaela FARR-DAVID with ECAS id farrdmi as
Participant Portal on 04/06/2020 at 07:34:17 (transaction id SigId- an authorised representative on 04-06-2020 09:03:58
71983- (transaction id SigId-72264-
oUsQqRiqcYsShmT1EX7qwJpvNzp3zmQKUgd4YPxgAzb17Dfye3
yZk5MAGAwUxCbnGe3yCgKvA2dbJdgpI84xHWm- dJ5KAeeoXdHtOwLioeu8wTUzQT5wOSzm8xENUcffwDIy
jpJZscgsw0K73X2i3UbBsu- HLcQlDtJQAM1bcZQSxndzU5ChDa0zo4A97SBztF3VMU-
U318XkCu0G0vrUzbpuzqwW0FB1rdwMXbupnTMhOjGZrG85JrW jpJZscgsw0K73X2i3UbBsu-
bTb9YdY4tWzyr8a6tzwQHdnclBrmrc4DCvSqPa). Timestamp by 8RCqAYY6FvYtcNPUcVwHqVujzi8uQ2Z62SrctAkEGHtx0
third party at ogwvy6EbxlZRUCUZRjVa5GS66XowzgN4QneG73x2u)
Thu Jun 04 08:34:23 CEST 2020 Thu Jun 04 09:04:02 CEST 2020
84
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
EUROPEAN COMMISSION
Directorate-General for Communications Networks, Content and
Technology
CNECT.H – Digital Society, Trust and Cybersecurity
H.3 – eHealth, Well-Being and Ageing
ANNEX 1 (part A)
Coordination and support action
NUMBER — 951938 — X-eHealth
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Table of Contents
1.1. The project summary................................................................................................................................. 3
1.2. The list of beneficiaries..............................................................................................................................4
1.3. Workplan Tables - Detailed implementation..............................................................................................6
1.3.1. WT1 List of work packages........................................................................................................... 6
1.3.2. WT2 List of deliverables................................................................................................................ 7
1.3.3. WT3 Work package descriptions................................................................................................. 11
Work package 1......................................................................................................................... 11
Work package 2......................................................................................................................... 15
Work package 3......................................................................................................................... 19
Work package 4......................................................................................................................... 22
Work package 5......................................................................................................................... 27
Work package 6......................................................................................................................... 32
Work package 7......................................................................................................................... 36
Work package 8......................................................................................................................... 40
Work package 9......................................................................................................................... 45
1.3.4. WT4 List of milestones................................................................................................................ 46
1.3.5. WT5 Critical Implementation risks and mitigation actions........................................................... 48
1.3.6 WT6 Summary of project effort in person-months........................................................................50
1.3.7. WT7 Tentative schedule of project reviews.................................................................................52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
1.1. The project summary
Project Number 1 951938 Project Acronym 2 X-eHealth
One form per project
General information
Project title 3
X-eHealth: eXchanging electronic Health Records in a commom framework
Starting date 4 01/09/2020
Duration in months 5 24
Call (part) identifier 6 H2020-SC1-DTH-2019-2
SC1-HCC-07-2020
Topic
Support for European eHealth Interoperability roadmap for deployment
Fixed EC Keywords
EHRxF; laboratory results; hospital discharge reports; medical imaging and reports; rare
Free keywords
diseases
Abstract 7
X-eHealth’s project stands herein for a project of strategic relevance for tomorrow’s European eHealth Union.
Assembling at the time of this proposal submission a shared commitment of 47 health actors, the underlying idea of
this project is to develop the basis for a workable, interoperable, secure and cross border Electronic Health Record
exchange Format in order to lay the foundation for the advance of eHealth sector while using the 3 pillars put forward
by the EC as reference.
Aimed at promoting a faster and sustainable EU digital transformation, this Cooperative and Support Action is made
up of 8 Work Package in which 4 exclusively focus on technical-functional activities (WP4 to WP7). From Generic
Aspects to System Architecture and Integration, passing by Functional and Technical Specifications, X-eHealth
objective is to move towards a uniform interoperable data-sharing format framework. In addition, to enhance EU’s
public health state of play, WP1 and WP8 are responsible for implementation studies, practicality and continuity of
eHealth interoperability development.
On this basis and building upon the already in place Patient Summary, X-eHealth purpose is to develop the
foundations for a common framework for medical imaging, discharge letters, laboratory results and rare diseases
to flow both alongside citizens care pathway and across health entities between EU Member States and Neighbour
Countries.
Focus on cross-border services, this consortium aims to advance an interoperable Common European Health Data
Space for citizens and health providers engagement in accordance with privacy and cybersecurity regulations.
To achieve this end, X-eHealth gathers 36 consortium partners plus 5 collaborative partners and 6 eHealth skilled
experts, eager to develop the abovementioned 4 domains, and distinguished by policy and political actors mixed with
national competent authorities to indeed concretely plan, implement and maintain national eHealth infrastructures.
Page 3 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
1.2. List of Beneficiaries
Project Number 1 951938 Project Acronym 2 X-eHealth
List of Beneficiaries
Project Project
No Name Short name Country entry exit
month8 month
SPMS - SERVICOS PARTILHADOS DO
1 SPMS Portugal 1 24
MINISTERIO DA SAUDE EPE
BUNDESMINISTERIUM FUER ARBEIT,
2 SOZIALES, GESUNDHEIT UND ATNA Austria 1 24
KONSUMENTENSCHUTZ
3 GESUNDHEIT OSTERREICH GMBH GÖG Austria 1 24
SERVICE PUBLIC FEDERAL SANTE
4 PUBLIQUE, SECURITE DE LA CHAINE FPS Health Be Belgium 1 24
ALIMENTAIRE ET ENVIRONNEMENT
INTEGRATING THE HEALTHCARE
5 IHE-EUR Belgium 1 24
ENTERPRISE-EUROPE AISBL
6 HL7 INTERNATIONAL FONDATION HL7 Europe Belgium 1 24
STICHTING KONINKLIJK NEDERLANDS
7 NEN Netherlands 1 24
NORMALISATIE INSTITUUT
HRVATSKI ZAVOD ZA ZDRAVSTVENO
8 HZZO Croatia 1 24
OSIGURANJE
9 UNIVERSITY OF CYPRUS UCY Cyprus 1 24
MINISTERSTVO ZDRAVOTNICTVI
10 MZCR Czech Republic 1 24
CESKE REPUBLIKY
11 VYSOCINA KRAJ Kraj Vysočina Czech Republic 1 24
12 SOTSIAALMINISTEERIUM MSAE Estonia 1 24
13 AGENCE DU NUMÉRIQUE EN SANTÉ ANS France 1 24
MINISTERE DES AFFAIRES SOCIALES
14 MoH-FR France 1 24
ET DE LA SANTE
DEUTSCHES INSTITUT FUR
15 MEDIZINISCHE DOKUMENTATION UND DIMDI Germany 1 24
INFORMATION (DIMDI)
16 GEMATIK GMBH GEMATIK Germany 1 24
TMF - TECHNOLOGIE UND
METHODENPLATTFORM FUR
17 TMF Germany 1 24
DIE VERNETZTE MEDIZINISCHE
FORSCHUNG EV
18 MINISTRY OF HEALTH MoHGR Greece 1 24
ALLAMI EGESZSEGUGYI ELLATO
19 AEEK Hungary 1 24
KOZPONT
20 SEMMELWEIS EGYETEM SE Hungary 1 24
21 DEPARTMENT OF HEALTH DoH Ireland 1 24
22 AGENZIA PER L'ITALIA DIGITALE AGID Italy 1 24
Page 4 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
1.2. List of Beneficiaries
Project Project
No Name Short name Country entry exit
month8 month
AZIENDA REGIONALE PER
23 ARIA Italy 1 24
L'INNOVAZIONEE GLI ACQUISTI S.P.A.
24 MINISTERO DELLA SALUTE MIN SAL Italy 1 24
25 REGIONE LOMBARDIA REGLOMB Italy 1 24
26 NACIONALAIS VESELIBAS DIENESTS NVD Latvia 1 24
LIETUVOS RESPUBLIKOS SVEIKATOS
27 SAM Lithuania 1 24
APSAUGOS MINISTERIJA
STICHTING NATIONAAL ICT
28 NICTIZ Netherlands 1 24
INSTITUUT IN DE ZORG
NARODNE CENTRUM
29 NCZI Slovakia 1 24
ZDRAVOTNICKYCH INFORMACII
NACIONALNI INSTITUT ZA JAVNO
30 NIJZ Slovenia 1 24
ZDRAVJE
31 FUNDACIO TICSALUT TICSALUT Spain 1 24
32 EQUALIS AB Equalis AB Sweden 1 24
33 E-HALSOMYNDIGHETEN SEHA Sweden 1 24
INSTITUT NATIONAL DE LA SANTE ET
34 INSERM France 1 24
DE LA RECHERCHE MEDICALE
Page 5 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
1.3. Workplan Tables - Detailed implementation
1.3.1. WT1 List of work packages
WP Person- Start End
WP Title Lead beneficiary10
Number9 months11 month12 month13
WP1 Project coordination 1 - SPMS 45.50 1 24
Dissemination, communication &
WP2 1 - SPMS 12.00 1 24
Stakeholders
WP3 Evaluation 3 - GÖG 7.00 1 24
Generic Aspects of EEHRxF
WP4 23 - ARIA 29.67 1 24
recommendation
Definition of EEHRxF functional
WP5 28 - NICTIZ 56.34 1 24
specifications
Definition of EEHRxF
WP6 6 - HL7 Europe 41.75 1 24
implementable specifications
Architecture integration and System
WP7 23 - ARIA 42.00 7 24
specifications
EEHRxF Communities of Practice:
from Proof of Concept to large
WP8 18 - MoHGR 28.50 1 24
scale adoption and Infrastructure for
Innovation
WP9 Ethics requirements 1 - SPMS N/A 1 24
Total 262.76
Page 6 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
1.3.2. WT2 list of deliverables
Due
Deliverable WP Dissemination
Deliverable Title Lead beneficiary Type 15 Date (in
Number14 number9 level16
months)17
Confidential,
only for members
of the consortium
D1.1 D1.1 - Interim report I WP1 1 - SPMS Report 12
(including the
Commission
Services)
Confidential,
only for members
of the consortium
D1.2 D1.2 Final Report WP1 1 - SPMS Report 24
(including the
Commission
Services)
D1.3 - Roadmap for
D1.3 WP1 28 - NICTIZ Report Public 24
new domains
Confidential,
D1.4 Proposal of a only for members
sustainable governance of the consortium
D1.4 WP1 28 - NICTIZ Report 24
model for eHDSI (including the
beyond CEF Commission
Services)
Confidential,
only for members
D1.5 - Readiness of the consortium
D1.5 WP1 28 - NICTIZ Report 24
assessment report (including the
Commission
Services)
Confidential,
only for members
D1.6 - Ethics of the consortium
D1.6 WP1 1 - SPMS Other 3
Requirements (including the
Commission
Services)
Confidential,
only for members
D1.7 Progress towards of the consortium
D1.7 WP1 1 - SPMS Report 12
internal deliverables (including the
Commission
Services)
Websites,
D2.1 - X-eHealth
D2.1 WP2 1 - SPMS patents Public 3
official website
filling, etc.
D2.2 D2.2 X-eHealth leaflet WP2 1 - SPMS Other Public 3
Confidential,
D2.3 - Communication,
only for members
D2.3 Dissemination and WP2 1 - SPMS Report 3
of the consortium
Engagement Plan
(including the
Page 7 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Due
Deliverable WP Dissemination
Deliverable Title Lead beneficiary Type15 Date (in
Number14 number9 level16
months)17
Commission
Services)
Websites,
D2.4 X-eHealth
D2.4 WP2 1 - SPMS patents Public 6
promotional video
filling, etc.
Confidential,
only for members
D2.5 - X-eHealth
of the consortium
D2.5 Dissemination WP2 1 - SPMS Report 12
(including the
Activities Report I
Commission
Services)
D2.6 X-eHealth
D2.6 WP2 1 - SPMS Other Public 18
Stakeholders leaflet
Confidential,
only for members
D2.7 - X-eHealth
of the consortium
D2.7 Dissemination WP2 1 - SPMS Report 24
(including the
Activities Report II
Commission
Services)
Confidential,
only for members
D3.1 Project evaluation of the consortium
D3.1 WP3 3 - GÖG Report 5
plan and impact matrix (including the
Commission
Services)
Confidential,
only for members
D3.2 - Overall of the consortium
D3.2 WP3 3 - GÖG Report 24
Evaluation report (including the
Commission
Services)
D4.1.1 eID in eHealth:
D4.1 survey of national WP4 23 - ARIA Other Public 6
solutions
D4.1.2 eID in eHealth:
D4.2 from national solutions WP4 23 - ARIA Report Public 18
to eIDAS
D4.2.1 Information
paper on the current
challenges in legal
D4.3 WP4 11 - Kraj Vysočina Report Public 9
aspects of cross-border
exchange of personal
data
D4.2.2
Recommendation
D4.4 WP4 11 - Kraj Vysočina Report Public 14
paper on legislative
enablers for cross-
Page 8 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Due
Deliverable WP Dissemination
Deliverable Title Lead beneficiary Type15 Date (in
Number14 number9 level16
months)17
border personal data
interoperability
Confidential,
only for members
D4.3.1 European trust of the consortium
D4.5 WP4 20 - SE Report 5
space background (including the
Commission
Services)
Confidential,
D4.3.2 Policy
only for members
recommendation for EU
of the consortium
D4.6 level actions to achieve WP4 20 - SE Report 24
(including the
digital health data trust
Commission
in the cyber space
Services)
D5.1 X-eHealth
D5.1 use cases driven WP5 16 - GEMATIK Report Public 23
methodology
D5.2 EEHRxF and
D5.2 its relationship with WP5 23 - ARIA Report Public 23
clinical guidelines
D5.3 Laboratory
Requests and Reports
D5.3 WP5 10 - MZCR Report Public 23
guideline and functional
specifications
D5.4 Medical Imaging
and Reports guideline
D5.4 WP5 28 - NICTIZ Report Public 23
and functional
specifications
D5.5 Hospital
Discharge Reports
D5.5 WP5 11 - Kraj Vysočina Report Public 23
guideline and functional
specifications
D5.6 Refine
PS functional
specifications to
D5.6 WP5 25 - REGLOMB Report Public 23
account for eHN
Guidelines and rare
diseases
D5.7a Final
D5.7 Conclusions and WP5 28 - NICTIZ Report Public 24
Recommendations
D6.1 X-eHealth
D6.1 WP6 5 - IHE-EUR Report Public 24
Services Specifications
D6.2 X-eHealth Testing
D6.2 WP6 5 - IHE-EUR Report Public 24
Tools
D6.3 X-eHealth
D6.3 WP6 6 - HL7 Europe Report Public 24
Implementation Guide
Page 9 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Due
Deliverable WP Dissemination
Deliverable Title Lead beneficiary Type15 Date (in
Number14 number9 level16
months)17
D7.1 EEHRxF
D7.1 architecture WP7 23 - ARIA Report Public 15
specifications
D7.2 EEHRxF
D7.2 WP7 5 - IHE-EUR Report Public 22
Testability strategies
D7.3 Possible upgrades
D7.3 of eHDSI core and WP7 33 - SEHA Report Public 24
generic services
D7.4 Proposal
guidelines to implement
D7.4 WP7 33 - SEHA Report Public 24
EEHRxF in National
Services
D8.1 EEHRxF
D8.1 WP8 6 - HL7 Europe Report Public 6
Community of Practice
D8.2 Report on
EEHRxF proof of
D8.2 WP8 23 - ARIA Report Public 19
concept demonstrators
for-rare diseases
D8.3 Report on
EEHRxF proof of
concept demonstrators
D8.3 WP8 18 - MoHGR Report Public 20
for chronic disease
management and
prevention
D8.4 Exploratory study
for decision aids and
D8.4 WP8 6 - HL7 Europe Report Public 21
citizen driven health-
science
D8.5 EEHRxF as
D8.5 infrastructure for WP8 7 - NEN Report Public 23
innovation
D8.6 Evaluation of
D8.6 EEHRxF proof of WP8 9 - UCY Report Public 22
Concept
Confidential,
only for members
POPD - Requirement of the consortium
D9.1 WP9 1 - SPMS Ethics 1
No. 1 (including the
Commission
Services)
Confidential,
only for members
POPD - Requirement of the consortium
D9.2 WP9 1 - SPMS Ethics 1
No. 2 (including the
Commission
Services)
Page 10 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
1.3.3. WT3 Work package descriptions
Work package number 9 WP1 Lead beneficiary 10 1 - SPMS
Work package title Project coordination
Start month 1 End month 24
Objectives
Feature by WP1, the Project Coordinator's objectives are to ensure:
Smooth development and successful execution of X-eHealth purposes;
Productive guidance, efficient communication and proper coordination of X-eHealth bodies, partners, and associates;
Optimization of the allocated necessary inputs so processes may be reformed and updated toward enhancing the project
sustainability;
Deliverables are promptly produced and thoroughly reviewed for delivery to the EC;
Communication between Member States and the EC for close cooperation aimed at further developing the exchange
of health data across borders in Europe;
Compliance with the "ethics requirements" set out in this work package;
Description of work and role of partners
WP1 - Project coordination [Months: 1-24]
SPMS, MoHGR, NICTIZ, TICSALUT
T1.1: Project management, quality control and risk management (Lead: SPMS; QM, RM) M1-M24
Being vertically accountable to the EC by virtue of the Grant Agreement, the Project Coordinator stands as the official
interface connecting the Consortium and the EC. Aimed to succeed in carrying out the abovementioned objectives, this
task consists of organizing, controlling and coordinating the whole project with the outmost quality standards.
It is the responsibility of this task to: ensure communication practices between WPs occur regularly to better monitor
the variations that are to arise against the relevant schedule line, thus ensuring milestones are carried out smoothly and
conflicts are settled with consensus.
To further support project management capabilities, both the Quality and Risk Managements stand as integral fractions
of the PC (WP1). The appointed Quality and Risk managers shall ensure that the Quality Assurance of Deliverables and
the Risk Assessment procedures are both thoroughly e observed and nforced as outlined in section 3.2.
T1.2: Project administrative and financial management (Lead: SPMS) M1-M24
Aimed at strengthening X-eHealth's administration and financial management, this task focuses exclusively on
complying with the time limits, fostering a reporting mechanism and improving budgetary governance.
Its objective is to continuously compile partners' financial activities to enhance budget management and, whenever
required, accountability reports to the EC. Amendments to the Grant Agreement shall be executed within this task.
This task functionalities comprise all administrative issues, from legal to financial and from technical to organizational,
and shall ultimately ensure X-eHealth develops smoothly towards a successful impact.
This task deals with the ongoing financial reporting, budget management as well as the establishment of the work
procedures and operational rules. It aims to establish the project’s reporting mechanism and set the general rules of
operations for all involved bodies and partners.
T1.3: Roadmap of new domains and sustainability plan (Lead: NICTIZ; Participant: SPMS, MoH-GR, TIC-Salut) M1-
M24
This proposal addresses the development of four use cases: medical images, lab results, hospital discharge letters and
patient summary supporting patients with rare disease. The EEHRxF should enable the subsequent expansion of cross
border exchange of health data. To this end, this task will develop a roadmap for the identification of new domains
and use cases to be included in the EEHRxF. The national challenges as identified in Task 1.4 as well as specified
enablers and barriers will be taken into consideration in the development of the roadmap. Active involvement and close
cooperation between MS's and EC are essential for viable future developments.
Additionally, this task will develop a sustainability model for the structural management, maintenance and further
development of the eHealth Digital Service Infrastructure, in line with the EEHRxF roadmap.
The development of the roadmap and the sustainability plan will be aligned with the ongoing developments of the Joint
Coordination Process.
The work in this task will be aligned with the results of activities in programs with similar or related objectives, such
as eHAction (D6.1), IPS and the gap analysis produced by the EC on the adoption of IPS guidelines.
Page 11 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
T1.4: Mapping national challenges for EEHRxF adoption (Lead: NICTIZ; Participant: SPMS, MoH-GR, TIC-Salut)
M1-M24
The objective of this task is to assess the readiness of MS’s to deploy the use cases developed in this proposal.
A framework, based on the ReEIF model, will be developed to perform a general mapping of MS’ readiness. The
assessments will be executed in workshops organized at the beginning, mid-term and end of the project. The mapping at
the start of the project is a preliminary gap-analysis intended to offer useful information to WP 5, 6 and 7. At mid-term,
the assessment is used to formulate a set of recommendations, barriers and enablers intended for use in the guidelines
for the developed use cases. The iterative approach is aimed at the development of solutions that are suitable for rapid
deployment and adoption by MS’s.
The work in this task will be aligned with the work of relevant EU working groups/projects, such as eHMSEG, JCP,
eHN Subgroup on Semantics, etc.
Task 1.5: Ethics Requirements (Lead: SPMS; Participant: ARIA and Vysocina) M1-M24
Task 1.5 objectives are: to ensure compliance with the ethics requirements established by the General Data Protection
Regulation (i), to set out the ethics requirements that the project must comply with (ii), and to produce a deliverable
clearly stating that the personal data from workshop and survey participants will be handled in a GDPR compliant
manner, therefore in accordance with the ‘data minimisation' principle (iii). In addition, this sub-task will specify in its
associated deliverable D1.6 that all the deliverables produced by X-eHealth must contain a section specifically designed
to address the ethics requirement that the same deliverable content may rise.
Participation per Partner
Partner number and short name WP1 effort
1 - SPMS 36.00
18 - MoHGR 1.00
28 - NICTIZ 7.50
31 - TICSALUT 1.00
Total 45.50
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type 15
Dissemination level 16 Date (in
Number14
months)17
Confidential, only
for members of the
D1.1 D1.1 - Interim report I 1 - SPMS Report consortium (including 12
the Commission
Services)
Confidential, only
for members of the
D1.2 D1.2 Final Report 1 - SPMS Report consortium (including 24
the Commission
Services)
D1.3 - Roadmap for new
D1.3 28 - NICTIZ Report Public 24
domains
Confidential, only
D1.4 Proposal of a
for members of the
sustainable governance
D1.4 28 - NICTIZ Report consortium (including 24
model for eHDSI beyond
the Commission
CEF
Services)
Page 12 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type 15
Dissemination level 16 Date (in
Number14
months)17
Confidential, only
for members of the
D1.5 - Readiness
D1.5 28 - NICTIZ Report consortium (including 24
assessment report
the Commission
Services)
Confidential, only
for members of the
D1.6 - Ethics
D1.6 1 - SPMS Other consortium (including 3
Requirements
the Commission
Services)
Confidential, only
for members of the
D1.7 Progress towards
D1.7 1 - SPMS Report consortium (including 12
internal deliverables
the Commission
Services)
Description of deliverables
D1.1 - Interim report I (M12)
X-eHealth 12 months report on performed activities, deliverables and milestones.
D1.2 - Final report (M24)
This report describes the CSA implementation and the results achieved.
D1.3 - Roadmap for new domains (M24)
A plan for the identification of new domains and use cases to be included in the EEHRxF.
D1.4 - Proposal of a sustainable governance model for eHDSI beyond CEF (M24)
A model for the structural management, maintenance and further development of eHDSI
D1.5 - Readiness assessment report (M24)
This report contains a mapping of national characteristics and challenges per MS for each of the developed use cases.
D1.6 - Ethics Requirements (M03)
This deliverable states how the personal data collected from workshop and survey participants will be limited to
the purposes of the research project (in accordance with the ‘data minimisation’ principle) and handled in a GDPR
compliant manner. This deliverable also describes the technical and organisational measures that will be implemented
to safeguard the rights and freedoms of data subjects.
D1.7 - Progress towards internal deliverables (M12)
To be submitted during the first reporting period, this deliverable objective is to ensure that the progress of all internal
deliverables pops up formally into an official deliverable of the project. This way, allowing the EC to check the
internal work of the project while fostering a mechanism for keeping tracked the progress of X-eHealth internal
deliverables.
ID1.5.1 - Readiness assessment report (M04)
ID1.5.2 - Readiness assessment report (M12)
D1.1 : D1.1 - Interim report I [12]
X-eHealth 12 months report on performed activities, deliverables and milestones.
D1.2 : D1.2 Final Report [24]
This report describes the CSA implementation and the results achieved.
D1.3 : D1.3 - Roadmap for new domains [24]
A plan for the identification of new domains and use cases to be included in the EEHRxF
D1.4 : D1.4 Proposal of a sustainable governance model for eHDSI beyond CEF [24]
A model for the structural management, maintenance and further development of eHDSI
Page 13 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
D1.5 : D1.5 - Readiness assessment report [24]
This report contains a mapping of national characteristics and challenges per MS for each of the developed use cases.
D1.6 : D1.6 - Ethics Requirements [3]
This deliverable states how the personal data collected from workshop and survey participants will be limited to
the purposes of the research project (in accordance with the ‘data minimisation’ principle) and handled in a GDPR
compliant manner. This deliverable also describes the technical and organisational measures that will be implemented
to safeguard the rights and freedoms of data subjects.
D1.7 : D1.7 Progress towards internal deliverables [12]
To be submitted during the first reporting period (M12), this deliverable objective is to ensure that the progress of all
internal deliverables pops up formally into an official deliverable of the project. This way, allowing the EC to check
the internal work of the project while fostering a mechanism for keeping tracked the progress of X-eHealth internal
deliverables.
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
MS1 MS1.1 1 - SPMS 1 Consortium agreement
MS2 MS1.2 1 - SPMS 12 Report template for partners
Page 14 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Work package number 9 WP2 Lead beneficiary 10 1 - SPMS
Work package title Dissemination, communication & Stakeholders
Start month 1 End month 24
Objectives
Being liable for the project Communication and Dissemination strategy, WP2 objectives are:
• Development and implementation of X-eHealth Communication, Dissemination and Engagement Plan to maximize
impact
• To ensure effective communication among partners so that results can be published in a timely fashion and generated
knowledge disseminate accordingly
• Management, development and updating of X-eHealth’s media to enhance the project visibility among external
stakeholders, in accordance with the provisions for cross-border eHealth services
• To support the organization of X-eHealth face-to-face and virtual events to advance the assimilation of knowledge
and experience among Member States’ entities
• To produce suitable, sophisticated and tailored content materials for digital dissemination
Description of work and role of partners
WP2 - Dissemination, communication & Stakeholders [Months: 1-24]
SPMS, GÖG, IHE-EUR, HL7 Europe
T2.1: Communication, Dissemination and Engagement Plan (Lead: SPMS; Participant: IHE, HL7) M1-M24
This task comprises the development of the project's strategic communication plan to ensure it reaches national decision-
makers as well as business, scientific and societal stakeholders. The plan builds upon a set of activities (different
diffusion channels, content types and actions) aimed at supporting the dissemination of the project outcomes.
T2.2: Healthcare providers, Health professionals and Citizens motivation (Lead: SPMS; Participant: GoeG, HL7) M3-
M24
This task consists of furthering communication activities through target capacity-building training sessions earmarked
to instruct and qualify health professionals concerning the usage of cross-border services while raising knowledge of
the different MS legislative environment. Health care providers, in turn, should act as direct means of communication,
addressing citizens with information on how to use digital services.
As regards citizens’ engagement, specific communication actions will be designed and implemented in order to raise
awareness of European citizenship rights in relation to cross-border care services, as well as its accessibility and
interoperability with national health systems. For this purpose a glossary with common terms shall be developed together
with WP 3. HL7 will support from the perspective of the CoP (WP8.4).
T2.3: MS and National Authorities involvement (Lead: SPMS; Participant: GOeG, HL7) M1-M24
The purpose of this task is to convey MS and National Health Authorities the development progress of X-eHealth
activities. Decision-makers will be approached to enhance the achievement of eHealth cross-border services. Overall
strategies and the action roadmap should be agreed upon engaged Member States and implemented according to national
specificities. HL7 will support from the perspective of the CoP (WP8.4).
T2.4 Industries, researchers and developers’ liaison (Lead: SPMS, Participants: HL7) M3-M24
This task goal is to promote liaison with major players of the health sector in order to promote knowledge sharing and
exchange of relevant experiences among X-eHealth partners. Representatives from leading health industries, researchers
and developers will be actively involved at different stages of the project, thus contributing to enhancing its development
and outcomes. HL7 will support from the perspective of the CoP (WP8.4) linking to collaborative partners.
T2.5 “X-Hospitals” - Hospital Network for the exploration of the EEHRxF (Lead: SPMS; Participant: HL7) M1-M24
In this task it will be promoted network methodologies, such as, teleconference, between nationals’ hospitals across
Europe, with the objective of promote a dialogue and sharing of experiences and vision of how to contribute to develop
EEHRxF specifications in hospital relevant domains, such as the ones under the current call, but more importantly to
share awareness about the EEHRxF, and to foster cross-fertilization of methods of adoption, usage and overcoming
implementation challenges.
The EEHRxF can serve to create useful and needed interhospital digital connections, not just cross-border but even more
relevant, intraborders. It is by engaging concrete organizations providing care, that we are sure to guarantee usefulness
and pertinence to the all project. Such can build on existing networks of HP such as hospitals in the ERNs and other
networks, like research networks including hospitals.
Page 15 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
So synergies with those initiatives will be pursued actively. Sub tasks: satellite workshops or meetings in events where
many hospital representative may be, regular podcasts, regular TCONs of networks of hospitals, creation of collateral
and clustered (into domains) sub-networks of practical experience facing common interoperability challenges. Ensuring
national and EU level hospital or hospital managers associations include/incorporate into their dynamics debates and
follow-up on the development and later the deployment of the EEHRxF. HL7 will support connecting to the CoP
(WP8.4).
Participation per Partner
Partner number and short name WP2 effort
1 - SPMS 10.00
3 - GÖG 1.00
5 - IHE-EUR 0.50
6 - HL7 Europe 0.50
Total 12.00
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type 15
Dissemination level 16 Date (in
Number14
months)17
Websites,
D2.1 - X-eHealth official
D2.1 1 - SPMS patents Public 3
website
filling, etc.
D2.2 D2.2 X-eHealth leaflet 1 - SPMS Other Public 3
Confidential, only
D2.3 - Communication, for members of the
D2.3 Dissemination and 1 - SPMS Report consortium (including 3
Engagement Plan the Commission
Services)
Websites,
D2.4 X-eHealth
D2.4 1 - SPMS patents Public 6
promotional video
filling, etc.
Confidential, only
D2.5 - X-eHealth for members of the
D2.5 Dissemination Activities 1 - SPMS Report consortium (including 12
Report I the Commission
Services)
D2.6 X-eHealth
D2.6 1 - SPMS Other Public 18
Stakeholders leaflet
Confidential, only
D2.7 - X-eHealth for members of the
D2.7 Dissemination Activities 1 - SPMS Report consortium (including 24
Report II the Commission
Services)
Description of deliverables
D2.1 - X-eHealth official website (M03)
Page 16 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Development of an official website to communicate the project ongoing activities and disseminate outcomes-
Deliverables
D2.1 - X-eHealth official website (M03)
Development of an official website to communicate the project ongoing activities and disseminate outcomes.
D2.2 - X-eHealth leaflet (M03)
Development of a leaflet at the beginning of the project to promote the main objectives of X-eHealth to external
stakeholders.
D2.3 - Communication, Dissemination and Engagement Plan (M03)
This deliverable consists of the development of X-eHealth’s Plan for Communication, Dissemination and
Engagement. The plan shall outline the underlying strategy for effective communication to foster target stakeholders’
engagement.
D2.4 - X-eHealth promotional video (M06)
Promotional video highlighting X-eHealth activities and expected impacts.
D2.5 - X-eHealth Dissemination Activities Report I (M12)
Report on communication activities (dissemination, Deliverables, Milestones and outcomes) carried out in the first 12
months of X-eHealth.
D2.6 - X-eHealth Stakeholders leaflet (M18)
Development of a leaflet to disseminate expected benefits for X-eHealth stakeholders accordingly.
D2.7 - X-eHealth Dissemination Activities Report II (M24)
Report on communication activities (dissemination, Deliverables, Milestones and outcomes) carried out in the second
12 months of X-eHealth.
D2.1 : D2.1 - X-eHealth official website [3]
Development of an official website to communicate the project ongoing activities and disseminate outcomes
D2.2 : D2.2 X-eHealth leaflet [3]
Development of a leaflet at the beginning of the project to promote the main objectives of X-eHealth to external
stakeholders.
D2.3 : D2.3 - Communication, Dissemination and Engagement Plan [3]
This deliverable consists of the development of X-eHealth’s Plan for Communication, Dissemination and
Engagement. The plan shall outline the underlying strategy for effective communication to foster target stakeholders’
engagement
D2.4 : D2.4 X-eHealth promotional video [6]
Promotional video highlighting X-eHealth activities and expected impacts.
D2.5 : D2.5 - X-eHealth Dissemination Activities Report I [12]
Report on communication activities (dissemination, Deliverables, Milestones and outcomes) carried out in the first 12
months of X-eHealth.
D2.6 : D2.6 X-eHealth Stakeholders leaflet [18]
Development of a leaflet to disseminate expected benefits for X-eHealth stakeholders accordingly.
D2.7 : D2.7 - X-eHealth Dissemination Activities Report II [24]
Report on communication activities (dissemination, Deliverables, Milestones and outcomes) carried out in the second
12 months of X-eHealth.
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
MS3 MS2.1 1 - SPMS 12 1st X-eHealth Innovation Day
Professional Training
MS4 MS2.2 1 - SPMS 22
Sessions
Page 17 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
2nd X-eHealth Innovation
MS5 MS2.3 1 - SPMS 24
Day
X-eHealth interoperability
MS6 MS2.4 1 - SPMS 24
award 2022
Page 18 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Work package number 9 WP3 Lead beneficiary 10 3 - GÖG
Work package title Evaluation
Start month 1 End month 24
Objectives
The success of this undertaking depends on the effectiveness and productiveness to achieve the defined outcomes and
goal. To do so, both the project management and the vertical Work Packages (WPs) need to come up with comprehensive
deliverables of high-quality bringing value to the overarching goal of well implemented interoperable eHealth services
for European health professionals and citizens.
The main objective of the “WP3 Evaluation” is to verify if the Action is being implemented as planned and whether
it reaches its foreseen objectives.
Description of work and role of partners
WP3 - Evaluation [Months: 1-24]
GÖG, IHE-EUR, UCY, MoHGR, REGLOMB
The evaluator will take stock on the achievements of the project, e.g. assessing if the necessary pillars and building
blocks for a Common European eHealth space were produced or at least prepared for the next steps.
The evaluator will use a Logic Framework Approach as a starting point, as it is considered as an appropriate point of
reference for evaluating EC funded projects since published in 2004. It allows to look at the rationale of the various
planned undertakings, their interdependencies and is an import building block to ascertain the quality of results.
T3.1: Evaluation Plan and Impact Matrix (Lead: GOeG; Participant: MoH-GR, Reg. Lombard., IHE, UCY) M1-M6
As first milestone we would generate as part of the evaluation plan an impact matrix with perhaps the following headings
(draft for display only).
We aim to measure the impact on the following potential user of results
• Decision makers in e-Health (Competent Authorities, EU services)
• eHealth Agencies
• eHealth Stakeholders (e.g., service providers)
• General population
The evaluation plan will include a set of measurable indicators for the three pillars (Citizens' secure access to their health
data, also across borders; Personalised medicine through shared European data infrastructure and Citizen empowerment
with digital tools for user feedback and person-centred care).
Per pillar each two to three “process”, “output” and “outcome” indicators will be defined that will allow for a monitoring.
Examples could be, e.g.
• how many Member States EHR solutions were assessed by the end of the project and in which way or
• regarding deployment, the number of specifications based the European Commission recommendation on the European
EHR exchange format 2 or
• whether the targeted number of citizens (overall number and perhaps targets per participating country) using the
considered eHealth platforms (compliant with EC recommendations)
Also, a sort of glossary of common terms used in the undertaking will be prepared at the beginning to ensure that the
same things are meant throughout the collaboration and in the different work packages.
T3.2: Continuous Evaluation and Monitoring (Lead: GOeG; Participant: IHE, MoH-GR, Reg. Lombard., UCY) M6-
M24
For evaluation we suggest using a “triangulated” approach, meaning that different evaluation instruments, ranging from
on-the-spot surveys in meetings, via observation and document analysis to individual phone/e-mail mini-surveys with
WP-leads and co-leads will be used. The necessary tools to support information collection (e.g., Mentimeter®) or
WebEx© are available to the Evaluator.
The evaluation will include internal evaluation, i.e. if the working structure and project team communication is working
accordingly. Questions could be for instance:
• Are there cross-WP-interactions to avoid “silo-thinking”?
• Are WP leaders and co-leaders taking actively part in (online) meetings etc.
Based on the proceedings the evaluator will also try to up-date the glossary, that should be put on the project website
in a constant manner.
The progress of the project will be assessed based on indicators, deliverables and milestones achievement. Any
discrepancies in accomplishing the specific steps should be reported to the project lead SPMS who will act as supervisor
Page 19 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
of the evaluation. We also foresee an internal milestone in M14, a mid-term evaluation report in form of a presentation
at one of the planned partner meetings to show-case the state of play and giving the participants room to re-adjust
activities if necessary.
Both the evaluation plan, and the evaluation report (D 3.2) will be prepared by the Evaluator and assessed by other WP
leads and co-leads, namely WP 8, as WP3 is clearly complementary to the proof of technical concept and upscaling
to practice. It will summarise the achievements made towards the project objectives. The report will contain graphical
displays of achievements (infographics).
Participation per Partner
Partner number and short name WP3 effort
3 - GÖG 4.50
5 - IHE-EUR 0.50
9 - UCY 0.50
18 - MoHGR 0.50
25 - REGLOMB 1.00
Total 7.00
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type15 Dissemination level16 Date (in
Number14
months)17
Confidential, only
for members of the
D3.1 Project evaluation
D3.1 3 - GÖG Report consortium (including 5
plan and impact matrix
the Commission
Services)
Confidential, only
for members of the
D3.2 - Overall
D3.2 3 - GÖG Report consortium (including 24
Evaluation report
the Commission
Services)
Description of deliverables
D3.1 - Project evaluation plan and impact matrix (M5)
D3.2 - Overall Evaluation report (M24)
D3.1 : D3.1 Project evaluation plan and impact matrix [5]
n/a
D3.2 : D3.2 - Overall Evaluation report [24]
n/a
Page 20 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
MS7 MS3.1 3 - GÖG 5 Project Evaluation Strategy
Half-time evaluation report
MS8 IM3.1 3 - GÖG 14 in form of a presentation at a
partner meeting
Page 21 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Work package number 9 WP4 Lead beneficiary 10 23 - ARIA
Work package title Generic Aspects of EEHRxF recommendation
Start month 1 End month 24
Objectives
The EEHRxF Recommendation sets out a framework for the development of a European electronic health record
exchange format in order to achieve secure, interoperable, cross-border access to, and exchange of, electronic health
data in the Union.
This framework is intended for cross-border exchange of electronic health records which lists principles for access to
and cross-border exchange of electronic health records, namely that a) Member States should ensure that citizens are
able to access and securely share their electronic health data across borders, b) Member States are encouraged to give
citizens the ability to choose to whom they provide access to their electronic health data, and which health information
details are shared, and c) Member States should ensure that these principles are observed when developing solutions
enabling access to, and exchange of electronic health data in the Union.
To objective of this work package is to help define in more concrete terms what are the practical implications of
principles listed in the Recommendation, focusing on its link to ongoing eHealth initiatives, especially in regard to 1)
roadmapping of eID usage in health, 2) ethics of using personal data and analysing legal aspects and enablers needed for
interoperability, and 3) identifying common cybersecurity efforts directly related to electronic health record exchange.
The above listed three aspects are not the main goals of the project, but important to be permanently investigated to
ensure the continuous compliance of the project to achieve the best intended outcome. The below detailed three tasks
are highly interrelated – i.e. CyberSecurity by design can only be established if the background legal framework is
robust and transparent for all participants; eID implementation also build on legal blocks, and the trust of the services
is mostly dependent on its security levels.
The work of the tasks will be continuously aligned, as well as directly coordinate with the implementation WPs.
Description of work and role of partners
WP4 - Generic Aspects of EEHRxF recommendation [Months: 1-24]
ARIA, SPMS, ATNA, GÖG, HZZO, MZCR, Kraj Vysočina, MSAE, MoH-FR, AEEK, SE, AGID, NVD, NIJZ,
TICSALUT
T4.1: Electronic Identification implementation (Lead: ARIA; Participants: SPMS, ATNA, MZCR, SE, AgID, NIJZ,
TIC Salut) M1-M18
Task 4.1 will first take into consideration the outcomes achieved and the lessons learned from previous national
projects focused on the usage of eID instruments for the eHealth domain; a comprehensive view of national-specific
implementations among the core Member States of the proposal will be provided, highlighting how and where
improvements are needed (subtask 4.1.1).
Then, we will focus on a possible adaptation path which can lead MS to surpass national, specific solutions - often
expensive and difficult to integrate outside the country – in principle implementing a full eIDAS-based approach,
fulfilling the rights that patients have to use their national eID across European countries, taking into account usability
(subtask 4.1.2); an appropriate focus will be given on how an eIDAS cross-border authentication can improve the patient
journey, with a high level of security, which is a key concern in eHealth.
The alignment with the modern electronic identification standards must be matched with possible concrete use cases;
this goal will be covered by subtask 4.1.3, which will present, study and select different scenarios in order to deliver a
comprehensive patient empowerment and patient-centric solutions. Should the eIDAS approach raise usability aspects,
they will be taken into account and, where possible, different authentication solutions will be provided. The project
aims to establish a solid foundation for many years, so we will describe how the new eIDAS technical specifications
v1.2.00 – released by the EU in mid October 2019 - could be adopted, replacing during the project timeframe the current
implementation based on the 1.1 standard (subtask 4.1.4).
In order to be interoperable even with the Member States not yet ready with their eIDAS infrastructure, we will describe
an approach and an adaptation path to fulfill this need (subtask 4.1.5).
Considering the number of EU-funded projects that have already studied, or even implemented, solutions for the eID
in the eHealth domain, the subtask 4.1.6 - and the project as a whole - will leverage previous experience gathered
from different projects, e.g. Health-eID (https://www.spms.min-saude.pt/healtheid/) and Konfido (https://konfido-
project.eu/).
Page 22 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
T4.2: Legal aspects & enablers (Lead: Vysocina; Participants: SPMS, MZCR, MSAE, MoH-FR, SE, NIJZ, TIC Salut,
ARIA, AEEK) M1-M14
Task 4.2 will include two subtasks, namely 4.2.1 (Legal and ethical aspects of cross-border exchange of data) and 4.2.2
(Legal and ethical enablers for cross-border interoperability of personal data).
Task 4.2 will provide an analysis of the identified legislative aspects, challenges and enablers for cross-border personal
data interoperability, regarding the current cross-border exchange scenarios, and the planned new domains. The
Deliverables of this task shall serve as a guide for the other Work Packages.
Subtask 4.2.1 will be focused on the following topics. Cross-border exchange of personal health data is governed by
several legal documents, on EU as well as national level. While the cross-border exchange of some personal/patient data
is already taking place, it is necessary to re-think it in the light of the new domains, whether there are currently limitations
to further development of cross-border services or if the status-quo on the EU level is sufficient. The identification
of legal topics and the relevant EU legislation, with special focus on the protection of personal data, electronic
identification, and cybersecurity, needs to be performed in order to identify possible limitations and suggestions for
future improvements of interoperability of health data from a legal point of view. Considering the legislative differences
in Member States in combination with EU legislation, legal enablers for health data interoperability need be identified,
which form the foundation of free flow of personal/patient data in a cross-border setting. These enablers pertain to
the data use, protection and security, data privacy, data transparency, and ethics of using personal data. The main goal
of 4.2.2 will be to analyze legal obstacles for data use, data protection and security in a cross-border setting, as well
as to identify legal enablers in order to improve the cross-border exchange of personal data, data privacy, and data
transparency on the EU level which is a crucial step towards ensuring that data subject rights’ are respected in cross-
border healthcare. The cross-border exchange of patient data naturally raises further issues, which are not only the
subject-matter of legislation but cross the legal boundary into the ethical domain. This is the case particularly in the
question of secondary use of personal/patient data. Such issue should not be omitted in a discussion regarding the flow
of data of patients among healthcare providers of European countries, as national legislations regarding secondary use of
such sensitive data may differ. The legal and ethical limitations of secondary use of personal/patient data in the current
setting, as well as with regards to the new domains, will be explored to the extent of their association with obstacles
to cross-border data exchange.
T4.3: Cybersecurity (Lead: SE; Participants: SPMS, ATNA, GOeG, HZZO, MZCR, ARIA, AgID, NVD, Vysocina,
AgID) M1-M24
The first subtask needs to ensure, that project partners know from the very beginning which building blocks can be used,
thus we have to take an inventory of common criteria certification, common policies (e.g. ENISA), ICT scenarios, the
current and forming standards (e.g. NATO) and EU level regulations as well as the current environment.
The aim is to paint a quick landscape extracting information from the relevant stakeholders (4.3.1: European trust space
background). The second step is to create a recommendation for suitable cyber security methodology along the lines of
data source inventory, data protection, F.A.I.R. principles, sensitivity and risk management. The work of this subtask
should be closely coordinated with subtask 4.2.2. (4.3.2: Methodology framework recommendation).
The aim of the 3rd subtask is to compile a decision support document policy actions to obtain the highly necessary trust
factor for health data exchange through cyber security efforts. This document is the main product of the work within
the task, combining the cyber actions with certification, standardisation needs and legal framing of the actions.
The high level proposals should be based on findings from stakeholder conversation, collecting case studies and
analysing them internally (ensuring MS differentiation, user level outcome, experience and benefit) as well as on
stakeholder workshops to enable wide support for the recommendations (4.3.3: Policy recommendation for EU level
actions to achieve digital health data trust in the cyber space).
The first technical subtask is formulating the minimum technological expectations, directly relating to and aligning with
the work of T4.1. The minimum criteria should consider the independent transaction log, privileged user security control
level and rules of enforcing multi-channel data access (4.3.4: Confidential document for standardised security control).
The second technical subtask is working out the methodology of the implementation process of the cyber solutions.
The proposed methodology manual should be based on a certification process, which is unique to health cybersecurity
standards. The proposal should elaborate recommendations for a standardised validation process with minimum
cybersecurity controls, cyber range testing and validated test data collection. The nature of this product is sensitive, its
dissemination should be limited and carefully orchestrated (4.3.5: System modelling).
Participation per Partner
Partner number and short name WP4 effort
1 - SPMS 1.50
Page 23 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Partner number and short name WP4 effort
2 - ATNA 1.50
3 - GÖG 1.50
8 - HZZO 0.50
10 - MZCR 1.00
11 - Kraj Vysočina 6.17
12 - MSAE 3.00
14 - MoH-FR 0.50
19 - AEEK 0.50
20 - SE 4.00
22 - AGID 1.00
23 - ARIA 5.00
26 - NVD 0.50
30 - NIJZ 1.50
31 - TICSALUT 1.50
Total 29.67
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type 15
Dissemination level 16 Date (in
Number14
months)17
D4.1.1 eID in eHealth:
D4.1 survey of national 23 - ARIA Other Public 6
solutions
D4.1.2 eID in eHealth:
D4.2 from national solutions to 23 - ARIA Report Public 18
eIDAS
D4.2.1 Information paper
on the current challenges
D4.3 in legal aspects of cross- 11 - Kraj Vysočina Report Public 9
border exchange of
personal data
D4.2.2 Recommendation
paper on legislative
D4.4 enablers for cross- 11 - Kraj Vysočina Report Public 14
border personal data
interoperability
Confidential, only
for members of the
D4.3.1 European trust
D4.5 20 - SE Report consortium (including 5
space background
the Commission
Services)
Page 24 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type 15
Dissemination level 16 Date (in
Number14
months)17
D4.3.2 Policy Confidential, only
recommendation for EU for members of the
D4.6 level actions to achieve 20 - SE Report consortium (including 24
digital health data trust in the Commission
the cyber space Services)
Description of deliverables
D4.1.1 – eID in eHealth: survey of national solutions (M06)
This deliverable will describe the state of play of eID in the eHealth domain
D4.1.2 - eID in eHealth: from national solutions to eIDAS (M18)
This deliverable will propose an adaptation path towards a comprehensive eIDAS-ready approach
D4.2.1 – Information paper on the current challenges in legal aspects of cross-border exchange of personal data
(M09)
The deliverable to identify and analyse current legislative obstacles to cross-border data exchange (so, unlike
eHAction T6.2 which "only" lists and briefly elaborates on the current legislative documents and uses a simple
language in order to inform non-experts; D4.2.1. would be an expert analysis of legal issues that cross-border
exchange of personal data is facing, aimed at a more expert level). The analysis will list all current and foreseen
challenges in cross-border exchange of personal data
D4.2.2 – Recommendation paper on legislative enablers for cross-border personal data interoperability (M14)
The aim of which is to provide legislative and technical recommendations for tackling challenges identified in D4.2.1,
most notably those pertaining to: a) Data Use, b) Data Protection & Security, c) Data Privacy, d) Data Transparency,
e) Data Ethics in the context of cross-border exchange of personal data, and others identified in D4.2.1, in order to
improve the current state of personal data exchange in the EU and enable the deployment of future eHealth services.
D4.3.1 – European trust space background (M05)
This deliverable will present a state of play of the cybersecurity technology landscape
D4.3.2 – Policy recommendation for EU level actions to achieve digital health data trust in the cyberspace (M24)
Decision support document for policy actions
ID4.3.1 – Methodology framework recommendation (M08)
Standard template
ID4.3.2 – Confidential document for standardised security control (M18)
Minimum technological expectations
ID4.3.3 – Recommendation for cyber implementation process methodology (M24)
Confidential methodology manual of the implementation process.
D4.1 : D4.1.1 eID in eHealth: survey of national solutions [6]
This deliverable will describe the state of play of eID in the eHealth domain
D4.2 : D4.1.2 eID in eHealth: from national solutions to eIDAS [18]
This deliverable will propose an adaptation path towards a comprehensive eIDAS-ready approach
D4.3 : D4.2.1 Information paper on the current challenges in legal aspects of cross-border exchange of personal data
[9]
The deliverable to identify and analyse current legislative obstacles to cross-border data exchange (so, unlike
eHAction T6.2 which "only" lists and briefly elaborates on the current legislative documents and uses a simple
language in order to inform non-experts; D4.2.1. would be an expert analysis of legal issues that cross-border
exchange of personal data is facing, aimed at a more expert level). The analysis will list all current and foreseen
challenges in cross-border exchange of personal data
D4.4 : D4.2.2 Recommendation paper on legislative enablers for cross-border personal data interoperability [14]
The aim of which is to provide legislative and technical recommendations for tackling challenges identified in D4.2.2,
most notably those pertaining to: a) Data Use, b) Data Protection & Security, c) Data Privacy, d) Data Transparency,
Page 25 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
e) Data Ethics in the context of cross-border exchange of personal data, and others identified in D4.2.1, in order to
improve the current state of personal data exchange in the EU and enable the deployment of future eHealth services
D4.5 : D4.3.1 European trust space background [5]
This deliverable will present a state of play of the cybersecurity technology landscape
D4.6 : D4.3.2 Policy recommendation for EU level actions to achieve digital health data trust in the cyber space [24]
Decision support document for policy actions
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
Generic aspects of EEHRxF –
MS9 MS4.1 26 - NVD 9
Part 1
Generic aspects of EEHRxF –
MS10 MS4.2 26 - NVD 24
Part 2
Page 26 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Work package number 9 WP5 Lead beneficiary 10 28 - NICTIZ
Work package title Definition of EEHRxF functional specifications
Start month 1 End month 24
Objectives
1. Define a common methodology for WP5, 6 and 7 based on a Use Cases driven methodology;
2. Identify business (functional) requirements.
3. Establish a common definition of the medical information set to be used;
4. Examine the clinical terminologies and information structures currently used by EHR systems for exchange in the
given domains;
5. Determine a mechanism for managing terminology and concept mapping within the scope of this project;
6. Specify the context and meaning of the exchanged content, using a common clinical data structure;
7. Identify information structures with essential/recommended or optional elements;
8. Define functional specifications for new services.
Description of work and role of partners
WP5 - Definition of EEHRxF functional specifications [Months: 1-24]
NICTIZ, SPMS, FPS Health Be, IHE-EUR, HL7 Europe, UCY, MZCR, Kraj Vysočina, MSAE, ANS, DIMDI,
GEMATIK, TMF, MoHGR, AEEK, DoH, ARIA, MIN SAL, REGLOMB, SAM, NCZI, NIJZ, TICSALUT, Equalis
AB, INSERM
Interoperability as a practical necessity.
Sharing health information is vital in healthcare nowadays. Over the last decades, the relation between healthcare
providers and patients has shifted from a one-to-one, often one-way relationship to networked care, where the patient
also has become a valuable member of the healthcare team.
For the healthcare process to work efficiently, information needs to be shared, combined and reused.
Shareable information also means reusable information, for scientific research, discharge letters, decision support,
financial-, management- and quality reporting et cetera.
Scope
Work Package 5 focuses on functional requirements for a common set of shared information building blocks and
assets on all levels of interoperability that can be used by European Member States (MS) as a means of achieving
true interoperability in exchange of EHR content across borders and within MS. It proposes principles and methods to
achieve this goal, as well as a basic framework for the further development and maintenance of these building blocks.
Work Package Tasks
T5.1 provides the principles, architecture and tools for the definition of the subsequent Tasks. It aims at the definition
of a collaborative process to reach agreement between member states on the architecture of this growing EEHRxF
information standardisation framework. It provides a methodology for the description of use cases, the process steps
and the information needed to assist these process steps. It will also provide guidance on the concept of clinical models
that can be used as reusable information building blocks throughout the EU.
T5.2 complements these activities by proposing and developing methods to establish consensus between stakeholders
on clinical content, where cross-border exchange and reusability is the goal. T5.3 (laboratory), T5.4 (images), T5.5
(hospital discharge reports) and T5.6 (extending PS for rare diseases) aim at extending the pool of internationally usable
clinical content “modules”. These also require alignment of already existing initiatives. T5.7 compiles and summarizes
the WP results, outlining a way forward to a growing set of sustainable and consensus-based “European core building
blocks”.
This Work Package will create a model to establish a coordinated process to connect MS partners using collaborative
tools, where results are made publicly available for sharing knowledge and experiences. Wherever possible, partners
will build on and connect to current strategic and networking activities within and between their countries, establishing
of National Digital Health Networks, as foreseen in the EEHRxF recommendation.
WP5 provides the basis for the subsequent technical specifications of WP6 and WP7. Note: As WP 5, 6 and 7 are closely
related, networking between these WPs is an important aspect to achieve the goals of the project.
T5.1: X-eHealth use cases driven methodology (Lead: GEMATIK; Participants: SPMS, MZCR, MoH-GR, ARIA,
NICTIZ, TIC Salut) M1-M24
Task 5.1 delivers a general introduction to definition of EEHRxF functional specifications. It provides principles,
guidelines and frameworks for the collaborative definition and sustainable maintenance and governance in a multi-
Page 27 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
national environment. A tight cooperation with WP6 is envisioned to support the co-creation of the functional
specifications. This Task will identify and provide access to tools that capture reusable elements, to support a use case-
based approach within the domain-specific tasks. Both WPs jointly strive for maximum reuse of interoperability assets
such as clinical building blocks and models, document exchange patterns, users and their roles, value sets etc.
T5.2: EEHRxF and its relationship with clinical guidelines (Lead: ARIA; Participants: MZCR, DoH-IR, INT, NICTIZ,
equalis) M1-M24
This Task represents the link with the national and international organisations who already have developed clinical
guidelines that specify the relevant information for different use cases. As an example, in the CSA H2020 PHC-34
“VALUeHEALTH”, the Guidelines from the European Association of Diabetologist were used to quickly identify
the key elements to be considered in the PS for Unplanned and Planned Care of diabetic patients, Task 5.2 will
define a methodology for retrieving and mapping the clinical requirements in the collaborative framework for clinical
requirements and data structures to be provided by T5.1.
T5.3: Laboratory Requests and Reports guideline and functional specifications (Lead: MZCR; Participants: SPMS, IHE,
ANS, TMF, DoH-IR, MIN SAL, SAM, NICTIZ, NIJZ, TIC Salut, equalis) M1-M24
This Task will follow the work of the ongoing activities of the CEF eHDSI eHealth Member State Expert Group
(eHMSEG) Semantic Task Force. CEF eHDSI eP/eD and PS functional specifications will be revised to the adaptation
of EEHRxF to the new Laboratory domain.
Its main objective is to formulate a set of clinical and functional requirements and definitions for the Laboratory domain,
based on the identified use cases. The scope of this Task includes logical definition of the necessary data elements and
data structures and specification of links to the terminologies needed for Laboratory orders and reports in the selected
subdomains that are considered essential for cross-border EHR exchange. Existing national conventions for coding
laboratory results (LOINC, NPU, SNOMED) will be reflected as viable starting points towards European laboratory
data harmonization. Additional guidelines will be provided for subdomains that are out of the scope of this Task.
T5.4: Medical Imaging and Reports guideline and functional specifications (Lead: NICTIZ; Participants: SPMS, FPS,
IHE, UCY, MIN SAL, MZCR, TIC Salut) M1-M24
Based on the identified use cases, Task 5.4 focuses on the requirements for interoperable and safe exchange of
medical images and imaging reports. It provides guidance, principles, definitions and examples on different levels of
interoperability (of the ReEIF model). It will take into account the international standardization activities in this field.
T5.4 provides recommendations on standardization of the classification of medical images and imaging reports. It will
also look into the structured reporting of radiological studies. As an example, a functional specification of a radiological
report (e.g. for colon cancer imaging reports) will be added. Infrastructural topologies for the sharing of medical images
and imaging reports will be proposed to enable the fair, secure and timely availability of medical images and imaging
reports across Europe.
T5.5: Hospital Discharge Reports guideline and functional specifications (Leader: Vysocina; Participants: SPMS, FPS,
HL7, MZCR, MSAE, AEEK, SAM, NICTIZ, NCZI, TIC Salut) M1-M24
This Task will provide the requirements for the structured definition of different Hospital Discharge Reports. It will
build upon the already existing functional definition of the PS, extending its use to planned care where specialists report
on episodes of care.
Extra sections that are foreseen at this point in time are: Laboratory test results, Imaging results report, Reason for
Referral, Procedures performed, Conclusions, Discharge Medication, Advance Directives and other typical sections that
are common in Hospital Discharge Letters.
A methodology will be presented to organise the growing number of structured information elements, and an example
will be provided as an illustration of this methodology. It is assumed that the existing MVC can be reused, to enable
alignment of future development.
T5.6: Refine PS functional specifications to account for eHN Guidelines and rare diseases (Lead: INT; Participants:
SPMS, MZCR, MSAE, ANS, DIMDI, NICTIZ, INSERM) M1-M24
Task 5.6 will also build upon the already existing data definitions of the current PS. The activity will be two-folded:
align with the Version 3 of the eHN European Guidelines on PS/eP, including the adoption of the CEN International
Patient Summary (CEN IPS) and the extensions to make the PS suitable for patients with Rare Diseases, in line with
the European Reference Network (ERN) requirements and the results of the RD-Action.
This Task provides an extension of the Problems list with the identified rare diseases (aligned with current scope of
concepts, such as Orphacode, in accordance with the ongoing EU project RD-Code ); a review on existing rare-disease-
related exchange specifications (from relevant regional or national initiatives) suitable as PS extensions; the addition
of the healthcare organisation that is currently assigned to the rare disease patient; and the possibility to link the PS to
relevant scientific information on these rare diseases. A functional definition of these rare disease related data items
will be provided in the relevant development tools. Examples of these will also be provided.
T5.7: Final Conclusions and Recommendations (Lead: NICTIZ; Participants: MZCR, MoH-GR) M20-M24
Page 28 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Task 5.7 captures conclusions and recommendations that were gathered during the creation of this Work Package, from
the collaboration with the other WPs, from connections with representatives of the knowledge fields, and from ideas and
suggestions for further development on the topic of structured data definition. Recommendations on further development
of the functional elements of EEHRxF and the ReEIF, and on the basic structures for Enhancing National Digital Health
Networks will be presented by this Task.
Participation per Partner
Partner number and short name WP5 effort
1 - SPMS 6.50
4 - FPS Health Be 1.00
5 - IHE-EUR 2.00
6 - HL7 Europe 1.00
9 - UCY 1.00
10 - MZCR 7.00
11 - Kraj Vysočina 4.34
12 - MSAE 2.00
13 - ANS 2.00
15 - DIMDI 1.00
16 - GEMATIK 2.00
17 - TMF 1.00
18 - MoHGR 2.00
19 - AEEK 1.00
21 - DoH 1.50
23 - ARIA 2.50
24 - MIN SAL 1.00
25 - REGLOMB 0.00
INT 2.50
27 - SAM 1.00
28 - NICTIZ 7.00
29 - NCZI 1.00
30 - NIJZ 1.00
31 - TICSALUT 2.00
32 - Equalis AB 1.50
34 - INSERM 1.50
Total 56.34
Page 29 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type 15
Dissemination level 16 Date (in
Number14
months)17
D5.1 X-eHealth use cases
D5.1 16 - GEMATIK Report Public 23
driven methodology
D5.2 EEHRxF and its
D5.2 relationship with clinical 23 - ARIA Report Public 23
guidelines
D5.3 Laboratory
Requests and Reports
D5.3 10 - MZCR Report Public 23
guideline and functional
specifications
D5.4 Medical Imaging
and Reports guideline
D5.4 28 - NICTIZ Report Public 23
and functional
specifications
D5.5 Hospital Discharge
D5.5 Reports guideline and 11 - Kraj Vysočina Report Public 23
functional specifications
D5.6 Refine PS
functional specifications
D5.6 to account for eHN 25 - REGLOMB Report Public 23
Guidelines and rare
diseases
D5.7a Final Conclusions
D5.7 28 - NICTIZ Report Public 24
and Recommendations
Description of deliverables
Deliverables
The produced principles, guidelines and tools that are the result of this WP, including the functional artefacts will be
made available in an appropriate repository for enabling the discovery, the reuse and the sustainable hand-over of the
produced artefacts.
ID5.1 - X-eHealth use cases driven methodology (M3)
Use case driven approach. Generic principles, methodologies and tools that support the objectives of this Work
Package and Tasks 5.3 to 5.6.
ID5.2 - EEHRxF and its relationship with clinical guidelines (M3)
Definition of the methodology to exploit Clinical Guidelines, clinical data structure for EEHRxF enriched by Clinical
Guidelines.
ID5.3 - Laboratory Requests and Reports guideline and functional specifications (M4)
Definition of functional requirements – Laboratory requests and reports.
ID5.4 -Medical Imaging and Reports guideline and functional specifications (M4)
Definition of functional requirements – Medical Imaging and Reports
ID5.5 - Hospital Discharge Reports guideline and functional specifications (M4)
Hospital Discharge Reports guideline and functional specifications
ID5.6 -Refine PS functional specifications to account for eHN Guidelines and rare diseases (M4)
Detailed refinement of PS for ERN functional requirements.
D5.1 - X-eHealth use cases driven methodology (M23)
Use case driven approach. Generic principles, methodologies and tools that support the objectives of this Work
Package and Tasks 5.3 to 5.6.
D5.2 - EEHRxF and its relationship with clinical guidelines (M23)
Page 30 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Definition of the methodology to exploit Clinical Guidelines, clinical data structure for EEHRxF enriched by Clinical
Guidelines.
D5.3 - Laboratory Requests and Reports guideline and functional specifications (M23)
Definition of functional requirements – Laboratory requests and reports.
D5.4 - Medical Imaging and Reports guideline and functional specifications (M23)
Definition of functional requirements – Medical Imaging and Reports
D5.5 - Hospital Discharge Reports guideline and functional specifications (M23)
Hospital Discharge Reports guideline and functional specifications
D5.6 - Refine PS functional specifications to account for eHN Guidelines and rare diseases (M23)
Detailed refinement of PS for ERN functional requirements.
D5.7 -Final Conclusions and Recommendations (M24)
Conclusions from the entire WP, and recommendations for Enhancing National Digital Health Networks.
D5.1 : D5.1 X-eHealth use cases driven methodology [23]
Use case driven approach. Generic principles, methodologies and tools that support the objectives of this Work
Package and Tasks 5.3 to 5.6.
D5.2 : D5.2 EEHRxF and its relationship with clinical guidelines [23]
Definition of the methodology to exploit Clinical Guidelines, clinical data structure for EEHRxF enriched by Clinical
Guidelines.
D5.3 : D5.3 Laboratory Requests and Reports guideline and functional specifications [23]
Definition of functional requirements – Laboratory requests and reports.
D5.4 : D5.4 Medical Imaging and Reports guideline and functional specifications [23]
Definition of functional requirements – Medical Imaging and Reports
D5.5 : D5.5 Hospital Discharge Reports guideline and functional specifications [23]
Hospital Discharge Reports guideline and functional specifications
D5.6 : D5.6 Refine PS functional specifications to account for eHN Guidelines and rare diseases [23]
Detailed refinement of PS for ERN functional requirements
D5.7 : D5.7a Final Conclusions and Recommendations [24]
Conclusions from the entire WP, and recommendations for Enhancing National Digital Health Networks.
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
Preliminary (internal) release
MS11 IMS5.1 28 - NICTIZ 3 of the overall principles and
guidelines (D5.1 and D5.2)
Preliminary (internal)
release of the Functional
MS12 IMS5.2 28 - NICTIZ 4
Specifications (D5.3, 5.4, 5.5
and 5.6).
Definiton of EEHRxF
MS13 MS5.1 28 - NICTIZ 23 technical specifications – Part
1
Definiton of EEHRxF
MS14 MS5.2 28 - NICTIZ 24 technical specifications – Part
2
Page 31 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Work package number 9 WP6 Lead beneficiary 10 6 - HL7 Europe
Work package title Definition of EEHRxF implementable specifications
Start month 1 End month 24
Objectives
• Specify how to technically implement the use cases selected by WP5 by using existing standards and profiles. This
will be done by
o Providing an implementable standard representation of the clinical content defined by WP5, hopefully provided
as clinical models. This includes also the specification of the Value Set and Value Set Bindings, taking in account
terminologies requirements identified by WP5. [Content specifications]
o Specifying the transport mechanisms for this content relying on security requirements and other infrastructural services
developed by WP4 and implemented in WP7. [Service specifications]
• Facilitate the discovery, the reuse and the testing of the content and service specifications, and of the related assets
for example used in eHDSI.
• Generate the testing tools (e.g. test scripts, validation tools)
Description of work and role of partners
WP6 - Definition of EEHRxF implementable specifications [Months: 1-24]
HL7 Europe, SPMS, IHE-EUR, HZZO, UCY, MZCR, MSAE, ANS, MoH-FR, GEMATIK, MoHGR, DoH, AGID,
ARIA, MIN SAL, REGLOMB, NVD, SAM, NCZI, TICSALUT, Equalis AB, INSERM
This WP concurs with WP5 to the achievement of these project goals for a set of selected domains and use cases (e.g.
Laboratory Results, Imaging Reports, Discharge Letter, Rare Diseases Patient Summary): support cross-border and
inter-institutional interoperability; contribute to requirements, specifications and guidelines at national and cross-border
level; support integration under the eHDSI; provide open, extensible and harmonisation-based citizen health records
solution for service and app developers.
While WP5 collects and formalizes the clinical and functional requirements for the content and the processes; WP6
is responsible to convert these requirements into implementable specifications and associated validation tools. A tight
cooperation with WP5 is envisioned to support the co-creation of the functional specifications. This WP will also explore
the use of appropriate repository/ies for enabling the discovery, the reuse and the hand-over of the produced artefacts
and specifications (e.g. CDA templates, any other relevant specifications, value sets). It is envisioned that WP5 will
consider and provide guidelines and models for several use cases within the identified domains (e.g. Laboratory request
and reporting; Laboratory Results); a set of relevant cases (e.g. Laboratory Results), at least one per domain, will be
then converted by WP6 into technical content and services specifications.
To take properly in account the complexity of the different dimensions involved, a matrix approach has been applied:
domain focused tasks have been chosen, while their results (and deliverables) have been grouped per type (e.g. content
specifications, validation tools and so on), this will also facilitate their mapping with the ReEIF and assure the separation
of concerns. It will also permit their generalization into common cross-domain building blocks (the actual E-EEHRxF)
and enable their reuse in different contexts or environments.
T6.1: Definition of technical specification for the Laboratory Domain (Lead: IHE; Participants: SPMS, HL7, MZCR,
ANS, MoH-FR, MoH-GR, AgID, MIN SAL, NVD, SAM, TIC Salut, equalis) M1-M12
This task has as the main objective to publish a set of implementable specifications for the Laboratory domain. This task
will be performed starting from the requirements (e.g. use cases, terminologies) collected by WP5 and taking in account
the constraints from each country involved in the action as collected by WP5, the CEF eHDSI technical specifications
and the most recent international standardization activities (e.g. IHE XD-Lab, HL7 IPS).
An implementable representation of the Laboratory results (e.g. CDA Template) expressed by using standardized
computable formats will be at least produced (D6.1) and published in a human readable form. The produced artefacts
(e.g. Value Set; CDA Templates) will be then made available in an appropriate repository for enabling the discovery,
the reuse and the hand-over of the produced artefacts. This task will also concur to the definition of the technical
specifications (D6.6) used for the exchange of the identified content.
T6.2: Definition of technical specification for the Medical Imaging Domain (Lead: IHE; Participants: SPMS, HL7,
UCY, AgiD, ARIA, MIN SAL, TIC Salut, equalis) M1-M15
This task has as main objective to publish a set of implementable specifications for the Medical Imaging Reports. This
task will be performed starting from the requirements collected by WP5 and taking in account the constraints from each
Page 32 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
country involved in the action as collected by WP5 and the most recent international standardization activities (e.g.
DICOM SR; DICOMWeb; XDS-I, HL7 IPS).
An implementable representation of the Medical Imaging Results (e.g. CDA Template) expressed by using standardized
computable formats will be at least produced (D6.2) and published in a human readable form. The produced artefacts
(e.g. Value Set; CDA Templates or other relevant specifications) will be then made available in an appropriate repository
for enabling the discovery, the reuse and the hand-over of the produced artefacts. To take in account the specificity
of the imaging part, a dedicated deliverable for imaging evidences will be also produced (D6.8) by using the most
appropriate formalism (e.g. DICOM Conformance Statement). This task will also concur to the definition of the services
specifications (D6.5) used for the exchange of the medical results and reports and, depending on the solution chosen
(e.g. XDS-I), for the imaging evidences.
T6.3: Definition for the technical specifications Hospital Discharge Reports (Lead: HL7; Participants: SPMS, IHE,
HZZO, MZCR, ANS, GEMATIK, TMF, DoH-IR, AgiD, ARIA, MIN SAL, SAM, NCZI, TIC Salut) M3-M15
This task has as main objective that of publishing a set of implementable specifications for Hospital Discharge Reports.
This task will be performed starting from the requirements collected by WP5 and taking in account the constraints from
each country involved in the action as collected by WP5, the CEF eHDSI technical specifications and the most recent
international standardization activities.
An implementable representation of the Hospital Discharge Reports (e.g. CDA Template) expressed by using
standardized computable formats will be produced (D6.3) and published in a human readable form. The produced
artefacts (e.g. Value Set; CDA Templates) will be then made available in an appropriate repository for enabling the
discovery, the reuse and the hand-over of the produced artefacts. This task will also concur to the definition of the
services specifications (D6.5) used for the exchange of the identified content.
T6.4: Refinement of Patient Summary (PS) technical specifications for supporting rare diseases (Lead: HL7;
Participants: IHE, HZZO, ANS, DoH-IR, ARIA, INT, NVD, TIC Salut, INSERM) M1-M12
This task has as main objective that of refining the PS specifications to extend the use of the PS to rare diseases. This
task will be performed starting from the requirements collected by WP5 and taking in account the constraints from
each country involved in the action as collected by WP5, the CEF eHDSI technical specifications and the most recent
international standardization activities (International Patient Summary).
An implementable representation of the patient summary for rare diseases (e.g. CDA Template), based on the cases
identified by WP5, expressed by using standardized computable formats, will be produced (D6.4) and published in
a human readable form. The produced artefacts (e.g. Value Set; CDA Templates) will be then made available in an
appropriate repository for enabling the discovery, the reuse and the hand-over of the produced artefacts. This task will
also concur to the definition of the services specifications (D6.5) used for the exchange of the identified content.
T6.5: Publication and maintenance of the services specifications and testing tools (Lead: IHE; Participants: HL7, MZCR,
MoH-FR, MIN SAL, SEHA) M10-M24
This task aims to assure the cross-domain harmonization of the service specifications and of the testing tools; and their
maintenance during the project. All main contributors of the other WP6 tasks will be engaged.
Service technical specifications, defining how the specified contents should be exchanged, will be created and
maintained during the whole project life, in order to continuously improve them based on the lessons learned during
the project. [D6.5]. A set of testing tools for content and technical specifications that include test scripts will be also
selected and specified from the defined specifications [D6.7].
Finally, for the service part, suggestions for CEF eHDSI change proposals will be produced and shared with WP7. The
possibility to maintain backward compatibility with the current solutions of PS and eP/eD will be carefully analysed.
T6.6: Publication and maintenance of the X-eHealth Implementation Guide (content) (Lead: HL7; Participants: IHE,
MZCR, GEMATIK, MoH-GR, AgiD, MIN SAL, TIC Salut, equalis, SEHA) M10-M24
This task aims to assure the cross-domain harmonization of the content specifications (X-eHealth implementation
guide); and their maintenance during the project. All main contributors of the other WP6 tasks will be engaged.
An Implementation Guide collecting the content specifications and associated artefacts specified by the T6.1-T6.4 will
be created and maintained during the whole project life, in order to continuously improve this guide based on the lessons
learned during the project. [D6.6].
Finally, for the content part, suggestions CEF eHDSI change proposals will be produced and shared with WP7. The
possibility to maintain backward compatibility with the current solutions of PS and eP/eD will be carefully analysed.
Participation per Partner
Partner number and short name WP6 effort
1 - SPMS 1.50
Page 33 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Partner number and short name WP6 effort
5 - IHE-EUR 5.00
6 - HL7 Europe 6.50
8 - HZZO 1.00
9 - UCY 1.00
10 - MZCR 1.75
12 - MSAE 2.50
13 - ANS 1.00
14 - MoH-FR 1.00
16 - GEMATIK 1.75
18 - MoHGR 2.00
21 - DoH 1.75
22 - AGID 2.00
23 - ARIA 1.50
24 - MIN SAL 1.00
25 - REGLOMB 0.00
INT 1.00
26 - NVD 1.50
27 - SAM 1.50
29 - NCZI 1.50
31 - TICSALUT 2.00
32 - Equalis AB 1.50
34 - INSERM 1.50
Total 41.75
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type 15
Dissemination level 16 Date (in
Number14
months)17
D6.1 X-eHealth Services
D6.1 5 - IHE-EUR Report Public 24
Specifications
D6.2 X-eHealth Testing
D6.2 5 - IHE-EUR Report Public 24
Tools
D6.3 X-eHealth
D6.3 6 - HL7 Europe Report Public 24
Implementation Guide
Description of deliverables
ID6.1 - X-eHealth Implementation Guide: Laboratory Domain [M12].
First release of the content technical specifications (e.g. CDA Template) for the Laboratory domain, expressed by
using standardized computable formats and published in a human readable format. Internal deliverable (IHE).
Page 34 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ID6.2.1 - X-eHealth Implementation Guide: Medical Imaging Domain [M12].
First release of the content technical specifications (e.g. CDA Template) for the Medical Imaging domain, expressed
by using standardized computable formats and published in a human readable format. Internal deliverable (IHE).
ID6.2.2 - Technical Specifications for Images [M15].
First release of the content technical specifications for the imaging evidences. Internal Deliverable (IHE).
ID6.3 - X-eHealth Implementation Guide: Hospital Discharge Report [M15].
First release of the content technical specifications (e.g. CDA Template) for the Hospital Discharge Report, expressed
by using standardized computable formats and published in a human readable format. Internal deliverable (HL7).
ID6.4 - X-eHealth Implementation Guide: Patient Summary for Rare Diseases [M12].
First release of the content technical specifications (e.g. CDA Template) for the Patient Summary for Rare Diseases,
expressed by using standardized computable formats and published in a human readable format. Internal deliverable
(HL7).
ID6.5.1 - X-eHealth Services Specifications [M15].
Service (e.g. transport services) technical specifications for the domain and use cases selected. Interim release. (IHE)
ID6.5.2 - X-eHealth Testing Tools [M16].
A set of testing tools for content and technical specifications that include test scripts. Interim release. (IHE)
D6.1 - X-eHealth Services Specifications [M24].
Service (e.g. transport services) technical specifications for the domain and use cases selected. (IHE)
D6.2 - X-eHealth Testing Tools [M16 (interim) – M24 (final)].
A set of testing tools for content and technical specifications that include test scripts. (IHE)
D6.3 - X-eHealth Implementation Guide [M24].
Implementation Guide collecting harmonized and updated content technical specifications and associated artefacts
initially specified by the Tasks 6.1-6.4. (HL7)
D6.1 : D6.1 X-eHealth Services Specifications [24]
Service (e.g. transport services) technical specifications for the domain and use cases selected
D6.2 : D6.2 X-eHealth Testing Tools [24]
A set of testing tools for content and technical specifications that include test scripts
D6.3 : D6.3 X-eHealth Implementation Guide [24]
Implementation Guide collecting harmonized and updated content technical specifications and associated artefacts
initially specified by the Tasks 6.1-6.4
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
First Content Specifications
MS15 IMS6.1 6 - HL7 Europe 12
(ID6.1, ID6.2.1, ID6.4)
First Release of Technical
Specifications and Testing
MS16 IMS6.2 6 - HL7 Europe 16
Tools (ID6.2.2, ID6.3,
ID6.5.1, ID6.5.2).
Final Release of Technical
MS17 MS6.1 6 - HL7 Europe 24 Specifications and Testing
Tools
Page 35 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Work package number 9 WP7 Lead beneficiary 10 23 - ARIA
Work package title Architecture integration and System specifications
Start month 7 End month 24
Objectives
The objective of WP 7 is to define the X-eHealth architecture for the new use cases EEHRxF domain and for dealing
with all issues impacting on the sustainability of X-eHealth services beyond the proof of concept stage. The X-eHealth
architecture shall take as a starting point the current eHDSI architecture.
WP7 will be responsible for:
• Make a coherence check of the specifications produced within the other work packages to be able to create a coherent
architecture.
• Define the appropriate changes needed in the current eHDSI architecture for both core and generic service.
• Create guidelines on how to adopt the new EEHRxF domain within the member states
• Create testing strategies for the new use-cases in the EEHRxF domain
Description of work and role of partners
WP7 - Architecture integration and System specifications [Months: 7-24]
ARIA, SPMS, FPS Health Be, IHE-EUR, HL7 Europe, HZZO, UCY, MZCR, Kraj Vysočina, ANS, MoH-FR,
GEMATIK, TMF, MoHGR, SE, DoH, AGID, REGLOMB, NIJZ, TICSALUT, Equalis AB, SEHA
In order to exchange health information between the member states the epSOS project created a common architecture
to do so. The resulting infrastructure has been put into production through CEF eHDSI and the integration by member
states of the National Infrastructures. The architecture was created for two specific use-cases, ePrescription and Patient
Summary. With the advent of the new use-cases form of the EEHRxF domain this architecture may need to be revised
in order to make it fit for purpose. That is the main purpose of this work package. But it is not limited to that. The work
package will also create guidelines for easier adoption of the new use-cases by the member states within the Country
and cross-border, as well as creating testing strategies for the new use-cases.
T7.1: Global architecture for EEHRxF Domains use (Lead: ARIA; Participants: SPMS, FPS, IHE, HL7, HZZO, UCY,
MZCR, GEMATIK, TMF, MoH-GR, SE, DoH-IR, AgiD, Reg Lomb, NIJZ, TIC Salut, equalis, SEHA) M7-M24
To make a coherent and sustainable architecture and infrastructure it is necessary to go through the documents created
by WP4, WP5, WP6 and analyse, find and correct the inconsistencies. This will ensure that all documents are aligned
to create a solid and sustainable architecture and infrastructure.
In order to make the uptake of the new use-cases of the EEHRxF domain, defined in WP5 and addressed in WP6, as
easy as possible it is necessary to explore the member states national prerequisites, cooperating with Task 1.4. What
are the commonalities and differences facing the member states regarding architecture and infrastructure? Armed with
this information it is possible to describe different architecture options that face the member states in order to adopt the
new use-cases of the EEHRxF domain at a national level. Suggestions of a few alternative architecture solutions for the
integration of EEHRxF components in the services will be provided.
The scenarios will cover different options of implementation of EEHRxF on national level and the architectural solutions
will promote support for the cross-border eHealth services (eHDSI).
These will include possible new ways of providing data (e.g. FHIR resources) and performing transactions (e.g. foresee
document push-mode, in addition to the current pull-mode).
As for the ERN, the possibility of going beyond the eHDSI architecture will be considered, by assessing the needs and
the possibility of feeding clinical documents to the ERN collaborative platform, mainly for second opinion services.
This task will organize in a structured manner lessons learned. In the second part of the CSA, this task will perform the
verification of coherence between requirements and the specifications develop by WP7.
T7.2: Testing strategies (Lead: IHE; Participants: SPMS, GEMATIK, DoH-IR, AgiD, ARIA, Reg Lomb) M13-M22
This task will define the process, rules, test plan and criteria for testing the conformity of products and solutions
implementing the X-eHealth specifications developed in WP7 at the cross border and national levels by extending the
existing eHDSI test framework already available. The Testing strategy will be based on the adoption of the Testing
Tools developed in WP6.
In the other hand provide guidance based on the EURO-CAS guideline for implementing the national/regional scheme
(EURO-CAS D4.4) to national programme for implementing the testing strategy for their own needs. In the case of the
eHDSI extension, a Change proposal will be the main input of the task when a specific framework will be specified in
the case of the national context. These draft change proposals will be gathered by Task T7.4.
Page 36 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
The outcomes from T7.2 will be transferred to WP8, for implementing the demonstrators.
T7.3: Needs for upgrade of CEF eHDSI core and generic services (Lead: SEHA; Participants: HL7, MZCR, Vysocina,
ANS, TMF, SE, AgiD, ARIA, INT, TIC Salut) M15-M24
Task 7.3 will analyse the new use-cases in the EEHRxF domain and their impact on both the eHDSI core and generic
services. It will highlight, describe and quantify where there is a need to make changes in order to make the core and
generic services fit for purpose for the new use-cases. The task will describe the difference between the as-is state and
the to-be state of the eHDSI core and generic services.
The draft change proposals, originated by this and other Tasks, will be gathered and transferred to theEEHRxF Joint
Coordination Group, for further assessment and handing over to CEF eHDSI Solution Provider and to the relevant eHN
Subgroups.
T7.4: Guidance for the new EEHRxF domains (Lead: SEHA; Participants: IHE, HL7, HZZO, MZCR, Vysocina, MoH-
FR, GEMATIK, MoH-GR, AgiD, ARIA, Reg Lomb, equalis) M13-M24
With materials from mainly task 7.2 and task 7.4, this task is responsible for giving guidance on how to establish national
and cross-border services for the new EEHRxF domain. It will emphasize cross-border compliance, made evident by
the adoption of the testing strategies defined in T7.3.
Additionally, sharing of lessons learned, organized in a structured manner by Task T7.2, will be part of the training
materials, which will emphasize cross-border compliance and possibilities for the establishment of stable national and
cross-border services.
Task T7.4 will provide inputs to WP1 task 1.3, as a contribution to define the Roadmaps and inputs to WP8 as support
material for the Community of Practice and for the evaluation processes.
Participation per Partner
Partner number and short name WP7 effort
1 - SPMS 2.00
4 - FPS Health Be 1.00
5 - IHE-EUR 3.50
6 - HL7 Europe 2.00
8 - HZZO 1.00
9 - UCY 1.00
10 - MZCR 1.50
11 - Kraj Vysočina 1.00
13 - ANS 1.00
14 - MoH-FR 1.00
16 - GEMATIK 1.50
17 - TMF 1.00
18 - MoHGR 1.50
20 - SE 1.50
21 - DoH 1.00
22 - AGID 2.00
23 - ARIA 8.50
25 - REGLOMB 2.00
INT 0.50
30 - NIJZ 1.00
31 - TICSALUT 1.50
Page 37 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Partner number and short name WP7 effort
32 - Equalis AB 1.00
33 - SEHA 4.00
Total 42.00
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type15 Dissemination level16 Date (in
Number14
months)17
D7.1 EEHRxF
D7.1 architecture 23 - ARIA Report Public 15
specifications
D7.2 EEHRxF Testability
D7.2 5 - IHE-EUR Report Public 22
strategies
D7.3 Possible upgrades
D7.3 of eHDSI core and 33 - SEHA Report Public 24
generic services
D7.4 Proposal guidelines
D7.4 to implement EEHRxF in 33 - SEHA Report Public 24
National Services
Description of deliverables
ID7.1 - EEHRxF architecture specifications (M12)
It will define the architecture to implement and deploy EEHRxF services.
ID7.2 - Proposal guidelines to implement EEHRxF in National Services (M20)
It provides guidelines proposals for the implementation of EEHRxF at National level, to allow cross-border
deployment.
D7.1 - EEHRxF architecture specifications (M15)
It will define the architecture to implement and deploy EEHRxF services.
D7.2 -EEHRxF Testability strategies (M22)
Based in WP6 Testing Tools, it will extend the current CEF eHDSI Testng Strategy to EEHRxF domains.
D7.3 - Possible upgrades of eHDSI core and generic services (M24)
It will include the draft Change Proposals to extend CEF eHDSI attest to EEHRxF.
D7.4 - Proposal guidelines to implement EEHRxF in National Services (Internal deliverable on M20, Official final
deliverable M24)
It provides guidelines proposals for the implementation of EEHRxF at National level, to allow cross-border
deployment.
D7.1 : D7.1 EEHRxF architecture specifications [15]
It will define the architecture to implement and deploy EEHRxF services.
D7.2 : D7.2 EEHRxF Testability strategies [22]
Based in WP6 Testing Tools, it will extend the current CEF eHDSI Testng Strategy to EEHRxF domains
D7.3 : D7.3 Possible upgrades of eHDSI core and generic services [24]
It will include the draft Change Proposals to extend CEF eHDSI attest to EEHRxF
D7.4 : D7.4 Proposal guidelines to implement EEHRxF in National Services [24]
It provides guidelines proposals for the implementation of EEHRxF at National level, to allow cross-border
deployment.
Page 38 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
Definition of Architecture
MS18 MS7.1 23 - ARIA 16
specifications
EEHRxF Testing Strategy
MS19 MS7.2 23 - ARIA 22
definition
Provision of the CEF eHDSI
Change Proposals and
MS20 MS7.3 23 - ARIA 24
guidelines to implement
EEHRxF at National Level
Page 39 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Work package number 9 WP8 Lead beneficiary 10 18 - MoHGR
EEHRxF Communities of Practice: from Proof of Concept to large scale adoption and
Work package title
Infrastructure for Innovation
Start month 1 End month 24
Objectives
• Deliver, demonstrate, and evaluate proof-of-concept demonstrators for selected EEHRxF use cases for rare diseases
patients and patients with chronic disease and comorbidities, and decision aids delivering value for citizens.
• Build capacity in an EEHRxF Community of Practice (CoP) engaging stakeholders including patients, implementers,
developers, clinicians, researchers, business analysts, and policy makers.
• Support implementers and developers of EEHRxF in member states and across the world.
• Engage collaborative partners and other interested projects in implementing EEHRxF identifying a priority list
of scenarios, tools and resources needed for future use cases in eHDSI bringing together government, healthcare
organisations, industry and research in the transformation of health and care and enabling innovative paradigms that
actively empower the patient.
• Collaborative partners such as Digital Europe, MedTech, EFMI, ECPC, COCIR, ECHALLIANCE, EHTEL: trade,
patient advocacy, and professional associations will be engaged in the activities of this WP. At the same time, outreach
for synergies, in coordination with WP2, will involve other sectors (e.g. transport), innovation hubs, large scale public
private partnerships such as programs in life sciences e.g. ELIXIR, IMI and BDVA, EU projects, as well as regional,
national and international interoperability initiatives. Karolinska institute will contribute to T8.3 under subcontract with
HL7
Description of work and role of partners
WP8 - EEHRxF Communities of Practice: from Proof of Concept to large scale adoption and Infrastructure
for Innovation [Months: 1-24]
MoHGR, ATNA, HL7 Europe, NEN, HZZO, UCY, MoH-FR, GEMATIK, ARIA, REGLOMB, NVD, SAM,
INSERM
In this work package, participants will connect within and beyond x-eHealth and will liaise with digital health
stakeholders, including large scale programs and initiatives to deliver and evaluate proof of concept demonstrators of
EEHRxF in selected use cases that cover local, regional, national and cross-border/international aspects, to also deliver
value for European citizens.
This WP, respectively T8.1, T8.2, and T8.3 will cooperate closely with WP1 (T1.3/T1.4 sustainability), WP2
(Dissemination), WP5, WP6, and WP7. TP8.4 will establish the CoP in the first 6 months of the project, building and
extending of the concept of the Global IPS Community of Practice.
The EEHRxF CoP will be established and linked to any recognised entity in the domain, for example eHDSI, application
providers, innovation hubs, standards affiliates (HL7), CEN national member bodies, national deployment committees,
PCHA, IHE, HIMSS affiliated entities, and ecosystems and will be clustered to relevant ongoing H2020 and future
Digital Europe projects related to the exchange or sharing of health data. The aim of the EEHRxF CoP is twofold:
• to accelerate EEHRxF adoption by considering different representations (HL7 CDA, HL7 FHIR) and in collaboration
with other standard bodies.
• to build capacity through training, tools, and a mentorship program.
Driven by community interest and formalized collaborations with large scale initiatives, this WP will allow to check
and validate the feasibility of scaling up, adoption, and implementation of extensions to EEHRxF for e.g. clinical and
outcomes-based research, use of genomics information, AI, patient decision aids, and citizen driven health science, etc,
all in the context of the prospective EEHRxF roadmap.
In cooperation with WP2 (Dissemination), partnerships with connectathons, transferathons, datathons, hackathons,
ideathons or other similar innovation events, will allow to further prove fitness for purpose of EEHRxF, raising
awareness and building capacity and knowledge in Europe. The output will inform governments, trade associations,
patients, health professionals, and informal care giver associations as well as new use cases of the eHN multiannual
work programme.
The specific tasks are as follows:
Task 8.1: Proof of concept: EEHRxF in rare diseases (lead: ARIA, Participants: UCY, MoH-GR, INT, NVD, INSERM):
M9-M19.
Page 40 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
This task uses the EEHRxF domains to construct the patient case of a rare disease and interface rare disease registries.
The project would seek to collaborate with a rare disease network for this proof of concept concentrating on meaningful
data. The actual use case will be selected from the output of T1.4 (Mapping national challenges of EEHRxF adoption)
according to the use cases of T5.1 (X-eHealth use cases driven methodology) and T5.2 (EEHRxF and its relationship
with clinical guidelines) and elaborated in T5.6 (Refine PS functional specifications to account for eHN guidelines and
rare diseases) and T6.4 (Refinement of Patient Summary (PS) technical specifications for supporting rare diseases).
Taking a patient-centric approach, this work will contribute towards addressing local, national, cross-border/
international aspects along with professional collaboration with patients, multi-lingualism, differences in terminology,
and other well-known organizational barriers. This task will provide feedback to WP5 and WP6 to refine patient
summaries, discharge summaries, lab results, images studies and reports for rare disease patients. Output D8.2.
Task 8.2: Proof of concept: EEHRxF in chronic diseases management and prevention (Lead: MoH-GR, Participants:
HZZO, UCY): M9-M20.
This task will provide at least one proof of concept EEHRxF demonstrator for chronic disease patients or patients
suffering from comorbidity. The actual use case(s) will be selected earlier in the project, according to the use cases of
T5.1 and T5.2 and carried out in collaboration with other projects, e.g. in cancer, diabetes, chronic pain, hypertension,
cardiovascular/stroke, or other chronic conditions. The work will contribute towards addressing local, national,
cross-border/international aspects along with professional collaboration with patients, multi-lingualism, differences in
terminologies, and other existing barriers.
This task will provide feedback to WP5 and WP6 to refine patient summaries, discharge summaries, lab results, images
studies and reports for chronic disease patients or patients suffering from comorbidity. Output D8.3.
Task 8.3: Exploratory Proof of concept study: from EEHRxF to decision aids and citizen driven health-science (Lead:
HL7; Participants: UCY, MoH-FR, MoH-GR, SAM) M9-M21.
This exploratory task links EEHRxF to parallel initiatives that are in the process of assessing and integrating new
concepts and tools such as for example AI, outcomes-based research, clinical research, clinical trial integration, business
analytics, decision aids for patients, and citizen-driven health-science, etc.
The study would result into clear recommendations for incorporating the EEHRxF in these areas taking into account
technical, legal, procedural, and other barriers. Collaborative partners, projects or initiatives that wish to explore the
implications of using EEHRxF in their area of work, will do so by engaging in the CoP. Output D8.4.
Task 8.4: EEHRxF community of practice: building capacity and scaling up (Lead: HL7; Participant: UCY, GEMATIK,
MoH-GR, ARIA, SAM, SEHA, INSERM): M1-M24
This task will build capacity and a European community that understands EEHRxF and use it in their daily work as
developers, designers, health professionals, policy makers, etc., or as needed.
This task can be connected to several KPIs: number of people aware of EEHRxF, number of people able to implement
it, procurers that refer to it, projects that support its development or adoption, etc.
In the first 6 months of the project, the community of practice will be set up delivering in output: D1, terms of reference,
and online presence.
For the rest of the project, the task will be nurturing the community; for example with training, sample data, reference
implementations, tools, meetups and events, broadly supporting T8.1, T8.2, T8.3, with participation of all x-eHealth
partners. Regular updates in KPIs will be consolidated in periodic reports. Output D8.1
Task 8.5: Exploitation: EEHRxF as infrastructure for innovation (Lead: MoH GR; Participants: ATNA, HL7, UCY,
MoH-FR, GEMATIK, MoH-GR, ARIA, NSH, SAM, NEN, SEHA, INSERM) M19-M23
This task is exploring the role of EEHRxF in other domains, broadly noted registries, etc. The task will deliver a priority
list for use cases, tools, and resources for the future, aligned with the policy agenda of the European eHealth Network.
MoH GR will also ensure and provide input to the sustainability task of the project (T1.3-Roadmap of new domains
and sustainability plan).
The task will strongly involve the CoP with standardization stakeholders at the national, European, and international
level, including CEN/ISO national member bodies and HL7 affiliates and will provide input to the rolling plan for ICT
standardization and similar activities. Output D8.5.
Task 8.6: Evaluation of EEHRxF proof of concept demonstrators (Lead: UCY; Participants: HZZO, MoG-GR, NVD,
SAM, NEN, SEHA, INSERM): M18-M22
This task will evaluate the proof of concept outcomes of T8.1 and T8.2 with a formal methodology and will provide
input to the sustainability task of the project (T1.4) avoiding duplications with WP3 on overall evaluation.
The following domains will be evaluated across the proof of concept practices to infer optimised EEHRxF adoption and
implementation framework/s: readiness for implementation, organisation capacity to implement changes, integration
into existing workflows and the adoption of new ones, workforce training and education needs. Best practise guidelines
will be prescribed to drive efficiencies and accelerate the interoperability in EEHRxF implementation. Output: D8.6
Page 41 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Participation per Partner
Partner number and short name WP8 effort
2 - ATNA 1.00
6 - HL7 Europe 5.00
7 - NEN 1.00
8 - HZZO 1.00
9 - UCY 3.00
14 - MoH-FR 0.50
16 - GEMATIK 2.00
18 - MoHGR 7.00
23 - ARIA 2.50
25 - REGLOMB 0.00
INT 0.50
26 - NVD 2.00
27 - SAM 2.00
34 - INSERM 1.00
Total 28.50
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type15 Dissemination level16 Date (in
Number14
months)17
D8.1 EEHRxF
D8.1 6 - HL7 Europe Report Public 6
Community of Practice
D8.2 Report on EEHRxF
proof of concept
D8.2 23 - ARIA Report Public 19
demonstrators for-rare
diseases
D8.3 Report on EEHRxF
proof of concept
D8.3 demonstrators for chronic 18 - MoHGR Report Public 20
disease management and
prevention
D8.4 Exploratory study
for decision aids and
D8.4 6 - HL7 Europe Report Public 21
citizen driven health-
science
D8.5 EEHRxF as
D8.5 infrastructure for 7 - NEN Report Public 23
innovation
Page 42 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type 15
Dissemination level 16 Date (in
Number14
months)17
D8.6 Evaluation of
D8.6 EEHRxF proof of 9 - UCY Report Public 22
Concept
Description of deliverables
D8.1 - EEHRxF Community of Practice: terms of reference [HL7, M6]
This deliverable will provide the terms of reference as well as governance and operations manual for the community
of practice.
D8.2 - Report on EEHRxF proof of concept demonstrators for rare diseases [ARIA, M19]
This deliverable describes the proof of concept demonstrator (s) for rare diseases noting links to projects and
collaborative partners.
D8.3 - Report on EEHRxF proof of concept demonstrators for chronic disease management and prevention [MoH GR
M20]
This deliverable describes the proof of concept demonstrator (s) for chronic disease patients and multimorbidity
noting links to projects and collaborative partners.
D8.4 - Exploratory study for decision aids and citizen driven health-science [HL7, M21]
This study describes the process of assessing and integrating new concepts and tools such as for example AI,
outcomes-based research, clinical research, clinical trial integration, business analytics, decision aids for patients, and
citizen-driven health-science.
D8.5 - EEHRxF as infrastructure for innovation [NEN, M23]
This deliverable will compile lessons learned and identify areas where further funding, coordination and
standardisation work is needed, in order to successfully position the EEHRxF in the context of the projected
development of digital health and care in Europe. D8.5 is overseen and validated by MoH GR.
D8.6 - Evaluation of EEHRxF proof of Concept [UoCyprus, M22]
A methodology is defined and applied to evaluate this proof of concept.
D8.1 : D8.1 EEHRxF Community of Practice [6]
This deliverable will provide the terms of reference as well as governance and operations manual for the community
of practice.
D8.2 : D8.2 Report on EEHRxF proof of concept demonstrators for-rare diseases [19]
This deliverable describes the proof of concept demonstrator (s) for rare diseases noting links to projects and
collaborative partners.
D8.3 : D8.3 Report on EEHRxF proof of concept demonstrators for chronic disease management and prevention [20]
This deliverable describes the proof of concept demonstrator (s) for chronic disease patients and multimorbidity
noting links to projects and collaborative partners.
D8.4 : D8.4 Exploratory study for decision aids and citizen driven health-science [21]
This study describes the process of assessing and integrating new concepts and tools such as for example AI,
outcomes-based research, clinical research, clinical trial integration, business analytics, decision aids for patients, and
citizen-driven health-science.
D8.5 : D8.5 EEHRxF as infrastructure for innovation [23]
This deliverable will compile lessons learned and identify areas where further funding, coordination and
standardisation work is needed, in order to successfully position the EEHRxF in the context of the projected
development of digital health and care in Europe. D8.5 is overseen and validated by MoH GR.
D8.6 : D8.6 Evaluation of EEHRxF proof of Concept [22]
A methodology is defined and applied to evaluate this proof of concept
Page 43 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
Establishment of the
MS21 MS8.1 18 - MoHGR 6
European EEHRxF CoP
Proof of concept
MS22 MS8.2 18 - MoHGR 21
demonstrators completed
Evaluation of the EEHRxF
MS23 MS8.3 18 - MoHGR 22
proof of Concept
Page 44 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Work package number 9 WP9 Lead beneficiary 10 1 - SPMS
Work package title Ethics requirements
Start month 1 End month 24
Objectives
The objective is to ensure compliance with the 'ethics requirements' set out in this work package.
Description of work and role of partners
WP9 - Ethics requirements [Months: 1-24]
SPMS
This work package sets out the 'ethics requirements' that the project must comply with.
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type15 Dissemination level16 Date (in
Number14
months)17
Confidential, only
for members of the
POPD - Requirement No.
D9.1 1 - SPMS Ethics consortium (including 1
1
the Commission
Services)
Confidential, only
for members of the
POPD - Requirement No.
D9.2 1 - SPMS Ethics consortium (including 1
2
the Commission
Services)
Description of deliverables
The 'ethics requirements' that the project must comply with are included as deliverables in this work package.
D9.1 : POPD - Requirement No. 1 [1]
The beneficiary must explain how all of the personal data they collect from stakeholder workshop participants will be
limited to the purposes of the research project (in accordance with the ‘data minimisation ‘principle) and handled in a
GDPR compliant manner.
D9.2 : POPD - Requirement No. 2 [1]
A description of the technical and organisational measures that will be implemented to safeguard the rights and
freedoms of the data subjects/research participants in compliance with GDPR must be submitted. This must be done
for the processing of patients' personal data (if applicable).
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
Page 45 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
1.3.4. WT4 List of milestones
Due
Milestone WP
Milestone title Lead beneficiary Date (in Means of verification
number18 number9
months)17
MS1 MS1.1 WP1 1 - SPMS 1 Consortium agreement
MS2 MS1.2 WP1 1 - SPMS 12 Report template for partners
MS3 MS2.1 WP2 1 - SPMS 12 1st X-eHealth Innovation Day
Professional Training
MS4 MS2.2 WP2 1 - SPMS 22
Sessions
2nd X-eHealth Innovation
MS5 MS2.3 WP2 1 - SPMS 24
Day
X-eHealth interoperability
MS6 MS2.4 WP2 1 - SPMS 24
award 2022
MS7 MS3.1 WP3 3 - GÖG 5 Project Evaluation Strategy
Half-time evaluation report
MS8 IM3.1 WP3 3 - GÖG 14 in form of a presentation at a
partner meeting
Generic aspects of EEHRxF –
MS9 MS4.1 WP4 26 - NVD 9
Part 1
Generic aspects of EEHRxF –
MS10 MS4.2 WP4 26 - NVD 24
Part 2
Preliminary (internal) release
MS11 IMS5.1 WP5 28 - NICTIZ 3 of the overall principles and
guidelines (D5.1 and D5.2)
Preliminary (internal)
release of the Functional
MS12 IMS5.2 WP5 28 - NICTIZ 4
Specifications (D5.3, 5.4, 5.5
and 5.6).
Definiton of EEHRxF
MS13 MS5.1 WP5 28 - NICTIZ 23 technical specifications – Part
1
Definiton of EEHRxF
MS14 MS5.2 WP5 28 - NICTIZ 24 technical specifications – Part
2
First Content Specifications
MS15 IMS6.1 WP6 6 - HL7 Europe 12
(ID6.1, ID6.2.1, ID6.4)
First Release of Technical
Specifications and Testing
MS16 IMS6.2 WP6 6 - HL7 Europe 16
Tools (ID6.2.2, ID6.3,
ID6.5.1, ID6.5.2).
Final Release of Technical
MS17 MS6.1 WP6 6 - HL7 Europe 24 Specifications and Testing
Tools
Definition of Architecture
MS18 MS7.1 WP7 23 - ARIA 16
specifications
Page 46 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Due
Milestone WP
Milestone title Lead beneficiary Date (in Means of verification
number18 number9
months)17
EEHRxF Testing Strategy
MS19 MS7.2 WP7 23 - ARIA 22
definition
Provision of the CEF eHDSI
Change Proposals and
MS20 MS7.3 WP7 23 - ARIA 24
guidelines to implement
EEHRxF at National Level
Establishment of the
MS21 MS8.1 WP8 18 - MoHGR 6
European EEHRxF CoP
Proof of concept
MS22 MS8.2 WP8 18 - MoHGR 21
demonstrators completed
Evaluation of the EEHRxF
MS23 MS8.3 WP8 18 - MoHGR 22
proof of Concept
Page 47 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
1.3.5. WT5 Critical Implementation risks and mitigation actions
Risk
Description of risk WP Number Proposed risk-mitigation measures
number
Set a single shared platform containing all X-
Key partner or person leaves WP1, WP2, WP3, WP4, eHealth essential information in order to ensure
1
the project (Medium) WP5, WP6, WP7, WP8 continuity and smoothness in the event of a
permanent or temporal replacement.
X-eHealth partners are well aware of this situation
Lack of budgetary resources WP1, WP2, WP3, WP4, and if it turns unsustainable and jeopardizes X-
2
(High) WP5, WP6, WP7, WP8 eHealth purposes, the PC may address the EC for
issue solving.
Delay in submission of key
The RM should have predicted the delay and
Deliverables and Milestones WP1, WP2, WP3, WP4,
3 reported to the PC. The Conflict Resolution
due to disagreement on scope WP5, WP6, WP7, WP8
process shall be applied if needed.
and purpose (Low)
Low quality WP4, WP5, WP6, WP7, Further deepening AB and CPs involvement to
4
recommendations (Low) WP8 address internal gaps
Meaningful National Differences categorization by type and degree.
WP4, WP5, WP6, WP7,
5 differences for EEHRxF Align MS with similar levels to assess, brainstorm
WP8
usage (Medium) and overcome identical challenges
Disagreements on how to Organize an internal series of teleconferences and
6 WP8
exploit outcomes (Low) face to face meeting to reach a consensus
Lack of time to develop WP1, WP2, WP3, WP4, Keep WP's closely aligned and determine in early
7
useful deliverables (Medium) WP5, WP6, WP7, WP8 stage the required level of detail for deliverables
A MS/C adapts an Include as many partners as possible in WP5
inconsistent standard in a WP1, WP4, WP5, WP6, and 6; assess readiness multiple times during the
8
national flavor, undermining WP7 project to recognize this possibility as early as
interoperability (Low) possible
Different work packages
or tasks that are dependent
WP4, WP5, WP6, WP7, Increase alignment efforts between work packages
9 of each other operate at
WP8 and tasks
different speed or fail to align
(Low)
Early alignment during development of
Gaps in specifications
WP4, WP5, WP6, WP7, specifications with partners involved in CoP's,
10 become apparent in CoP's
WP8 to enable timely discovery and addition of
(Low)
incomplete specifications
No consensus on clinical
guidelines due to The objections will be clearly documented and
11 irreconcilable differences WP5 efforts to overcome those in practice will be
between medical experts documented.
(Low)
Low risk of participation into Perform additional awareness activities, increase
12 the Community Of Practice - WP8 the number of invited entities, review the
COP (Low) governance documentation of the COP
Collaborate with WP1, WP5, WP6 and WP7 to
Difficulty to allocate proof of review technical documentations and apply minor
13 WP8
concepts (Medium) relaxations or use cases simplifications, perform
additional dissemination and awareness activities.
Page 48 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Risk
Description of risk WP Number Proposed risk-mitigation measures
number
Large scale initiatives not
14 WP8 Additional dissemination support
engaged in WP8 (Low)
Page 49 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
1.3.6. WT6 Summary of project effort in person-months
Total Person/Months
WP1 WP2 WP3 WP4 WP5 WP6 WP7 WP8 WP9
per Participant
1 - SPMS 36 10 0 1.50 6.50 1.50 2 0 ✓ 57.50
2 - ATNA 0 0 0 1.50 0 0 0 1 2.50
3 - GÖG 0 1 4.50 1.50 0 0 0 0 7
4 - FPS Health Be 0 0 0 0 1 0 1 0 2
5 - IHE-EUR 0 0.50 0.50 0 2 5 3.50 0 11.50
6 - HL7 Europe 0 0.50 0 0 1 6.50 2 5 15
7 - NEN 0 0 0 0 0 0 0 1 1
8 - HZZO 0 0 0 0.50 0 1 1 1 3.50
9 - UCY 0 0 0.50 0 1 1 1 3 6.50
10 - MZCR 0 0 0 1 7 1.75 1.50 0 11.25
11 - Kraj Vysočina 0 0 0 6.17 4.34 0 1 0 11.51
12 - MSAE 0 0 0 3 2 2.50 0 0 7.50
13 - ANS 0 0 0 0 2 1 1 0 4
14 - MoH-FR 0 0 0 0.50 0 1 1 0.50 3
15 - DIMDI 0 0 0 0 1 0 0 0 1
16 - GEMATIK 0 0 0 0 2 1.75 1.50 2 7.25
17 - TMF 0 0 0 0 1 0 1 0 2
18 - MoHGR 1 0 0.50 0 2 2 1.50 7 14
19 - AEEK 0 0 0 0.50 1 0 0 0 1.50
20 - SE 0 0 0 4 0 0 1.50 0 5.50
21 - DoH 0 0 0 0 1.50 1.75 1 0 4.25
22 - AGID 0 0 0 1 0 2 2 0 5
23 - ARIA 0 0 0 5 2.50 1.50 8.50 2.50 20
Page 50 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Total Person/Months
WP1 WP2 WP3 WP4 WP5 WP6 WP7 WP8 WP9
per Participant
24 - MIN SAL 0 0 0 0 1 1 0 0 2
25 - REGLOMB 0 0 1 0 0 0 2 0 3
· INT 0 0 0 0 2.50 1 0.50 0.50 4.50
26 - NVD 0 0 0 0.50 0 1.50 0 2 4
27 - SAM 0 0 0 0 1 1.50 0 2 4.50
28 - NICTIZ 7.50 0 0 0 7 0 0 0 14.50
29 - NCZI 0 0 0 0 1 1.50 0 0 2.50
30 - NIJZ 0 0 0 1.50 1 0 1 0 3.50
31 - TICSALUT 1 0 0 1.50 2 2 1.50 0 8
32 - Equalis AB 0 0 0 0 1.50 1.50 1 0 4
33 - SEHA 0 0 0 0 0 0 4 0 4
34 - INSERM 0 0 0 0 1.50 1.50 0 1 4
Total Person/Months 45.50 12 7 29.67 56.34 41.75 42 28.50 262.76
Page 51 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
1.3.7. WT7 Tentative schedule of project reviews
Review Tentative Planned venue
Comments, if any
number 19 timing of review
RV1 12 Luxembourg Linked to payment
RV2 24 Luxembourg Linked to payment
Page 52 of 52
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
1. Project number
The project number has been assigned by the Commission as the unique identifier for your project. It cannot be
changed. The project number should appear on each page of the grant agreement preparation documents (part A
and part B) to prevent errors during its handling.
2. Project acronym
Use the project acronym as given in the submitted proposal. It can generally not be changed. The same acronym should
appear on each page of the grant agreement preparation documents (part A and part B) to prevent errors during its
handling.
3. Project title
Use the title (preferably no longer than 200 characters) as indicated in the submitted proposal. Minor corrections are
possible if agreed during the preparation of the grant agreement.
4. Starting date
Unless a specific (fixed) starting date is duly justified and agreed upon during the preparation of the Grant Agreement,
the project will start on the first day of the month following the entry into force of the Grant Agreement (NB : entry into
force = signature by the Commission). Please note that if a fixed starting date is used, you will be required to provide a
written justification.
5. Duration
Insert the duration of the project in full months.
6. Call (part) identifier
The Call (part) identifier is the reference number given in the call or part of the call you were addressing, as indicated
in the publication of the call in the Official Journal of the European Union. You have to use the identifier given by the
Commission in the letter inviting to prepare the grant agreement.
7. Abstract
8. Project Entry Month
The month at which the participant joined the consortium, month 1 marking the start date of the project, and all other start
dates being relative to this start date.
9. Work Package number
Work package number: WP1, WP2, WP3, ..., WPn
10. Lead beneficiary
This must be one of the beneficiaries in the grant (not a third party) - Number of the beneficiary leading the work in this
work package
11. Person-months per work package
The total number of person-months allocated to each work package.
12. Start month
Relative start date for the work in the specific work packages, month 1 marking the start date of the project, and all other
start dates being relative to this start date.
13. End month
Relative end date, month 1 marking the start date of the project, and all end dates being relative to this start date.
14. Deliverable number
Deliverable numbers: D1 - Dn
15. Type
Please indicate the type of the deliverable using one of the following codes:
R Document, report
DEM Demonstrator, pilot, prototype
DEC Websites, patent fillings, videos, etc.
OTHER
ETHICS Ethics requirement
ORDP Open Research Data Pilot
DATA data sets, microdata, etc.
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
16. Dissemination level
Please indicate the dissemination level using one of the following codes:
PU Public
CO Confidential, only for members of the consortium (including the Commission Services)
EU-RES Classified Information: RESTREINT UE (Commission Decision 2005/444/EC)
EU-CON Classified Information: CONFIDENTIEL UE (Commission Decision 2005/444/EC)
EU-SEC Classified Information: SECRET UE (Commission Decision 2005/444/EC)
17. Delivery date for Deliverable
Month in which the deliverables will be available, month 1 marking the start date of the project, and all delivery dates
being relative to this start date.
18. Milestone number
Milestone number:MS1, MS2, ..., MSn
19. Review number
Review number: RV1, RV2, ..., RVn
20. Installation Number
Number progressively the installations of a same infrastructure. An installation is a part of an infrastructure that could be
used independently from the rest.
21. Installation country
Code of the country where the installation is located or IO if the access provider (the beneficiary or linked third party) is
an international organization, an ERIC or a similar legal entity.
22. Type of access
VA if virtual access,
TA-uc if trans-national access with access costs declared on the basis of unit cost,
TA-ac if trans-national access with access costs declared as actual costs, and
TA-cb if trans-national access with access costs declared as a combination of actual costs and costs on the basis of
unit cost.
23. Access costs
Cost of the access provided under the project. For virtual access fill only the second column. For trans-national access
fill one of the two columns or both according to the way access costs are declared. Trans-national access costs on the
basis of unit cost will result from the unit cost by the quantity of access to be provided.
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
History of Changes (HoC)
Part/ Section
Date Change Description Change Justification
/ Page
Incorporation of the instructions put
forward by the Annex 1 – Description of
the Action (part B).
Remove cover page & list of
participants
Restructuring of Annex 1 – Add a table with HoC and a table B / entire
13/04/2020 Part B according to the Grant of contents document
Agreement instructions Remove tables 3.1a, 3.1b, 3.1c,
3.2a, 3.2b and 3.4a.
Include proposal number and
acronym as footer
Include section 5 – ethics and
security
Following the EC’s Ethics Apprisal
Report, task T1.5 Ethics Requirements
was added to the project coordination A / 1.3.3 / 11-
workpackage (WP1). 12
Ethics Requirements
The objectives of WP1 were
Task and deliverable complemented accordingly.
13/04/2020
adjustment
Together with T1.5, a deliverable named
T1.5 – Ethics Requirements
D1.6: Ethics Requirements was also
created. A / 1.3.3 / 13
Both the task and deliverable are
described in detail in Part A.
Update of the project gant chart in
13/04/2020 Gantt Chart update accordance with the ethics requirements’ B / 3.1 / 15
task and deliverable mentioned above.
Although some partners initially planned
Section 4.2 to subcontract, as described in section 4.2
of part B of Annex 1, this situation is no
Sub-contracting longer true. B / 4.2 / 158;
13/04/2020
162
5 – IHE Thus, the respective section 4.2 of these
11 – Vysocina same partners has been changed to: it
does not plan to subcontract.
Linked Third Party Although MZCZ and DoH initially B / 4.2 / 161;
13/04/2020
envisioned that part of their work were to 167-68
10 – MZCZ
1
951938 X-eHealth – Part B
23 – DoH be performedAssociated
by linked third parties, as
with document Ref. Ares(2020)2778062 - 28/05/2020
described in section 4.2 of part B of
Annex 1, this situation is no longer true.
Thus, the respective section 4.2 of these
same partners have been changed to: it
does not envision to have part of its
work performed by a linked third
party.
Due to capacity-related matters, THL
informed their intention to withdraw from
the X-eHealth Consortium.
This withdrawal affects the following A / 1.2 / 4
Withdraw from project features: A / 1.3.3 / 22-
27/04/2020 Consortium List of beneficiaries 23
13 – THL WP4 – T4.2 participant and effort A /1.3.3 / 27-29
(1.00)
A / 1.3.6 / 50
WP5 – T5.5 participant and effort
(2.00)
WT6 Summary of project effort in
person-months
Vysocina
T4.2 – Vysocina assumes the role and
A / 1.3.3 ; 1.3.6
effort of THL in WP4.
/ 24 ; 50
This way, Vysocina increases their effort
Filling the gap opened by in WP4 from 4 to 6.17 PMs.
27/04/2020 THL’s withdrawal
11 - Vysocina Vysocina
T5.5 Lead – Vysocina takes over the role
A / 1.3.3 ; 1.3.6
and effort of THL in WP5.
/ 28-29 ; 50
This way, Vysocina becomes a
participant in WP5 with 4.34 PMs
As a result of THL departure, the
beneficiaries whose number identification
Filling the gap opened by is after 13, go down 1 number to readjust
THL’s withdrawal the order. A & B / entire
27/04/2020
Beneficiary Number That is to say: document
Reajustment ANS (former 14) becomes 13
Beneficiary (X>13) becomes X-1
INSERM (former 36) becomes 35
Section 4.2 Adding and update of further
Sub-contracting information in section 4.2 of the
following beneficiaries: B / 4.2 / 156;
27/04/2020 1 – SPMS 159-160; 163-
SPMS – explanation added 164
7 – NEN
NEN – update
13 – ANS ANS – update
2
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Table 3.4b: Other Direct Update of Table 4.3b by adding missing
Costs partners information and readjusting the
27/04/2020 B / 3.4 / 22-26
correct amount requested for other direct
Update costs.
Due to the current context and since
CNAM’s “LEAR” is not reachable for
the time being, CNAM will be removed
from the Consortium in order to X-
eHealth meet the EC’s deadline and
therefore, be able to sign the Grant
Agreement.
Withdraw from
Consortium Once CNAM’s “LEAR” is available, an
amendment to the GA shall take place to A & B / entire
28/04/2020
(temporally) undeal this same change. document
14 – CNAM Concerning CNAM’ budget, SPMS
(coordinator) will hold its resources until
this situation is solved.
This situation also impacts in the
beneficiaries whose number is after 14.
The same logic applied for THL’s
withdrawal is herein applied as well.
In order to ensure that progress towards
Internal Deliverables all internal deliverables are also described
Report in the formal deliverables of the project, a A / 1.3.2; 1.3.3 /
28/04/2020
D1.7 - Progress towards deliverable named D1.7 "Progress 7; 13-14
interim deliverables towards interim deliverables” was added
to WP1.
3
951938 X-eHealth – Part B
Table of Contents Associated with document Ref. Ares(2020)2778062 - 28/05/2020
1. Excellence 5
1.1 Objectives 5
1.2 Relation to the work programme 8
1.3 Concept and methodology; quality of the measures 9
2. Impact 10
2.1 Expected impacts 10
2.2 Measures to maximise impact 12
3. Implementation 14
3.1 Work plan – Work packages and deliverables 14
3.2 Management structure and procedures 15
3.3 Consortium as a whole 21
3.4 Resources to be committed 22
4. Members of the consortium 27
4.1. Participants (applicants) 27
4.2 Third parties involved in the project (including use of third partiy resources) 155
4.3. Financial support to third parties 173
5. Ethics and Security 177
5.1 Ethics 177
5.2 Security 178
4
951938 X-eHealth – Part B
1. Excellence Associated with document Ref. Ares(2020)2778062 - 28/05/2020
1.1 Objectives
The lack of interoperability is the most persistent barrier to the deployment of the digital health services and one
major factor holding back investments in digital health infrastructures. Well implemented and interoperable eHealth
services used by health professionals and citizens can be a major societal contribution to improve healthcare in Europe
with a high socio-economic return.
Support the Digital Transformation of Health and Care (DTHC) and its priorities
The digital transformation of health and care is among the top priorities on the EU’a agenda. Recognizing that digital
health and care has the potential to innovate and increase the overall efficiency of the healthcare sector, X-eHealth
intends to contribute to the Digital Single Market Strategy of the European Commission. The underlying idea of
realising a connected Digital Single Market in Europe is based on three pillars:
1. Pillar 1: Citizens’ secure access to their health data, also across borders
In order to position the citizen as active and determinant actor in the process of sharing health data, each person needs
to be electronically identified and authenticated. The General Data Protection Regulation GDPR and eIDAS
Regulation1 are major enablers for citizen’ access to and management of their personal health data, by providing a
European legal framework for cross-border sharing of health data. Adding to efforts and contributions undertaken by
the eHealth Network (eHN), the eHealth Digital Service Infrastructure (eHDSI) and the wide number of projects e.g.
under H2020 Conneting Europe Facility (CEF) and Innovative Medicines Initiative (IMI), the X-eHealth is aiming
to foster the uptake of European Eletronic Health Record Exchange Formant (EEHRxF) on regional, national and
European level. This is done by defining on functional and technical level the requirements for the newly added use
cases Laboratory Results, Medical Imaging and Reports and Hospital Discharge Reports, by specifying them and by
demonstrating and measuring their technical feasibility for cross-border data sharing as well as on local, regional or
national level within Member States. The already introduced use case patient summary will be reassessed in the light
of possible reuse of technical and semantical components and also applied to rare and undiagnosed diseases. The
proposal brings together key European policy leaders to drive forward collaboration on this 1st priority of DTHC.
The X-eHealth proposal will bring recommendations to secure data access and sharing with compliance of the EU
regulations, as GDPR (Regulation (EU) 2016/679), eIDAS (Regulation (EU) N°910/2014) and PSI.
In order to guarantee this compliance, our proposal will be contributing to: better articulation of eHealth services
with the progressive and common use of Digital identification in health (in alignment with strategies currently being
discussed in the ehealth); digital ID analysing legal aspects and enablers needed for interoperability; identifying
common cybersecurity efforts directly related to electronic health record exchange. This project intends to contribute
to better access for consumers and businesses to digital services across Europe.
2. Pillar 2: Personalised medicine through shared European data infrastructure
The eHealth digital service infrastructure needs to evolve towards a more European citizen centred approach and
usage. This will facilitate once implemented, tailored diagnosis and treatment of citizen in need of acute emergency
care or suffering from chronic diseases and help through dedicated health services to be better prepared to respond
to cross-border health threats.
X-eHealth aims to contribute to sharing health data for research, faster diagnosis and improved health by introducing
and defining reusable semantic and technical components, which can be used on local, regional, national and
European level. X-eHealth intends to streamline existing efforts on EU-level and align them with e.g. established
initiatives for national genomic databanks. The proposed project will among also refine the patient summary’s
functional and technical specifications to support rare diseases and connect with dedicated registries.
3. Pillar 3: Citizen empowerment with digital tools for user feedback and person-centred care
Citizen participation, prevention and care integration have been recognised as key aspects to successfully address
current health system challenges.2
Due to an ageing population, more and more people in the EU are suffering from multiple chronic diseases. This
increases the demand for healthcare. At the same time, there is a shortage of medical professionals3. Digital health,
1
https://www.eid.as/home/
2
State of the Health in the EU Companion Report 2017. https://ec.europa.eu/health/sites/health/files/state/docs/2017_companion_en.pdf
3
European Public Health Alliance. “Digital Solutions for Health and Disease Management; Digital Health Discussion Paper”. May, 2017
5
951938 X-eHealth – Part B
starting with the standardisation of health information, can increaseAssociated
both thewith
quality and Ref.
document the Ares(2020)2778062
efficiency of healthcare,
- 28/05/2020
by streamlining the effective exchange of information, reducing the administrative burden and clears the way to
secondary use of information, such as scientific research, management information, benchmarking, decision support
and deep learning techniques. Structured information also allows solutions where medical information can made
more understandable to citizens using laymen’s term for clinical information.
In this sense, X-eHealth strengthens citizen’ empowerment by supporting individualized care through national and
cross-border available digital services. The digital eHealth services can improve the prevention and management of
chronic conditions and allow patients to provide feedback to healthcare providers and act as an important partner in
shared decision making. Health systems will also benefit from innovative care models that use telehealth and mHealth
to address the rising demand for healthcare. Rural geographic areas can profit significantly, if patients can receive
care in their home environment.
Digital patient-centred health solutions need to be deployed more widely and in a more innovative way. X-eHealth
aims to provide principles, guidelines, models and specifications of functional and technical level for the above-
mentioned use cases Laboratory, Imaging, Hospital Discharge letters and rare diseases, thus widening the scope of
interoperability to better support European citizens. It will also deliver proof-of-concept demonstrators for selected
EEHRxF use cases in rare diseases, chronic disease patients and patients with comorbidity, delivering value for
citizens. Additionally, the project aims to build capacity in an EEHRxF Community of Practice engaging stakeholders
including patients, healthcare professionals, developers, business analysts, and policy makers and also to explore
infrastructures for innovation, including mobile solutions for the citizens’ use.
Align efforts of ongoing initiatives supporting the DTHC priorities
The strategic initiatives put forward by the European Commission to advance towards a borderless eHealth Union
are emphasised by two priority measures: start the application of a common and uniform Electronic Health Record
exchange Format (EEHRxF) to ensure interoperability in the use of ICT and to incite a rapid and sustainable digital
transformation of national healthcare systems in the light of the EU eGovernment Action Plan 2016-20204.
Focusing on the practical application of cross-border initiatives, the operationalisation of this projects is supported
by the Joint Action supporting the eHN (eHAction) and conducted in accordance with the Multiannual Work Program
2018-20215 of the eHealth Network. Thus, under the Commission’s Digital Single Market umbrella, this
intergovernmental eHealth cooperation action established eight working groups, five of which focus exclusively on
delivering technical-scientific expertise for the advancement of the eHealth sector. Building on that, X-eHealth is
aimed at improving both the quality and well-being of citizen’s health within Member States and on European level.
During the 13th eHN meeting held on 15th May 2018, eHealth interoperability and policy actions to improve semantic
interoperability in the EU were discussed.6 This was intended to initiate a constructive discussion among members
of the eHN with the objective to further improve semantic interoperability in the EU. As a result of this discussion,
it was noted by the participants that a Common Semantic Strategy (CSS) in the EU was needed. As such, a provisional
working group was raised under the eHAction activities, to discuss the principles, scope and ambition of such a
strategy. This group is composed by the MS representatives and wrote the CSS document with a 5-year semantic
strategy for semantics on EU. It considers the 5 information domains from the EEHRxF EC recommendation 7
(Patient Summary; ePrescription/eDispensation; Laboratory Results; Medical Imaging and Reports and Hospital
Discharge Reports) to describe the semantic strategy. The group got mandate from eHN to integrate their scope under
the name “eHN Subgroup on Semantics” to develop and elaborate guidelines and recommendations regarding this
strategy.
Currently, the information domains Patient Summary and ePrescription/eDispensation are managed by the eHMSEG
STF. The other 3 domains (Laboratory Results; Medical Imaging and Reports and Hospital Discharge Reports),
however, still need to be integrated to their scope. The CSS document propose the integration of these three domains
to the eHMSEG in order to extend their mandate and provide support to all 5 information domains described in the
EEHRxF recommendation.
This way, this consortium recognizes the importance of health data interoperability as a key enabler for digital
transformation in health and care, for which a common semantic language, as well as a common data exchange
format, needs to be available.
4
https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52016DC0179&from=EN
5
https://ec.europa.eu/health/sites/health/files/ehealth/docs/ev_20171128_co01_en.pdf
6
Cover Note by eHealth Network Secretariat: https://ec.europa.eu/health/sites/health/files/ehealth/docs/ev_20180515_co02_en.pdf
7
https://ec.europa.eu/digital-single-market/en/news/recommendation-european-electronic-health-record-exchange-format
6
951938 X-eHealth – Part B
On this basis, X-eHealth project aims to lay the foundations to advance
Associated the integration
with document process- 28/05/2020
Ref. Ares(2020)2778062 of the
abovementioned eHealth services features into the already in place European cross border Patient Summary.
The overall vision of X-eHealth is to contribute to a Europe with integrated health processes in which the health
record of every European citizen can be immediately accessed in any Member State. Regardless of where in Europe
the patient receives health care, every health professional will fully understand the patient data with the European
Electronic Health Record exchange Format (EEHRxF).
An important goal of X-eHealth is to contribute to a Common European Health Data Space, that addresses the
challenge of healthcare integration through interoperable and implementable data models, exchange formats and
standardized solutions, at cross-border, but also at national, regional and local levels, between providers themselves
and between providers and citizens and taking into account privacy and cybersecurity regulations.
Thus, the proposed work is to highlight, contribute and support the European eHealth interoperability and the
implementation of the EEHRxF through standardisation and harmonisation of health data, providing with quality
and safety and empowering the patients, professionals and health institutions.
The overarching goal of the project is the contribute to a future adoption of a eHealth governance framework and an
Information & Communication Technology (ICT) infrastructure that will enable secure across borders access for the
citizens and health professionals to the patient health information, particularly with respect to laboratory results,
medical imaging and reports and hospital discharge letters and add rare diseases to the patient summary service.
The project will focus also on verifying the feasibility on re-using eHealth assets created by both European and
national initiatives and projects, as well as the potential of accelerated deployment of these services across borders.
For this purpose, the consortium intends to support the presently running eHDSI infrastructure (Patient Summary and
ePrescription/ eDispensation services) for the different referred services of EEHRxF. The project aims to define the
appropriate changes needed in the current eHDSI architecture for both core and generic services. This way the project
intends to enhance the interoperability and security of national digital health systems and support the secure exchange
of health data across borders, the I services mentioned in the previous paragraph.
It is the objective of the X-eHealth consortium to proceed to a national analysis/mapping of the challenges for
EEHRxF adoption (electronic identification implementation, legal aspects & enablers and cybersecurity) in order to
define the EEHRxF specifications, functional and implementable, related to the laboratory results, medical
imaging and hospital discharge reports and rare diseases. Thus, the work plan of the project is organised to guarantee
that the following clear, measurable and realistic objectives will indeed be achieved within the duration of the propose
two-year project:
The key goals are to:
Improve the healthcare quality and safety for citizens by allowing them to access and manage their
electronic health record from any place in the EU
Contribute to standardisation and harmonisation of eHealth services in the EU by setting European
agreements on diverse levels of interoperability
Contribute to defragmentation of European services
Facilitat interaction between patients and healthcare providers, to support prevention and citizen
empowerment
X-eHealth specific objectives are:
1. To reach a common understanding in the EU on the efforts needed to adopt the commonly defined EEHRxF
specifications at different levels and within their nationIEHR solutions
2. To define, specify and demonstrate the EEHRxF use cases laboratory results, medical imaging and reports,
hospital discharge reports and patient summary for those suffering from rare disease and/or comorbidities.
3. To elaborate the roadmap for the above-mentioned use cases for future uptake on the eHDSI as well as for
the additional usage within MS on national, regional or local level
4. To submit the outcomes and recommendations of X-eHealth regarding EEHRxF deployment to the relevant
bodies on policy, strategic and operational level (e.g. eHealth Network, National Competence Centres for
eHealth, eHDSI operators)
7
951938 X-eHealth – Part B
5. To propose a governance framework for the sustainable maintenance,
Associated evolution
with document and distribution
Ref. Ares(2020)2778062 of
- 28/05/2020
standardisation and interoperability
1.2 Relation to the work programme
X-eHealth recognizes the importance of the future usage of Electronic Health Record exchange Format within the
EU. The project is fully aligned with the Horizon 2020 Programme’s Call theme of “Digital transformation
in Health and Care” and addresses the topic “Support for European eHealth Interoperability roadmap for
deployment” (SC1-HCC-07-2020).
It focuses on defining and agreeing on the exchange formats for the EEHRxF8 use cases laboratory results, medical
imaging and reports, hospital discharge reports and rare diseases as part of the patient summary. Health data acquired
at the point of care will be recorded in a standard way, according to the agreed standards and formats. This allows
for an easy and understandable exchange of information among healthcare systems in EU. X-eHealth will set the
scene for the definition, deployment, maintenance and monitoring of interoperable eHealth services within the EU,
which can be used both across and within national borders.
X-eHealth will build on past and current efforts and activities in cross-border eHealth, which have been very valuable
contributions to standardisation and harmonisation on structured health information and on privacy and security.
Crucial milestones towards eHealth interoperability in the EU have been reached by projects and initiatives such as:
epSOS I and II, EXPAND, national CEF eHealth projects to connect to the eHDSI, VALUEeHEALTH,
openMedicine and eSENS. The X-eHealth project will carry on these important efforts.
The X-eHealth roadmap will envisage steps to create an open and interoperable digital health ecosystem where health
data and information flow securely between and across platforms from different vendors and across borders.
It’s also important to refer that the Directive on open data and the re-use of public sector information, also known as
the ‘Open Data Directive’ (Directive (EU) 2019/1024) replaces the Public Sector Information (PSI) Directive, also
known as the ‘PSI Directive’ (Directive 2003/98/EC). All the work of X-eHealth project will follow these EU
regulations to develop its work and ensure compliance to any kind of updates during the two-years of
project.Directive 2003/98/EC). The Directive on open data and the re-use of public sector information, also known
as the ‘Open Data Directive’ (Directive (EU) 2019/1024) replaces the Public Sector Information (PSI) Directive, also
known as the ‘PSI Directive’ (Directive 2003/98/EC). All the work of X-eHealth project will follow these EU
regulations to develop their work and ensure compliance to any kind of updates during the two-years of project.
The work proposed by X-eHealth will completely follow the scope of the H2020 topic: We are considering the Health
Records at national context (WP 1 – T1.4), the empowerment of the European Citizens (WP 2 and WP 8), compliance
with GDPR (WP 4 – T4.2 and T4.3), as well as the ethics and legal issues for all relevant data (WP 4 – T4.2, that will
closely work with eHMSEG group). The X-eHealth goals will be pursued successfully and commonly by its
consortium, its collaborative partners and its advisory board.
Call specific challenges/scope vs How they are addressed in WPs, tasks and outputs
The Call supports the deployment and monitoring of eHealth interoperability resulting in real life interoperable
solutions for use by citizens, researchers, health services and the workforce across borders in the EU Digital Single
Market
Tasks & Outputs
X-eHealth’s WP1, T1.4, will analyse and map national challenges for EEHRxF adoption, by assessing the current
state of the play. This knowledge will allow us to understand better the current digital platforms and solutions
available for usage by citizens, researchers and health services and to develop a support methodology and
monitoring of eHealth interoperability across borders of those solutions. The focus will be in 4 domains: laboratory
results, medical imaging and reports, hospital discharge reports and explore rare diseases into the patient summary.
8
Commission Recommendation on European Electronic Health Record exchange format. European Commission. 02.02.2019. https://ec.europa.eu/digital-
single-market/en/news/recommendation-european-electronic-health-record-exchange-format
8
951938 X-eHealth – Part B
The project will, especially through WP8, connect eHealth experts within
Associated and
with beyond
document Ref.ofAres(2020)2778062
the x-eHealth project
- 28/05/2020
and will liaise with digital health stakeholders, including large scale programs to deliver and evaluate proof of
concept applications of EEHRxF for selected use cases. The use cases will be dedicated to rare diseases, chronic
diseases and related with the decision aids and citizen driven health-science (T8.1, T8.2 and T.8.3) and cover local,
regional, national and cross-border interoperability aspects. The work will contribute towards addressing local,
national, cross-border/international interoperability challenges in a collaborating and multilingual manner,
which also takes into account semantic and terminology issues.
The deployment should build on the Commission Recommendation on the European EEHRxF format and be
guided by strong and systemic contributions for better data and better computational approaches to advance disease
prevention and personalised medicine.
Tasks & Outputs
The EC Recommendation of EEHRxF suggests a framework for cross-border exchange of electronic health records
which lists principles for access to and cross-border exchange of electronic health records, namely that a) Member
States should ensure that citizens are able to access and securely share their electronic health data across borders,
b) Member States are encouraged to give citizens the ability to choose to whom they provide access to their
electronic health data, and which health information details are shared, and c) Member States should ensure that
these principles are observed when developing solutions enabling access to, and exchange of electronic health data
in the Union.
The WP4 will be dedicat“d to "Generic Aspects of EEHRxF recommen”ation" and will be define, in more concrete
terms, what are the practical implications of the aforementioned principles. This will be done by keeping in mind
relevant ongoing eHealth initiatives, especially regarding 1) road mapping of eID usage in health, 2) analysing
legal aspects and enablers needed for interoperability, and 3) identifying common cybersecurity efforts directly
related to electronic health record exchange.
The outcomes of WP4 will be used by the WP5, WP6 and WP7 for the definition of functional and technical
specifications and for the global architecture of the four concrete use cases: laboratory results, medical imaging,
hospital discharge letters and rare diseases into the patient summary service.
The deployment should consider interoperability of electronic Health Records across national borders, the
empowered European citizen, compliance with the General Data Protection Regulation, the Network and
Information Systems Directive and the operation in a European digital single market.
Tasks & Outputs
The X-eHealth project and its outcomes strives to significantly support the initiative of a Common European
Health space, that through interoperable and standardized platforms and solutions, which are compliant with the
data protection, privacy and cybersecurity laws will foster cross-border exchange of patient data through future
eHealth services such as but not limited to: laboratory results, medical imaging, hospital discharge letters and
rare diseases into the patient summary service. Especially WP1 T1.3 “Roadmap of new domains and
sustainability plan” will develop a sustainability model for the management, maintenance and further development
of the eHealth DSI, in line with the EEHRxF Roadmap and other relevant ongoing and upcoming strategic
activities.
1.3 Concept and methodology; quality of the measures
X-eHealth will support the vision of the European roadmap for building innovative communities of knowledge in
digital health by promoting and demonstrating the joint work on the definition and practical usage of EEHRxF.
As a Coordination and Support Action X-eHealth will on one hand coordinate almost all Member States to work
jointly on the definition and adoption of EEHRxF and on the other hand support the uptake of EEHRxF by 1) fostering
decisions making on policy level about the implementation of EEHRxF and 2) initiate communities of practice for
support to early implementers and users, and capacity building.
The main approach is a broad collaboration and networking mechanism with relevant EU projects, bodies and
organisations to support the standardization and uptake of EEHRxF through open innovation strengthening European
9
951938 X-eHealth – Part B
participation. This joint work will be done in an innovative and incremental approach,
Associated with documentkeeping an open eye -on
Ref. Ares(2020)2778062 new
28/05/2020
and approaching technologies without losing track off established technical standards. For instance, X-eHealth will
take actions to facilitate the adoption of EEHRxF in the mobile health market by providing also appropriate technical
specification using FHIR resources for EEHRxF use cases: laboratory results, medical imaging, hospital discharge
letters and considering rare diseases into the patient summary service.
X-eHealth will develop and undertake in collaboration with large scale projects and initiatives Proof of Concept
demonstrators on EEHRxF in rare diseases and one on EEHRxF in chronic diseases management and prevention.
Additionally, an explanatory proof of concept study on EEHRxF to support decision aids and citizen driven health-
science will be done as well as an exploitation of the possible the role of EEHRxF in other domains, broadly noted
registries, etc. The evaluation of the proof of concepts and their demonstrators will be used to capture and share best
practices and guidelines for EEHRxF implementation.
X-eHealth reveals a balanced scale between coordination and support activities. The consortium with partners across
Europe collaborates in developing, reviewing and validating interoperability EEHRxF assets, receiving strategic
advices from relevant experts and leaders from all MS and European level organisations and stakeholders.
In order to achieve its objectives, X-eHealth will rely on and make use of relevant network of European networks
(e.g. eHN, eHMSEG and their working groups) and other projects and initiatives through bilateral cooperation, which
brings added value to both sides. Furthermore, X-eHealth will remain open for other organizations, which may join
forces non-funded as collaborative partners and advisory board members during the project lifetime. Already,
collaborative partners, EHTEL, COCIR, and ECHAlliance, representing the industry and local ecosystems have
expressed interest to act as multipliers of impact for EEHRxF activities in X-eHealth.
It is also important to mention that in order to ensure the success of the tasks, within the stipulated time, in addition
to the Deliverables that will be submit to the EC (D), they will be also produced Internal Deliverables
(ID)10nalysenalyze the current situation of each WP. In the same way, there will be Milestones (M) and Internal
Milestones (IM).
2. Impact
2.1 Expected impacts
X-e’ealth's commitment is to add societal and scientific value by preparing, validating the EEHRxF for deployment.
Aimed at expanding the already in place Patient Summary services to support rare disease patients as well as patients
with comorbidities, this CSA intends to systematically harmonize the exchange of images, laboratory results and
discharge letters so that local, regional, national and European health entities can effectively interoperate with each
other, thus enhancing the positive impact of technology and in particular of digital transformation on society.
The opportunity that large amounts of health data exploration offer for public health management, empower health
providers with the availability of real-time data to improve clinical decision making, whether for more reliable
prevention, accuracy or even innovation in health and care. Nevertheless, as far as information exchange is concerned,
interoperability standards are still poorly tailored to users’ needs. With this in mind, Figure 1 outlines what has
ultimately to be achieved by this CSA:
10
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Standardisation and Harmonization of Digital Platforms and Solutions
•Making data accessible in an actionable form for exchange and portability by citizens, researches,
health services and health professionals
Increase levels of Digital Literacy
•Endow users (citizens and health providers) with the essential eSkills to enhance preventive approaches
and advance the timeliness of intervention
System Integration and Architecture
•Full development of a citizen-centred health record solution that enhance citizens self-management
whilst adding-on supplementary data for a tailored Digital Service Infrastructure
Citizens / Patients
• Better and easier online access to citizens' health record information to ensure greater confidence and
safety when traveling across Europe
Figure 1 – X-Health targets for expected impact.
Working on the basis of a European-wide electronic health reId (EHR) exchange format supported by the Connecting
European Facility, this Consortium, comprising 36 entities from 22 Member States/Countries, embraces this specific
challenge with the aim of putting the C’mmission's EEHRxF Recommendation into action in the form of a flexible
and sustainable solution, broad enough to address most barriers to cross-border interoperability.
By relying on the outcomes in open specifications and software delivered by previous projects (epSOS 1 and 2,
EXPAND, eHDSI, VALUEeHEALTH and eSENS), X-eHealth expected impact builds upon this framework to
ensure safer freedom of movement for EU citizens on the basis of an integrate and interoperable EU healthcare
system, in which’citizens' health information flows alongside their care pathway with minimal loss of meaning (or
no loss at all), thereby facilitating the provision of health care whenever needed.
For this purpose, the roadmap put forward by this project thrives on a meaning-oriented strategy that whilst
aggregating health data records within a shared integrated system, strive for capitalizing the different strands of
information sharing to ensure that it has the intended impact. From easier access and portability of EHRs for the
citizen to more effective and personalized care for eHealth professionals, the X-eHealth roadmap envisions to
advance thorough research by supporting a faster pace for innovation in the sector.
EU
•Digital Service
Member States Infrastructure
•National Health •Regulation
Health System
Providers
Citizen •Administration
•Better
•Self- decision-
management making
•Cost & time •Cost & time
effectiveness effectiveness
Figure 2 – Actors’ roles for developing eHealth interoperability in EU.
Looking ahead to an interoperable eHealth Europe, these 22 Member States/Countries, acting on the basis of the
recommended EEHRxF guidelines, supported by Standards Developing Organizations (HL7, IHE, NEN) commit
themselves to further develop coordination mechanisms for assessing the long-term sustainability of the EEHRxF.
Through a joint cooperative approach, the impact that X-eHealth aspires to is: to move forward into the Digital
Single Market by ensuring that developed health services based on the EEHRxF specifically contribute to
improving the health conditions of citizens and health providers, thereby improving the state of health in the
EU as a consequence of alignment to the EEHRxF specifications.
11
951938 X-eHealth – Part B
Risks: Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Two types of obstacles stand to obstruct achieving in full the expected impacts of X-eHealth. These are obstacles
that might prevent or constrain the development of cross-border care services and can be procedural and / or structural.
While procedural obstacles may result from meaningful differences at the time of developing functional and technical
specifications for the interoperability of eHealth services, structural obstacles emphasize underlying issues between
national legislations, therefore making the advancement of cross-border e-care services inconsistent, competitive and
overlapping
In order to jointly overcome the above obstacles, the methodology proposed by this consortium as well as the
established problem-solving mechanism will cooperate to get over this induced lack of interoperability by bridging
Memb’r States' legal diversity towards the common purpose of a better and healthier tomorrow.
2.2 Measures to maximise impact
a) Dissemination and exploitation of results
To maximise project impact, a special focus is given to the development of X-eHealth’s Plan for Communication,
Dissemination and Engagement (see also WP2 DoW). On the basis of effective application of measures tailored to
stakeholder conditions, this Plan purpose is to ensure the intended information reaches out and touches the target
audience – citizens, academia, business, health professionals, health providers and decision-makers – to the maximum
extent possible, for cross-border health care services awareness-raising. Towards this end, this plan objective is to
inform target stakeholders with X-eHealth’s results in order to engage them in the process of its development and
improvement whilst fostering wider dissemination.
Besides releasing project results, the dissemination strategy aims at bringing together the European eHealth actors to
share information on best practices and interoperability assets to serve the needs of the community. Likewise, X-
eHealth is citizen-centred, thus meant to raise people’s consciousness of their own rights and benefits concerning the
eHealth domain, particularly at cross-border healthcare level.
The first steps taken toward establishing a plan for the dissemination and exploitation of the project results were
identifying the target audience, the most suitable approaches and measures to maximise its reach.
The identified target audience comprises the following stakeholder groups:
Citizens;
Health Professionals and healthcare providers;
Industries, researchers and developers;
Member States and National Health Authorities.
The approaches and measures pointed out to reach the target audience are:
create X-eHealth official – identity - logotype;
create X-eHealth Website, Facebook and Twitter;
provide timely information keeping stakeholders up to date;
customize the approach for each stakeholder group to ensure greater receptiveness;
promote interactive initiatives to attract and engage stakeholders;
boost stakeholder’s engagement and keep them interested.
All the project’s actions and results will be given large and appropriate visibility to have an impact on the public in
general. Before proceeding with the communication approach, the model illustrated in Figure 3 shows what is aimed
to accomplish, as outlined below:
12
951938 X-eHealth – Part B
Attention or A-wareness: attract the attention of the stakeholders andwith
Associated keepdocument Ref. Ares(2020)2778062 - 28/05/2020
raising awareness through the partners’ websites updates/briefings/notes of
events. Awareness does not come from website updates though, it must come
from the public outreach, via potential multipliers.
Interest: raise user’s interest by focusing on and demonstrating advantages
and benefits of using EEHRxF nationally and across-borders; raise
stakeholders’ interest on the H2020 programme, in order to become engaged
on the EU health policies and programmes.
Desire: convince stakeholders that using EEHRxF best practices will enhance
a Common Europe culture and increase EU competitiveness.
Action: lead stakeholders towards taking action by promoting joint events and Figure 3 - AIDA methodology
activities.
We propose to add an additional point to this methodology:
Sustain: the interest of people on the project must be sustained, so they boost the use of EEHRxF and contribute
to the growth of Europe health ecosystem. Sustainability and scalability are key aspects that must be kept in mind
from the beginning onward as a fundamental pillar of all work.
Reaching the audiences will be achieved by a set of tools among which we have identified the following essentials:
e-publications that have the power to rapidly disseminate on the web while keeping the essence of solid
publications;
posters, roll-ups and physical display materials to be placed in as many relevant events connected to public health
as possible;
videos with a viral edge that allow the image of an evolved health system, ✓ presentation in wide international
public events and initiatives.
and most importantly, shareable content that can be created from scratch or curated from other sources and
published on official channels of the awareness-raising campaign, such as the applicants’ websites and the
applicants’ Twitter and LinkedIn accounts.
The targeted dissemination strategy of X-eHealth aims to share the early results of the project among the eHealth
stakeholders and bring together the eHealth community in Europe sharing information on best practices of
interoperability. The plan for dissemination and exploitation of project results will be driven by Work Package 2
from the beginning of the project to promote X-eHealth among the community. In the Communication activities
section further information will be given on the specific dissemination channels to be used and actions to be
implemented before, during and after the project.
The dissemination activities of X-eHealth will be multiplied by the contribution of collaborative partners and through
the community of practice (WP8), which will serve both in developing the European culture of interoperability but
also in building capacity among developers and implementers.
b) Communication activities
Communication plays a crucial role both internal and externally. Thus, to maximise the project impact among its
stakeholders, different dissemination channels, content types and actions will be managed in order to achieve this
goal.
The selected dissemination channels will be used accordingly:
X-eHealth Website (to be launched and updated as often as needed);
X-eHealth social networks (to be launched and updated as often as needed);
news agencies and media outlets (to reach a wider audience whenever applicable);
mailing list (to share any kind of information internally or externally).
The following content will be produced and provided in accordance:
13
951938 X-eHealth – Part B
news articles (reporting project activities on time); Associated with document Ref. Ares(2020)2778062 - 28/05/2020
social media posts (including infographics and videos);
periodic newsletters (to be set as monthly or quarterly);
press releases and papers (to reach a wider audience whenever applicable);
X-eHealth booklets and flyers (online and print versions);
project video (for online and event dissemination);
customised –aterial - pens and notebooks with X-eHealth logo (events).
The following initiatives will be promoted face to face and/or online:
Consortium meetings;
X-eHealth Work Packages’ Workshops;
X-eHealth Innovation Days, in partnership with HL7 (other entities to be confirmed):
o 1st X-eHealth Innovation Day - at the end of the 1st year,
o 2nd X-eHealth Innovation Day - at the end of the 2nd year;
X-eHealth interoperability award 2022;
Portugal eHealth Summit 2020;
Other conferences or events to be confirmed.
In this context, the overall dissemination objectives are: raise a–areness - ensuring the key initiatives are spread and
understood among stakeholders, through tailored methods and channels to increase awareness and eventual feedback;
sustain stakeholders’ engagement; influence decision makers concerning person-centred integrated care and digital
innovations and ensure sustainability of the effective and structured vision after the end of project.
3. Implementation
3.1 Work plan – Work packages and deliverables
Figure 4 – X-eHealth’s Work Packages relationship
14
951938 X-eHealth – Part B
Work Package Year 1 Year 2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Task 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
WP1 Project coordination
1.1 Project management, quality control and risk management
1.2 Project administrative and financial management
D1.3
1.3
Roadmap of new domains and sustainability plan D1.4
1.4 Mapping national challenges for EHRxF adoption ID1.5.1 ID1.5.2 D1.5
1.5 Ethics Requirements D1.6
WP2 Dissemination, Communication & Stakeholders
D2.1
2.1 Communication, Dissemination and engagement plan D2.2 D2.4 D2.5 D2.6
D2.3
2.2 Health professional and citizens education
2.3 MS and stakeholder involvement D2.6
2.4 Industries, researchers and developers' liaison
2.5 Hospital digital network
WP3 Evaluation
3.1 Establish evaluation strategy D3.1
3.2 Evaluation of results for the new services D3.2
WP4 Generic Aspects of EHRxF recommendation
4.1 Electronic Identification implementation D4.1.1 D4.1.2
4.2 Legal aspects & enablers D4.2.1 D4.2.2
D4.3.2
4.3 Cybersecurity
D4.3.1 ID4.3.1 ID4.3.2 ID4.3.3
WP5 Definition of EHRxF functional specifications
5.1 X-eHealth use cases driven methodology ID5.1 D5.1
5.2 EHRxF and its relationship with clinical guidelines ID5.2 D5.2
5.3 Laboratory Results guideline and functional specifications ID5.3 D5.3
5.4 Medical Imaging and Reports guideline and functional specs ID5.4 D5.4
5.5 Hospital Discharge Reports guideline and functional specs ID5.5 D5.5
5.6 Refine PS guideline and functional specifications to account for rare diseases ID5.6 D5.6
5.7 Final conclusion and recommendations D5.7
WP6 Definition of EHRxF implementable specifications
6.1 Definition of technical specification for the Laboratory Domain ID6.1
6.2 Definition of technical specification for the Medical Imaging Domain ID6.2.1 ID6.2.2
6.3 Definition for the technical specifications Hospital Discharge Reports ID6.3
6.4 Refinement of Patient Summary (PS) technical specifications for supporting rare diseases ID6.4
D6.1
6.5 Publication and maintenance of the services specifications and testing tools
ID6.5.1 ID6.5.2 D6.2
6.6 Publication and maintenance of the X-eHealth Implementation Guide D6.3
WP7 Architecture integration and System specifications
7.1 Global architecture for EHRxF Domains use ID7.1 D7.1
7.2 Testing strategies D7.2
7.3 Needs for upgrade of CEF eHDSI core and generic services D7.3
7.4
Guidance for the new EHRxF domains ID7.2 D7.4
EHRxF Communities of Practice: from Proof of Concept to large scale adoption and Infrastructure for
WP8 Innovation
8.1 Proof of concept: EHRxF in rare diseases D8.2
8.2 Proof of concept: EHRxF in chronic diseases management and prevention D8.3
8.3 Exploratory Proof of concept study: from EHRxF to decision aids and citizen driven health-science D8.4
8.4 EHRxF community of practice: building capacity and scaling up D8.1
8.5 Exploitation: EHRxF as infrastructure for innovation D8.5
8.6 Evaluation of EHRxF proof of concept demonstrators D8.6
Figure 5 – Gantt Chart
3.2 Management structure and procedures
Organized into two segments, this section outlines the project organizational structure and describes the frames
procedural practices with a special focus on their roles and accountabilities.
By acknowledging the managerial complexity of this large-scale project, X-eHealth consortium partners firmly
believe that the best way to operationalize the exchange of electronic health records within a common framework is
best accomplished by Project Management Pro’essional's best practice approach (PMP) developed by the
internationally distinguished Project Management Institute (PMI).
Aiming at jointly working for the effective deployment of the objectives, the agreed management methodology is
specifically designed for projects in controlled environments and is commonly used by X-eHealth consortium
partners as a managerial tool in their activities for such kind of projects.
Modelled on the flexible concept of preventive maintenance, the chosen arrangement is designed to promptly adjust
to change and unexpected events so that the project may keep on delivering the right results on time and within
budget, towards causing the desired impact.
Making the best of existing opportunities while mitigating the threats arising throughout the project, this
organizational structure is conceived to strengthen risk management, to enhance operational quality and efficiency,
and to meet regulatory requirements.
Furthermore, to assure the smooth and effective development of X-eHealth purposes, we outline herein the
behavioural principles that will conduct these consortium cooperation procedures for the next two years:
Figure 6 displays X-eHealth’s governance structure, which consists of the following bodies, functions and roles:
15
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Figure 6 – X-eHealth’s governance structure
1. Steering Board (SB)
Designed to be the highest decision-making body in the project, the Steering Board assembles all X-eHealth
consortium partners to jointly leading the project on the strategic level.
Its responsibilities range from decision-making to monitoring as all issues with possible significant effects on the
project have to be decided within this body. These include financial/administrative decisions such as amendments to
the Grant Agreement, project procedural rules, resources reallocation and deliberating recommendations.
The SB shall assemble at least once every three months to present the progress of the project to its associates and to
disseminate outcomes. In-person meeting shall occur twice a year. Extraordinary meetings are to be arranged if
circumstances demand so. Herein, voting rights are exclusively held by consortium partners (one per partner). The
PC shall chair these body meetings.
Concerning decision-making procedures, a consensus is the preferred practice, however, the Steering Board decides
by a two-thirds majority when the quorum is reached (half of the partners with voting rights are present).
2. Project Coordinator (PC)
The PC takes on the responsibility of organizing, controlling and coordinating the entire project. The project
coordinator shall guarantee by appropriate management tools that the project develops smoothly and effective
communication is ensured between bodies, partners and associates.
To optimize its coordination responsibilities, the PC role (feature by WP1) shall be aligned with the WPs for
dissemination and evaluation, WP2 and WP3 respectively. The PC chairs and shall act as a link between the Steering
and the Executive Boards assemblies. PC team shall carry out all the project administrative issues, from legal to
financial and from technical to organizational.
WP1 is responsible for monitoring project activities (including risk and quality management) while maintaining an
up-to-date view of progress, serving at the same time as the official interface between the consortium and the EC.
3. Executive Board (EB)
The Executive Board is responsible for aligning, coordinating and monitoring the course of the project across all
WPs. These liabilities shall factor to address the PC with recommendations for its overall coordination and are to be
reported to the SB semi-annually.
Although the SB stands as the highest decision-making in X-eHealth, it is the EB’s competence to undertake
executive decision that does not require the SC approval. Executive decisions that go beyond its competence shall be
prepared by this body and proposed as recommendations for deliberation in the SB.
16
951938 X-eHealth – Part B
The EB is chaired by the PC and comprises the representatives of each WP:with
Associated Leaders, Co-Leaders
document and Task Leaders.
Ref. Ares(2020)2778062 - 28/05/2020
(The risk and quality managers are herein represented by WP1 Leaders). The EB shall assemble via monthly
telephone conferences and might have face to face meetings each half a year.
The EB decides by a simple majority, still, a consensus is the preferred practice. Each WP and Task Leader holds
one vote only, despite of leading more than one WP or Task within the project.
The quorum is reached if half of the partners with voting rights are present.
4. Advisory Group (AG)
Designed as an external body with counselling functions, the Advisory Group for digital health innovation and
practice was instituted to assist the EB with the technical-scientific expertise in the following domains:
interoperability assets, use cases, and future pilots.
Jointly composed of senior experts and representatives of international organizations, this body gathers a set of high-
level strategic advisors eager in the abovementioned domains with a special focus on the EEHRxF component. Their
role in X-eHealth is to contribute with high-quality advice to the project strategic direction, to provide operational
guidance and to assess programme effectiveness when the group needs.
The AB shall meet twice a year by using remote communication means. The AG does not have voting rights neither
budget allocation. However, travel costs to attend X-eHealth conferences may be provided by the project funds.
More names will be added to the Advisory Group, for now are mention:
Daniel Karlsson, , MSc, PhD. Daniel has a master of computer science and received PhD in medical informatics
in 2001 from Linköping University. He has worked as a research assistant and later a senior lecturer at Linköping
University and as a health terminologist at Östergötland County Council. Daniel has been active in national and
international standardisation, e.g. as a secretary of CEN/TC 251 terminology and knowledge representation working
group, chair of the corresponding Swedish working group, a member of the NPU Terminology steering committee,
and in several advisory roles in SNOMED International. Daniel has participated in European research projects from
GALEN-IN-USE in the 1990ies to ASSESS CT in 2015-16, and is the Swedish representative of the eHealth Network
subgroup on semantics. He is currently employed at the Swedish National Board of Health and Welfare.
Jeremy Thorp, , was Business Architecture Director in the Health and Social Care Information Centre.
Previously, he was the Director for the NHS Information Reporting Services (NIRS) Programme, run jointly by NHS
Connecting for Health and the NHS Information Centre. Prior, Jeremy Thorp was Director of Business Requirements
in NHS Connecting for Health with responsibility for the Business Architecture of the National Programme for IT in
England, liaising closely with the Department of Health on policy and strategy issues. Jeremy Thorp worked at
national, regional and local levels in the NHS: nationally in the Department of Health Information Policy Unit and in
the NHS Information Authority, regionally in the South and West, and locally in the Bristol area.
Larry Garber, , is the Medical Director of Informatics at Reliant Medical Group, in USA. a 525-provider
multispecialty group practice. He is a board-certified Clinical Informaticist and has had decades of experience and
success in Medical Informatics. He is Chair of the Massachusetts eHealth Collaborative’s Executive Committee, a
member of the Massachusetts State Health Information Technology Council, and has been a member of ONC Policy
Committee’s Interoperability Workgroup, Jason Task Force, Privacy & Security Tiger Team, and Interoperability
Experience Task Force.
Jaime Ferguson, , is a Fellow at the Institute for Health Policy and Vice President of Health Information
Technology Strategy and Policy for Kaiser Permanente, responsible for health IT informatics standards, health IT
policies and priorities, as well as government relations and industry relations for IT. Prior to these assignments Jamie
was Executive Director of Information Management at Kaiser Permanente. He is also active in national and
international organizations for health IT and informatics. Before joining Kaiser Permanente Jamie worked as a
research investigator in the Department of Molecular Biophysics and Biochemistry at Yale University School of
Medicine, specializing in renal and hepatic protein structures and pathways. He also was employed as an economist
in the Federal Reserve System and at Bank of America, and as an independent consultant.
17
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Kai Rannenberg, , is a Full Professor, Department Director at Goethe University Frankfurt. He has been at Goethe
University since 2002, before which he was with the System Security Group at Microsoft Research Cambridge,
focussing on “Personal Security Devices and Privacy Technologies “, such as within the CamWebSIM project. For
six years from 1993, Kai worked at Freiburg University and coordinated the interdisciplinary “Kolleg Security in
Communication Technology,” sponsored by the Gottlieb Daimler and Karl Benz Foundation, that worked on
multilateral security, especially protection for users and subscribers. Since 1991, Kai has been active in the
international (ISO/IEC) standardization of IT Security and Criteria (JTC 1/SC 27/WG 3 “Security Evaluation
Criteria”). Since 2007, he has served as Convenor of the SC 27 Working Group 5 on “Identity management and
privacy technologies” after having led the SC 27 Study Periods on Privacy and Identity Management.
Liora Alschuler, , is a developer of XML-based standards for the exchange of electronic healthcare information,
and a consultant in their application to providers and system vendors. In 1997, she led the project that produced the
design of the first XML-based exchange specification for healthcare—the Health Level Seven (HL7) Clinical
Document Architecture (CDA). As CEO the Lantana Consulting Group, Liora oversees the company’s
implementation of standards-based solutions for the nation’s largest healthcare providers and public health agencies.
She provides leadership on projects with clients such as the Centers for Medicare & Medicaid Services (CMS), the
Centers for Disease Control and Prevention (CDC), the American Society of Clinical Oncology (ASCO), and
commercial clients, including Vanderbilt University Medical Center, Dartmouth Hitchcock Medical Center,
McKesson, and GE. Liora is an active volunteer promoting healthcare interoperability. She co-founded and served
on the executive committee for the Healthcare Information and Management Systems Society (HIMSS) Health Story
Project, which develops and promotes the adoption of information technology standards. Liora served on the HL7
International Board of Directors 2005-2008, and as co-chair of the HL7 Structured Documents Work Group. She is
a frequent guest speaker at industry events.
5. Collaborative Partners (CPs)
CPs bring together a set of international organizations with the interest and expertise to be a significant asset for X-
eHealth areas of focus.
On the table below it is the list of the collaborative partners, al’hough it's important to mention that new names will
be add to this list.
Table 3.2: Collaborative partners
Entity Name Contact
MedTech Europe Michael Stubin
[email protected]
COCIR Nicole Denjoy
[email protected]
EFMI Lacramoira Stoicu-Tivadar
[email protected]
EHTEL Marc Lange
[email protected]
ECHAlliance Brian O’Connor
[email protected]
Established as an external resource aimed at supporting the project development, engaged collaborative partners are
free to integrate the WPs of their area of interest. Still, the EB shall encourage CPs involvement to match the project
needs. MedTech Europe, EHTEL, COCIR, EFMI, and ECHALLIANCE have already agreed to participate as
collaborative members.
18
951938 X-eHealth – Part B
CPs shall be part of EB meetings whenever X-eHealth consortium Associated
considerswith
their expertise
document Ref.needed and appropriated.
Ares(2020)2778062 - 28/05/2020
CPs do not hold voting rights neither budget allocation. Still, travel costs to attend X-eHealth F2F meetings may be
granted if consortium partners deem it appropriate.
6. Quality Management (QM)
Since knowledge generated by the project arises from the
elaboration of deliverables, X-eHealth could not but have
a fraction focuses exclusively on the Quality Assurance
of Deliverables.
The Quality Manager is liable to ensure that the process
of deliverables production follows a structural approach,
to meet the required standards in order to be considered
final and therefore, delivered thoroughly to the European
Commission (see figure 7).
The Quality Manager shall be nominated by the PC. The
QM stands as an integral part of WP1.
Figure 7 – Quality Management Process
7. Risk Management (RM)
RM is accountable for the process of Risk Assessment and its management of all the risks which may arise throughout
the project lifetime. Divided into three stages, the RM shall systematically: (1) identify and assess potential risks,
while in parallel, (2) plan and perform mitigation measures and (3) control outcomes and track the project’s response
and progress.
To perform these tasks, a risk manager shall be nominated by the PC and is an integral part of WP1.
8. Work Package Leaders (WPL)
By acknowledging the operational challenge of some of WPs, this consortium agreed that the number of managerial
agents should be enlarged in the working packages where technical-scientific tasks require greater coordination and
engagement.
This way, each WP is jointly represented by a designated Leader and Co-Leader, and depending on the degree of
specificity of each WP’s content, Task Leaders are designated to reinforce the same WP managerial features.
This Leaders shall be co-responsible for leading their designated WP and its respective Tasks, according to the
objectives put forward in that same WP description of work.
These three agents shall coordinate, monitor and assess the progress of the working group in close cooperation,
supporting each other, making decisions and being able to substitute each other, if needed, in meetings and
communication activities.
9. Innovation Management (IM)
With the view of setting up X-eHealth in pursuit of Digital Health Innovation Practices, this consortium recognised
the need to establish an IM fraction.
Aimed at capitalizing the innovative potential that are to arise from the multiple tasks, this fraction brings together
the collaborative partners and the working group Leaders for innovative ways for EEHRxF exploitation (WP8). These
responsibilities shall be herein aligned to enhance the deployment of EEHRxF.
To perform this task, the IM is responsible for nominating a spokesperson who shall factor as a direct link to effective
communication between IM insights and the overall governance of X-eHealth.
19
951938 X-eHealth – Part B
The operationalization of this responsibility should be done throughAssociated
teleconferences on aRef.
with document regular basis. IM ideas
Ares(2020)2778062 shall
- 28/05/2020
be presented in the form of recommendations to the PC and
the EB.
The IM is overseen and shall report to the SB.
10. Conflict Resolution
In order to strengthen ’-eHealth's internal management,
this consortium presents herein the conflict resolution
process to be used in case of disagreement on the conduct
and purpose of the project activities.
In accordance with figure 8, the process of conflict
settlement shall first be addressed, informally, by the WP
Leaders at issue. If the issue persists, the EB shall be
formally informed to settle the conflict. At the last resort,
the SB shall assemble to take the final decision.
Figure 8 – Conflict resolution process
11. Risk Mangement
RM Purpose Identify Risk Assess Risk Risk Control Implementation Monitorization
Measures
• Objectives • Analysis • Degree • Plan • Structure • Layout
• Responsibilities • List causes • Likelihood • Design • Procedures • Review
• Impact • Prioritization progress
Risk Identification Risk Estimation Risk Evaluation
Figure 9 – Risk assessment framework
Conceived as an integral element ’f the PC's body therewith its own designated manager and responsibilities, the risk
assessment procedure established by X-eHealth is divided into three main stages consisting of six steps. This
procedure’s underlying idea is to identify and overcome internal and external issues that might jeopardise the purpose
of X-eHealth workflows.
As displayed in figure 9, the risk assessment framework sets a stepwise and consecutive approach to ultimately
transform arising risks into opportunities through continuous processes of risk identification, risk estimation and risk
evaluation.
To ensure X-eHealth delivers the proposed outcomes, it is the responsibility of the RM, headed by its representative,
to identify risks, categorize them, design appropriate safety measures, implement control actions and monitor the
project reaction to them, as illustrated above.
The risk manager shall maintain regular contact with WP Leaders and, as the need arises, single X-eHealth associates
to better perceive the project milieu, thus optimizing RM issue awareness and effectiveness. Potential risks shall be
communicated to the PC and EB and reported to the SB.
The main risks identified at this stage as well as their respective risk-mitigation measures are listed hereinbelow.
20
951938 X-eHealth – Part B
3.3 Consortium as a whole Associated with document Ref. Ares(2020)2778062 - 28/05/2020
X-eHealth’s project stands herein for a project of strategic relevance for tomorrow’s European eHealth
Union. Assembling at the time of this proposal submission a shared commitment of 47 health actors, the
underlying idea of this project is to develop the basis for a workable, interoperable, secure and cross
border Electronic Health Record exchange Format in order to lay the foundation for the advance of
eHealth sector while using the 3 pillars put forward by the EC as reference.
Aimed at promoting a faster and sustainable EU digital transformation, this Cooperative and Support Action
is made up of 8 Work Package in which 4 exclusively focus on technical-functional activities (WP4 to
WP7). From Generic Aspects to System Architecture and Integration passing by Functional and
Technical Specifications towards a uniform interoperable data-sharing format framework. In
addition, to enhance EU’s public health state of play, WP1 and WP8 are responsible for implementation
studies, practicality and continuity of eHealth interoperability development.
On this basis and building upon the already in place Patient Summary, X-eHealth purpose is to develop
the foundations for a common framework for medical imaging, discharge letters, laboratory results
and rare diseases to flow both alongside citizens care pathway and across health entities between EU
Member States and Neighbour Countries.
Aimed at promoting the flourish of health care cross border services at the European level, X-eHealth gives
a special focus to the legal and security issues arising from national legislations diversity. By
acknowledging this context, WP4 for Generic Aspects of EEHRxF was conceived to address most of these
issues and reckons on the established methodology which combines strong theoretical foundations with
practical and political considerations.
Hence, this consortium makes efficient use of project resources through eliminating overlap, the smart
selection and prioritisation of the sector and the regions covered at this stage and the maximisation of
synergies among all partners. As such this consortium ensures:
WPs are correctly aligned and effectively communicate occurs regularly for keeping on delivering
what has been agreed upon the list of Deliverables and Milestones and displayed in the Gantt Chart
Detailed risk management plan identifying potential project risks along with appropriate risk
management/mitigation actions
Cybersecurity and legal issues are not a hindrance to the X-eHealth purposes
Functional and technical specifications are developed in tune to build up the basis for a common
framework for the proposed domains
Emerging knowledge of Deliverables is made public and dissemination events and activities are
strategically arranged for raising community awareness.
This consortium represents a smart combination of best-in-class expertise across the health sector. From
Public to Private and from Non-for-profit to Standards to Profile Developing Organisations and Academia
research, X-eHealth covers the value chain through a combination of 36 entities:
11 Government and Public Administration Organizations
18 Public Health Entities
4 Solutions Providers / Universities
3 Standards and Profile Developing Organisations on European level
In total, X-eHealth gathers 36 consortium partners plus 5 collaborative partners and 6 eHealth skilled
experts. A total number of 47 health actors are involved in the project. 22 Member States / Countries are
constituent parts of X-eHealth consortium. The consortium also very well represents policy and political
actors mixed with national competent authorities to indeed concretely plan, implement and maintain
national eHealth infrastructures.
21
951938 X-eHealth – Part B
Additionally, consortium members will make use of their wide varietywith
Associated ofdocument
contactsRef.
and formal and informal
Ares(2020)2778062 - 28/05/2020
exchanges with actors in their own country or beyond, e.g. other member states, which are not a beneficiary
of this consortium. Together with the project-specific dissemination activities of WP2 each member of the
X-eHealth consortium plays their facilitating role in sharing experience and the transfer lessons learned of
the X-eHealth project to other Union member states and regions and foster the project’s impact to the
broadest extend possible.
3.4 Resources to be committed
Table 3.4 b ‘Other direct cost’ items (travel, equipment, infrastructure, goods and services, large
research infrastructure)
1/SPMS Cost (€) Justification
Travel 56 200 It is planned 3 types of events (Steering Board – 2/year, Executive Board
– 2/year and Workshops – 5/year). SPMS, as Coordinator should be
present in all meetings (18 in total). 2 people will be attending each
event. This value includes also the cost with the external experts’ travels.
It was considered an average price per trip of 700€. For the external
experts’ travels it was considered an overall value of 31 000€
Other goods and 52 199 In total it’s planned 18 events, this value should cover expenses with
services catering, room rental, etc.
Total 108 399
2/ATNA Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
3/GOeG Cost (€) Justification
Travel 18 200 The partners WP leader/co-leader will be present in 4 Steering Board, 4
Executive Board and 5 Workshops. 2 people will be attending each event.
It was considered an average price per trip of 700€.
Total 18 200
4/FPS Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
5/IHE Cost (€) Justification
Travel 18 200 The partners WP leader/co-leader will be present in 4 Steering Board, 4
Executive Board and 5 Workshops. 2 people will be attending each event.
It was considered an average price per trip of 700€.
Total 18 200
6/HL7 Cost (€) Justification
22
951938 X-eHealth – Part B
Travel 18 200 The partners WP leader/co-leader willdocument
Associated with be present
Ref.in 4 Steering Board,
Ares(2020)2778062 4
- 28/05/2020
Executive Board and 5 Workshops. 2 people will be attending each event.
It was considered an average price per trip of 700€.
Total 18 200
7/NEN Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event.
It was considered an average price per trip of 700€.
Total 9 100
8/HZZO Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
9/UCY Cost (€) Justification
Travel 18 200 The partners WP leader/co-leader will be present in 4 Steering Board, 4
Executive Board and 5 Workshops. 2 people will be attending each event.
It was considered an average price per trip of 700€.
Total 18 200
10/MZCR Cost (€) Justification
Travel 18 200 The partners WP leader/co-leader will be present in 4 Steering Board, 4
Executive Board and 5 Workshops. 2 people will be attending each event.
It was considered an average price per trip of 700€.
Total 18 200
11/Vysocina Cost (€) Justification
Travel 27 300 The partners WP leader/co-leader will be present in 4 Steering Board, 4
Executive Board and 5 Workshops. 2 people will be attending each event.
It was considered an average price per trip of 700€.
Total 27 300
12/ MSAE Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
13/ANS Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
23
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
14/MoH-FR Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
15/DIMDI Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
16/GEMATIK Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
17/TMF Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
18/MoH-GR Cost (€) Justification
Travel 18 200 The partners WP leader/co-leader will be present in 4 Steering Board, 4
Executive Board and 5 Workshops. 2 people will be attending each event.
It was considered an average price per trip of 700€.
Total 18 200
19/AEEK Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
20/SU Cost (€) Justification
Travel 18 200 The partners WP leader/co-leader will be present in 4 Steering Board, 4
Executive Board and 5 Workshops. 2 people will be attending each event.
It was considered an average price per trip of 700€.
Total 18 200
21/DoH-IR Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leadea/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
24
951938 X-eHealth – Part B
22/AgiD Cost (€) Justification Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
23/ARIA Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
24/MIN SAL Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
25/Reg. Lomb. Cost (€) Justification
Travel 13 100 The partners WP leader/co-leader will be present in 4 Steering Board, 4
Executive Board and 5 Workshops. 2 people will be attending each event
(partner chose to lower travel costs). It was considered an average price
per trip of 700€. This value includes the cost with the travels of link 3ª
parties.
Total 13 100
26/ NVD Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
27/SAM Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 675€.
Total 9 100
28/NICTIZ Cost (€) Justification
Travel 18 200 The partners WP leader/co-leader will be present in 4 Steering Board, 4
Executive Board and 5 Workshops. 2 people will be attending each event.
It was considered an average price per trip of 700€.
Total 18 200
29/NCZI Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
25
951938 X-eHealth – Part B
Total 9 100 Associated with document Ref. Ares(2020)2778062 - 28/05/2020
30/NIJZ Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
31/TIC Salut Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
32/equalis Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
33/SEHA Cost (€) Justification
Travel 18 200 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 5 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 18 200
34/INSERM Cost (€) Justification
Travel 9 100 The partners (that aren’t WP leader/co-leader) will be present in 4
Steering Board and 3 Workshops. 2 people will be attending each event. It
was considered an average price per trip of 700€.
Total 9 100
26
951938 X-eHealth – Part B
4. Members of the consortium Associated with document Ref. Ares(2020)2778062 - 28/05/2020
4.1. Participants (applicants)
Partner Full N–me SPMS - Serviços Partilhados do Ministério do Saúde, E.P.E
Short Name SPMS Partner No. 1
Country Portugal Website www.spms.pt
Type of Public organisation/ Logo
organisation eHealth Agency
Brief Partner Profile
SPMS stands for Shared Services of the Ministry of Health and is the Health Ministry Central
Purchasing and the national IT authority.
Conceived in 2010 as a State-Owned Enterprise (SOE) by the Ministries of Health and Finance,
SPMS purpose is to provide shared services – in the areas of purchasing and logistics, financial
services, human resources and ICT – to entities who operate specifically in the area of health
and health care, in order to “centralise, optimise and rationalise” the procurement of goods and
services within the Portuguese National Health System (NHS).
Focus on the development of shared services for information systems and technologies,
SPMS, SOE objective is to cooperate on the basis of knowledge and information sharing
while developing projects and activities for the advance health care services in the areas of
health information and communications systems and technologies. Aimed at ensuring that all
information is available in the best way for all citizens, SPMS plays a central role in
disseminating health services state of play, thus promoting digital literacy for better
prevention and selfcare in Portugal and European Union. In addiction, SPMS also promotes
the definition and use of standards, methodologies and requirements that guarantee
interoperability and interconnection of health information systems with each other and with
cross-sectional information systems of the Public Administration.
Main tasks in Project
SPMS main tasks in X-eHealth are the following:
WP1 – Project Coordinator (Leader)
T1.1: Project management, quality control and risk management (Leader)
T1.2: Project administrative and financial management (Leader)
T1.3: Roadmap of new domains and sustainability plan
T1.4: Mapping national challenges for EHRxF adoption
WP2 – Dissemination, Communication & Stakeholders (Leader)
27
951938 X-eHealth – Part B
T2.1: Communication, Dissemination and Engagement Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Plan (Leader)
T2.2: Healthcare providers, Health professionals and Citizens motivation (Leader)
T2.3: MS and National Authorities involvement (Leader)
T2.4 Industries, researchers and developers’ liaison (Leader)
T2.5 Hospital Digital Network (Leader)
WP4 – Generic aspects of EHRxF recommendation
T4.1: Electronic Identification implementation
T4.2: Legal aspects & enablers
T4.3: Cybersecurity
WP5 – Definition of EHRxF functional specification
T5.1: X-eHealth use cases driven methodology
T5.5: Hospital Discharge Reports guideline and functional specifications
T5.6: Refine PS functional specifications to account for eHN Guidelines and rare diseases
WP6 – Definition of EHRxF technical specifications
T6.3: Definition for the technical specifications Hospital Discharge Reports
T6.4: Refinement of Patient Summary (PS) technical specifications for supporting rare
diseases
WP7 – Architecture integration and System specification
T7.1: Global architecture for EHRxF Domains use
T7.2: Testing strategies
Relevant expertise and experience of the institution
As the Portuguese national authority for cross-border matters in the field of eHealth, SPMS
represents Portugal in the eHealth Network (eHN), the voluntary network of national
authorities of Member States responsible for eHealth, with a view to enhance cooperation,
knowledge sharing and good practices between Member States.
SPMS active participation and involvement in the eHN is emphasised by the nomination of its
President, Prof. Henrique Martins, to jointly Co-Chair the eHN (on behalf of Member States)
with the European Commission. This involvement builds upon insightful contributions at the
time of dratfting the eHN Multi-Annual Work Plan (MWP 2018-2021), acting as rapporteur.
Furthermore, SPMS played an active role in JAseHN, participating in four Work packages of
this project. JAseHN objectives were to ensure the regular production of instruments and
recommendations to be presented to the eHN, as well as to ensure the smooth functioning of the
Work Packages.
SPMS background also reckons on an active membership on the eHealth Member States
Expert Group (eHMSEG), having coordinated the application process of 20 countries to the
28
951938 X-eHealth – Part B
2015 EC call for proposals on Patient Summary & ePrescription/eDispensation, CEF
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
TELECOM CA–LS 2015 - CEF-TC-2015-2: eHealth.
On the basis of its active and leading role in definition and implementation of eHealth Strategy at
European level, in May 2017, SPMS was nominated by EU Member States to assume the coordination
of the ongoing Joint Action on eHealth (3rd JA – eHealth Action). Currently, eHealth Action just
complete its first of three years of action and so far, the project has been developing smoothly.
Further to the above, SPMS has a solid track record of successful implementation of international
collaborative projects, and is currently involved in several Horizon 2020 funded projects, of which we
highlight: CEF eHDSI Cross-Border services deployment (on Cross-Border Patient Summary &
ePrescription/eDispensation), eStandards (a coordination and support action to strengthen the
standards & interoperability pillar of Digital Agenda for Europe 2020), VALUeHEALTH (on how
interoperability of health information can consistently create, deliver, and capture value for all
stakeholders), EURO-CAS (aiming at maintaining and developing the adoption and take-up of testing
the interoperability of ICT solutions against identified eHealth standards and profiles defined in the
eHealth European Interoperability Framework), ProEmpower (a PCP aiming at tackling the incidence
of type 2 diabetes among populations through patient empowerment), Trillium II (on further
advancing the agenda of the EU/US roadmap on eHealth/HIT collaboration), ESPDint (aiming at
implementing a “customised” European Single Procurement Document, service into the existing
software solutions of tendering/pre-qualifications platforms in 6 MS, including Portugal)
Among the concluded projects we highlight the participation in projects such as epSOS,
Antilope, e-Sens, TrilliumBridge or Expand (for which it was coordinator).
Key Personnel’s CVs (incl. gender)
Arlete Monteiro – Chief Information Office, , PMP® graduated in Mathematics (Computing
and Operations Research) and Mathematics (Teaching) with post-graduations in Project
Management and Evaluation from Universidade Católica Portuguesa and in Advanced
Management for Healthcare Organizations from AESE Business School. Since 2011 she works
in SPMS, and at the present is an IT director, responsible for several areas, including Mobile
and Citizens Services, Hospital Systems and ePrescription.
Diogo Martins – SPMS’ Coordinator for International Relations and Projects, , MD, Graduated in
Health Equipment and Technology, academic background consists on Electronics, ICT & Medical
Devices. Holds a MD in Healthcare Information Systems Management obtained in partnership between
the Polytechnic Institute of Leiria (IPL) and Faculty of Medicine of Oporto (FMUP) with thesis in
eHealth field: “Impact of using mobile handheld technology in health care delivery: a Systematic
review”. He has worked as Medical devices consultant, key account manager and most recently as ICT
Project Manager in SPMS working on Healthcare data sharing – Radiology and DICOM Imaging;
Infrastructure for Healthcare data–sharing - XDS, IHE and Telemedicine Platform. He has been able to
make a “bridge” from ICT field experience how important is to engage Healthcare professionals and
citizens to healthcare improvements. Currently he works at SPMS and is responsible for the
International Projects as well as and International Cooperation.
29
951938 X-eHealth – Part B
Lília Marques – SPMS’executive secretary for International Relations and Projects, , has a
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
degree in Systems Engineering from University of Minho. She has more than 20 years of
experience in Information systems in the health domain. Currently works at the International
Relations and Projects Unit of SPMS. She has been involved in several eHealth European projects,
namely: EXPAND as project manager and quality manager, epSOS as project coordinator deputy
and also in e-SENS, Trillium Bridge, CARDLINK 2 as technical responsible and SHINE as project
manager and technical responsible. She supported the eHMSEG chair directly, collaborating
actively with the eHMSEG chairs in the coordination activities of eHMSEG with the goal to
promote and achieve a harmonized and shared collaboration among countries on cross-border
services deployment under CEF funding.
Cristiano Marques – SPMS’ Coordinator for Services Integration Platforms for Citizen Care, ,
MD, is the current Head of Integration Platforms and Citezen Services at Ministry of Health in
Portugal. He started his career in banking sector with financial projects. About six years ago, he
went to health where he went through several eHealth projects, namely: death certificate system,
patient portal, national registry of professionals, etc. He has a degree in Computer Engineering
and h’s master's degree in Artificial Intelligence and Software Engineering.
Relevant publications, products, services, or other achievements (max. 5)
SPMS is involved and committed to generate scientific material and knowledge, and to present
them in international conferences. In accordance with X-eHealth pruposes, we outline
hereinbelow SPMS’ relevant achievements:
Santos, A., Sá, P., Romão, R., D’Arrábida, C., Coelho, A., Alexandre Diniz, J., Martins,
H., The Rare Disea’e Person's Card Implementation Strategy in Portugal, Procedia
Computer Science, Volume 64, 2015, Pages 1149–1156 Conference on ENTERprise
Information Systems/International Conference on Project MANagement/Conference on
Health and Social Care Information Systems and Technologies, CENTERIS/ProjMAN /
HCist 2015 October 7-9, 2015
Moen, A., Bruun-Rasmussen, M., Mendes, R., Hurlen, P., Chronaki, C., eHealth Consumers at
the age of hyper-personalization, 2016, STC 2016
– Paris
Gomes, R., Soares, B., Cybersecurity Match Supply And Demand in Portuguese
HealthCare Sector – Industry Collaboration, 2016, HC–st 2016 - International Conference on
Health and Social Care Information Systems and Technologies On the Paperless Prescription
project not only was developed a reference implementation but all the technical specifications
were provided to the market to develop e-Prescription and e-Dispensation
systems
Marques, C., Monteiro, A., Rebuge, A., Martins, H., Mob–le SICO - Mobile E-Death
Certification, Procedia Computer Science, Volume 64, 2015, Pages 1149–1156 Conference on
ENTERprise Information Systems/International Conference on Project
MANagement/Conference on Health and Social Care Information Systems and Technologies,
CENTERIS/ProjMAN / HCist 2015 October 7
30
951938 X-eHealth – Part B
-9, 2015 Associated with document Ref. Ares(2020)2778062 - 28/05/2020
SPMS is both a software development and an eHealth regulation entity. There are several
projects with high visibility that were developed internally as well as several mHealth
initiatives under the umbrella of the My SNS branding. To name a few: Portuguese Health Data
Platform (PDS), Paperless Eletronic Medication Prescription (RSP) and Digital Heath
Certificates (SICO) are some of the available features in My SNS family apps (for more
information see https://comunity.mysns.pt).
Within My SNS family apps, these are our latest products:
1. My SNS – a National Health Service informational app;
2. My SNS Tempos – this app shows the average waiting times of the national health
service emergency departments;
3. My SNS Carteira – provide all the health and administrative information of the patient
on a modular way, like a wallet, where every bit of information is a card;
My SNS was developed to provide alerts and display the news of the NHS, feed by the NHS
portal; provides information related to the health services provided by the NHS; provides
geographical information of the Hospitals, Primary Care Facilites and Pharmacies, and a way to
evaluate them. An international, initially in English, version is planned, and the introduction of
general public health alert is also planned.
My SNS Tempos provides a way for patients to choose which hospital emergencies are closer
geographically and where the waiting times are lower, right now two languages are available
Portuguese and English. All hospitals are listed but currently only about 84% of institution
share waiting times. There is a new version planned that will include the display of average
waiting times for specialty medical appointments and surgeries.
My SNS Carteira objective is to help patients managing their health information. The app is
based on four principles: security, safety, portability and tailoring. Regarding security features,
several technical mechanisms provide a truly secure information exchange and storage.
In order to foster organizational synergy and knowledge sharing, and in view of the need to
protect’citizens' information, MySNS Community seeks to be a collaborative platform for all
citizens, health professionals and programmers, promoting the sharing of related information
with the technologies used in the development as well as the dissemination of the built code,
ensuring transparency and a thorough knowledge of their operation.
Through an online platform, any citizen can have access to the open source code, as well as
guidelines and other information, and can contribute adequately and safely to the technological
advance31nalyse31 european panorama, the implementation of this project would “eet the
"Open source software strategy ”014-2017" published by European Commission, which aims to
strengthen the role of open source software for many of its key services and ICT software
31
951938 X-eHealth – Part B
solutions. The renewed strategy puts a special emphasisAssociated
on procurement, contribution to open
with document Ref. Ares(2020)2778062 - 28/05/2020
source software projects and providing more of the software developed within the Commission
as open source.
The existen32nalyse32 european online community, would facilitate access to information and
a wider dissemination and contributions to existing projects in each country, giving a special
emphasis on procurement, contribution to open source software projects and providing more of
the software developed within the Commission as open source. Also, highlights the cooperation
between countries, bringing citizens and health professionals closer to technological
development and innovation.
Previous projects or activities related to the project subject (max. 5)
eHAction – SPMS features as Project Coordinator. eHAction is the 3rd Joint Action supporting
the eHealth Network, which, in its Multiannual Work Programme 2018-2021, sets targets for
deepening further the eHealth sector with the goal to facilitate the management of chronic
diseases and multi-morbidity, by increasing sustainability and efficiency of health systems, and
by facilitating personalized care and empowering the citizen.
Specifically, it is working to find ways to empower people (WP4) by giving them an active role
in managing their health care data and processes, to use health data in an innovative way and to
enhance continuity of care through the use of interoperable and cross-border solutions.
eHAction is in line with the Third EU Health Programme. Together, the JA and the
Programme, aim to advance European public health status by promoting the use of eHealth in a
structured policy framework.
eHAction also functions as a platform for organizational, strategic and technical cooperation
between MS/C, including close collaboration with EC, DG SANTE, DG CONNECT and DG
DIGIT and other EU stakeholders.
The commitment undertaken by eHAction shall lead to quality results for the continuity, safety
and efficiency of ICT, supporting healthcare. Therefore, this will result, as much as possible, in
practical results for the users (citizens, healthcare providers, health professionals, decision
makers, etc.).
“Exames sem papel” – Paperless exams
It is an important national initiative from the Portuguese Ministry of Health developed by
SPMS that aims to dematerialize the processes of request, realization and invoicing of
Complementary Diagnostic and Therapeutic Means (MCDT), as well as ensure that all the data
related with the execution of the exams follows the patient in digital support. The project is
from SPMS responsibility and started at 19th July of 2019 on the primary care units and later on
Hospital Care services. At October 2019, SPMS already have registration of 2.598.501 paper-
less exams.
32
951938 X-eHealth – Part B
EXPAND was a project coordinated by SPMS that aimed to preserve the actives of the
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
infrastructure of European scope that were developed by European projects, namely epSOS,
SemanticHealthNet, HER.Q or eH4CR until the launch of CEF. The project faced the challenge
of skip from set of pilot solutions to the large-scale implementation of cross-border eHealth
services. EXPAND ensured the sustainability and the expansion of epSOS services, including
the suitable deliver until the launch of CEF (eHDSI) and promoted the reuse of the eHealth
actives created at national and European level.
RSE – Electronic Health Record
This national project started in 2019 and its implementation organized into 3 phases. RSE aims
to gather essential information of each Citizen for the improvement of the provision of health
care. The 1st phase consisted only on a small sample, the 2nd phase is target to family physicians
identified to the pilot together with the PEM team (Electronic Prescription of medicines) and
the 3rd and final phase will the national scale. The project objective is to develop a Electronic
Health Record plataform that compiles patients basic health data to be provided to health
professionals, always that it is needed an urgent service or a scheduled service in a national
health entity or foreigI. The EHR includes the patient identification, unit healthcare and family
physician identification, allergies, chronic medication, vaccines, medical diagnosis, medical
procedures and medical devices) accessible to healthcare professionals and the patients
themselves.
eHDSI
The eHealth Digital Service Infrastructure (eHDSI or eHealth DSI) is the initial deployment and
operation of services for cross-border health data exchange under the Connecting Europe Facility
(CEF). eHDSI sets up and starts deploying the core and generic services, as defined in the CEF, for
Patient Summary and ePrescription. The generic services are the necessary implementation of data
exchange at country level, the core services at EU level. These together enable the provision of Cross
Border eHealth Information Services (CBeHIS).
The eHDSI is financed by the Member States and the European Union through the CEF programme.
The core services are set-up and deployed by the European Commission using its own resources and
through calls for tender financed by CEF. The generic services are funded from the national sources
and supported by grants from the CEF through a call for proposals.
Following SPMS’ (the national authority for eHealth) active participation in the epSOS,
EXPAND and e-SENS projects, Portugal is fully committed to converging and pursuing EU-
wide interoperability for cross-border healthcare. With that specific context as blueprint,
Portugal is preparing, testing, deploying (Patient Summary in 2018 and the ePrescription in
2019) and operate the National Contact Point for eHealth (NCPeH), according best practices
and sound experience, properly connected with the already available national infrastructure.
33
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Partner Full Bundesministerium für Arbeit, Soziales, Gesundheit und
Name Konsumentenschutz
Short Name ATNA Partner 2
No.
Country Austria Website www.sozialministerium.at
Type of Ministry Logo
organisation
Brief Partner Profile
The Federal Ministry of Labour, Social Affairs, Health and Consumer Protection (ATNA) is
the national authority in health-related policy areas in Austria. Amongst others, the Ministry
is responsible for health system legislation and financing, health insurance, consumer health,
eHealth, communicable and non-communicable diseases, health promotion, vaccination,
medicinal products and medical devices, genetics, public health but also for animal health and
food safety. ATNA is in the lead of the Austrian e-health initiative and is engaged in several
national and international eHealth projects. The most important national eHealth project in
Austria is the Electronic Health Record system (ELGA), which is implemented nationwide
and which introduces a unique communication platform for Austrian in- and outpatient health
care providers with a view to increasing quality of services and patient safety. Over the past
15 years ATNA had taken over several leading roles in European projects, committees and
initiatives, such as the role of the Members States co-chair in the eHealth network, project
coordinator and work package leader for instance.
Main tasks in Project
ATNA will participate in this CSA project as contributor:
WP4 – Generic aspects of EHRxF recommendation
T4.1: Electronic Identification implementation
T4.3: Cybersecurity
WP8 – EHRxF Communities of Practice: from Proof of Concept to large scale adoption
and Infrastructure for Innovation
T8.5: Exploitation: EHRxF as infrastructure for innovation
Relevant expertise and experience of the institution
In its role as a Ministry and thus a public national authority, ATNA is responsible for the
public health system in Austria, with a high priority on eHealth governance deployment.
ATNA has been acting as the eHealth Network Member States co-chair between 2013 and
2018 and has also contributed to the transformation process of the informal high-level eHealth
34
951938 X-eHealth – Part B
governance group to the eHealth Network, which is since its establishment acting on a legal
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
base according to Directive 2011/24/EU. Since 2013, ATNA had also been chairing several
sub-groups of the eHealth Network: One among those dealing with the implementation of the
Communication on the Digital Transformation of Health and Care, has delivered the
“Guideline on an interoperable eco-system for digital health and investment programmes for a
new/updated generation of digital infrastructure in Europe”, which is closely linked to the
“Commission Recommendation on the Iopean EHR exchange format”. This can be
considered as a result from the informal Council meeting in fall 2018 (under the Austrian EU
Presidency), where the topic “Investment in Digital Health” was considered a priority. ATNA
is still leading the ongoing work of this sub-group which is currently still in progress aiming
to further define the governance process related to it.
From 2015 until 2018 ATNA was the project coordinator of the Joint Action to support the
eHealth Network (JAseHN), that acted as the sole preparatory body for the eHealth Network
and delivered several policy documents, frameworks and guidelines serving as the main basis
for the establishment of the eHealth Digital Service Infrastructure, under which eHealth
Information Services (based on real patient data) are being exchanged across European
countries.
ATNA chaired both, the joint action and the thematic network of the eHealth Governance
Initiative as project coordinator from 2011 until 2014. This initiative successfully established
a governance structure for eHealth within Europe in order to ensure continuity of healthcare
on the national level and across borders, while seeking a strong coordinated political
leadership and the integration of eHealth into national health policies.
ATNA was leading WP2 Dissemination of epSOS project and was engaged in project eSENS.
In project STORK I, ATNA was co-leading the eHealth field test and in project STORK II in
charge of the eHealth pilot.
ATNA is further involved in epidemic surveillance dealing with a complete infrastructure and
corresponding workflows from LABS to the Ministry and furthermore to ECDC via online
communication.
ATNA is also managing surveillance including workflows to EMA, UNODC, etc.
Key Personnel’s CVs (incl. gender)
35
951938 X-eHealth – Part B
Robert Scharinger , Chief Information Officer. Studied computer science and IT in healthcare
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
in Austria and United Kingdom. Delegate to e.g. the European Medicines Agency (EMA), to the
European Centre of Communicable Diseases (ECDC), and to the eHealth Member States Expert
Group (eHMSEG) of the European Commission; member of the national ICT coordination
platform; experience in eHealth coordination; experience in project management, system
planning, implementation and operation as well as in quality assurance, especially in eHealth
projects on a national and on an international level.
Christopher Ozvald , IT Security Officer and Cyber Security Coordination for eHealth. He
studied information and communication systems in the’bachelor's programme with a focus on
IT-security and is currently continuing his studies in t’e master's programme on IT-security. He
supports the work of the Ministry, respectively the department for health telematics, since 2011
in several areas, such as digitalization, cybersecurity, IT-security, national coordination of ICT
activities. In those areas he has been working as project, process and application manager, IT-
security architect, database administrator and national coordinator. He currently also acts as the
national delegate in CISO AG in the course of cyber security governance in eHealth.
Relevant publications, products, services, or other achievements (max. 5)
In particular, all passed laws (or published draft laws) in the health sector are to be considered
as publications. Most relevant is the Health Telematics Law for securing the transmission of
sensitive patient data. The law elaborates security measures already stipulated in the Data
Protection law 2000 and aims at preventing malpractice and assure confidentiality of sensitive
individual data travelling through networks. It further aims to harmonize data safety measures
Austrian-wide and raise the standards of those measures. Moreover it shall provide broad
baseline information for decision makers.
ATNA has published information in the form of national drug reports, national epidemic
reports and bulletin and national public health bulletin. In addition, information on current
topics is published on an ongoing basis and the population is informed accordingly via
various channels.
Previous projects or activities related to the project subject (max. 5)
On the national level, the Electronic Health Record system ELGA is the most important
success achieved so far when it comes to a nationwide implementation of a Iional EHR
system. ELGA is an information system that simplifies the process of accessing patients
health records for patients and their doctors, as well as other healthcare professionals at
hospitals, care facilities and pharmacies. Health data such as a patient’s test results are
generated by a variety of health institutions. ELGA networks all of them and makes them
available digitally by means of a link.
ATNA is also focusing on epidemic surveillance, web-services for ECDC and complete
online workflow processes for the healthcare sector.
36
951938 X-eHealth – Part B
Partner Full Name Austrian National Public Health Institute
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
in German; Gesundheit Österreich GmbH (GÖG)
Short Name GOeG Partner No. 3
Country Austria Website http://www.goeg.at/
Type of Public Health Logo
organisation Institute
Brief Partner Profile
The Austrian National Public Health Institute (Gesundheit Österreich GmbH, GÖG) is the
institution responsible for researching and planning public healthcare in Austria, and also acts
as the national competence and funding centre for the promotion of health. It is organised in
three business units. Set up by federal law on 1 August 2006, GÖG has the federal government
as its sole shareholder, represented by the Ministry of Health.
The staff of the Austrian National Institute for Health Services Research (in German:
Österreichisches Bundesinstitut für Gesundheit, OeBIG) founded in 1973 analyses data,
provides comprehensive information in the field of public health policy, and facilitate reform
and innovation processes. For a few years GÖG is working in the field of e-Health and Digital
Health, being the partner already in the three Joint Actions to support the e-Health Network.
Main tasks in Project
GOeG will participate in this CSA project as partner in:
WP 2 Dissemination, Communication & Stakeholders
T2.2: Healthcare providers, Health professionals and Citizens motivation
T2.3: MS and National Authorities involvement
WP 3 Evaluation (Leader)
WP 4 Generic Aspects of EHRxF recommendation
T4.3: Cybersecurity
Relevant expertise and experience of the institut37nalysehe approx. 220 persons working
for us are multi-disciplinary, with backgrounds in health economics, epidemiology, sociology,
planning, ICT, psychology, statistics, medicine, communication, prevention, gender health,
etc.).
Current research focuses on supporting the ongoing national healthcare reform (e.g. in the field
of digital health and web-based health information) and in reaching the national health targets.
Besides working for national stakeholders (e.g., ministries, provinces, social insurance
institutions) we perform a number of projects and consultancies for the European Commission,
WHO and countries like the Ukraine. We are also involved in a number of Joint Actions,
among them the previous and current JAs on eHealth. We also have performed a number of
37
951938 X-eHealth – Part B
evaluations using a variety of tools for national and lately international undertakings. A full list
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
of references can be provided in German language.
The Executive Department ‚Digital Health and Innovation‘ has been created in 2019 to support
evidence-based health policy-making around the issues of digitalisation and innovation. The
department has an in-house role as a knowledge and network hub around digital health
supporting units across the entire organisation. Externally, department experts support national
and international digital health-related research projects and policy-making.
Also we run the Austrian national electronic health information platform
www.gesundheit.gv.at.
Key Personnel’s CVs (incl. gender)
Mag. Claudia A. Habl, . Head of International Affairs and Consultancy Department and
lEAR of GOeG. After completing her studies in Business Administration and her post-graduate
in hospital management, Claudia Habl is working in the field of health care for almost 25 years.
After working in hospital administration, she joined the Austrian National Public Health
Institute GOeG in 1998, where she worked on a number of topics in the field of health and
social care. She is (co-)author of a number of publications in the field, for instance the recently
published EU Study on Big Data in Public Health, Telemedicine and Healthcare and has more
than a decade of experience in managing and leading large-scale EU project. She has more than
20 years of experience in working on cross-country projects, also involving monitoring
activities and dissemination on conferences of public interest.
Dr. Alexander Degelsegger-Márquez, , heads the executive department “Digital Health and
Innovation” at GOeG. In this role, he advises national stakeholders in digital health-related
policy-making. He also carries out research and policy advisory work in a number of national
and international projects. Before joining GÖG at the beginning of 2019, Alexander was Head
of Department for “Research Policy and Development” at the Centre for Social Innovation in
Vienna/Austria and coordinator of a number of evaluation studies as well as a Horizon 2020
research project on science diplomacy.
Alexander has a background in political science, international development and the sociology
of science and innovation. He holds a PhD from the University of Vienna’s Science and
Technology Studies department and currently lectures on big data in health at the University’s
political science department.
PhDr. Isabella Weber, M.A., , employed by GOeG but works for ATNA since 2010. She
studied European Economics and entrepreneurship and holds a PhDr for health administration.
She was responsible operational project coordinator in the eHealth Governance Initiative. She
was project coordinator of the Joint Action to support the eHealth Network (JAseHN and is
leading WP 3 Evaluation in the current eHAction Joint Action to support the e-Health Network.
38
951938 X-eHealth – Part B
Dipl.-Ing. (FH) Kathrin Trunner, MSc, , obtained two academic degrees from the
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
University of Applies Sciences Technikum Wien in Vienna and is currently responsible for the
management of national and EU-funded projects in the field of health telematics / eHealth at
the public health institute Gesundheit Österreich GmbH. From 2010 until 2019 she has worked
for the Federal Ministry of Health in Austria where she was the national contact point and a
Work Package Leader in the biggest EU large scale eHealth pilot. She also wrote the feasibility
study on behalf of the Minister of Health on the implementation of an electronic vaccination
data system in Austria, which is currently being realized as a project.
Thomas Fleischmann, is employed by GOeG but works for ATNA since 2008. He works as
IT-architect and IT-expert, especiIy for EHR systems. He is responsible for the technical
management of the ministry’s big data and knowledge management platform. Furthermore, he
is engaged in the European projects the Ministry is involved in as IT-coordinator and deals with
a smooth exchange of knowledge between the many actors involved in technical and
organisational processes.
Relevant publications, products, services, or other achievements (max. 5)
Together with Sogeti from Luxembourg, GÖG investigated the potential of Big Data in the health
sector and developed recommendations for exploiting its potential in the EU Member States. The
results can be found in the recently published Study on Big Data in Public Health, Telemedicine and
Healthcare.
GOeG is involved and committed to generate scientific material and to present it in international
conferences, such as:
Habl, C., Laschkolnig, A.: How Big Data could improve the performance of health care
systems in Europe. European Health Management Association 2018 Annual Conference,
22nd of June 2018, Budapest.
Habl, C., Are EU healthcare systems ready for medical innovation? Biogen Workshop
“A new era for Alzheimer’s”. European Health Forum Gastein, 3rd of October 2018,
Gastein.
Services:
Among others, GOeG runs the Austrian national electronic health information platform
www.gesundheit.gv.at and the health professional register.
Previous projects or activities related to the project subject (max. 5)
Related projects with GOeG participation:
eHAction, http://ehaction.eu/: Taking over the work from JAseHN, the 3rd Joint Action called
eHAction continues the operational, strategic and technical support of the eHealth–Network - a
group of representatives from all EU Member States getting together twice a year.
39
951938 X-eHealth – Part B
TO.REACH, https://to-reach.eu/: TO-REACH is Associated
a coordination and support action (CSA) to
with document Ref. Ares(2020)2778062 - 28/05/2020
prepare a joint European research programme aimed at producing research evidence supporting
health care services and systems to become more resilient, effective, equitable, accessible,
sustainable and comprehensive (in Europe, and abroad).
Among the concluded projects we highlight the participation in projects such as JAseHN,
InfAct and Euripid.
Partner Full FPS Health Belgium
Name
Short Name FPS Health Partner 4
Belgium No.
Country Belgium Website https://www.health.belgium.be/en?fodnlang=fr
Type of Public Logo
organisation organisation/
Public
Health
Brief Partner Profile
The SPF Public Health is responsible for the protection of human health, in particular the
provision of well-organized and high-quality health care services that are affordable, accessible
and integrated and meet the needs of the population, nutrition policy, the provision of medical
expertise in the context of the exercise of professional activities and alcohol, tobacco and
cosmetics policies;
In the field of human health, health care, with the exception of medicines, is largely a matter of
national competence, which is widely shared and interconnected between the federal level and
the communities. The latter, after all, exercise many powers with regard to the organization of
health care institutions, preventive health care and health care professions. Other policies (eg
related to consumer and trade products, environment) have a direct or indirect impact on health
and are set at international level. The Interministerial Public Health Conference is the
coordinating body for both inter-federal consultations and the international representation of
Belgium. The FPS is responsible for its secretariat, as well as for the antimicrobial resistance
(AMR) working group.
The federal level coordinates and interprets, for th“ domain "hum”n health", the Belgian
position in the international forums. The FPS is also in charge of the secretariat of the
international inter-cabinet working group of the IMC Public Health, which has a mandate that
has been extended to all international bodies competent in the field of health. The FPS also
organizes coordination with the other partners at the federal level, i.e., among others, the
40
951938 X-eHealth – Part B
FAMHP and the RIZIV. In this context, the basic principle implies that the FPS in its cap“city
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
as "Ministry ”f Health" is the first point of contact for international organizations and the other
Member “tates. ("National Fo”al Point").
Main tasks in Project
SPF Health Belgium will be a partner in 2 workpackages:
WP5 Definition of EHRxF functional specifications
T5.3. Laboratory Results guideline and functional specifications
T5.4. Medical Imaging and Reports guideline and functional specs
T5.5. Hospital Discharge Reports guideline and functional specs
WP6 Definition of EHRxF technical specifications
T6.1. Coherence check for system integration
WP7 Architecture integration and System specifications
T7.1: Global architecture for EHRxF Domains use
Relevant expertise and experience of the institution
An integrated actionplan on eHealth, called the roadmap eHealth 2013-2018, has terminated at
the end of 2018 and was followed by a new actionplan eHealth 2019-2021, with new and
updated principles and accents.
This actionplan eHealth 2019-2021 has been signed by all responsible ministers, both on
federal as on regional level.
Among the accents are continuation of on-going projects (like e-prescription), extension of
existing systems to other target audiences of healthcare domains, focus on ‘Operational
Excellence’ (meaning the support during the use of the systems), connection with Europe and
international initiatives and programs.
This actionplan eHealth 2019-2021 contains 44 projects, bundled in 7 clusters. All of the
projects aim to contribute to the program goals, being a better quality of healthcare and a more
effective healthcare.
A number of the projects are so-called concept-projects where the goal is to define a clear
description of the implementation solution of a given problem, allowing to achieve the
necessary support by all stakeholders before actually building the system.
Other projects build new, extend or optimize existing systems.
The Interministerial Conference on Public Health decided in 2018 to prepare a new Action
Plan. A number of principles and points of attention were used as a basis for the preparation of
this new plan:
41
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Continuing inter-federal cooperation on eHealth strategy and further optimization of the
cooperation model continue where appropriate, adjust if necessary, and systematically finalize
ongoing projects and / or extend them to new target groups or fields of application
reinforce and monitor the focus on operational excellence to continuously improve the
availability and performance of the systems and tools used by the patient and the healthcare
provider pay more attention to European and international eHealth initiatives
Based on these principles, 7 clusters of 44 interdependent projects have been identified and
clear ambition and objectives were agreed for each of them.
The 7 clusters are:
The foundation of the eHealth landscape: for example, the management and evolution of the
principles and systems of computerized patient consent, the service access matrix and eHealth
information for patients. providers, management and use of basic services, terminology and
technical standaI used ... This means that the same rules and agreements apply to patients,
healthcare providers and software providers.
Cross-cutting aspects of the eHealth plan: for example, ensuring proper communication, as
well as ensuring good project management and monitoring by closely monitoring their
coherence.
Support for implementation: this includes, for example, the policy on incentives for health
care providers to use eHealth services.
Operational excellence: Over the 2013-2018 period, we have moved from many eHealth
projects from the ideation phase to their development and actual application in the field. A
number of issues and concerns have also been identified, for example with regard to the stability
of the systems and the quality levels to be achieved. As noted above, the CIM believes that
improving operational excellence is an important work area; that is why the Action Plan also
includes concrete projects aimed at ensuring the smooth implementation of new tools and
systems, with both a solid / reliable technical infrastructure and support and support initiatives
for all stakeholders. actors: citizens, healthcare providers, software pIiders ...
Healthcare providers and care institutions: This cluster includes a series of projects aimed at
delivering value-added services to healthcare providers, such as multidisciplinary and
transmural data exchange tools, further development of prescriptions the development of DPI in
hospitals, the implementation of the BelRai inIument ... As can be seen, these are to a large
extent projects that had already been launched in the previous Action Plan. and which are now
realized and extended.
The patient as co-pilot: This cluster includes eHealth projects that directly target the patient.
This is for example the further development of the Personal Health Viewer (MaSanté) personal
health portal, with the ambition that a citizen, through a single portal of entry, access all
electronic information existing health records, regardles“ of th” "source". Citizens will also
have the opportunity to directly manage their donation return.
42
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Mutualities: a specific cluster of the eHealth plan tar43nalyse mutuals with which a series of
projects are underway in the field of digital transformation of administrative processes with
health care providers, patients and public authorities, such as eAttest, eFacturation , the
digitization of agreements and authorizations such as the drugs of ChIer IV ...
The eHealth Action Plan 2019-2021 describes, for each of the 7 clusters and 44 projects, the
current situation, the desired situation and the main challenges to achieve this desired situation.
A program director has been appointed, along with project leaders for each of the 44 projects,
to translate the ambitions of the eHealth plan into concrete work plans. Mechanisms for
consultation with patients, healthcare providers, industry, mutual societies and other
stakeholders exist and will be supported by program management. The Inter-Ministerial
Conference will periodically monitor the implementation of the eHealth plan.
Key Personnel’s CVs (incl. gender)
Erik Vertommen Program Manager–eHealth - Federal Public Service Health Belgium
Supported by a long and rich experience and a history of successful projects and programs in
many areas of IT. His main goals are to anchor the results in the organization by highlighting
the right structures, communication, and the centrality of people.
And to strive for a transparent, predictable and efficient IT organization that has added value to
its business customers.
Core competencies are
- IT Service Management
- IT Strategy
- Infrastructure
- Program Management
- Data Center
- Integration
For further details
https://www.linkedin.com/in/erik-vertommen-5b6b165/?originalSubdomain=be
Andries Nelissen - Project Manager–eHealth - Federal Public Service Health Belgium
Responsible for the project management of the Iject ‘EHR in care institutions’ one of the
projects of the actionplan eHealth 2019-2021 which contains 44 projects, bundled in 7
clusters. All of the projects aim to contribute to the program goals, being a better quality of
healthcare and a more effective healthcare. Main goal is to establish contacts, develop
networks, encourage consultation between different partners to achieve shared results.
43
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Core activities:
- Project Management
- Management Support of Intercabinet Working Group on eHealth.
- Participation in Benelux Task Force on cross-border eHealth initiatives.
- Participation in Task Force to improve security and resilience of hospitals information systems.
For further details
https://www.linkedin.com/in/andries-nelissen-424b742/
Relevant publications, products, services, or other achievements (max. 5)
The program management of this integrated eHealth actionplan is organised by the FPS
Public Health.
An limited excerpt of all 44 projects :
- Project 0.5 ‘Information standards’ : define and implement the standards for data exchange
that will be used for new projects. These standards will be based on international standards, like
FHIR.
The techno-informatic basis of the projects of the e-health action plan has largely contributed to
the growth and the extension of e-health.
The development of e-health in Belgium is largely based on international information standards
interoperability and information security (XMISOAP, ....). In some areas, however, others
standards are emerging now (REST, JSON, OAuth, etc.).
Based on the current situation, in Belgium, e-Health is built on the Belgian KmeHR standard for
structuring of messages. There are now also international standards in this area, such as HL7-
CDA, HIFHIR, ........
It is desirable that the future development of eHealth is based, as far as possible, on
open and advanced international organizations offering reasonable guarantees of backward
compatibility. It will be very certainly the case for new projects.
In this context, it is desirable that the Belgian KmeHR standard evolve towards international
standards. This will be a necessity at the international level, but it is also a demand from
software vendors. In this good practices developed in other countries, such as the Netherlands
with Nictiz, or can serve as examples.
- Project 0.6 ‘Terminology’ : provide validated codifications and thesaurus (like SnoMed CT) in
Dutch and French
A well-thought-out terminology policy should contribute to better communication between
different actors of care and the improvement of the quality of care, among others, by decision
and alerts. Reducing the administrative burden associated with the responsible extraction of
information from secondary purposes (such as billing, quality control, scientific research and
information policy) also contributes to the achievement of this goal.
This project related to the following high-level objectives continues in the framework of the
2019-2021 action plan
- The development of an operational coordination center and expertise at the level of the FPS
Health terminology (including the designation of SNOMED CT as a standard
central terminology).
44
951938 X-eHealth – Part B
- Support for other projects in the use of structured health data storage encoded.
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
The mission of the terminology center is to define, coordinate, facilitate and stimulate the use of
terminology standards in Belgian health care. Through a phased approach, the long-term
objective term is to achieve full implementation of the SNOMED CT terminology standard in
the system of Belgian health.
Phasing consists of focusing first on the second and third lines and then, but only
in a later stage, on the first line.
- Project 4.1 ‘Multidisciplinary data exchange’ : define and implement data exchange flows
between different care professionals, based on international standards
This project starts from the availability of a Computerized Patient Record (IPR) for all
professional groups concerned (so-called AR78 care providers). A number of occupational
groups (doctors, pharmacists, nurses, dentists, physiotheIists, ...) have already set up this
system, but some others still have to do it. This definition will describe the different blocks of
information that must be included in a CIO so that you can share the data with other care
providers.
The next step is to design and implement an exchange system: whatever the type of
data exchanged between different providers, there is a model and fixed activities (between
others, data filling, data publication, data storage in a data structure,
secure storage, data retrieval, data adaptation, access rules). An inventory of
roles and responsibilities (including software developers) is built for each generic step
specific project objectives. Then, the information blocks are elaborated, these blocks of
information are called Care-Sets.
The way in which information blocks are structured in terms of information technology depends
on the choices project 0.5 Information standards and the possibility of using existing structures
to abroad (for example, Nictiz Clinical Building Blocks, HL7 FHIR or IHE7 CDA / XDS).
- ProjI 4.9 ‘EHR in care institutions’ : stimulating the implementation of an inIrated EHR in care
institutions by providing financial incentives in a structured and well-defined way. The
important goal is to share patient information among all concerned means of highly integrated
applications and a single portal.
Another important goal is the establishment of what is known as Clinical Decision Support,
which implies that the systematic structuring and codification of data is taken into account from
departure.
Creating an added clinical value is also a mI. The EHR must also be connected to the eHealth
platform and support extramural collaboration. Because, in fact, the inIrated EHR is in a context
that allows a system-wide and secure exchange of health information. An inIrated EHR is,
moreover, a base and a facilitator for effective resource planning (machinery, equipment and
people) within a health facility.
For the hospitals the Belgian Meaningful Use Criteria were defined, a set of ambitious, but
realistic criteria. A significant amount of financial support is provided by the federal
government to the hospitals to implement these criteria.
45
951938 X-eHealth – Part B
- The B.M.U. criteria are not only focusing on automation of internal workflows but also on
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
connecting the hospitals to the first line care providers so to advance away from a disease-
centered model of care toward patient-centered approaches.
Previous projects or activities related to the project subject (max. 5)
The previous e-Hea–th 2015 - 2018 action plan was finalised at the end of 2018
Some of the achievements were
1. Personal Health“Viewer
"m”santé.be" gives people access to all their health data that is digitally available, so they are
better informed and can play a more active role in their care.
From the portal you can click through to all platforms that offer health data (medical,
administrative, advance directive, etc.). You only have to register once and you can go
anywhere.
The new portal site is a work in progress. At this moment you can request information about
the summary of your file from your doctor; hospital reports and results; electronic medication
prescriptions and vaccinations; information about implants; the permission for healthcare
providers to share medical data electronically; registration as an organ donor and directives.
The FPS Public Health is already working on the next version of the personal health viewer,
which is scheduled to be launched in end of 2019. Some mutual societies will have made the
link with Masanté, which will allow citizens to have direct access to their personal health
insurance file since portal. It will also be possible to report side effects of medications through
the personal health viewer and patients will be able to access their home nursing record in just a
few clicks.
In addition to these innovations, the various actors in the field are striving to improve and
expand the existing range of products and services. For example, many hospitals are making an
increasing amount of digital information available to their patients.
2. CoBRHA (Common Base Registry for HealthCare Actor)
CoBRHA is the common, consolidated authentic source of the various public institutions that
are competent for the recognition of healthcare actors in Belgium (RIZIV, FPS Public
HealthIAMHP, ...).
46
951938 X-eHealth – Part B
Via this database 3 questions can be answered regarding a healthcare actor:
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
- Who is he? This actor can be a healthcare professional (doctorIurse, ...) or a healthcare
institution (hospital, retiremeIhome, ...)
- What can he do? For a healthcare institution it is about the recognized activities of this
institution (general hospital, intensive care, SMUI MUG, ...). For a professional it is about the
professional recognition and recognized specializations of this person (diploma, RII-nr., ...).
- What are his responsibilities? This corresponds to the roles of the actors in health care, possibly
with regard to another actor in health care (head doctor in a hIital, ...).
CoBRHA +: Phase 1 of the unique counter has been completed. The unique counter went into
production on 1 May 2016, which means that individual care providers can consult their
personal and professional data in the unique counter. Phase 2 was completed on October 23,
2016, which means that individual healthcare providers can also change their data.
A working group has been set up to elaborate a proposal for the creation and allocation of a
unique identification number of care providers and care institutions in CoBRHA (+). This
number must be unique over authentic sources, healthcare actors and healthcare institutions. It
must be meaningless and stable over time.
The next important milestone for the unique counter is the granting of access to healthcare
institutions (phase 3).
Recip-e–Recip-e - Electronic regulations in the ambulatory sector
Recip-e is a system for the temporary storage of encrypted, electronic outpatient care
regulations. The care provider who creates the electronic prescription encrypts it and sends it to
the Recip-e server. The care provider chosen by the patient to perform the care prescription
collects it from the Recip-e server and decrypts it. Recip-e therefore only stores the care
prescriptions (both prescriptions for medicines and physiotherapy prescriptions or nursing
prescriptions) temporarily and encrypted until the care provider chosen by the patient comes to
collect the prescription to perform it. Every electronic data exchange takes place via the
eHealth platform.
Advantages: making fraud impossible, integration into medical and pharmaceutical files,
additional functions such as “feedback to the prescriber”, integration with MyCareNet query for
insurability, possibility of withdrawing a prescription if justified and, in the long term, making
paper unnecessary.
3. Mobile Health
From the end of October 2018, producers can register their mobile health applications
(hardware and software) at Mobile Health Belgium, an initiative of Minister De Block
supported by the Riziv, the FPS Public Health, the FAMHP, the eHealth platform and sector
47
951938 X-eHealth – Part B
federations Agoria and beMedTech. A validation pyramid will be used to assess whether the
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
applications meet the necessary conditions in terms of quality, safety and effectiveness.
The validation pyramid consists of three levels:
Level 1 defines the basic criteria for all registered applications. The application must have a CE
marking and must comply with the regulations for medical devices. The Federal Agency for
Medicines and Health Products monitors this. The application must also comply with the
European regulation on data protection.
Level 2 determines the conditions for interoperability with other mobile applications and with
other digital applications within the healthcare sector, such as the basic services of the eHealth
platform. The eHealth platform defines these conditions, the effective testing of interoperability
will be done by independent testing centers. In addition, all basic criteria (level 1) apply.
Level 3 is reserved for applications with proven health-economic added value. An adapted
financing model is being developed for these applications. The Riziv checks whether they have
a place within a broader treatment plan. All Level 3 applications must also meet all Level 1 and
2 criteria.
On www.mhealthbelgium.be the applications are published per level that meet the required
criteria. In the first instance it will be about level 1 apps. The other two levels are currently
being finalized.
Partner Full IHE-Europe
Name
Short Name IHE Partner 5
No.
Country Belgium Website www.ihe-europe.net
Type of AISBL Logo
organisation
Brief Partner Profile
48
951938 X-eHealth – Part B
IHE-Europe is a non-profit association dedicated to interoperability in Health IT. IHE-Europe
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
gathers a broad range of stakeholders to advance the shared exchange of patient information. It
begins with an open process of developing integration profiles to assure IT systems can talk to
each other. Then it requires testing these systems to verify that complex system delivers the data.
Finally, IHE-Europe actively promotes wider awareness and use of these methods for assuring
continued conformance and compatibility. As the mission of IHE is to improve interoperability
(1) IHE develops Technical Framework Documents for IHE Integration Profiles, (2) organizes the
IHE Connectathon to provide a possibility to test interoperability, (3) organizes IHE
demonstrations in order to promote the use of interoperable products, (4) and ensures the
credibility of interoperability claims by individual vendors. IHE-Europe has two operational
committees: IHE-Services offers services of testing developed by IHE testing hosted at Kereval,
which is an ISO/IEC 17025 accredited company dedicated to IHE profiles assessment scheme.
IHE-Europe was the technical coordinator of the Antilope project, which developed the refined
ehealth Interoperability Framework and the definition of the quality label and certification
processes in Europe. The main recommendations on Labelling processus were introduced in the
European project EURO-CAS that defines the conformity assessment scheme for Europe
(www.EURO-CAS.eu).
IHE-Europe is developing the Gazelle management tools (a GITB c49nalyset testBed platform)
used for the epSOS Projectathon, EXPANDATHON , eHDSI and any other epSOS tests,
including the tests of the Patient Summary, ePrescription, and eDispensation. IHE-Europe is
developing a high level of quality on testing methodology. www.ihe-europe.net.
Main tasks in Project
IHE-Europe will actively contribute on:
WP2 Dissemination, Communication & Stakeholders
T2.1: Communication, Dissemination and engagement plan
WP3 Evaluation (Co-Leader)
WP5 Definition of EHRxF functional specifications
T5.3: Laboratory Requests and Reports guideline and functional specifications
T5.4: Medical Imaging and Reports guideline and functional specifications
WP6 Definition of EHRxF technical specifications (Co-Leader)
T6.1: Definition of technical specification for the Laboratory
Domain (Leader)
T6.2 : Definition of technical specification for the Medical
Imaging Domain (Leader)
T6.3: Definition for the technical specifications Hospital
Discharge Reports
T6.4: Refinement of Patient Summary (PS) technical
specifications for supporting rare diseases
49
951938 X-eHealth – Part B
T6.5: Publication and maintenance of the services Associated with document Ref. Ares(2020)2778062 - 28/05/2020
specifications and testing tools (Leader)
T6.6: Publication and maintenance of the X-eHealth
Implementation Guide
WP7 Architecture integration and System specification
T7.1: Global architecture for EHRxF Domains use
T7.2: Testing strategies
T7.4: Guidance for the new EHRxF domains
Relevant expertise and experience of the institution
IHE-Europe has been implementing for many years the use case driven approach (see also
papers below) and has developed a broad expertise on
Integrating profiles and more specifically the 27 profiles that were identified by the
European Commission in 2015. All the profiles are based on basic standards such as HL7
CDA and FHIR, DICOM, OASIS, CEN IPS, internet standards; IEEC, etc;
The testing: IHE is developing the Gazelle test platform that is used in mamy projects in
Europe and beyond, such as eHDSI project, Suisse EPD project, Sequoaia project etc. The main
objectif is to reduce costs and to mutualize efforts on testing in order to improve the data quality
in eHealth;
The organisation of testing event such as the IHE connectathon and projectathons and
contribute to several testing strategy. IHE developed the testing strategy of eHDSI. A
projectathon is a testing event dedicated to assess the project specifications in a control
environment using Gazelle platform.
The Conformity assessment Scheme specifications (EURO-CAS, Suisse certification).
In conclusion IHE team has a deep expertise on
Implementing methofdology (use case driven approach);
Implementing all types of standards;
Developingtesting strategy and testing tools and methods;
Organising connectathon and projectathons.
Key Personnel’s CVs (incl. gender)
Dr Karima Bourquard, PhD (female) is IHE-Europe Director of Interoperability, and Senior
Consultant and founder of IN-SYSTEM. She assists several regional/national projects on
teleradiology and telemedicine or cooperation between Healthcare Professionals. She has a solid
background on Healthcare IT as eHealth project director and on eHealth interoperability.
During the last 15 years, she contributed to the creation and development of IHE (Integrating the
Healthcare Enterprise) in France and in Europe. She is user co-chair of IHE-France and was IHE-
Europe user co-chair (www.ihe-europe.net). She is member of IHE International. She is currently
Director of Interoperability of IHE-Europe and board member of InteropSanté in France, working
on EU Affairs. She was involved in several European projects such as epSOS, Antilope (she was
50
951938 X-eHealth – Part B
the technical coordinator),eStandards, EXPAND, etc.. SheAssociated
is currently scientific coordinator of
with document Ref. Ares(2020)2778062 - 28/05/2020
EURO-CAS project (www.euro-cas.net )
With the expertise of ISO/IEC 17025, she contributed as IHE International team member to the
design and development of the Conformity Assessment Scheme (CAS), and the certification
scheme in Switzerland
She also contributes to several European national programs in Europe or worldwide by providing
her expertise.
Charles Parisot (Male) chair of IHE-Services Committee of IHE-Europe, InteropeHealth,, is
working in the interoperability technologies. He was in charge of standardisation and IT
architecture coordinating overall GE Healthcare products implementation of health information
exchange standards. Through his extensive experience in contributing to a user driven
harmonisation and implementation of interoperability standards, Charles has earned the trust of
many healthcare user communities in Europe and in the USA to effectively achieve the rapid
adoption of interoperability standards using a collaborative approach.
Charles was one of the key contributors in the European eHealth Standards Mandate that
delivered a recommendation to the European Commission on how to organise effectively the
European-wide agreement on eHealth interoperability specifications across the 27 European
countries. He is also contributing to epSOS, a European large scale project, where he has been
elected to the Steering Committee of the Industry Team representing more than 30 vendors. He
has contributed to the epSOS decision to base its interoperability specification on IHE profiles,
to leverage the use of IHE test tools, and to organise the epSOS Projectathon, based on the
model of IHE Connectathon. Charles is also engaged in the eHealth Governance Initiative
(eHGI).
He brings an extensive and practical understanding of the entire healthcare interoperability
standards value chain, from standards development (HL7, DICOM, ISO TC215), to use case
profiling (IHE and Continua), to product implementation, testing and market adoption.
Charles has been a member of the IHE-Europe Steering Committee since the inception of IHE-
Europe in the early 2000. He is currently member of the IHE International Board, as a past co-
chair of the Radiology and the IT Infrastructure Technical Committees.
Active in the national healthcare field for the past 20 years, Charles has focused on bridging the
clinical and business domains with the complex technical domain of health IT interoperability
standards. In doing so, he has gained the respect of several physician societies, regional and
international health information exchange projects, the European Commission and leading
government health officials around the world.
Hilary Rabé (Kereval sub-contracting), female, is working for Kereval. She is an expert for
Art décor and validate the CDA templates used in several IHE profiles. She also adds some
CDA definitions that were missing in ART-Décor IHE instance. She also worked for Ireland
Cross Border project and she created a sample to validate the Art Décor Irish instance (2019).
51
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Relevant publications, products, services, or other achievements (max. 5)
1. Bourquard K, Orlova A, Parisot C. Understanding User Needs for Interoperability:
Collaborative Approach. JAHIMA. 2017. 88(10): 58-61: URL:
http://bok.ahima.org/doc?oid=302323
2. Bourquard,Karima and Berler, Alexander. Use case driven approach for a pragmatic
implementation of interoperability in eHealth. IGI Global Journal
3. Abderrerrazk Boufahja, Eric Poiseau, Guillaume Thomason, Anne-Gaelle Bergé. Model-
Based analysis of HL7 CDA R2. Conformance and requirements coverage. IHIC 2015.
4. Ib Johansen, Morten Bruun-Rasmussen, Karima Bourquard, Eric Poseau, Milan Zoric,
Charles Parisot, Michael Onken. Quality Management System for Interoperability Testing.
MIE- Publication 2011.
5. Georg Heidenreich, Michael Onken, Charles Parisot, Eric Poiseau, Morten Bruun-Rasmussen,
Karima Bourquard, Jos Devlies. Combining functional and interoperability–testing - Results
from the HITCH project. In: Schreier G, Hayn D, Ammenwerth E, editors. Tagungsband der
eHealth 2011. 26-27 May 2011; Vienne, OCG, 2011.
Previous projects or activities related to the project subject (max. 5)
1. epSOS and eHDSI: the project demonstrated the cross border exchange of medical data
(Patient Summary, ePrescription and dispensation) among European countries. 25
European countries were involved in the project during 6 years (2008-2014).
www.epsos.eu.
2. ANTILOPE (2013- 2015) supported the dissemination and adoption of the eEIF and built a
Refined eEIF (ReEIF) with use cases and a selection of a set of 27 profiles. Quality
management on interoperability testing, test methods were considered as well as a
framework for supporting the development of a Conformity Assessment Scheme regarding
HITCH recommendations. www.antilope-project.eu
3. Trillium Bridge (2014-2015) supported the extension of the cross border European
medical exchanges (epSOS) to the US. The testing strategy that was developed was aligned
to the epSOS strategy. www.trilliumbridge.eu
4. eHDSI (eHealth Digital Service Infrastructure) (2016-) is the initial deployment of services
cross border health data exchanges under CEF. eHDSI is built upon epSOS and EXPAND
projects https://ec.europa.eu/cefdigital/wiki/display/EHOPERATIONS/eHDSI+Mission
5. EURO-CAS (2016-2018) – European eHealth Interoperability Conformity Assessment
Scheme aims at maintaining and developing the adoption and take-up of testing the
interoperability of ICT solutions against identified eHealth stand52nalyse5252rotocoles
defined in the ReEIF
HL7
Partner Full Name HL7 International Foundation Europe
52
951938 X-eHealth – Part B
Short Name HL7 Europe PartnerAssociated
No. with6document Ref. Ares(2020)2778062 - 28/05/2020
Country Belgium Website http://www.hl7.org/
Type of organisation Non-profit Logo
Brief Partner Profile
The vision of HL7 is a world in which everyone can securely access and use the right health data when
and where they need it. Its mission is to provide standards that empower global health data
interoperability.
The HL7 Foundation established in Brussels in 2010, addresses European standardization needs in the
area of digital health, 23 years after the establishment of Health Level Seven International in 1987. It
works in close cooperation with 21 European Affiliates and umbrella organizations in Europe and
supports the creation of health information technology standards that are widely and easily used
enabling interoperability in healthcare. Specifically, the objectives of HL7 in collaboration with its
Affiliates currently established in European Countries are: (a) to promote and encourage the use of HL7
frameworks and protocol specifications that serve the needs of the European community by health
systems and service providers; (b) to provide education services, promote tools and facilitate testing
and certification (c) to enable high quality, cost-effective use of information systems in health and
healthcare related environments.
The HL7 International Foundation has been actively involved or coordinated a range of currently active
EU funded projects in the area of interoperability such as UNICOM, Gatekeeper, FAIR4Health,
mHealth Hub, as well as previously the Trillium Bridge, open Medicine, Antilope, Expand, eHDSI, and
currently Trillium II scaling up adoption of patient summaries (HL7 FHIR IPS).
HL7 International provides a comprehensive framework and related standards for the exchange,
integration, sharing, and retrieval of electronic health information that supports clinical practice and the
management, delivery and evaluation of health services. Notable and broadly adopted HL7 standards
are the HL7 Clinical Document Architecture (CDA) used by the European Digital Health Infrastructure
(eHDSI) to record patient summaries and ePrescriptions. HL7 is also the home of Fast Healthcare
Interoperability Resources (FHIR) and profiles, which facilitate access to health data to unlock their
innovation potential and improve quality and safety of care.
Main tasks in Project
HL7 Foundation will be:
Leading WP6 Definition of EHRxF implementable specifications
Co-leading WP8 EHRxF Communities of Practice: from Proof of Concept to large scale
adoption and Infrastructure for Innovation,
and contributing to:
WP2 Dissemination, communication & Stakeholders
WP5 Definition of EHRxF functional specifications
WP6 Definition of EHRxF implementable specifications
WP7 Architecture integration and System specifications
53
951938 X-eHealth – Part B
The contribution of HL7 center in standardization aspects, in the implementation of HL7
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Standards for the EHRxF, as well as issues related to the adoption of proof of concept
demonstrators, and path-finding exploratory studies. Moreover, HL7 will contribute in
education, community building and adoption aspects in WP8. It will provide educational
resources, extend and adapt FHIR profiles as needed and facilitate further adoption of the
HL7 FHIR IPS and EHRxF liaising with standardization stakeholders beyond the consortium.
Relevant expertise and experience of the institution
HL7 Europe has been part o54nalyse5454abntiatives supporting standardization in cross-
border health care, starting with the CALLIOPE action, the eHealth Governance
Initiative, antilope, expand, assessCT, and open Medicine. and successfully coordinated
Trillium Bridge and Trillium II, and estandards projects. HL7 has been instrumental in the
development, promotion and alignment of the International Patient Summary (IPS) standards
collaborating closely with CEN and other standards developing organizations under the Joint
Initiative Council. Through Trillium Bridge and Trillium II, HL7 has been also instrumental in
engaging stakeholders across the Atlantic. This experience will be used in x-eHealth to develop
and refine the EHRxF, and prove its being fit for use in the selected use cases, while also
exploring AI and outcomes based research. HL7 Europe is particularly fit for this role engaging
the 22 national HL7 affiliates in Europe, and also engaging collaborative partners.
Key Personnel’s CVs (incl. gender)
Catherine Chronaki (female) (Dipl Eng1988, MSc 90, 91); Secretary General HL7 Foundation.
Catherine has engaged in eHealth projects since the early 90’s. She has played a key role within
National and European eHealth projects, addressing the wider scope of eHealth: health Information
Infrastructures employing interoperability standards for integrated Electronic Health Records (EHRs)
and digital health services. Catherine has served on the HL7 International Board (as Affiliate Director
2008-2012). She is member of the Board of HL7 Hellas, the Council of the European Federation of
Medical Informatics and current Vice President (EFMI), and the eHealth Stakeholders group of the
European Commission. She has served on the Nucleus of the eCardiology WG of the European Society
of Cardiology. She recently concluded the Trillium II and Trillium Bridge project operational arm of
the EU/US MoU Roadmap, and the eStandards support action which collects evidence to deliver a
standardization roadmap for large scale eHealth deployment in Europe.
Giorgio Cangioli (male) Senior Consultant of ICT in Health and Social Care, Degree in Physics,
PhD in Energy Engineering, Master in ICT for Radiology. Giorgio worked for several years for
private ICT companies in different roles (Production Manager, QMS Responsible, R&D
Responsible) and has been a consultant since 1999. He has more than 15 years of experience in
ICT, standards and business process reengineering applied to health and social care. Giorgio is
involved in several European, National and Regional projects of telemedicine; teleradiology,
social care, primary care, Regional/National/Cross-Country HIE (Health Information Exchange),
eGov projects. It was also involved in eHealth Regional projects assessments on behalf of an
Italian governmental agency. He provides coaching and learning servic54nalyse5454 modeling,
methodologies, and standards applied to the Health and Social Care. Giorgio has been responsible
of the Clinical and Semantic Experts Group in epSOS and WP lead in several eHealth EU Project.
Involved in the past in IHE and DICOM WG 5 (author of the DICOM Supp 88), he is the main
54
951938 X-eHealth – Part B
author of the International Patient Summary Implementation Guides and author of the CEN IPS
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
standards (currently Chair of HL7 Italy and he has been elected as International Affiliate
Representative to the HL7 Technical Steering Committee (2012; 2014-2015).
Relevant publications, products, services, or other achievements (max. 5)
Schulz S., Stegwee R., Chronaki C. (2019) Standards in Healthcare Data. In: Kubben P.,
Dumontier M., Dekker A. (eds) Fundamentals of Clinical Data Science. Springer, Cham
https://link.springer.com/chapter/10.1007/978-3-319-99713-1_3
Chronaki C, Stegwee R, Moen A (2017) In search of a digital health compass to navigate the
health system, Medinfo2017,China
Heitmann K, et al. Interoperability Assets for Patient Summary Components: a Gap Analysis,
MIE2018, Gothenburg, Sweden
CE Chronaki, F Ploeg: Towards mHealth Assessment Guidelines, in Proc. pHealth2016 Heraklion,
May 29-31 2016
Previous projects or activities related to the project subject (max. 5)
FAIR4Health (2018-2021): GA 824666
Trillium II (2017-2019): Scaling adoption of the International Patient Summary and advancing
interoperability of EHRs (coordinator)
eStandards (2015-2017): Create a Roadmap for the large-scale adoption of eHealth interoperability
standards (coordinator)
openMedicine (2015-2016): Advance equivocal identification of medicines in Europe
AssessCT- Assessing SNOMED CT for Large Scale eHealth Deployments (2015-2016)
Partner Full Name Stichting Nederlands Normalisatie Instituut
Short Name NEN Partner No. 7
Country Netherlands Website www.nen.nl
Type of organisation Non-profit Logo
Brief Partner Profile
NEN is a not for profit organ55nalysen (approx. 300 employees) that stimulates and supports
the development of standards. NEN is the Dutch national member body of CEN and ISO,
respectively the European Committee for Standardization and the International Standardization
Organization. In this project, NEN represents CEN/TC 251 Health Informatics, for which NEN
holds the secretariat. NEN will align the project’s efforts with its partnership in the Joint
Initiative Council (JIC) in whic’ the SDO's ISO/TC 215, CEN/TC 251, HL7, SNOMED
International, GS1, CDISC, IHE, DICOM and PCHA cooperate to enable common, timely
health informatics standards by addressing and resolving issues of gaps, overlaps, and
counterproductive standardization efforts.
55
951938 X-eHealth – Part B
NEN is well experienced in managing European, international and national projects; NEN was
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
responsible for the standardization projects, facilitated by the European Commission, for the
eHealth Mandate 403 Phase 1 and the development of 5 European and international standards
in the domain of ‘Identification of Medicinal products’( IDMP) (EN ISO 11238, EN ISO
11239, EN ISO 11240, EN ISO 11615 and EN ISO 11616 and the accompanied technical
specifications as implementation guides ) and ‘Pharmacovigilance’ (EN ISO 27953-1 and -2).
NEN, representing CEN/TC251, has also participated in the successful projects Antilope,
Trillium Bridge, OpenMedicine, eStandards and Trillium II.
Over the last 2 years, CEN/TC 251 developed with the support by European Commission (ref.
SA/CEN/2015-16) the European standard ‘N 17269 'The International Patien’ Summary' and CEN/‘S
17288 'The International Patient–Summary - Guideline for European Imple’entation'. The European
standard EN 17269 has bee adopted by ISO/TC 215 to be further developed as ISO standard as well.
Main tasks in Project
NEN is a member of the Project consortium, with main input–to
WP8 - EHRxF Communities of Practice: from Proof of Concept to large scale adoption
and Infrastructure for Innovation,
and will also contribute–to:
WP2 - Dissemination, communication & Stakehol–ers
WP4 - Generic Aspects of EHRxF recommendation
WP5 – Definition of EHRxF functional specificat–ons
WP6 - Definition of EHRxF implementable specifications
It will align the project’s efforts with its core business related to standardization where it acts
on the behalf of CEN/TC 251 and through its partnership in the Joint Initiative Council (JIC).
Relevant expertise and experience of the institution
CEN/TC 251 delivers and maintains health informatics standards for Europe, preferably
by producing them in co-operation with other SDOs at a global level and by adopting
standards from other SDOs. Over the last years, experts have participated in EU projects to
engage and interact with other experts to deliver univocal guidance for the EC and other
relevant stakeholders. In parallel, the projects results flow back into related standardisation
activities.
The International Patient Summary activity is integral to taking the eHN guidelines to the next
stage in terms of providing a workable and productive level of standardization for Europe.
Key Personnel’s CVs (incl. gender)
Robert A. Stegwee (M) - Robert A. Stegwee, PhD is Principal Consultant for IT in Healthcare.
He has been involved in healthcare IT in different capacities since 1993, starting in a hospital
56
951938 X-eHealth – Part B
environment and consulting in different sectors of healthcare, including at national and
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
international level. Robert has participated in the development of the HL7 standards and has
served as chairman of the board of HL7 the Netherlands. He has served as co-chair of the HL7
International Council and HL7 Affiliate Representative to the Joint Initiative Council on SDO
Global Health Informatics Standardization (JIC). As of March 2011, Robert serves as chair of
the European standards organization CE‘/TC 251 'Health In’ormatics' and represents CEN in
the JIC. Robert has been WP Co-lead in eStandards and Trillium II projects.
Shirin Golyardi (F) - Shirin Golyardi, LLM, is senior consultant and has broad experience as a
project manager of standardization processes in the healthcare sector in topics such as
information security and interoperability. Shirin is the secretary of the European standards
committee CE‘/TC 251 'Health in’ormatics' and the ISO Working Group Iso/TC‘215/WG6
'Pharmacy and m’dication'. Shirin has law degree in European and international law and Dutch
law. Currently, the European standard ‘N 17269 'International Patien’ Summary' and its
accompanying implementation guide (CEN/TS 17288) are being finalized.
Stephen–Kay (M) - Stephen Kay, Ph.D FBCS FACMI, has been involved in Health
Informatics since 1976. He was elected international fellow of the American College of
Medical Informatics. He has been the British Computer Society (BCS) Health representative on
BSI since the early 90’s. He is on the senior management teams of BSI IST/35, CEN/TC 251,
ISO/TC 215 and the Joint Initiative Council. He is the current Vice Chair of CEN/TC 251. He
was team leader for the EHRCOM Architecture (Part 1 of 13606) between 1996-2000 and
gained the first BCS funded project on System Accreditation tools for Primary Care in the UK.
As well as authoring over 80 papers, he has been editor of an international journal and led
numerous research projects in health Informatics. He was CEN’s expert on the SHN,
Antilope, Trillium Bridge, eEIF, VALUeHEALTH, ASSESS CT and part of the NEN/CEN
team in eStandards and Trillium II projects. Over the last 2 years, Steve was the Project Lead
for the development of EN 17269 and CEN/TS 17288, the European standard and
implementation guide for the International Patient Summary.
Matthias Pocs (M) - is the convenor of CEN/TC 251/WG I and has been actively working in
health ICT innovation projects with leadership experience in research and innovation in several
EU projects related to eHealth and active and healthy aging in relation to privacy and data
protection. Matthias is also ANEC head of delegation at CEN-CENELEC/JTC 13/WG 5,
executing EC Standardization Request M/530, and involved in international standardization
activities in ISO/TC 215 as well as in the national mirror committee as a representative of DIN-
Verbraucherrat. His work is related to the demand side of health informatics products and
services, in particular, society and citizens. His network includes representatives of data
protection authorities, e.g., in the technology subgroup of European Data Protection Board
(ARTICLE 29 Working Party) and EC policy units.
57
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Relevant publications, products, services, or other achievements (max. 5)
R Stegwee, CE Chronaki: The case for formal standardization in large scale eHealth deployment,
White Paper, Oct 2015.
S Kay: The Concurrent Use reports, Workshops organized by CEN/TC 251 during 2012-2015.
S Kay: Final CEN IPS workshop report, March 2019
Communication with all CEN/European member bodies and JIC via meetings and website
Previous projects or activities related to the project subject (max. 5)
E-Health Mandate M/403 – Phase 1 (SA/CEN/ENTR/000/2007-20)
Participation in eHealth Interoperability Framework Study (eHealth EIF) (Framework contract N°
DI/06691-00)
eStandards (H2020 PHC34-GA643889): A roadmap for the coexistence and gradual alignment of
standards in large scale eHealth deployment
Trillium II (H2020-727745-2)
CEN IPS (SA/CEN/2015-16)
Partner Full Name Hrvatski zavod za zdravstveno osiguranje
Short Name HZZO Partner No. 8
Country Croatia Website www.hzzo.hr
Type of organisation national health Logo
insurance fund
Brief Partner Profile
Hrvatski zavod za zdravstveno osiguranje HZZO (Croatian Health Insurance Fund) is a key
stakeholder in the national health care system. HZZO is the single purchaser of health care
services provided within the MHI (mandatory health insurance) scheme. It may also offer
supplemental VHI (voluntary health insurance) to persons insured under the MHI scheme.
Under the supervision of HZZO, large scale health care projects have been implemented
using national and foreign resources. HZZO also operates the central information system with
the registry of patients, health resources registry including portal of messaging system for
communication between health providers and HZZO.
Main tasks in Project
58
951938 X-eHealth – Part B
HZZO will participate as partner in X-eHealth in the following tasks:
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Task 4.3 - Cybersecurity
Task 5.1 - X-eHealth use cases driven met–odology - relative effort
Task 5.5 - Hospital Discharge Reports guideline and function–l specs - relative effort
Task 5.6 - Refine PS guideline and functional specifications to account for rare –
iseases - relative effort
Task 6.3 - Definition for the technical specifications Hospital Discharge Reports
Task 6.4 - Refinement of Patient Summary (PS) technical specifications for supporting
rare diseases
Task 7.1 - Global architecture for EHRxF Domains use
Task 7.4 - Guidance for the new EHRxF domains
Task 8.2 - Exploratory Proof of concept study: from EHRxF to decision aids and
citizen driven health-science
Task 8.6 - Evaluation of EHRxF proof of concept demonstrators
Relevant expertise and experience of the institution
HZZO was involved in few cross-european projects such as the epSOS, EXPAND, ENJECT,
INCA, AdriHealthMob, JAseHN, EESSI, eHAction and project for the upcoming period
within HORIZON 2020-ASSESS CT. HZZO has a main role in implementation and
deployment of eHealth in Croatia and together with Ministry of Health a significant role as
policy maker concerning health in general.
Key Personnel’s CVs (incl. gender)
Hrvoje Jezidžić , Bsc EE graduated from the University of Zagreb, Faculty of Electrical
Engineering and Computing. Within 25+ years of his career in HZZO, he was working as
System Admin, IT manager, Head of Technical Department, Head of Informatics Department.
He was working as project manager and consultant for the Ministry of Health. Hrvoje was
evaluator in The World Bank project „ Drafting the procurement documents (proposed
specification for consulting services) for public bidding procedure for the integration of
national health registers (databases) in Croatian health system.“ Hrvoje is supervisor of
system CEZIH (Central health information system in Republic of Croatia) and he is internal
auditor in implementation ISO 9001:2008 Quality Management System in Croatian Health
Insurance Fund and Internal auditor and EOQ ISMS MANAGER (ISO 27001:2013) in
implementation ISO 27001:2013 Information security management in Croatian Health
Insurance Fund. From April 2017 he is assistant director for ICT in HZZO. He is member of
eHealth Member States Expert Group and he is participating eHAction project.
Jelena Curać Bsc in Physics, graduated from the University of Zagreb, Faculty of Science,
Department of Physics. She has 20+ years of working experience in software maintenance for
59
951938 X-eHealth – Part B
health insurance information system and software development of new applications in HZZO.
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
She was Project leader in implementing electronic data exchange between HZZO and other
government institution in Croatia. Since 2011, she is Department Manager responsible for
Decision Support and Business Reporting. She is participating eHAction and EESSI project
Sanja Gusić graduated in Faculty of Electrical Engineering and Computing (University of
Zagreb). She works in IT section. She has a background in software and information strategy
development and implementation. She has been involved in national projects such as CEZIH,
ePrescriptions, etc. She is participating eHAction and EESSI project.
Vesna Kronstein Kufrin , Bsc Math graduated from the University of Zagreb, Faculty of
Science, Department of Mathematics. She has 30 years experience in Information
technologies and project management. She was a project manager for the BI project financed
by the World Bank and some other projects of Software development and implementation in
CHIF. She has successfully finished internal workshop on project lifecycle. She was the
Project Manager on the‘project 'Development and implementation of the new information
solution for national screening’programs'. Project activities included coordination among
several institution and their–experts - Ministry of Health, HZZO, Croatian Institute of Public
Health, ho60nalyse6060abilicologists and GPs. All users of the newly developed solution
uses ePrescription and eRefferal on a daily basis. She was responsible for monitoring the
implementation in all healthcare institution involved in providing national screening
programs.
Tomislav König , prof. spec. ing. logist. graduated at the University of Applied Sciences
Velika Gorica, professional study of Management of Logistic Systems and Processes. He has
60nalyse6060aexperince in IT sector in Croatian health insurance fund and actively planed
and worked at several National eHealth projects such as the ePrescriptions, eRefferal and
eResult , eOrdering and eWaiting lists. He is participating eHAction project
Relevant publications, products, services, or other achievements (max. 5)
JAseHN
D6.1.1 Report on the implementation of Patient Summary Guidelines
D6.1.3 Report on the The Implementation of Patient Registries Guidelines in Member States
Previous projects or activities related to the project subject (max. 5)– JAseHN - HZZO
was responsible for preparing the Legal Agreement for future CEF eHealth project. It
becamed the legal basis for cross-border exchange of ePrescription and Patient Summary in
MS.–
D6.1.1 - Report on the implementation of Patient Summary Guideline–
D6.1.3 - Report on the The Implementation of Patient Registries Guidelines in Member States
HZZO has participate in several cross-european projects such as the epSOS, JAseHN,
EESSI, eHAction and project within HORIZON 2020-ASSESS CT. HZZO has a main role
in implementation and deployment of eHealth in Croatia and together with Ministry of Health
a significant role as policy maker concerning health in general.
60
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Partner Full University of Cyprus
Name
Short Name UCY Partner 9
No.
Country Cyprus Website www.ucy.ac.cy
Type of No profit Logo
organisation organization,
University
Brief Partner Profile
The University of Cyprus (UCY) is a young university, established in 1989 as the first
university in Cyprus with the aim to become a leading educational and research institution,
distinguishing itself internationally through the promotion of scholarship and being
recognised as an institution of excellence in the Mediterranean region. The most recently
founded schools of UCY are the School of Engineering (founded in 2003) and the School of
Medicine (founded in 2013). While a relatively young university with 7,000 students and
nearly 1,000 employees (academic and administrative), UCY has many accomplishments to
show over a very short period of time. Apart from being the leading university and the most
active research institution in Cyprus (according to the most recent European Research
Rankings), UCY is the youngest institution to be ranked in the top 550 Higher Education
Institutions in the world (placed in the 351-400 group for 2015-2016 in the Times Higher
Education World University Rankings). Furthermore, UCY has been recently ranked 55th
worldwide in the “150 Under 50 Rankings” of the top 150 universities under 50 years old
(The World University Rankings). Furthermore, it currently delivers up to 350 externally
funded research projects, including several FP7 and H2020 projects, and 10 ERC Grants, as
well as national and regional research programmes funded by the National Research
Promotion Foundation and the European Structural Funds.
The Department of Computer Science has 22 faculty members, and more than 130
postdoctoral Research Fellows and PhD students. The Department is highly research oriented
with an overall rate of ~ 5 journal publications per faculty per year. Since Cyprus joined the
EU in 2004, it has participated in over 250 projects funded by various frameworks of the
European Union as well as other local and international sources with a total funding in the
level of about 35M EUROs. Currently the active department projects are over 22 with a total
funding that exceeds the 5 MEUROs.
Main tasks in Project
61
951938 X-eHealth – Part B
UCY will participate in the following tasks: Associated with document Ref. Ares(2020)2778062 - 28/05/2020
WP3 Evaluation
WP5 Definition of EHRxF functional specif
ications
T5.4: Medical Imaging and Reports guideline and functional specifications
WP6 Definition of EHRxF technical specifications
T6.2: Definition of technical specification for the Medical Imaging Domain
WP7 Architecture integration and System specification
T7.1: Global architecture for EHRxF Domains use
WP 8 EHRxF Communities of Practice: from Proof of Concept to large scale adoption
and Infrastructure for Innovation (Co-Lead: UCY)
T8.1: Proof of concept: EHRxF in rare diseases
T8.2: Proof of concept: EHRxF in chronic diseases management and prevention
T8.3: Exploratory Proof of concept study: from EHRxF to decision aids and citizen
driven health-science
T8.4: EHRxF community of practice: building capacity and scaling up
T8.5: Exploitation: EHRxF as infrastructure for innovation
T8.6: Evaluation of EHRxF proof of concept demonstrators (Leader)
Relevant expertise and experience of the institution
eHealth Lab (www.medinfo.cs.ucy.ac.cy) – Department of Computer Science – The lab has
more than 20 years’ experience with funded eHealth research projects. It hosts a
multidisciplinary team of experts with a strong background on eHealth, mHealth, intelligent
diagnostic systems, medical imaging, and life sciences informatics and has a long list of
completed and on-going projects in the above areas in Europe and internationally with a total
funding managed in excess of 7 MEuro. The Lab has a long-standing experience in eHealth
projects and is strongly collaborating with the Ministry of Health of Cyprus (including the
Nicosia and Pafos General Hospitals, and numerous rural centres), major private hospitals
(Areteion, Ippokratio), “Paedi” Center for Specialized Pediatrics and the Cyprus Institute of
Neurology and Genetics. Moreover, the lab is collaborating with numerous eHealth
informatics and sensor informatics SMEs (3AHealth, Unilogic, Infotex, Signal Generix,
Stremble, Istognosis, and other).
The eHealth Lab of the Department of Computer Science of the University of Cyprus, and the
Ministry of Health of the Republic of Cyprus have a long-standing collaboration on eHealth
projects, consulting and services spanning in the last 25 years. Selected activities are
62
951938 X-eHealth – Part B
highlighted simply to demonstrate the strength of collaboration in support of the CEF
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
proposal. The eHealth Lab team in collaboration with the Accident & Emergency Department
of the Nicosia General Hospital participated in one of the first EU eHealth projects carried out
in Cyprus (when Cyprus was eligible for inclusion in EU projects). The AMBULANCE
project was funded by FP4 in 1996-1998 and targeted in the development of a mobile unit for
health care provision via telematics support. This project was followed by Emergency-112
(1998-2000). Both projects were a great success and the mobile units developed that
facilitated the collection of vital signs (ECG, blood pressure, SPO2, and other) and the
wireless transmission from the mobile unit to the base station in Nicosia were installed in 2
ambulance units and 1 remote medical centre. The systems developed in emergency
telematics were further advanced via the funding of 2 Interreg IIIB projects (2004-2008) that
enabled the connection of 2 more remote medical centres to the Pafos General Hospital.
Moreover, several projects were awarded by the 2 collaborators related to higher and
continuing medical education and the establishment of a Mediterranean network (Leonardo
Da Vinci Programmes (1997-2001) and Interreg IIIB & IIIC projects (2004-2008).
More recently, as it has been mentioned above, the 2 organisations are collaborating for the
Deployment of Generic Cross Border eHealth Services in Cyprus funded by the EU CEF
INEA Agency. Cyprus will be a Wave 3 Country with respect to the eHDSI Go-Live plan.
Moreover, the 2 organisations also are collaborating in the development of the project entitled
Integrated National eHealth Ecosystem (eHealth4U) funded by the Research Promotion
Foundation of Cyprus. These 2 projects are also carried out in collaboration with the newly
established eHealth Authority of Cyprus.
Key Personnel’s CVs (incl. gender)
Constantinos S. Pattichis (male) is Professor with the Department of Computer Science
and Co-Director of the eHealth Lab of the University of Cyprus, as well as Co-Leader of
MRG 7 Smart, Ubiquitous, and Participatory Technologies for Healthcare Innovation in
the Research Centre on Interactive Media, Smart Systems and Emerging Technologies
(RISE). He has 30 years of experience in Digital Health, Connected Health, eHealth,
mHealth, Medical Imaging and Video, Biosignal Analysis and AI, Machine Learning and
Intelligent Systems. He has been involved in numerous projects in these areas funded by EU
and other bodies, with a total funding managed in excess of 11 million Euro. He is also
leading the “Deployment of Generic Cross Border eHealth Services in Cyprus”, an EU
Innovation and Networks Executive Agency (INEA) Connecting Europe Facility (CEF)
funded project where 23 member states participate. He was Co-PI of the EU H2020-
WIDESPREAD-04-2017-Teaming Phase 1 project “Integrated Precision Medicine
Technologies Research Centre of Excellence (IPMT)”. More recently, he was awarded as Co-
PI the development and implementation of a highly competitive national integrated project
entitled “Integrated National eHealth Ecosystem (eHealth4U)”, that targets to develop the
national eHealth infrastructure based on strict adherence to interoperability protocols for the
offering of advanced big-data eHealth services. He has published more than 100 journal
publications, 220 conference papers, and 30 chapters in books in these areas (no. of citations
63
951938 X-eHealth – Part B
more than 8000, h-score 47). He is Co-Editor of M-Health: Emerging Mobile Health Systems
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
(considered to be the first published book on mHealth), and Ultrasound and Carotid
Bifurcation Atherosclerosis, published in 2006 and 2012 by Springer, and more recently of
the Handbook of Speckle Filtering and Tracking in Cardiovascular Ultrasound Imaging and
Video, published by IET, UK, 2018. He is Guest Co-Editor of the Special Issues of the IEEE
Journal of Biomedical and Health Informatics (J-BHI) on Integrated Precision Medicine
Informatics (2019) and on Computational Solutions to Large-Scale Data Management and
Analysis in Translational and Personalized Medicine (2014). He was also Guest Co-Editor of
the Special Issues of the IEEe Trans. on Information Technology in Biomedicine on
Emerging Technologies in Biomedicine (2009), Computational Intelligence in Medical
Systems (2009), Citizen Centered eHealth Systems in a Global Health-care Environment
(2011), and Atherosclerotic Cardiovascular Health Informatics (2012). Moreover, he served
as Distinguished Lecturer (2013-2014), and currently serves as member of the Technical
Committee on Biomedical and Health Informatics of the IEEE EMBS, and an Associate
Editor and Member of the Steering Committee of the IEEE J-BHI. He was Program Co-chair
of the IEEE International Conference on Biomedical and Health Informatics (BHI 2019 and
2018), IEEE Computer-Based Medical Systems (CBMS2017), General Co-chair of the IEEE
4th Middle East Conference on Biomedical Engineering (MECBME 2018), IEEE
International Conferences on Information Technology Applications in Biomedicine (ITAB
2009), Bioinformatics and Bioengineering (BIBE 2012), and 13th Medical and Biological
Engineering and Computing (Medicon 2016). He is a Fellow of IEEE, IET, International
Academy of Medical and Biomedical Engineering (IAMBE) and European Alliance for
Medical & Biological Engineering & Science (EAMBES).
Prof. Christos N. Schizas (male) is Professor with the Department of Computer Science
and Co-Director of the eHealth Lab, and Director of the Computational Intelligence Lab
(CIL). http://www.ehealthlab.cs.ucy.ac.cy/index.php/faculty. He has 35 years of experience in
information systems development with more emphasis on eHealth, computational intelligence,
medical diagnosis, medical informatics, biosignal analysis, intelligent, and more recently in
brain activity modelling with emphasis on attention. He was born in Cyprus and studied at
QMC, University of London, UK, B.Sc. (Eng). Graduate studies at the University of
Indianapolis, USA, MBA, and at QMC, University of London, UK, PhD in 1981. He received
the William Lincoln Shelley award from the University of London for excellence in research,
and a Fulbright fellowship for collaborative research in the USA. He served as Postdoctoral
Fellow at the University of London, and Professor of Computer Information Systems at the
University of Indianapolis. Since 1991 he has been with the Department of Computer Science
at the University of Cyprus and he served as Vice Rector of the University during 2002-2006.
He published more than 150 research papers in International Scientific Journals, International
Conferences, and Edited Book volumes. He is the Section Editor (eHealth) of the journal
Technology and Health Care, served as area editor of the journal IEEE Transactions on
Information Technology in Biomedicine, and member of the editorial board of the journal of
Intelligent Systems. His research interests include eHealth, computational intelligence, and
64
951938 X-eHealth – Part B
system modeling & identification of brain activity. He is the founder of the Computational
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Intelligence lab and co-director of the eHealth lab of the University of Cyprus. He is one of the
founders–of RISE - Research Centre on Interactive Media Smart Systems and Emerging
Technologies and member of the Board of Directors of RISE Ltd. He has taken part in
European Commission initiatives for promoting the Information Society, especially the Euro-
Mediterranean partnership and the eHealth initiatives. He attends regularly as invited speaker
the annual EU Ministerial Forum meeting on eHealth. He is since 2016 the national
representative to EU for the SC1 (Health) HORIZON 2020 Program Committee Expert.
In August 2015 he has been appointed as personal advisor to the Cyprus Minister of Health on
all eHealth matters, especially in proposing the road map for implementing the National Health
System and monitoring its steps. Chair of the Ad hoc eHealth Committee, appointed by the
Minister of Health. In April 2016 he has been appointed by the President of the Republic of
Cyprus as Presidential Counselor for eHealth and matters related to the National Health
System (ΓεΣΥ) reform. Participated in the eHealth Week, Ministerial meeting – Dublin 2013
as National Representative and invited speaker at the eHealth Forum, Ministerial meetings in
Athens, Riga, and Amsterdam. He lectures two courses on eHealth in the School of Medicine
(UCY) and at master’s level in the CS Department.
Dr Marios Neofytou (♂) is a Senior Research Scientist of the eHealth Lab of the
Department of Computer Science of the University of Cyprus. He received his diploma
degree in Electrical & Computer Engineering from the National Technical University of Athens
(NTUA) and his Ph.D. degree in Biomedical Engineering from the department of Electrical &
Computer Engineering of the National Technical University of Athens, Greece. He is working
in research projects (IPPOKRATHS, CATIA, InteMEDnet, LLM, Meducator etc.) dealing with
e-learning, medical imaging, telemedicine, and image processing.
Dr. Andreas. S. Panayides (♂) is a Senior Research Scientist of the eHealth Lab of the
Department of Computer Science of the University of Cyprus and a Visiting Assistant
Professor at the Image and Video Processing and Communications Lab of the University
of New Mexico, and the R&D Project Manager of Integrated Precision Medicine Technologies
(IPMT) phase 1 project, a competitive EU funded project. Dr. Andreas S. Panayides (EMBS
Member, Senior IEEE Member) is a Visiting Assistant Professor and Assistant Director at the
Image and Video Processing and Communications Lab of the University of New Mexico and a
Senior Research Fellow with the Electronic Health (eHealth) Laboratory of the University of
Cyprus. He is also the R&D project manager of the Integrated Precision Medicine
Technologies (IPMT) – Teaming Phase 1 project. Formerly, he was a Marie Curie Fellow with
the Communications and Signal Processing group at Imperial College. His research interests
are in adaptive video delivery for real time applications, computer vision for healthcare
applications, interactive and distributed analytics of large video databases, and mHealth and
eHealth systems. He has published more than 55 peer-reviewed journal and conference papers,
and book chapters, in these areas. He was the lead Guest Editor of IET Healthcare Technology
65
951938 X-eHealth – Part B
Letters; Special Issue on mHealth-Emerging Mobile Health Systems and Services, published in
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
September 2016 and the lead organizer of the special session entitled The Potential of Big Data
Medical Video Analytics in Healthcare in the IEEE Biomedical and Health Informatics
International Conference, BHI 2017, USA. Dr. Panayides is actively involved in national and
international research projects, funded by the European Commission, the Research Promotion
Foundation of Cyprus, and the National Science Foundation, USA. In 2016, he cofounded
3AHealth (3ahealth.com), a start-up company based in Cyprus, that provides integrated
solutions for electronic health Iords (EHR) storage, sharing, and analysis based on IHE
interoperability profiles, where he holds the position of R&D Director. At the same time, Dr.
Panayides has cofounded and is the Head of Engineering at ClearStream Technologies LLC
(2017), a start-up company based in Albuquerque, New Mexico, USA, that optimizes video
encoding for adaptive video delivery applications (including telemedicine). CleaStream
licensed rights to a pending patent in adaptive video coding and delivery that Dr. Panayides co-
invented at UNM. ClearStream was a National finalist to the 2017 Creative Business Cup,
USA.
Relevant publications, products, services, or other achievements (max. 5)
1. Schiza, E. C., Kyprianou, T. C., Petkov, N., & Schizas, C. N. (2018). Proposal for an
ehealth based ecosystem serving national healthcare. IEEE Journal of Biomedical
and Health Informatics, 23(3), 1346-1357.
2. A.S. Panayides, M. S. Pattichis, S. Leandrou, C. Pitris, A. Constantinidou, and C.S.
Pattichis, Radiogenomics for Precision Medicine with A Big Data Analytics
Perspective, IEEE Journal of Biomedical and Health Informatics, pp. 1-17, 2018. DOI:
10.1109/JBHI.2018.2879381.
3. Schiza, E., Matsangidou, M., Neokleous, K. and Pattichis, C.S., 2019. Virtual Reality
Applications for Neurological Disease: A Review. Frontiers in Robotics and AI, vol.
6, pp. 1-14. doi: 10.3389/frobt.2019.00100
4. Pattichis, C.S. and Panayides, Connected Health, A.S, Frontiers in Digital Health,
vol. 1, pp. 1, 2019, Frontiers.
5. Christoforou, E.G., Panayides, A.S., Avgousti, S., Masouras, P., Pattichis, C.S., An
Overview of Assistive Robotics and Technologies for Elderly Care, Mediterranean
Conference on Medical and Biological Engineering and Computing, pp. 971-976,
2019, Springer.
Previous projects or activities related to the project subject (max. 5)
66
951938 X-eHealth – Part B
Integrated National eHealth Ecosystem (eHealth4U):
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Co-PI, Research Promotion
Foundation, Cyprus, Restart 2016-2020 – Integrated Projects, Oct. 2018 – Apr. 2021,
Funding: 1,000,000 Euro
Integrated Precision Medicine Technologies Research Centre of Excellence (IPMT):
EU H2020-WIDESPREAD-04-2017-Teaming Phase 1. Sept. 2017 – Aug. 2018, Funding:
399,999 Euro (UCY 140,287 Euro)
Deployment of Generic Cross Border eHealth Services in Cyprus: EU Innovation and
Networks Executive Agency (INEA). Depa–tment C - Connecting Europe Facility
(CEF).Unit C4 Energy & ICT [2015-CY-IA-0095]: Jan. 2017 – Dec. 2020, Funding:
593,356 Euro
Future Internet Social and Technological Alignment Research (FI-STAR): Electronic
Health Record Application Support Service EIlers (EHR-EN): EU FP7 THEME Future
Internet ICT: 604691 [FI.ICT-2011.1.8]: April 2014 – September 2015, Funding: 121,120
Euro
A Next-Generation, Secure Linked Data Medical Information Space for
Semantically-Interconnecting Electronic Health Records and Clinical Trials Systems
Advancing Patients Safety in Clinical Research (Linked2Safety): FP7-ICT-2011-7,
Oct. 2011-Sept. 2014, Funding: 560,600 Euro
Partner Full Name National eHealth Centre, Ministry of Health of the Czech Republic
Short Name MZCR Partner No. 10
Country Czech Republic Website http://www.mzcr.cz
Type of Ministry of Logo
organisation Health,
Brief Partner Profile
MZCR is a department (directorate) of the Ministry of Health of the Czech Republic. MZCR is
responsible for strategic development and national architecture of the digital health services in
the Czech Republic and being part of the ministry bears responsibility for preparation of
legislative environment and national standardization in the field of digital healthcare. National
eHealth Centre was created in January 2019 by ministerial decision.
Main tasks in Project
MZCR will participate in all key project activities, especially in the activities –f:
WP 4 - Generic Aspects of EHRxF recommenda–ion
67
951938 X-eHealth – Part B
WP5 - Definition of EHRxF functional specificat–ons
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
WP6 - Definition of EHRxF implementable specificat–ons
WP7 - Architecture integration and System specifications
MZCR will be a co-leader of the WP 5, task leader of the task T5.3, active participant in WP4
– with focus on Legal aspects & Enablers and Cyber security, WP6 – with main focus on lab
and discharge letter and WP7.
Relevant expertise and experience of the institution
MZCR team, before its formal establishment, developed national e-Health strategy under the
umbrella of the MoH. The work was conducted by several workgroups with broad presentation
of all relevant stakeholder organizations during period of 2014 – 2016. Strategy document was
formally adopted by the Czech government at the end of 2016.
MZCR committed several national projects since its establishment: Strategic management of
development of digital health in the Czech Republic, Development of basic digital health
infrastructure, Strengthening of the capacity of the Ministry of health in the Czech Republic in
its effort to set up a National eHealth Centre, Development of the communication strategy of
the Digital Health and Care in the Czech Republic. MZCR team also participated in several EU
wide and eHealth network (eHN) projects. As the Czech national authority for cooperation
matters in the field of eHealth, MZCR represents Czech Republic to the eHealth network (eHN),
the voluntary network of national authorities of Member States responsible for eHealth, and is
currently involved as partner in the CEF eHDSI Cross-Border services deployment (on Cross-
Border Patient Summary & ePrescription/eDispensation). MZCR is a partner of the eHAction,
co-leading one of its Work packages (Cyber security, Data Protection). Furthermore, MZCR
actively contributed to several eHAction workgroups: CSS – Common Semantic Strategy WG
andIRxF – EHR exchange format workgroup. Recently, MZCR participates in the development
of the eHN Guidelines to the MS and EC on an interoperable eco-system for digital health and
investment programmes for a new/updated generation of digital infrastructure in Europe.
Key Personnel’s CVs (incl. gender)
Martin Zeman – Chief Executive Officer of MZCR , Studied Cybernetics.
He obtained his master’s degree in technical cyb–rnetics - medical biocybernetics at the Czech
Technical University in Prague and postgraduate Diploma in Management Studies,
specialization for management of health service organizations at The Nottingham Trent
University. He has several publications in the area of management and informatics in
healthcare. He currently works at MZCR as director. MZCR is the national e-Health authority
under the Ministry of Health. He was formerly the Chief Information Officer (CIO) of the
North Bohemia Regional Hospital Trust. He is aChairman of the Czech Society of Medical
Informatics and Scientific Information. Martin is responsible for nationwide strategy and
implementation of the digital health services in the Czech Republic.
68
951938 X-eHealth – Part B
Jiri Borej – leading eHealth architect, , Studied Electrical Engineering.
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Jiří Borej holds a master’s degree in the Electrical Engineering at the Czech Technical
University in Prague. He works 12 years in ICT management positions in top management of
international TELCO companies, over 12 years as business consultant. He has been awarded
the highest ISACA certification –f CGEIT - ISACA (Certified in the Governance of Enterprise
IT). He is currently working for the Ministry of the Czech Republic in several roles: Major
Enterprise Architect of eHealth, Head of Department, and member working group of
Government Council for Information Society.
Tomas –ezouska - Cyber Security manager, , Studied Information sciences and
economics.
Tomáš Bezouška graduated with a’bachelor's degree (Bc.) in information sciences and
economics at the Faculty of Economics of Technical University of Liberec. He was certified as
a Certified Information Systems Auditor (CISA) by Information Systems Audit and Control
Association (ISACA). In 2010 has Tomáš Bezouška cofounded the Czech Republic Group of
the Information and Records Management Society (IRMS CRG) and was elected its President.
In 2016 IRMS CRG was transformed to non-profit organisation (IPSD) closely cooperating
with both central and local government institutions in areas of records management, personal
data protection and digitisation of public administration and Tomáš Bezouška was confirmed as
a President of IPSD. Mr. Bezouška is a member of the Cyber Security Council of the Office of
the Government of the Czech Republic and a Cyber Security Architect of the Ministry of
Health of the Czech Republic. He regularly lectures and publishes in areas of Records
Management, Data Protection, Cyber Security and Personal Data Protection.
Hynek Kruzik – Senior Consultant, , Studied Cybernetics.
Hynek graduated in technical cyb–rnetics - medical biocybernetics at the Czech Technical
University of Prague. He works in healthcare sector since his graduation. Since 2006 he started
his freelance healthcare IT consultancy carrier and he conducted many international healthcare
ICT and consultancy projects in Europe, Asia and Central America where he utilized his long-
term experience from development of healthcare information systems, regional and national
digital health solutions. Hynek also worked with Hewlett-Packard (HP) as a member of the
CEE Business Development Group. Hynek works as external consultant of the Czech Ministry
of Health since 2013. He is one of the key contributors to the Czech National eHealth strategy
2016-2020 and Digital Health Semantic strategy of the Czech Republic. Hynek is currently a
national representative of the Czech Republic in the European Union eHealth Digital Service
Infrastructure semantic woIroup, EHR exchange format (EHRxF) workgroup and EU Common
strategy workgroup (CSS). He is responsible for semantic interoperability in cross border
services project and for preparation of new projects in the area of digital health and
standardization. Hynek is a leader of the semantic WG of the Czech MoH. He is a member of
69
951938 X-eHealth – Part B
the Czech HL7 affiliate office, Czech Society of Medical Informatics and Scientific
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Information and Czech National e-Health standards WG.
Milan Cabrnoch, M–D., MBA - Senior Consultant, , Studied Medicine
Milan Cabrn70nalyse7070abiliatrician. He graduated from the Faculty of Pediatrics of Charles
University in Prague. He has two attestations in paediatrics. He worked at the’children's ward
of the hospital. Later he worked at the Ministry of Health as a deputy minister responsible for
public health insurance and legislation and was a member of the Parliament of the Czech
Republic and the European Parliament.
Now Milan Cabrnoch works as an independent consultant in health and social care. He teaches
at the CEVRO Institute in Prague. Milan is currently working as s head of the eHealth
education centre at the Institute of Postgraduate Education in HealthCare. In 2007 Milan
established the NGO Czech National eHealth Forum and still is a chairman of it. He has been
involved in eHealth issues for many years, specifically in areas such as PHR and health
pro’essional's education.
Petr Tu–a, M.D. - Clinical terminology specialist, , Studied Medicine
Petr Tůma has M.D. diploma from the Charles University in Prague. He worked as an
endoscopist and later as a manager of healthcare facility. He is expert in clinical terminology
and clinical coding systems and medical data analyst. Petr is a member of the Czech national
semantic WG and participates in the work of the eHMSEG semantic workgroup.
Eliska Urbancova – Project management specialist , Studied Project management
Eliška Urbancová is a project manager. She graduated with a’bachelor's degree (Bc.) in
management and economics at the Faculty of Economics and Management of the Czech
University of Life Sciences in Prague. She obtained her master´s degree (Ing.) from project
management at the same faculty. Eliska has Prince2 Foundation certificate in project
management. Currently she works as a project manager in Department of the National eHealth
Centre for the Ministry of Health.
Irena Rubeso–a, M.D. - Clinical terminology specialist, , Studied Medicine and
Mathematical and Computer Sciences
Irena Rubesova has M.D. diploma from the Charles University in Prague (1999) and graduated
with a’bachelor's degree in Mathematical and Computer Sciences at the University of Nimes in
France (2014). She worked as an internist and later as DRG hospital manager. Currently she
works as terminologist in Department of Clinical Classifications in the Institute of Health
Information and Statistics of the Czech Republic.
70
951938 X-eHealth – Part B
Relevant publications, products, services, or other achievements (max. 5)
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
List of relevant publications:
MZCR team prepared a national e-Health strategy for 2016-2020 of the Czech Republic and e-
Health Action Plan. Both documents were adopted by the Czech government.
MZCR established a catalog of national e-Health standards, standards development processes,
and basic e-Health Dictionary system. MZCR prepared several legislative norms: regulation on
national Patient Summary and new e-health law that will be sent to the parliament in 2020.
Previous projects or activities related to the project subject (max. 5)
eHAction
eHDSI (CEF)
EPSOS
ANTILOPE
PROREC
Partner Full Vysočina Region
Name
Short Name Vysocina Partner 11
No.
Country Czech Republic Website www.kr-vysocina.cz
Type of Regional Logo
organisation Governing
Authority
Brief Partner Profile
Vysočina Region Regional Authority is the governing body of the Vysočina Region, which is
located in central part of the Czech Republic. In the past few years, Vysočina has profiled
itself as one of the leading public authorities in using advanced solutions in information and
communication technologies. The region has built its own backbone
optical“network”"ROWANet", which allows for fast and reliable data transfer in public
administration, among emergency rescue services and non-commercial data connections for
wide public. The IT Department of the regional authority has been involved in a number of
European projects.
Vysočina Region has been playing a major role in the implementation of eGovernment and
the electronization of health care (eHealth), particularly the eMeDocs project (the Exchange
of Medical Documentation System among medical facilities of the region).
In the implementation of eHealth projects, Vysočina Region relies on good cooperation with
the Ministry of Health of the Czech Republic, Institute of Health Information and Statistics of
71
951938 X-eHealth – Part B
the Czech Republic, Office for Personal Data ProtectionAssociated
of the with
Czech Republic as well as its
document Ref. Ares(2020)2778062 - 28/05/2020
own legal department.
Main tasks in Project
Vysočina Region will take part as the co-leader of WP 4 – Generic Aspects of EHRxF
recommendation. –ask 4.2 - Legal Aspects and Enablers.
And as a partner in WP7 – Architecture integration and System Specification – Tasks 7.3
(Needs for upgrade of eHDSI core and generic services) and 7.4 (Guidance for the new
EHRxF domains).
Relevant expertise and experience of the institution
Vysočina Region currently maintains and operates the NCPeH for Czech Republic, on the basis
of authorization by the Ministry of Health, for 2 services – patient summary (country A and B)
and ePrescription/eDispensation (country A and B). PS service is in operation, eP/eD service is
foreseen to enter operation in 2020/21.
Key Personnel’s CVs (incl. gender)
Mr. Petr –avlinec - head of the Vysočina Region IT Department, operational manager and
main architect of NCPeH for Czech Republic.
Mr. Jarosla– Krotký - head of the regional Applications and Database Maintenance Unit,
technical manager of NCPeH, responsible for OpenNCP implementation.
Mr. Milan Lysa – senior programmer, technical worker of NCPeH, responsible for OpenNCP
implementation.
Ms. Klára –iráková - lawyer and coordinator of national and international projects carried out
by the IT department, NCPeH CZ system coordinator, project manager of the CEF eHealth
project, and co-chair of the eHealth Member State Expert Group, eHDSI Legal Work Group co-
lead, Patient Summary Cluster WG co-lead.
Mr. Dominik Marek – IT security lead of NCPeH Czech Republic, cybersecurity manager of
Vysočina Region Regional Authority.
Relevant publications, products, services, or other achievements (max. 5)
Successful implementation of the eHDSI National Contact Point of Czech Republic, cross-
border exchange of patient summary (A and B). Currently working on the implementation of
cross-border exchange of ePrescription/eDispensation.
72
951938 X-eHealth – Part B
Operator of the regional medical exchange platform Associated
eMeDocS. with document Ref. Ares(2020)2778062 - 28/05/2020
Co-author of the national Ordinance on Medical Documentation – Patient Summary.
Working on national methodology for Patient Summary.
Previous projects or activities related to the project subject (max. 5)
Co-ordinator of the Czech Inter-regional eHealth Work Group
Project partner in the CEF HEALTHeID project.
Partner Full Ministry of Social Affairs/Health and Welfare Information Systems‘
Name Centre
Short Name MSAE /HWISC Partner 12
No.
Country Estonia Website www.sm.ee
Type of Public Logo
organisation organization/eHealth
mº,ç,. Agency
Brief Partner Profile
The Ministry of Social Affairs of Estonia operates under the vision that Estonia should be a sustainable
and innovative country, which is socially and economically balanced, where viable family
relationships, common social cohesion, and high-quality living environment would be the basis for the
social sense of security, well-being, and a high standard of living.
The role of the Ministry of Social Affairs is to plan health and social care policy and to organise its
implementation. We operate in the field of social security, where we have set for ourselves five
strategic objectives:
to ensuse people's economic prosperity and their good work;
to ensuse people's social coping and development;
to support the well-being of children and families;
to promo’e people's mutual care, equal opportunities, and gender equality;
to ensu’e people's long and high-quality life.
MSAE achieves this through a variety of actions:
- Compiles solution plans for ’he state's social issues and manages their implementation.
- Designs and implements the policy in the field of social security, ensures timely and targeted
granting and payment of social insurance benefits.
73
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
- Manages social insurance and welfare services.
- Develops and implements the working life and labour market policy, in order to ensure
prevailing of people with long-term working capacity and employment.
- Organises the protection of public health, as well as medical care.
- Promotes the equal treatment’of women'’ and men's equality, in order to incorporate different
social groups into the life of the society.
- Deals with social welfare and social security issues of disabled people.
- Coordinates the formulation of policies on’children's rights and child protection, and organises
international adoptions.
- Shapes the family policy, which sets a priority of collocation of working life and private life, as
well as parental education.
-
Further, the eHealth Strategy of the Ministry outlines five key priorities
- High-quality health information and an infrastructure of health data.
- Focus on persons and personal medicine.
- Comprehensive case management and cooperation of organisations.
- Effectiveness of health services and capacity for analysis.
- Development of remote services.
The Health and Welfare Information Systems’ Centre is the state’s e-services agency that operates
under the Ministry by providing technical expertise and services to achieve the goals of the Estonian
social security system. Among their areas of expertise are e-health interoperability & semantics and
cybersecurity.
Main tasks in Project
MSAE /HWISC shall be contributing–to:
WP4 - Generic Aspects of EHRxF recommendat–on
WP5 - Definition of EHRxF functional specificat–ons
WP6 - Definition of EHRxF implementable specifications
Relevant expertise and experience of the institution
The Ministry has overseen the development of the Estonian e-health system alongside
HWISC and its predecessor the Estonian e-Health Foundation. Estonia has implemented
numerous digital services within healthcare including a state-wide interoperable electronic
health record. MSAE /HWISC is the official representative of Estonia in the eHealth Network
and has actively contributed to discussions around eHealth interoperability in generalId the
EHR Exchange Format in particular. We are also permamently represented in the eHMSEG,
74
951938 X-eHealth – Part B
the subgroup on the implementation of the CommissionAssociated
Communication on the Digital
with document Ref. Ares(2020)2778062 - 28/05/2020
Transformation of Health and Care and the working group on the Common Semantic
Strategy. MSAE /HWISC was the co-chair of the mHealth subgroup of the eHealth Network
and is the current leader of the eHAction Work Package on Empowering People, with
particular regard to mHealth and Telehealth. MSAE /HWISC have also contributed to
eHAction work packages on enhancing continuity of care, overcoming implementation
challenges (data protection & interoperability guidelines) and integration into national
policies. MSAE /HWISC is also a member of the Global Digital Health Partnership, the
International Consortium for Personalized Medicine, SNOMED, HL7 and the 1 Million
Genomes Initiative. MSAE /HWISC were responsible for implementing the CEF cross-border
digital prescription in Estonia with HWISC as the NCC.
Key Personnel’s CVs (incl. gender)
Dr Priit Tohver, MD, male, is the Advisor for E-Services Innovation at the Ministry of
Social Affairs in Estonia, overseeing the digital transformation and innovation of health and
welfare systems in Estonia. Priit’s core function is to direct global cooperation in e-health
between Estonia and a variety of stakeholders. He is the official representative of Estonia in
the eHealth Network and the Global Digital Health Partnership. He thus works closely on
cross-border interoperability issues both for the primary and secondary use of health data. He
is the project manager on behalf of Estonia in the 3rd Joint Action to support the eHealth
Network and is leading the effort to reform the secondary use of health and social data within
Estonia. He is also a member of the board at the Digital Health Society, an ecosystem of
activists within digital health founded under the Estonian presidency of the Council of the
EU. He is a doctor by training and has previously served as an advisor to the Estonian
Mission in Geneva on diplomatic matters related to health, development and trade, covering
organizations such as WHO, UNCTAD and WTO. Priit also has six years of experience as a
civil society and global health activist, having also served as the Regional Director for Europe
at the International Federation of Medical Students’ Associations (IFMSA).
Kristel Niidas, female, MA (law). Kristel is working as a legal adviser at the Ministry of
Social Affairs. She is responsible for the legal aspects in digital development including
Estonia´s Health Information System and provides legal support for cross border data
exchange issues.
Nele Nisu, female, MA (Law). Nele is working as a Legal Adviser at the Ministry of Social
Affairs and deals with various topics concerning legislative drafting and among other issues
provides legal support in all aspects of privacy and data protection.
Katre Pruul, female, MSc. Katre is a semantics expert, who was formerly the Estonian
representative in eHMSEG as well as the project lead for the implementation of the cross-
75
951938 X-eHealth – Part B
border patient summary. She has previously contributedAssociated
to the eHAction consortium for
with document Ref. Ares(2020)2778062 - 28/05/2020
future eHDSI use cases and the development of a Common Semantic Strategy.
Relevant publications, products, services, or other achievements (max. 5)
- Successful implementation of CEF cross-border digital prescription exchange (both Country
A and Country B) and continued work in implementing cross-border Patient Summary.
- Contributor to Common Semantic Strategy, Roadmap for future eHDSI use cases and
interoperability guidelines for hospital CIOs, lead author of framework for people
empowerment under 3rd Joint Action to support the eHealth Network.
- Responsible entity for SNOMED CT Estonian extension to be released in autumn of 2019.
- Implemented numerous digital solutions in the Estonian healthcare system e.g. patient portal,
sIewide EHR, e-consultation, e-ambulance, e-booking etc. Responsible for e-health standards
and publishing centre.
- Responsible for drafting EU council conclusions on health in the digital society, covering also
data interoperability issues.
Previous projects or activities related to the project subject (max. 5)
The drafting of the Estonian E-Health Strategic Development Plan 2015-2020 was a
multistakeholder process focusing on, among other things, high quality health data
infrastructure, laying down a 5-year strategic plan for the reinvention of our national health
information system. This plan has been further developed into the New Generation Health
Information System roadmap by MSAE /HWISC.
Partner Full Agence des Systèmes d’Information Partagés de Santé (ANS)
Name
Short Name ANS Partner 13
No.
Country France Website https://esante.gouv.fr/
Type of Public organisation/ Logo
organisation eHealth Agency
Brief Partner Profile
76
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANS, the French Agency for eHealth, was created in 2009 and works under the auspices of the Ministry
of Health. The agency is in charge of the implementation of the digital transformation of the health
system.
The main mission of ANS is to build an environment of trust to allow secure share and exchange of
personal health data in compliance with the new legal framework (2016/01 health Modernisation Law).
The Agency is also mandated to implement strategic national eHealth programs, maintain the (French)
Health Terminologies Management Center (HTMC, Centre de Gestion des Terminologies de santé,
CGTS, in French) and works on different projects such as the secure health emailing system (MSSanté)
or the modernization of the hospital emergency departments information and telecommunication
systems (SI-Samu).
ANS fosters the development of the eHealth ecosystem in order to create value, and participates in the
construction of cross-border eHealth information services. ANS has been present since 2008 at
European level, both on strategical and operational levels, by actively participating in European
projects such as epSOS, JAseHN, CEF eHealth, EURO-CAS, eHAction…
Main tasks in Project
ANS will be a partner in 3 work packages:
WP5 – Definition of EHRxF functional specifications
WP6 – Definition of EHRxF workflow and technical specifications
WP7 – Architecture integration and System specifications
ANS intends to provide its expertise and experience on some of the new uses cases introduced
by t77nalyse7777abilimandation especially laboratory results and hospital discharge reports
that have, with patient summary, already successfully been defined and deployed in France at
national level.
Moreover, ANS will also make available its knowledge of the eHDSI Patient Summary both
as coleader of the Patient Summary cluster and French National Contact Point for eHealth
(NCPeH) to help assess impacts on the current Patient Summary specificiations as well as on
the eHDSI core and generic services.
Relevant expertise and experience of the institution
European expertise and experience
As part of the CEF eHealth project, ANS is mandated by the Ministry of Health as the National Contact
Point for eHealth (NCPeH). Very involved in the achievement of this European project, the agency is
co-leader of the Patient Summary Cluster and also an active participant of the different eHDSI working
groups (semantics, legal, technical, etc.).
With regards to the eHAction joint action, ANS acts with two roles: it is the risk manager and also
active partner of different work packages, particularly on empowerment people, future
us77nalyse7777abilityerability guidelines, legaIspects... Moreover, the agency has a coordinating role
in the work package on Integration in national policies and sustainability.
ANS has also active members in the European IHE’s consortium.
77
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
National expertise and experience
ANS has developed and is responsible for maintaining the Health Information Systems Interoperability
Framework (HIS-IF) based on international standards and norms. It is built on a strong structure of 3
layers (content, service and transport) including functional and technical specifications as well as end-
user systems integration requirements:
Content layer: Specification of exchanged or shared content in terms of structure and
vocabularies;
Service layer : Specification of content sharing or exchange services, their rules and usage
parameters;
Transport layer: Specification of exchange protocols used by services.
This interoperability framework has been fully implemented when ANS was building the Iional EHR,
the DMP (Dossier Medical Partagé) in 2009. As of today, DMP platform has more than 7 millions users
all over the country and aims to reach 40 millions in 2023, demonstrating the usability and efficiency of
the adopted standards.
This framework is public and used by all the eHealth ecosystem in France including local or regional
health institutions, private vendors, health professionals assIations...
The content layer defines more than 20 different types of medical document, the most relevant for this
project being laboratory results and hospital discharge reports.
On top of the classic layers of interoperability, ANS has also worked on a conceptual interoperability
layer that allows to manipulate health objects (MOS: “Modèle des objets de Santé”). The main
advantage of this approach is to be able to share the same understanding of various sources of data
standards. These objects are compliant with international standards such as the FHIR (Fast Healthcare
Interoperability Resources) Specification.
Key Personnel’s CVs (incl. gender)
Pascale Sauvage, , is the Deputy Director at ANS since July 2019. Previously, she was Director of
strategy at ANS from 2014 to 2018, before becoming Interim Director of ANS between 2018 and 2019.
Pascale is an expert in leading large public organizations and information systems projects. Graduated
in political public bodies before joining ministry of finance in 2002 to implement a new financial
system. Since she joined the public health sector in 2006, Pascale has been participating in strategic
projects and also managed a wide range of international activities, specifically with Europe and
Quebec.
Angelica Cavalcante Galvão, , is Project Manager at ANS since 2012. Previously working in the
eHealth projects department, she joined the direction of strategy in 2017. She was then appointed to
coordinate the European eHealth projects in which ANS is involved, in particular CEF eHealth and the
joint actions JASeHN and eHAction. As part of the eHAction project, Angélica Cavalcante Galvão is in
charge of the risk management and leads the operational team working on the work package Integration
in National policies and sustainability. Formerly, Angélica Cavalcante Galvão was responsible for the
accreditation of information systems for the Iional EHR, DMP (Dossier Médical Partagé), and also in
charge of the project of certification of information systems for MDPH (Institutes for Disabled People)
78
951938 X-eHealth – Part B
in France. Computer Engineer for Health Information Systems, she has also a Masters Degree in
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Innovation from Paris-Saclay University.
Florence Eon, , is Legal expert specialized in health, new technologies and data protection Law,
Florence Eon has started in healthcare facility, then in law practice and since 2012 she is working in the
legal department of ANS. She takes on the role of IT and freedom correspondent at ANS. Since October
2014, she was appointed director of the legal department. She contributes to define the legal framework
of eHealth major projects, as the secure health emailing system. She was actively involved in legal
tasks of JAseHN and she took part in the elaboration of D6.2 AGREEMENT between National
Authorities or National Organisations responsible for National Contact Points for eHealth on the
Criteria required for the participation in Cross-Border eHealth Information Services. Currently,
Florence Eon is a member of the the Legal Work Group of the CEF eHealth project.
Thierry Dart, , is Assistant-Director of the medical affairs department at ANS since 2017.
Beforehand he worked in the agency for more than 5 years as research manager. Medical doctor with a
Master Degree in Computer Science, specialized in healthcare software applications, Thierry Dart is a
semantic expert and an HL7 CDA spe79nalyse79activelly involved in the IHE community. He was also
a committed leader for the implementation of the Health Record Systems (HRS) at –he HEGP -
European Hospital Georges Pompidou (one of the most computerized hospital in France).
Alain Périé, , is a Program Manager for semantic interoperability at ANS. Very committed in the
eHealth policies area since 2006, he has participated in several French projects: Iional EHR (DMP), the
secure health emailing system (MSSanté), Cancer Services. He is now member of the medical affairs
department defining guidelines for semantic interoperability at the national level. At the European
level, he has been in charge of managing the epSOS project at ANS. He has participated in several work
packages and took part in the deployment of the national pilots of the epSOS project performed in
several French Universities, in coordination with the ERASMUS program. He was also in charge of the
risk management of the epSOS project and the JAseHN project.
Emmanuel Clout, , is Interoperability Project Manager in the medical affairs department at ANS,
since 2016. Since 2018, he worke79nalyshe french specification of laboratory report according to
Sharing Laboratory Reports Integration Profil (XD-LAB) and the maintenance of LOINC for France.
Before, he was Projet Directo79nalyshe french Electronic HealthIrd, konwn as “DMP”.
Manuel Metz, , is a security and interoperability senior engineer at ANS since 2007, Manuel Metz is
in charge of defining French security and interoperability frameworks for Health Information Systems.
As such, he is co-author of all transport and service layer documents in the Health Information Systems
Interoperability Framework and many documents of the General Security Policy for Health Information
Systems on various topics including non-repudiation, identification and authentication. Actively
involved in the IT Infrastructure domain of IHE since 2007, he has been co-chair of the ITI technical
committee from 2008 to 2010 and is participating to North American and European connectathons
where he is a reference monitor on XD profiles as well as a trainer for new monitors. At the European
level, Manuel Metz contributes to the EURO-CAS project (H2020 program). This project aims at
maintaining and developing the adoption and take-up of testing the interoperability of ICT solutions
against identified eHealth standards and profiles defined in the eHealth European Interoperability
Framework (eEIF).
Relevant publications, products, services, or other achievements (max. 5)
The most relevant national achievements of ANS for this project are :
79
951938 X-eHealth – Part B
French Health Information Systems Interoperability Associated
Frameworkwith document Ref. Ares(2020)2778062 - 28/05/2020
(HIS-IF) including patient
summaries, laboratory results and discharge reports
MOS : “Modèle des Objets de Santé » describing from a functional perspective and use-case
agnostic way how to deal with health data
French Health Terminologies Management Center (HTMC, Centre de Gestion des
Terminologies de santé, CGTS, in French)
National eHealth services : Secure health emailing system (MSSanté) used in the whole
country to securely exchange patient health data between health professionals; Iional EHR,
DMP (Dossier Medical Partagé)
Global security policy (PGSSI): This policy refers to the best health practices in terms of
information systems security. It contains organizational, legal, technical best practices than
can be used by different kind of stakeholders (software vendor, health professionals, patients,
CIO…)
Previous projects or activities related to the project subject (max. 5)
ANS has already been involved in several European eHealth projects, mainly :
epSOS project piloting cross border Patient Summary (country A and country B) and
gaining first experience in deploying operational solutions (real patient data) for cross
border services
JASeHN, as risk manager and active partner especially on work packag–s :
o WP5 - Interoperability & Standardizatio– :
T5.1 - Trusted eHealth National Contact Poin–s,
T5.2 - Electronic Identification for eHeal–h,
T5.4 - Alignment of standardization activities in eHeal–h,
T5.5 - Semantic Interoperabili–y,
T5.6 - CEF operational suppo–t ;
o WP6 - Monitoring & Assessment of Implementatio– :
T6.1 - Implementation of eHealth guideline–,
T6.2 - Legal challIes of EHR systems in the MS in the cross-border context
and recommendations on how to fill the gaps (with special emphasis on the
implementation of the new Data Protection Regulation);
o WP7- Exchange of Knowledg– :
T7.1 - Sharing of national eHealth strategies and action plans,
T7.3 - Research on added value eHealth too–s,
T7.5 - Patient access to electronic health records.
CEF eHealth, as national contact point for eHealth (NCPeH) and also as an active member
of the following working groups :
o Patient Summary Cluster, as co-leader
o Business requirement WG
o Semantic Task Force
o OpenNCP Community Working Groups
o OpenNCP Steering Working Group
o Technical Working Group
o Legal Work Group
eHAction, as risk manager and especially active on work packages :
80
951938 X-eHealth – Part B
o WP1 – Coordination (Risk Manager) Associated with document Ref. Ares(2020)2778062 - 28/05/2020
o WP4 – T4.1 mHealth and health apps reliability
o WP6 – T6.2 Support of legal eHDSI matters
o WP7 – T7.1 Implementing interoperability guidelines to cross-border health services
o WP8 – T8.1 (Co-leader) National and international eHealth strategies
o WP8 – T8.3 Post 2021 scenarios for eHealth policy cooperation
Partner Full Ministry of Solidarity and health
Name
Short –ame MoH - FR Partner 14
No.
Country France Website www.sante.gouv.fr
Type of Public Logo
organisation organisation
Brief Partner Profile
The Ministry of Solidarities and Health is responsible for laws, regulations and national policies within
the fields of health, public health, medical and social care, patient safety & security and social services.
The ministry is coordinating eHealth policies as well as proposing and following -up of the National
Strategy for eHealth through a dedicated permanent structure. This permanent structure is also
coordinating the French eHealth Agency (ANS). The French electronic health patient record DMP
(Dossier Medical Partagé) was created by law then designed and launched by ANS in 2011. In 2016, a
new legal framework had delegated the DMP to the National health insurance fund (CNAM see below)
which will progressively be in charge of running the system. In France, DMP is the vehicle to share
French Patient Summaries (Volet de synthèse médicale). Both ANS and CNAM, under the coordination
of the French Ministry of health have built a solid relationship of confidence that will be a strong asset
in the conduct of national programmes and projects.
Main tasks in Project
WP4 - generic aspects of the EHRxF recommendation
T4.2: Legal aspects & enab–ers
WP5 - definition of EHRxF functional specifications
T6.1: Definition of technical specification for the Laboratory Domain
81
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
T6.5: Publication and maintenance of the services specifications and testing t–ols
WP7 - architecture integration and system specifications
T7.4: Guidance for the new EHRxF domains
Relevant expertise and experience of the institution
The ministry is coordinating eHealth policies as well as proposing and following-up of the National
Strategy for eHealth through a dedicated permanent structure. This permanent structure is also
coordinating the French eHealth Agency (ANS).
MoH-FR was/is involved in many European programmes and projects on Health and eHealth such as
CALLIOPE, ePSOS, SemanticHealth, eHGI, Trillium, JAseHN, ASSESS-CT, ValueHealth, eHAction
as well as in studies, conferences and strategic plans at international level (OECD, WHO, ITU…).
Acting as the French eHealth authority, MoH-FR has coordinated the French participation in all the
projects mentioned above, led the interoperability roadmap in Calliope, led the international
cooperation with WHO and oECD in JAseHN as well as proposed a semantic interoperability roadmap
and under the umbrella of eHAct–on (WP8 - Leader) for the the post 2021 sustainability plan
preparation on the health data exchanges between Member States in the EU.
Key Personnel’s CVs (incl. gender)
Dr Michèle Thonnet, (female) neuropharmacologist, PhD, Michèle Thonnet is also graduate in applied
mathematics and medical informatics, political sciences and public law and from the industrial
strategies institute. She is a health, information systems and security specialist, with more than 30 years
of experience and over 190 publications. Michèle was assistant professor in Paris University, researcher
at INRIA (National research institute in computer sciences and automatic). She used to hold different
positions in the pharmaceutical industry as well as the IT one (international standardization) and works
many years in AP-HP hospitals. In the ministry of health after several years in the IT directorate, she
organised and works six years for the transversal department on information system integration in
policies at IGAS (General inspection of the MoH). Under the umbrella of the general secretariat of the
ministry, she actively participated to the discussions and negotiation for the French government on
several European texts (eIDAS, GDPR,…). She is the official representative of the French ministry of
Health, member of the eHealth Network set up under the art 14 of the DIR 2011/24/EU.
Michèle was/is involved in many European programmes and projects on Health and eHealth such as
CALLIOPE, ePSOS, SemanticHealth, eHGI, Trillium, JAseHN, ASSESS-CT, ValueHealth, eHAction
as well as in studies, conferences and strategic plans at international level (OECD, WHO, ITU…). For
example she has coordinated the French participation in all the projects mentioned above, led the
interoperability roadmap in Calliope, led the international cooperation with WHO and oECD in
JAseHN as well as proposed a semantic interoperability roadmap and under the umbrella of the
eHAction she presently leads the post 2021sustainability plan preparation on the health data exchanges
between Member States in the EU.
Thomas David, (male), is policy officer at DSSIS. He’s in charge of monitoring the work
programme of ANS and improving processes between ANS and its stakeholders. Thomas is a
high ranking public servant specialized in IT technologies. Before joining in the Ministry of
82
951938 X-eHealth – Part B
Health, he was leading a software development team (30+ developers) for the IT team of a
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
French ministry and has as strong experience in complex IT projects. Since his arrival at MoH,
he participated in the CEF project like the Boot Camp in February.
Relevant publications, products, services, or other achievements (max. 5)
Not applicable.
Previous projects or activities related to the project subject (max. 5)
eHealth Action
CALLIOPE
ePSOS
SemanticHealth
JAseHN
Partner Full Name German Institute of Medical Documentation and Information
Short Name DIMDI Partner No. 15
Country Germany Website www.dimdi.de
Type of Public Logo
organisation organisation
Brief Partner Profile
The German Institute of Medical Documentation and Information (DIMDI), an authority
within the German Federal Ministry of Health, provides high-quality information for all areas
of the health system via Internet. It publishes official medical classifications and maintains
medical terminologies, thesauri, nomenclatures and catalogues.
In addition, DIMDI develops and operates database-supported information systems for drugs,
medical devices, clinical studies, health technology assessment (HTA) and health care data.
DIMDI designs and maintains modern software applications for online access to its
information systems and operates its own computer centre.
Main tasks in Project
DIMDI main contribution will be in WP 5 – Definition of EHRxF functional specifications,
T5.6 Refine PS functional specifications to account for eHN Guidelines and rare diseases.
Relevant expertise and experience of the institution
83
951938 X-eHealth – Part B
DIMDI (German Institute of Medical Documentation and Information) publishes official
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
medical classifications and provides additional terminologies and standards for the health care
system on behalf of the German Federal Ministry of Health (BMG).
DIMDI contributed with its expertise on standardisation, coding and semantics in a number of
European eHealth projects.
There is a close collaboration between DIMDI and the World Health Organization on the
maintenance of ICD-10 and ICD-O-3 and for further development of new terminologies in
healthcare (diagnoses, procedures, functioning and disability covering also medical Devices
and active substances) . To institutionalize this collaboration, DIMDI was designated WHO
Collaborating Center for the Family of International Health Classifications. DIMDI is
participating in the work of several committees of the WHO Collaborating Centers since
several years and is active in the Joint Task Force on ICD-11.
DIMDI is in close cooperation with Regenstrief Institute for LOINC and maintains the
LOINC translation into German for Germany.
In Health Telematics and eHealth, in particular, only a consistent use of standards can ensure
interoperability. For that reason, the DIMDI is member of a range of standardisation
committees in an advisory role.
Key Personnel’s CVs (incl. gender)
The DIMDI classification team comprises of medical doctors and pharmacists with expertise
in medical informatics as well as classifications and terminologies, computer scientists
specialized in medicine, health information managers and team assistants. The classification
team is part of the medical information departm84nalyseth approx. 50 employees from all
fields of biosciences. This project can therefore rely on a widespread knowledge if need
arises. In particular the following persons will be involved:
Stefanie Weber, , MD, is the lead of the medical vocabularies unit at DIMDI.. She is head
of the German WHO Collaboration Centre for the Family of International Classifications and
active in several WHO committees. She oversees and coordinates a number of projects in
healthcare in Germany with semantic context, for example on electronic death certification or
on rare diseases. She is involved in European activities as RD Action, RD-Code and Common
Semantic Strategy.
Christine Haas, , studied pharmacy with specialization in drug information. She has a
working experience in hospital pharmacy and regulatory clinical product development. At
DIMDI, she gained experience as Project Manager for development and implementation of
registries and information systems. As a Member of DIN and ISO, she is involved in
standardization activities. On behalf of the German Ministry of Health and the German
Regulatory Agencies she was and is involved in interoperability and standardization projects
in healthcare and advisor in telematics projects. Currently she is also member of the eHDSI
Semantic Task Force.
Relevant publications, products, services, or other achievements (max. 5)
84
951938 X-eHealth – Part B
Marx MM, Dulas, FM, Schumacher, KM: ImprovingAssociated with document Ref. Ares(2020)2778062 - 28/05/2020
the visibility of rare diseases in health
care systems by specific routine coding (Verbesserung der Sichtbarkeit seltener Erkrankungen
in Gesundheitssystemen durch spezifische Routinekodierung).
Federal Health –ulletin - Health –esearch - Health Protection, May 2017.
Dulas FM, Marx MM, Hebestreit H, Himstedt C, Mohnike K, Mücke M, Ripke A, Stieber C,
Tunc S, Weber S: How to improve the codification of RD with ICD-10 and Orphacodes.
ECRD 2018
Faccin P, Mazzucato M, Dulas FM, Marx MM, Weber S, Angin C, KRamdi F, Salamanca E,
Messiaen C, Orly A, Rath A: Orphacodes’ use for the codification of rare diseases: results of
the testing activity carried out within the RD-Action framework. ECRD 2018
Dulas FM, Marx MM, Kirch K, Angin C, Kramdi F, Messiaen C, Salamanca E, Mazzucato
M, Facchin P, Weber s: Recommendation and Guidelines for the Coding with Orphacodes.
GMDS 2018
Dulas FM, Marx MM, Angin C, Choquet R, Facchin P, Weber S: How to make rare diseases
visible in European healthcare systems. ECRD 2016
Previous projects or activities related to the project subject (max. 5)
The following EU-projects include involvement of DIMDI:
epSOS project
RD-action (DIMDI was WP5 lead) (www.rd-action.eu)
RD-Code (ongoing) (www.rd-code.eu)
eHMSEG Semantic Task Force
National projects (relevant for this proposal):
“Coding of rare diseases 1+2” (https://www.dimdi.de/dynamic/en/classifications/icd/alpha-
id/)
Partner Full gematik – Gesellschaft für Telematikanwendungen der
Name Gesundheitskarte mbH
Short Name GEMATIK Partner No. 16
Country Germany Website https://www.gematik.de/
Type of Competence Logo
organisation Center
Brief Partner Profile
gematik was founded in 2005 by the 15 top organizations of the German Health System.
gematik is the non-governmental body responsible for telematic applications of the eHealth
card and the health telematics infrastructure in Germany and acts as the national competence
centre for EHealth. gematik is mandated to introduce, maintain and develop further the
eHealth card and its corresponding telematics infrastructure. This infrastructure is the
platform for various healthcare applications thus connecting all parties within the healthcare
85
951938 X-eHealth – Part B
system and facilitating secure data exchange. The eHealth card forms the key for this data
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
exchange.
gematik issues the specifications based on which the national telematics infrastructure is
implemented and operated.
gematik closely works with the Federal Ministry of Health, the Federal Office for Information
Security (BSI) and the Federal Commissioner for Data Protection and Freedom of
Information (BfDI).
Main tasks in Project
Gematik will be the task leader of T5.1: X-eHealth use cases driven methodology and takes
part in most of the content-related work packages and tasks. Gematik will contribute to the
CSA mainly with its technical, semantical and strategic experience in diverse eHealth areas.
Relevant expertise and experience of the institution
gematik is responsible for the health telematics infrastructure in Germany and is also the
national competence centre for eHealth.
gematik introduces, maintains and develops further the eHealth card and its corresponding
telematics infrastructure.
gematik issues the specifications based on which the national telematics infrastructure is
implemented and operated.
gematik commands all necessary competencies and is the key player in all eHealth activities
under the auspices of the German health system.
gematik was part of the epSOS, EXPaND and JAseHN consortia and is part of HEALTHeID
and eHealthAction consortia.
gematik coordinates the German consortium under CEF eHealth.
Key Personnel’s CVs (incl. gender)
Andreas Grode (Male), Head of Section “Innovation” at gematik, Expert in the working
group “Interoperability”, “Cards” and “Security” and Vice-Chair of section “Medical
Informatics” at DIN, Member of the technical committee of HL7 Germany, former
Rapporteur (Chairman) of the last AdHoc Group “eEHIC” of CA.SS.TM (EU DG EMPL);
former Project Manager in epSOS Technical Project Management. He is chairman of the
EHTEL/ELO-Group and member of the Board of Directors of EHTEL (European Health
Telematik Association).
Beatrice Kluge (Female) holds a master’s degree in medical information technology. At
gematik she works in the section “Innovation” on a number of future applications related to
the electronic health card and the national infrastructure. In that capacity she is frequently
involved with the stakeholders of the German health system and the reconciliation of diverse
interests in the various bodies and project groups of gematik. Within JAseHN she was in
charge of eID, of health professional registries and of Stakeholder Liaison with EC’s eHealth
Stakeholder Group. She is work package and task leader as well as member of the Leadership
and Steering Council of eHealthAction.
86
951938 X-eHealth – Part B
Christof Gessner (Male), Dr. rer. nat. (PhD), graduatedAssociated
in Physics, PhD, post-graduate study
with document Ref. Ares(2020)2778062 - 28/05/2020
in Medical Physics. 20 years professional experience in Medical Informatics and healthcare
IT, including experience as product manager, and as an independent consultant. Working at
gematik since 2012 in the department of Innovation, he is responsible for healthcare IT
standards and standardization in the context of establishing the national healthcare IT
infrastructure in Germany. Currently, he is also chairman of HL7 Germany, the national
Affiliate of Health Level Seven International (HL7). He actively contributes to European
projects, acting as a task leader in eHealthAction, and as a leader of the Architecture Work
Group of the eHMSEG Semantic Task Force.
Anna Wolfe (Female), PhD, in the telecommunications sector Anna worked as a senior
project manager in technical development bringing together the business interests of the two
partners in a German-Japanese Joint Venture or securing product delivery by large
multinational teams across borders. For gematik she joined the epSOS project as a technical
project manager in the ye–rs 2008 - 2012. In 2013 she joined the project management of the
national project facilitating the exchange of medical case records via the German telematics
platform. The project, like any executed by gematik, involves the balancing out of input and
requirements of the numerous affected stakeholders in the German health care sector.
Charly Bunar (Male) holds a Bachelor’s degree in Public Management & Governance and a
Master’s degree in E-Government. He previously worked in the Horizon2020-funded projects
VALUeHEALTH, MD-Paedigree, ASSESS-CT, and for the W“O study "From innovation to
implem–ntation - eHealth in the WHO European Region”. In his current role at gematik, he is
the Product Strategy Manager for thIerman EHR specification ePA being responsible for the
ePA roadmap and related stakeholder engagement activities. Charly is skilled in system
analysis and requirements engineering, as well as policy analysis and governance design.
Dr. Raik Kuhlisch (Male), an ITIL certified expert, former senior scientist and deputy IT
security commissioner of Fraunhofer FOKUS. Currently, Raik holds the position of an IT
architect at gematik where he is actively involved in designing the architecture of the national
Electronic Patient Record in accordance with the German Social Code Book (§ 291a SGB V).
He has many years of experience in Identity Management, Access Management, network
infrastructures and IT security. Raik participated in various national and EC-funded projects
with strong focus on security topics (e.g. Identity and Access Management). He led the
eHealth pilot implementation of the European integrated research project FutureID, which
aims at building a comprehensible, ubiquitously usable, interoperable, and privacy-aware trust
infrastructure for Europe. This implementation comprises enhancements to the epSOS
Extended Security Safeguards realizing end-to-end confidentiality via a password
authenticated key agreement/exchange protocol.
Relevant publications, products, services, or other achievements (max. 5)
gematik establishes and runs telematics systems for the German health system and does not
normally publish scientific papers. However, gematik engages in national, European and
global standardisation in several related organisations and contributes to the related
87
951938 X-eHealth – Part B
publications. Members of staff also contribute to scientific conferences which are reflected in
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
various conference papers.
Previous projects or activities related to the project subject (max. 5)
epSOS was instrumental for conceiving, implementing, and piloting eHealth services which
have now become part of the first wave of CEF implementations. As technical project
managers gematik was involved in all technical work packages and the overall control and
strategic development of the project.
Within EXPAND gematik was the leader of the key work package which devised,
orchestrated and undertook the handover of project results (assets) to CEF and beyond.
Within the Joint Action to support the eHealth Network (JAseHN) gematik engaged in topics
like eID, security, health professional registries and lead the work package dedicated on
stakeholder liaison.
Within CEF eHealth gematik is the coordinator of the German consortium and takes part in
the eHealth Member States Expert Group for Germany.
Within eHealthAction gematik leads the work package dedicated on enhancing the continuity
of care, which among other topics supports the further development of the eHDSI on strategic
and legal level. Gematik is also engaged in topics like patient access, data protection and
national eHealth strategies.
Partner Full Name Technology, Methods, and Infrastructure for Networked Medical
Research
Short Name TMF Partner No. 17
Country Germany Website www.tmf-ev.de
Type of Umbrella non-profit- Logo
organisation organisation
Brief Partner Profile
The TMF (Technology, Methods, and Infrastructure for Networked Medical Research) is the
umbrella non-profit organization for digitalisation of medical research in Germany. Being
settled in the field of enabling interdisciplinary health related research for more than 20 years. It
is the platform for interdisciplinary exchange as well as cross-project and cross-location
cooperation in order to identify and solve the organizational, legal/ethical and technological
problems of modern medical research. Solutions range from expert opinions, generic concepts,
and IT applications to checklists, practical guides, training, and consultation services. The TMF
makes these solutions available to the public free of charge.
Main tasks in Project
Field of action – TMF contribut–on
88
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
WP5 - Definition of EHRxF functional specifications
T5.3: Laboratory request and reports guidelines
WP7 – Architecture integration and System specifications
T7.1: Global architecture for EHRxF Domanins use
T7.3: Needs for upgrade of CEF eHDSI core and generic services
Relevant expertise and experience of the institution
The TMF contributes a valuable network of representatives from medical science, healthcare,
data protection, data science, statistics, industry, and politics, as well as relevant expert
associations. Playing a central role in various health-related flagship research projects (funded
by BMBF and DFG among others) and contributing to strategic national roadmapping actions
for the BMG, the TMF – in collaboration with dedicated network partners – currently
coordinates the national Medical Informatics Initiative (MII) and is therefore experienced in the
coordination of processes for LOINC subset definition, specification of laboratory information
in HL7 FHIR, and in the mapping of local codes to LOINC. Currently, the implementation
process of LOINC within all the university hospitals and in cooperation with responsible
partners of the out-patient health care sector (KBV) has been started.
Key Personnel’s CVs (incl. gender)
Sebastian C. Semler (male) is Executive Director and Head of the office of the TMF in
Berlin, since 2004. He is scientifically advising and steering specific working groups and
TMF-projects which are involved in clinical studies, data protection, pseudonymisation and
electronic archiving. His expert reputation in data standardisation, terminology and
interoperability issues in clinical and basic research settings has earned him important roles in
several management boards of various organisations, e. g. the Administrative Chair of the
German CDISC User Group, or as the Deputy Director of the Technical Terminology
Committee of HL7-Germany. He is founder of the German LOINC User Group and is
cofounder and actively participating in other organisations, such as PROREC-DE and
HealthGrid Association (EU). For the TMF he has been (is) participating and has initiated
several BMBF-funded projects, e. g., MediGRID (2009-2011) and Nationale
Forschungsplattform für Zoonosen (1st funding 2009-2011; 2nd funding period starting in
2012). Importantly, he has worked in a BMBF funded pilot project on networking issues of
heterogeneous biobanks, and in 2009, as co-leader, won a BMBF-funding to establish the
German Biobank-Register with an integrated User-Portal.
Irene Schlünder (female) is a lawyer and expert in EU data protection law and database
governance; she was invIed in EHR4CR (co-author of the IMI Code of Conduct) as well as
BioMedBridges and has recently led WP4 of DO-IT. She is closely collaborating with
89
951938 X-eHealth – Part B
BBMRI-Eric as a member of the Common Service ELSI and belongs to the core drafting
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
group of the BBMRI lead initiative for a “Code of Conduct for health research” under the
GDPR.
Karoline Buckow (female) is an Academic Advisor for Medical Informatics with focus on
Interoperability, she was involved in Coordination of the Interoperability working group of
the Medical Informatics Initiative, Conceptual planning, advice and project management for
research projects, Content-related preparation, conduct, and follow-up of scientific workshops
within the field of Medical Informatics.
Relevant publications, products, services, or other achievements (max. 5)
Semler SC, Wissing F, Heyder R“(2018). "German Medical Informatics Initiative. A National
Approach to Integrating Health Data from Patient Care and Medical ”esearch." Methods of
Information in Medicine, 57(S 01), Georg Thieme Verlag KG Stuttgart.
Kuchinke W, Aerts J, Semler SC, Ohmann C: CDISC standard-based electronic archiving of
clinical trials; in: Methods Inf Med. 48(5) 2009, S. 408 – 413(doi: 10.3414 /
ME9236).
Semler SC, Buckow K (Hrsg) (in print) Big Data im deutschen Gesundheitswesen –
Handlungsempfehlungen. Eine Bewertung aktueller Möglichkeiten und
Herausforderungen, Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin
Bahr A, Schlünder I: Code of practice on secondary use of medical data in European
scientific research Projects. International Data Privacy Law 5(4) (20–5), 279 − 291.
Buckow K, Quade M, Rienhoff O, Nussbeck SY (2014) Changing requirements and resulting
needs for IT-infrastructure for longitudinal research in the neurosciences. Neurosci. Res.
doi:10.1016/j.neures.2014
.08.005
Previous projects or activities related to the project subject (max. 5)
90
951938 X-eHealth – Part B
German Medical Informatics Initiative: (2016-2025) Funded by the German Ministry of
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Research (http://www.medizininformatik-initiative.de/en). TMF leads the CSA and acts as
an overall coordinator, including the working group of patient consent.
DO-IT: CSA of the BD4BO Programme of IMI, TMF acts as WP4 lead: developing harmonized
data protection clauses for a patient Informed Consent Form and aligning it with Ethics
Committees and Data Protection Authorities throughout Europe; coordinating the joint effort of
all BD4BO projects in resolving common legal and ethical issues (Legal Think
Tank).
EHR4CR (IMI_Call_20–9_2_09) - Electronic Health Records for Clinical Research. In this
project, Irene Schlünder co-developed with Anne Bahr from Sanofi the IMI “Code of
Practice on SECONDARY USE of MEDICAL DATA in SCIENTIFIC RESEARCH PROJECTS
Project management on “National Platform for zoonotic infection diseases” (2009-2018),
promoted by the German Federal Ministry of Education and Research
Project management on “Big Data in the Health Care System – guide and recommendations”,
2017-2018, promoted by the German Federal Ministry o
f Health
Partner Full Hellenic Ministry of Health (Greece)
Name
Short Name MoHGR Partner 18
No.
Country Greece Website https://www.moh.gov.gr
Type of Government Logo
organisation organisation/ Ministry
Brief Partner Profile
Hellenic Ministry of Health (Greece). MoHGR has the task of protecting and promoting the
health of the population through the planning and implementation of Public Health policies,
ensuring universal and equal access to the provision of quality and quantitative health care
services by the National Health System, as well as regulating the operation and oversight of
private healthcare providers. It is the Greek National Authority responsible for electronic health
and participates in the proceedings of the eHealth Network.
Main tasks in Project
91
951938 X-eHealth – Part B
MohGR will participate–in: Associated with document Ref. Ares(2020)2778062 - 28/05/2020
WP1 - Project coordina–ion
WP3 - Evalua–ion
WP5 - Definition of EHRxF functional specificat–ons
WP6 - Definition of EHRxF implementable specificat–ons
WP7 - Architecture integration and System specificat–ons
WP8 - EHRxF Communities of Practice: from Proof of Concept to large scale adoption
and Infrastructure for Innovation
Relevant expertise and experience of the institution
MoHGR represents Greece in the eHealth network (eHN), having active membership and
contribution in working groups such as the EHRxF, the eHN Multi-Annual Work Plan (MWP
2018-2021) and the mHealth subgroup. It is also an active member of the eHealth Member
States Expert Group (eHMSEG) and is in close cooperation with the 3rd Health Region
regarding JAsEHN and eHaction joint actions that support eHealth Network.
Currently, MoHGR is involved in several European funded projects, including CEF eHDSI
Cross-Border services deployment (on Cross-Border Patient Summary &
ePrescription/eDispensation), and SRSS Design and implementation of the national ehealth
interoperability framework (NeHIF) in Greece.
It has also a close collaboration with its strategic partner, IDIKA SA, gaining experience with former
ehealth related projects such as epSOS, Antilope, e-Sens, Trillium Bridge and Expand.
Key Personnel’s CVs (incl. gender)
Athanasios KELEPOURIS, , BSc, MHSA, Head of Department of Electronic Health
Services, Ministry of Health. He has been serving in the Ministry of Health since 2002 as a
computer scientist through national competition. Since 2011 he has been officially promoted to
Head of the Department of Informatics and since 2014, Head of the Department of Electronic
Health Services of the Division of e-Governance. His main tasks revolve around promoting
eHealth at nati92nalyse92 european level. He is a graduate of the Department of Applied
Informatics of the University of Macedonia, Thessaloniki, and holds’a Master's Degree in
Health Services Administration from the National School of Public Health. The subject of h’s
master's thesis was the Internet of Things in Health and the development of a relevant national
strategy. Since 2015, he has been appointed a National Representative on the eHealth Network
(alternate) and since 2016 a member of the National e-Health Governance Council.
Asimina BOUMPAKI, , BSc, MHSA, is an eHealth expert at the Electronic Health Services
Department of the Hellenic Ministry of Health whose work focuses on the development of
eHealth policies, the deployment of eHealth infrastructures and services, cross-border
healthcare delivery and the compliance with European Regulations, Directives and guidelines.
She has been a member of the European eHealth Network (eHN) and of the subgroup that
92
951938 X-eHealth – Part B
worked on the Multiannual Work Programme 2018-2021. She holds a Bachelor Degree in
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Electronic Computer Systems Engineering, with an MSc in Data Communications Systems and
a Masters in Health Services Administration. Before joining the Ministry of Health, Asimina
worked for 5 years at the IT Department of Sotiria General Hospital in Athens.
Dr. Christos TJORTJIS, , External Senior Expert to the MoHGR, is a tenured Assist.
Professor, recently elected Assoc. Professor in Knowledge Discovery and Software
Engineering systems at the International Hellenic University, School of Science & Technology.
He is scientifically responsible for the MSc in Data Science, the MSc in ICT systems and the
EMJMDs MSc in Smart Cities and Communities. He holds a Deng (Hons) from Patras,
Computer Eng. & Informatics, a BSc (Hons) from Democritus Law School, Greece, an MPhil
in Computation from UMIST, and a PhD in Informatics from University of Manchester (UoM),
U.K. He was Lecturer at UMIST, Computation, and the Schools of Informatics and Computer
Science, at Manchester UoM, adj. Senior Lecturer at Eng. Informatics & Telecoms, W.
Macedonia, and at Computer Science, Ioannina. His research focuses on Knowledge Discovery
and Data Mining emphasising in health software systems and analytics. He was involved as a
principal investigator or co-investigator in many R&D projects, leading 3. He published over
60 papers in int’l journals and conferences. He received over 780 citations (h-index 15). He
leads the Data Mining and Analytics Research Group, comprising 5 PhD and 5 MSc students.
Dr. Haralampos KARANIKAS, , External Senior Expert to the MoHGR, is a lecturer at
Department of Computer Science and Biomedical Informatics, University of Thessaly and
Senior Researcher at the University of Athens (Medical School), member of the European
Initiative EUnetHTA for Health Technology Assessment. Additional current positions include,
eHealth consultant in Athens Medical Society, member of the team that develops the
prescription protocols integrated in the Greek national electronic prescription system. General
Secretary of the Greek Society of eHealth Services and Education (EEMEPY) and member of
the National Committee for the implementation of protocols and monitoring of pharmaceutical
expenditure, under the authority of the Ministry of Health. Finally, he is Board member of HL7
Hellas, Technical Steering Committee Chair. He is actively involved in Health Information
Management as a focal research area. His research interests include eHealth, Patient Registries,
Medical Prescription Protocols, Electronic Health Records, Ontology construction, data and
text mining, and health big data. He has been involved in many research projects. For two and a
half years, he was special IT advisor of the General Secretary, Ministry of Health, scientific
responsible for the implementation of ESY.net (National health BI system), member of the
Greek DRGs implementation team and member of the Central Committee of the Ministry to
monitor the IT systems of the NHS. Haralampos Karanikas was board member of the Greek
Health Procurement Committee (E.P.Y.), an independent agency with administrative and
financial autonomy, reporting directly to the Minister of Health. E.P.Y. is responsible for
strategic and operational planning of the procurement system in the Health Sector. He was a
member of PARENT (Cross Border Patient Registries Initiatives) Executive Committee.
Haralampos Karanikas holds a PhD in the field of Temporal Text Mining at University of
Manchester on health data management.
93
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Dr. Alexander BERLER, , External Senior Expert to the MoHGR, has an MSc in
Biomedical Engineering and a PhD in Medical Informatics. He was affiliated with the
Electrical Engineering Department, National Technical University of Athens, Greece, as a
Postgraduate Student and Research Associate in the areas of healthcare information systems
interoperability, medical informatics and telemedicine until 1999. He has worked at
Information Society SA, the Greek official governmental information technology project office,
as a project director responsible for the large healthcare informatics projects of the Greek
government until 2006. He is an active member of the openNCP community on the creation of
tools for cross border healthcare across Europe and beyond. Currently he is also acting as the
IHE services director on behalf of IHE Europe, promoting the use of international standards via
the IHE Technical frameworks and Integration profiles. He is a member of several societies,
institutes and organizations (IEEE, ACM, etc), a member of several IHE Europe Committees
and the Chair of HL7 Hellas, the Greek HL7 International Affiliate.
Relevant publications, products, services, or other achievements (max. 5)
1. Alexander BERLER, Anastassios Tagaris and Catherine CHRONAKI, “European
Patient Summary Guideline: Focus on Greece”, pHealth 2016, N. Maglaveras and E.
Gizeli (Eds.), IOS Press, 2016, doi:10.3233/978-1-61499-653-8-1
2. Berler, A., & Apostolakis, I. (2014). Normalizing Cross-Border Healthcare in Europe
via New E-Prescription Paradigms. In C. El Morr (Ed.), Research Perspectives on the
Role of Informatics in Health Policy and Management (pp. 168-208). Hershey, PA:
doi:10.4018/978-1-4666-4321-5.ch011
3. “Electronic Healthcare Record: An implementation proposition for the Greek National
Healthcare System, A. Kouroubali, D. Katehakis, A. Berler, M. Tsiknakis, Technical
Report TR31 Jointly developed by ICS-FORTH and HL7 Hellas, 2012
4. Auffray C, Balling R, Barroso I, Bencze L, Benson M, Bergeron J… Karanikas H, et al.
“Making sense of big data in health research: Towards an EU action plan” Journal
Genome Medicine. 2016; 8:71.
5. P. Koukaras, D. Rousidis, C. Tjortjis, “Forecasting and Prevention mechanisms using Social
Media in Healthcare”, tentatively accepted by Advanced Computational Intelligence Paradigms
in He–lthcare - Springer Book Series, 2019.
Previous projects or activities related to the project subject (max. 5)
B.I. Health
The purpose of the Bi-Health Information and Business Intelligence System (2012 - ) is to
provide the Ministry of Health easy and immediate access to all available and qualitative
information needed for decision-making in the form of indicators and performance
measurement methodologies. This way it contributes in upgrading the operational capacity of
the Ministry of Health as well as the Health Units and Health Regions, helping them develop
94
951938 X-eHealth – Part B
policy and business plans, monitor their implementationAssociated
and thewithdeviations that arise, evaluate
document Ref. Ares(2020)2778062 - 28/05/2020
results and revise accordingly. The system is based on the interconnection, through web
services, of all Greek NHS health information systems by means of an automated raw data
collection mechanism and unified coding structures. Currently the Ministry has the
infrastructure in place to collect a huge amount of aggregated and analytical data, derived from
a total of 1780 fields of Hospital information on a monthly basis.
Νational ePrescription System:
The national ePrescription System was first introduced in 2010 and is the backbone of the
country’s deployed eHealth services with a high level of coverage and penetration that reaches
almost 100%. It incorporates medical act referrals (e-referrals) and a number of prescription
guidelines and therapeutic protocols whilst it offers a wide range of tools such as ruled based
prescription, monitoring of prescriptions’ dispensation and referrals’ validation, patient
medication summary, etc. The national ePrescription System has proven to be a valuable tool,
not only for evidence-based decision making that leads to improved patient safety, but also for
expenditure control and decision making: by enabling the aggregation of the data it collects
(through its BI system) the ePrescription supports the effective deployment of public health
policies aiming to better care provision.
Electronic HealtIecord-EHR for Primary Healthcare:
The Electronic Health Record for Primary Healthcare collects patient health information
generated by multiple encounters in the primary care delivery system and a number of sources
(the national ePrescription System, Health Units Information Systems, etc.) in order to improve
continuity of care and support a patient-centered approach to health services’ delivery. It
generates a complete record that contains demographic data, the patient’s medical history and
family history, lifestyle choices and risk factors, diagnoses, medications, treatments, allergies,
vaccinations, lab and tests results, gynecological history (when applicable), etc. in order to
automate the healthcare professional’s workflow and provide the patients’ with detailed and
comprehensive access to their own medical data (a patient consent system is also incorpoIed).
EHR for Primary Healthcare implementation is based on the use of international standards and
classifications.
Partner Full Name Állami Egészségügyi Ellátó Központ
(Name as registered in the funding-tenders portal:
95
951938 X-eHealth – Part B
ALLAMI EGESZSEGUGYI Associated
ELLATO KOZPONT)
with document Ref. Ares(2020)2778062 - 28/05/2020
Official name in English: National Healthcare Service Center
Short Name AEEK Partner No. 19
Country Hungary Website www.aeek.hu
Type of Public organisation/ Logo
organisation eHealth Agency
Brief Partner Profile
ÁEEK, as an umbrella agency of several authorities and the leading organization for health
provision, represents both the public (GOV) and End Us“r side. "Its tasks range from hospital
planning, care coordination, licensing of medical professionals and management of external
funding to implementation of national strategies and communication with international
research orga”izations" [OECD]. The mission of ÁEEK is to ensure the implementation of the
strategy for the healthcare sector “Healthy Hungary 2014-2020”. In addition, ÁEEK acts on
behalf of the controlled entities in centralized public procurement processes, and/or assists
them preparing and implementing procurement themselves.
ÁEEK owns, operates and controls public 100 hospitals (local, regional and national level)
and provides public procurement activities and methodological support for them, as well as
operates and develops the Electronic Health Cooperation Service Space (EESZT) nation-wide
Health Informatics / eHealth system supporting care coordination between different providers
and offering services to citizens (e.g. ePrescription). ÁEEK coordinates the work of the
professional branches of the advisory body to the health minister to define clear care
protocols and guidelines, as well as to streamline the pathway for patients with complex
needs, both the quality of care and efficiency of care delivery may be improved.
ÁEEK is responsible for national data management and analysis, supports the dissemination
of professional results, manages, and coordinates EU and other international projects related
to the health sector. The personnel of the organisation are highly-qualified experts, with
professional knowledge, who also have skills and competences, and relevant experience in
managing and participating in international projects. The organisation may perform economic
activity on the market e.g.: IT and health professional services.
Main areas of project expertise: We cooperates with all regulating, development and service
provider entities of the health care sector and are in contact with centres of excellence,
medical universities and professional international communities. ÁEEK participates in several
international cooperation programmes, e.g. FP7, LLL and EU Health Programme (joint
actions ”JA” and projects). It plays an active role in the national adaptation of results of
international research and development activities, and is keen to further strengthen
international relations. We are taking part in transnational projects for fostering quadruple
helix cooperation in healthcare innovation as well: HoCare & HELIUM (Interreg Europe) and
HoCare2.0 (Interreg Central).
96
951938 X-eHealth – Part B
Since 2011 ÁEEK has taken part in preparing and monitoring more than 120 ESIF and Swiss
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Contribution Fund (SCF) projects of health sector (exceeding 1 billion EURO total) and as
lead partner implementing 30 ones (exceeding 140 million EURO total). These ESIF projects
aim to execute development in prevention, primary care, outpatient and inpatient services.
Development activities covered methodology, HR, ICT (complex national eHealth system),
infrastructure (building and equipment) and national patient pathway reorganization.
Main tasks in Project
AEEK is interested in participating in:
Contribution:
Task 5.2 EHRxF and its relationship with clinical guidelines
Task 5.3 Laboratory Requests and Reports guideline and functional specifications
Task 5.4 Medical Imaging and Reports guideline and functional specs
Task 5.5 Hospital Discharge Reports guideline and functional specs
Task 6.1 Definition of technical specification for the Laboratory Domain
Task 6.2 Definition of technical specification for the Medical Imaging Domain
Task 6.3 Definition for the technical specifications Hospital Discharge Reports
Task 6.4 Refinement of Patient Summary (PS) technical specifications for supporting rare
diseases
Task 4.2 Legal aspects & enablers
Relevant expertise and experience of the institution
We regularly cooperate with WHO and various Directorates of the European. ÁEEK takes
part in the Joint Action Supporting the eHealth Network (eHAction). eHAction assists to
implement the 3rd Multiannual Work Programme (MWP 2018-2021) of the eHealth Network.
This MWP has a focus on four areas: Empowering People, Innovative use of health data,
Enhancing continuity of care, Overcoming Implementation Challenges. ÁEEK leads work
package 5, Innovative use of health data (WP5). The overall objective of WP5 is to support
the application of good practices in Member States/Countries (MS/C) and provide guidance at
EU level on handling big data in health within the existing EU regulatory framework, on
secondary use of personal health data, and consequently to ease the uptake of innovative
usage of data across the healthcare sector for the benefits of society, individuals and
performance of MS/C health systems. ÁEEK implements a CEF-TC-2015-2 action titled
AEEK implements the “Deployment of Generic Cross Border eHealth Services in Hungary”
project as well, which is financed by CEF Programme. The main objective of the Action is to
prepare, test and deploy the cross-border Patient Summary and ePrescription and operate a
National Contact Point for eHealth (NCPeH) in Hungary, taking into account the already
existing national infrastructure. The NCPeH, endorsed by the eHealth Network, will manag’
Hungary's eHealth services.
97
951938 X-eHealth – Part B
In November 2017 AEEK launched the Electronic Health Cooperation Service Space
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
(EESZT) transforming paper-based or locally working national healthcare system to a
modern, service-focused nation-wide Health Informatics / eHealth system (“Iional EHR
System”) which meets all the latest demands and requirements related to data security,
information technologies and healthcare. This is a nation-wide system with subtasks of (1)
functionally integrated inter-institutional and regional IT systems; (2) electronic patient
summaries; (3) intra-institutional, central services (Patient Privacy /IManagment Service,
ePrescItion, EHR-repository, Scientific Registry Engine, eConsultation, eReferral, etc.); (4)
message (reporting) transfer and content validation engine service; electronic publication of
official registries.
Key Personnel’s CVs (incl. gender)
István CSIZMADIA, MSc in Economics and Health Care Management (male): István
leads international programmes and projects at National Healthcare Service Centre (ÁEEK),
Hungary. He has extensive (29 years’) experience in a) Preparing, planning and managing EU
funded programmes, b) Strategic planning, c) Preparing and submitting applications for EU
grant, d) Implementing and coordinating EU projects, e) Evaluating applications and
monitoring projects, f) Generating and providing support to innovation, cluster, logistic,
transport, energy, environment and health programmes and projects, g) Working with
international organizations e.g. EU COM, EU Council, UN organizations, h) Preparing and
implementing bilateral and multilateral international agreements. Since June 2018 he has been
the Work Package leader of WP5 ‘Innovative use of health data’ in the Joint Action
supporting the eHealth Network (eHAction). Previously he used to be the representative of
Hungary in the Programme Committee of the Third Health Programme 2014-2020 and the
Steering Group on Health Promotion, Disease Prevention and Management of Non-
Communicable Diseases (SGPP), as well as the Head of Subgroup2 for sharing and analysing
experiences, best practices, to build up success factors for the effective use of Structural
Funds for health investments in the Reflection Process On Modern, Responsive And
Sustainable Health Systems (Council conclusions: Towards modern, responsive and
sustainable health systems). He h’s Master's Degree in Health Management, professional
qualification of Health Care Manager (2014) and Economics, professional qualification of
transport and logistics (1989).
Robert LANG, MBA, CFA (male): Senior advisor and consultant at National Healthcare
Service Centre (ÁEEK), Hungary. He has extensive experience a.) in strategic and financial
planning, b.) product and solution development in digital and online services, c.) e-learning
solutions, d.) preparing and submitting applications for EU grants in Healthcare, e.)
implementing EU projects. Robert worked as founder and top level executive at several
market oriented ICT firms and has deep entrepreneurial background with international scope.
Norbert TAKÁCS (male): Business consultant at ÁEEK. Norbert is business analyst and
project manager, experienced senior business analyst and project manager, having extensive
experience both in the public and private sector, banking, telecommunications, health and
educational industries internationally. He has a strong analytical, organizational and structural
98
951938 X-eHealth – Part B
thinking skills, gained through more than 20 years of experience as a programmer, project
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
manager and business analyst.
Dr. Béla MUZSIK MD (male): Béla is Director for Management, Data Analysis and Data
Supply at National Healthcare Service Center (ÁEEK), Hungary. He has extensive 16 years’
experience in a) Primary care, occupational medicine and occupational rehabilitation, b)
Healthcare quality management and audit, c) Patient safety, d) Training and education e)
Providing support to formal and informal care providers, f) Strategic planning, g) Preparing
and submitting applications for EU grant, h) Implementing EU projects and coordinating
work packages, i) System performance assessment.
Gergely HÉJA, M.Sc. in Electrical Engineering and M.Sc. in Biomedical Engineering
(male): Gergely is a senior eHealth expert at the National Healthcare Service Center with
extensive (17 years) experience in medical informatics. He has extensive experience in a)
biomedical terminologies, classification systems and ontologies, b) medical informatics
standards (EN/ISO 13606, HL7 I open EHR, HL7/OMG CTS2), and c) knowledge
representation standards (XML, OWL and SKOS). Gergely has been taking part in the
planning, development and maintenance of components of the Hungarian national health IT
infrastructure including terminology and ePrescription services, and participates in the
implementation of CEF-TC-2015-2 action titled “Deployment of Generic Cross Border
eHealth Services in Hungary”. Previously he took part in the epSOS, eHGI and PARENT
projects.
dr. Zoltán HUSZTI MD (male): Dr Zoltán HUSZTI MD, medical expert working at the
Data Analysis and Data Supply Department at National Healthcare Service Centre (ÁEEK).
He basically graduated as a medical doctor and has 8 years’ experience in a) health
technology assessment, b) health economy and c) drug reimbursement and four years’
experience in clinical drug development. He worked as a reviewer in Work Package 5
EUnetHTA projects, and made scientific presentations at ISPOR on the field of HTA, and
participated on HTA training at Vienna School of Health Outcome Research.
Melinda MÁTYUS (female) is Head of Department for Public Procurement for Healthcare
Institutions at ÁEEK. She has experience in a) co-ordinating and conducting (public)
procurements of public health institutions under the control of ÁEEK, b) preparation of
central public procurement guidelines and regulatory documents and monitoring of
supervisory tasks for healthcare institutions, c) commenting on draft legislation regarding
public procurement, d) mapping, assessing and evaluating (public) procurement needs and
requirements related to the operation and investment of health care institutions under the
control of ÁEEK, e) approval and control of the annual public procurement plan for health
care institutions, f) cooperation with centralized and joint public procurement bodies.
Mr. Ferenc WEIGL (male), MSc in Political Science (studia absolutorium to PhD) is the
project manager of InterReg projects in joint implementation by ÁEEK in consortia with its
international partners. He has had 15 years’ experience in international development and
policy planning including those related international instruments of the EU such as the IDP
and IfS. Since 2012 he has been involved in several international programmes and projects
99
951938 X-eHealth – Part B
elaborated and implemented by ÁEEK, and in that capacity he was in charge of the
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
implementation of the Public Health Initiatives of the Norway Grants in Hungary. Prior to
that he had acquired experience in foreign policy and diplomacy, being accredited to CERN
and NATO Science Committee as Hungary’s representative as well as working for the
diplomatic mission of the EU in Nepal as First Secretary.
Dóra LAMPERT (female), BSc in Economics, BBA, MA in marketing communication
(female) currently leads the communication team of the Hungarian national eHealth platform
(EESZT) at National Healthcare Service Center (ÁEEK), Hungary. She has 16 years’
experience in a) Preparing, planning and managing communication of EU funded
programmes, b) Implementing and coordinating the communication of EU projects in
Hungary, c) Being involved in transport, construction, environment and health programmes
and projects d) Working with international organizations willing to involve a Hungarian
project, e) Preparing and implementing bilateral and multilateral international events and
communication actions. Since 2013 she has been involved in the team developing the
Hungarian national eHealth platform. Her focus from July 2017 is on a powerful
communication towards all stakeholders of National eHealth Infrastructure (EESZT),
meaning more than 100 software developer companies, more than 10 000 Hungarian
healthcare provider institutions and the Hungarian citizens benefitting from the utilization of
the programme.
Éva KÁRPÁTI GRAYNÉ (female) is the communication manager for the Interreg Hocare
and Helium projects at the Department for Operational Planning and Implementation of the
National Healthcare Service Center (ÁEEK), Hungary. Éva, as communication expert, takes
part in the implementation of EFOP-2.2.0-16-2016-00002 project for infrastructural
development of the child and youth psychiatry, addictology care system (accessibility,
prevention, network development). She has extensive 30 years’ experience in corporate
communication, both in external and internal communication, communication campaigns,
CSR & fundraising, public affairs, event management and event planning. She has a solid
background in international coordination and project management of EU funded projects
related to themes of EU affairs, minority issues, education and elderly care gained in various
(NGO, public and business) sectors. She holds a Master’s Degree in English language and
literature and adult education.
Ágnes RÁKÓCZY (female) is programme financial coordinator at ÁEEK. She has
experience in controlling tasks related to projects funded by the European Union and other
international funds (general financial coordination, participation in guideline creation,
communication and contact with foreign consortium leaders, editing analytical accounts,
editing financial reports, editing budget modifications, up to date management of financial
documentation). She was responsible for the financial coordination tasks of the Programme
Operator related to the HU12 Public Health Programme of the Norwegian Financial
Mechanism 2009-2014.
Relevant publications, products, services, or other achievements (max. 5)
100
951938 X-eHealth – Part B
Toolbox for effective structural funds investments in Associated with document Ref. Ares(2020)2778062 - 28/05/2020
health 2014-2020: In 2011 EU Council
initiated a Reflection Process on EU health systems aiming to identify effective ways of investing
in health, so as to pursue modern, responsive and sustainable health systems. This Reflection
Process aimed to identify effective ways of investing in health, so as to pursue modern, responsive
and sustainable health systems, and has been conducted since then under the auspices of th’
Council's Senior Level Working Party on Public Health. One of the five work areas within this
process fo“used on "effective use of Structural Funds for health in”estments". This was discussed
in an informal group of 11 Member States (Bulgaria, Croatia, Czech Republic, Greece, Italy,
Latvia, Lithuania, Poland, Romania, Slovakia and Slovenia) chaired by Hungary, via our
organization. The group was led by ÁEEK (former name: GYEMSZI).
https://ec.europa.eu/eip/ageing/news/new-toolbox-effective-use-structural-funds-health-
investments_en
The Hungarian Health System Scan newsletter deals with the most important changes of
Hungarian healthcare and health policy, including legislation, reforms, and their outcomes. The
newsletter is published whenever important events take place in the Hungarian health system.
(https://www.aeek.hu/hungarian-health-system-scan)
Results and publications of closed projects which were implemented by the participation of
ÁEEK (incl. former names: GYEMSZI/ESKI): PARENT, eHGI, epSOS, EUnetHTA, PaSQ,
HoNCAB
http://www.parent-ror.eu/#/
http://www.ehgi.eu/default.aspx
http://www.epsos.eu
https://www.eunethta.eu/ja3-archive/
http://www.pasq.eu/
http://honcab.eu/
Previous projects or activities related to the project subject (max. 5)
1. JAseHN – Joint Action to support the eHealth Network
3. Health Programme
(2014-2020) JOINT ACTION
(HP-JA-2015)
01/04/2015 – 30/03/2018
In the field of health policy, it is a general intention of the EU members to utilize eHealth
approaches on a national as well as on EU level. In case of eHealth it is a fundamental
requirement that the data generated within the borders of a country should be reachable over the
borders too, in order to support effective healing and well-functioning healthcare.
Additionally, there is a great emphasize (in the EU) on mapping, harmonizing and
systematizing the organizational, technical, legal and semantical aspects of the opportunities in
the field of eHealth.
As the results of the efforts: in 2011 (based on the 2011/24/EU directive) an eHealth Network –
101
951938 X-eHealth – Part B
eHN was realized. The JAseHN project as one of the main body of eHN assigns political
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
recommendations and prepares collaboration tools in the following 4 priority areas:
interoperability and standardization
monitoring and executing evaluation
knowledge transfer
global collaboration and positioning
Role of AEEK: Consortium member
The project’s website: http://jasehn.eu/
2. eHaction
EU for The Third Health Programme
Joint Action
01/06/2018-01/07/2021
A key ambition of MS/C is to better integrate eHealth into their health policy and to better align
eHealth investments with overall health requirements, thus addressing the challenge of
sustainability of health systems. One central aspect is the transferability of health data across
borders of MS/C and therefore the organizational, technical, semantic and legal interoperability
of eHealth implementations across the countries. Another key aspect regards the access to
health information by citizens while maintaining highest privacy and data protections
requirements.
MS/C, but also the European Commission rely and depend on analyses, forward looking
information, strategy advice, frameworks and ultimately guidelines to be on top of the
development.
The eHealth Network is established in order to ensure progress on eHealth and to bridge the
gaps between the governance, strategy and operational levels. The eHN is the co-ordinating and
governing body, while the proposed eHAction is designed to support the Network in all aspects
which are defined in the MWP 2018-2021 and beyond, where appropriate. The eHAction will
continue the work of the current Joint action (JAseHN, Joint Action to support the eHealth
Network) but with an increased focus on citizens, innovation and acceleration of
implementation. The general objective of the eHAction is to act as the main preparatory body
for the eHealth Network which is the main addressee or “customer” of the eHAction. The
eHAction aims to develop strategic recommendations and instruments that could feed in the
political discussions and facilitates cooperation in the four priority areas that are specified in
the eHN MWP 2018-2021 to be adopted by the eHN in November 2017, namely:
A) Empowering people;
B) Innovative use of health data;
102
951938 X-eHealth – Part B
C) Enhancing continuity of care; Associated with document Ref. Ares(2020)2778062 - 28/05/2020
D) Overcoming implementation challenges.
Role of AEEK: Consortium member, WP lea–er, WP5 - Innovative use of health data
The project’s website: http://ehaction.eu/
3. Capacity Development and further improvement (by new functions) of Electronic Health
Cooperation Service Space (EESZT)
(EFOP-1.9.6-–6- 2017 - 00001)
Human Resources Development Operational Programme
24/04/2017-31/03/2020
Capacity Development and further improvement (by new functions) of Electronic Health
Cooperation Service Space (EESZT) (accessibility, mHealth, PHR)
This ongoing ESIF project is a flagship development of AEEK delivering at least 10 new
functions, among others introducing new centralised e-health services like e.g.:
• facilitate implementation of rules of regional care service obligation
• provide support to monitor and follow up passway within healthcare
• developing /improving access to channels of the Electronic Health Cooperation Service
Space
• Personal Health Record (PHR): Developing/ designing new services for Electronic Health
Cooperation Service Space with the aim to provide support for Telemedicine clinics;
• establishing specialized Big Data Registers in public health (immunization, pregnancy
childcare booklet, registry of exposure).
Total project budget ~€65M
Role of AEEK: Consortium leader
The project’s website: http://ehaction.eu/
4. Deployment of Generic Cross Border eHealth Services in Hungary
CEF Programme
CEF-TC-2015-2
The main objective of the Action is to prepare, test and deploy the cross-border Patient
Summary and ePrescription and operate a National Contact Point for eHealth (NCPeH) in
Hungary, taking into account the already existing national infrastructure. The NCPeH, endorsed
by the eHealth Network, will manag’ Hungary's eHealth services.
Role of AEEK: Final beneficiary
103
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Partner Full SEMMELWEIS UNIVERSITY
Name Health Services Management Training Centre
Short Name SU Partner 20
No.
Country Hungary Website http://semmelweis.hu/english/
http://semmelweis.hu/emk/en/
Type of University Logo
organisation
Brief Partner Profile
Introducing HSMTC Health Services Management Training Centr– (HSMTC - EMK) at
Semmelweis University was established 25 years ago with the aim to become a leading health
policy and management education, research and knowledge centre for Hungary and in the
broader region. The Centre has three main profiles: education, research and participation in
organisational and system level development activities. It plays active role both in Hungarian
and in international health policy and management affairs. Our regular staff is around 50
employees, and our expert network contains high level experts from all major domains of
health policy and management. Our host university the Semmelweis University at Budapest is
among the 500 top universities in the world (ranking: 401-500), according to the 2018 World
University Rankings by the Times Higher Education. Our Faculty of Health and Public
Services is the youngest and the most dynamically developing unit of the University. Health
Services Management Training Centre is a founding institute of the Faculty.
Main tasks in Project
WP4 co-lead Generic Aspects of EHRxF recommendati–n
T4.1 - Electronic Identification implementati–n
T4.2 - Legal aspects & enable–s
T4.3 - Cybersecurity
WP7 Architecture integration and System specificati–ns
T7.1 - Global architecture for EHRxF Domanins –se
T7.3 - Needs for upgrade of CEF eHDSI core and generic services
Relevant expertise and experience of the institution
104
951938 X-eHealth – Part B
We regularly cooperate with WHO and various Directorates of the European Commission and
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
also the World Bank. We are the regional Collaborating Centre of WHO in Health Human
Resources Strategy. Formerly we were a Europe and Central Asia partner institute of the World
Bank Institute Flagship training network on Health Reform and Sustainable Financing. In this
capacity, we have trained more than 1000 participants in the region. We are proud of our
international partnerships and cooperations. We have membership in and partnership with
various organisations e.g. EIT HEALTH, European Health Management Association, European
Health Property Network.
Key Personnel’s CVs (incl. gender)
Dr. Miklós Szócska (Male) graduated at the Semmelweis University (SU) of Medicine in
1989. He holds a Master of Public Administration degree from the John F. Kennedy School of
Government at Harvard University (1998), and a Ph.D. from the Semmelweis University in the
field of change management (2003).
His interest in the management of health services and organisations emerged in the late ‘80s-
when he served as a student president elected from the opposition- before the Hungarian regime
change. After his graduation at the SU he and his colleagues initiated the creation of the Health
Services Management Training Centre (HSMTC) which was officially established in 1995.
Between 1995 and 2000 he was serving as the deputy director and in 2000 he was appointed to
be the director of the Centre.
Between 2010-2014 Dr. Szócska served a full electoral term as the Minister of State for Health
of the Hungarian Government. During his term he developed an evidence based consultative
health policy. Besides managing to keep the sustainability of the Hungarian health services
during economic crisis he also introduced a broad range of significant health reforms among
others: the implementation of a radical public health regulatory framework with success and
popular support. This included the full ban of smoking in public places and workplaces, the
safety limitation of trans fat content of food, and the introduction of public health tax on food
and beverages with added sugar and salt. In his four years he also utilized central capacity
planning for the rationalisation and regionalisation of the health care provision system as well
as designed new efficient patient pathways.
Since the end of his term in office he serves again as the Director of HSMTC. His areas of
professional interest cover a range of topics – development of organisations, management of
change and leadership. He and his colleagues had extensive research in health human resources
migration and HR strategy for health. Most recently he focuses on network analysis, big data
solutions and data mining. The latest development of a case-based crisis communication
training is to be launched early next year.
Due to his experience in shaping e-Health strategy on European and national level, he became
responsible for the developments of the Institute of Digital Health Sciences at Semmelweis
University.
105
951938 X-eHealth – Part B
In 2016 Dr. Szócska was nominated by the Hungarian Government for the Director-General
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
position of the WHO.
Dr. Tamás Palicz (Male) returned back to his alma mater as the deputy director of strategy
after 15 years of his graduation at the Health Services Training Centre’s MSc Program.
Currently he is responsible for the implementation of the running projects at the Institute, as
well as is the leader of the Project and Dissemination Team.
Tamás graduated as a medical doctor at the University of Debrecen. In 2001 he received an
executive manager MSc at Semmelweis University and he also gained specialization in public
administration in 2013.
He embraced his first leadership experience in 2003 as the deputy director of the Strategic and
Operational Development Department at the Semmelweis University. From 2005 he served as
the medical director of the Kútvölgyi Clinical Unit (part of Semmelweis University) being
responsible for 4 billion HUF budget and 700 employees. Between 2010-2013 he directed the
Managing Authority of Human Resources Programmes of National Development Agency with
the responsibility of implementing the Social Renewal Operational Programme (budget: 1145
billion HUF) and the Social Infrastructure Operational Programme (budget: 560 billion HUF).
Between 2013 and 2015 he served as the deputy-director of the National Institute of Health
Development and led the implementation of the TÁMOP-612A-14/1-A special project to
complete the introduction of school health promotion.
Tamás Joó (Male) studied Economics and Health Care Policy, Planning and Financing at
Óbuda University and Eötvös Loránt University. Since 2013 he participates in the PhD
programme of the University of Debrecen.
After graduation he joined Pfizer as a market access trainee. Since 2012 he was an economic
analyst in the Ministry of Health. He worked as a project leader at the National Institute of
Quality- and Organisational Development in Health Care and Medicines, Budapest. In 2014 he
became the head of a strategic working group at the National Health Care Service Centre,
Budapest. Between 2013 and 2014 he was the personal assistant of Mr. Miklós Szócska, while
he was a Minister of Health. Since 2014 till present he is a health policy advisor at the
Hungarian National Assembly – Committee on Social Welfare, Budapest. Since that time he is
a policy expert at the Health Services National Training Centre, Semmelweis University.
Dr. László Bencze (Male) has got a background in law, holds an LLM and a postgraduate
degree in EU law. Started with environmental law, later worked in the health and social field as
a lawyer, consultant and diplomat. He joined HSMTC in 2015 as an expert in international
relations and projects.
106
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Márton Kis (Male) joined the team of HSMTC in the fall of 2014 as financial economist. He
is participating in finding of, application for and execution of different national and
international projects. As the member of the Dissemination Knowledge Centre he is
coordinating a number of Hungarian and international projects (JAseHN, EIT Health Innostars,
HTA Joint Action, Chrodis+ JA, IMI2 CSA, Helium, Erasmus+, Ecoquip), and active member
of the eHealth team of HSMTC.
Márton graduated in 1996 as financial economist, and in the last 25 years he has been working
in all ranks of a bank, from a clerk till management positions. Later he enriched his
management skills working on the field of telecommunication, IT, media, trade, sport
management and healthcare, in the management of different multinational and startup
companies, in Hungary and abroad as well. His speciality is innovation management, which is
backed now by a recently acquired MBA degree.
In his free time Márton is the Chairman of the Hungarian Cricket Association, vice-president of
the middle eastern section of the Budapest Chamber of Commerce and Industry, and volunteer
supporter of the Magic Lamp foundation.
Anna Kozák (Female) obtained her degree in Sociology in 2009. She studied health care
policy, planning, financing and health economics at Eötvös Loránt University. She studied
psychology at St. Andrew’s University, UK. She worked at the National Health Care Services
Centre between 2012 and 2015, when she joined Health Services Management Training Centre
as a junior expert.
Anna Fejér-Székely (Female) obtained her degree in Artist Designer (MA) in 2009 at
Moholy- Nagy University of Art and Design, and than as Design Manager in 2010. From 2008
to 2018 she worked as graphic designer and layout editor at local gowerment of Perbál, when
she joined Health Services Management Training Centre as graphic designer.
Kornél Tóth (Male) was graduated as an economist at college in the major of finance with a
specialisation in credit management. He holds a master’s degree in business development, and
completed the programme of postgraduate specialist training in business data analyst at
Corvinus University of Budapest. In his career he dealt with financial management of EU
funding projects, and than he worked for NISZ National Infocommunications Service Company
Limited by Shares, as the head of monitoring department, where he supporte’ the CEO's work.
At present he working as an expert in ehealth development ”rojects."
Antal Bódi (Male) is a Ph.D. student of Doctoral School on Safety and Security Sciences
Óbuda University and he is the Head of ITS Certification Office in the KTI Institute for
Transport Sciences Non-Profit Ltd. in Hungary and he is a cybersecurity expert in the
107
951938 X-eHealth – Part B
Semmelweis University Health Services Management Training Centre. His degrees are MBA
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Infocommunication and Management, MSc Engineer-physicist of Material Science, MSc
Teacher of Mathematics, Physics and Computing Sciences. In his career he has professional
experience in the Hungarian higher education and in the different field of ICT: eGovernment
services, IT architecture design, broadband services, GovCA, IT security and risk management
and IT business modelling. His research topic is the ITS Ecosystem and the related issues of
developing a complex ITS ecosystem that underpins traffic safety and security.
Relevant publications, products, services, or other achievements (max. 5)
Not applicable.
Previous projects or activities related to the project subject (max. 5)
JAseHN – Joint Action to support the eHealth Network
3. Health Programme
(2014-2020) JOINT ACTION
(HP-JA-2015)
01/04/2015 – 30/03/2018
In the field of health policy, it is a general intention of the EU members to utilize eHealth
approaches on a national as well as on EU level. In case of eHealth it is a fundamental
requirement that the data generated within the borders of a country should be reachable over the
borders too, in order to support effective healing and well-functioning healthcare.
Additionally, there is a great emphasize (in the EU) on mapping, harmonizing and
systematizing the organizational, technical, legal and semantical aspects of the opportunities in
the field of eHealth.
As the results of the efforts: in 2011 (based on the 2011/24/EU directive) an eHealth Network –
EHN was realized. The JaseHn project as one of the main body of EHN assigns political
recommendations and prepares collaboration tools in the following 4 priority areas:
interoperability and standardization
monitoring and executing evaluation
knowledge transfer
global collaboration and positioning
Role of HSMTC: Consortium member
The project’s website: http://jasehn.eu/
108
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
eHaction
EU for The Third Health Programme
Joint Action
01/06/2018-01/07/2021
A key ambition of MS/C is to better integrate eHealth into their health policy and to better align
eHealth investments with overall health requirements, thus addressing the challenge of
sustainability of health systems. One central aspect is the transferability of health data across
borders of MS/C and therefore the organizational, technical, semantic and legal interoperability
of eHealth implementations across the countries. Another key aspect regards the access to
health information by citizens while maintaining highest privacy and data protections
requirements.
MS/C, but also the European Commission rely and depend on analyses, forward looking
information, strategy advice, frameworks and ultimately guidelines to be on top of the
development.
The eHealth Network is established in order to ensure progress on eHealth and to bridge the
gaps between the governance, strategy and operational levels. The eHN is the co-ordinating and
governing body, while the proposed eHAction is designed to support the Network in all aspects
which are defined in the MWP 2018-2021 and beyond, where appropriate. The eHAction will
continue the work of the current Joint action (JAseHN, Joint Action to support the eHealth
Network) but with an increased focus on citizens, innovation and acceleration of
implementation. The general objective of the eHAction is to act as the main preparatory body
for the eHealth Network which is the main addressee or “customer” of the eHAction. The
eHAction aims to develop strategic recommendations and instruments that could feed in the
political discussions and facilitates cooperation in the four priority areas that are specified in
the eHN MWP 2018-2021 to be adopted by the eHN in November 2017, namely:
A) Empowering people;
B) Innovative use of health data;
C) Enhancing continuity of care;
D) Overcoming implementation challenges.
IMI 2 DO IT Big Data for Better Outcomes Coordination and Support Action
H2020
109
951938 X-eHealth – Part B
01/02/2017 – 31/01/2019 Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Big Data for Better Outcomes (BD4BO) programme was launched in 2015 within the
framework of the IMI2 programme. BD4BO programme aims to maximise the potential of
large datasets (big data) in order to support and promote patient and outcome focused
healthcare in Europe as well as developing innovative methods for using big dat110nal4BO
willl ensure a platform for bringing together the disease specific projects of IMI2. The
Coordination and Support Action (CSA) will support all of the projects of BD4BO programme
in the following Work Packages:
WP1 Strategy Development
WP2 Knowledge Repository
WP3 Dissemination
WP4 Data Privacy
HSMTC is the WP leader in WP3 and active member of the other WPs too.
Role of HSMTC: Consortium member
The project’s website: http://bd4bo.eu/
To develop organizational efficiency in institutions affected by structural reforms:
Establishing regional cooperation
TÁMOP-6.2.5-B-13/1-2014-0001
01/04/2014 – 30/11/2015
The main aim of the project was to increase the efficiency and the effectiveness of the care
system through the tools of professional organizational management and by taking advantages
of territorial cooperation.
The project rethinks the tools of health organization and develops effective execution functions
meanwhile creates the community health organization model, taking closer the level of decision
making to the level of citizens.
Role of HSMTC: Consortium member
Professional Methodological Development of The Health Care System
EFOP-1.8.0-VEKOP-17-2017-00001
01/06/2017 – 30/09/2020
110
951938 X-eHealth – Part B
The main goals of this project are to improve the overall health status of the community,
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
increase life expectancy at birth, years spent in health, and decrease the burden caused by non-
infectious chronic diseases. The current problems are planned to be addressed by improving the
preventive functions of the healthcare system, the health literacy of the community and
decreasing regional differences.
Current patient safety related improvements aim to create an organisational culture and
approach where the healthcare workers will be able to identify the risks during their activity,
recommend preventive measures, and where it will be possible to discuss mistakes and adverse
events openly with educational purposes. It is also important to involve the institutional
management in improving patient safety.
Specific goals:
to coordinate primary and public healthcare duties by creating a high quality complex
system that combines the disease-focused approach of primary care and the health-
focused approach of public healthcare;
to improve health literacy in childhood and adolescence in order for them to be able to
make conscious lifestyle decisions;
to improve prevention, health awareness and access to public health services and
knowledge;
to develop a tool and health improvement possibility which allows and supports the
prevention, recognition and treatment of mental illnesses;
to improve the level of knowledge of healthcare workers regarding the prevention and
handling of adverse events during healthcare;
to create, implement, control and assess methodologies, good practices, guidelines and
protocols that aim the improvement of patient safety;
to develop and improve evaluation methodologies which will help assessing the level of
patient safety;
to improve health literacy in the community regarding the prevention of adverse events
Partner Full Name Department of Health
Short Name DoH Partner 21
No.
Country Ireland Website Health.gov.ie
Type of Government Logo
organisation organisation/
Ministry
Brief Partner Profile
111
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
The role and function of the Department of Health is to provide strategic leadership for the health
service and to ensure that Government policies for the sector are translated into actions and
implemented effectively. It supports the Minister and Ministers of State in their implementation of
Government policy. Key functions of the Department include the preparation of national health policy
based on identified need, the preparation of legislation, planning and monitoring of financial and
manpower resource and monitoring the performance of the health services.
Main tasks in Project
As participants, the Department of Health will have an active role and make contributions to
activities related –o:
WP5 - Definition of EHRxF functional specifications
T5.2: EHRxF and its relationship with clinical guidelines
T5.3: Laboratory Requests and Reports guideline and functional specifications
T5.4: Medical Imaging and Reports guideline and functional specifications
T5.5: Hospital Discharge Reports guideline and functional specifications
T5.6: Refine PS functional specifications to account for eHN Guidelines and rare dise–ses
WP6 - Definition of EHRxF implementable specifications
T6.1: Definition of technical specification for the Laboratory Domain
T6.2: Definition of technical specification for the Medical Imaging Domain
T6.3: Definition for the technical specifications Hospital Discharge Reports
T6.4: Refinement of Patient Summary (PS) technical specifications for supporting rare dise–
ses
WP7 - Architecture integration and System specifications
T7.1: Global architecture for EHRxF Domains use
T7.4: Needs for upgrade of CEF eHDSI core and generic services
Relevant expertise and experience of the institution
The Department of Health, along with our Health Service Executive (HSE) colleagues, will
contribute its expertise in eHealth policies, strategies, interoperability, and patient-centred
integrated care. The Department and HSE are actively involved with the current CEF–project
- Deployment of Cross Border eHealth Services with a patient centred focus of utmost
importance.
Key Personnel’s CVs (incl. gender)
112
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Eamon Coyne (m) has worked in ICT with the national Health Service Executive in Ireland for over
15 years. Involved in the successful delivery of various regional projects and national projects, now
working on international projects also. A patient centred focus is of paramount importance, with a
vested interest in the delivery of a robust eHealth architecture utilising interoperability standards
enabled through building blocks currently being implementing such as XDS infrastructure,
interoperability specifications, national testing tools and document modelling tools. Current focus as
programme lead is on the Irish delivery of the the EU eHealth Digital Services Infrastructure Open
NCP Cross Border project and the implementing of this eHealth architecture to deliver the Patient
Summary and ePrescription and future Use Cases. Eamon also participates in the eHDSI Semantic Task
Force, Technical Communities and serves as a member with four others from Europe on the Technical
Steering group. He is also active on the EU Common Semantic Strategy and served as an external
advisor to the EUROCAS project. Background includes certificate, diploma and BSc.Hons degree in
Computer Science, Prince2 ”nd TOGAF"
Theresa Barry (f) is working for the Office of the Chief Information Officer (OoCIO) in the Health
Service Executive (HSE). She is the Lead on Terminology services in particular SNOMED CT. She is
the Member Forum representative for Ireland in the SNOMED international group. Her role is to
facilitate local projects to leverage and develop SNOMED for their systems whilst giving input to and
accessing the international body of knowledge. She facilitates input to the international community and
work in Ireland with HIQA and the Department of Health on the SNOMED agenda. She is also the
clinical terminology lead for 2 EU projects, namely the Common Semantic Strategy and the Common
Semantic Taskforce for the National Contact Point, and her background includes being a Registered
General Nurse and Registered Midwife, Higher Diploma in Project Management (PMBoK) and
Masters in Health Informatics, as well as having a Business Qualification with Cork Enterprise Board.
Caitriona Wray (f) has a background in ICT, strategy development and has worked in the health area
for more than 10 years at policy and operational level. She holds a BSc in Computer Science.
Relevant publications, products, services, or other achievements (max. 5)
eHealth Strategy for Ireland (2013)
Knowledge and Information Plan, (HSE, 2015)
Sláintecare Implementation Plan (2018)
Previous projects or activities related to the project subject (max. 5)
Connecting Europe Facility: CEF DSI Call for P–oposals - Deployment of Cross Border
eHealth Services i” Ireland"
Joint Action supporting the eHealth Network: Active participants in WP’s 5, 6 & 7.
eHAction: Co-lead on WP6. Lead on T6.3. Active Participants in WP’s 4, 5, 7 & 8.
Partner Full Agenzia per l’Italia Digitale
Name
Short Name AgID Partner 22
No.
113
951938 X-eHealth – Part B
Country Italy Website http://www.agid.gov.it/
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Type of Public Logo
organisation Administration
Brief Partner Profile
The National Agency for Digital Italy (in short, AgID) is the Government agency responsible
for the implementation of the Italian Digital Agenda. The Agency is the Italian representative
at EU level, in the subjects of its competence. Furthermore, AGID promotes the definition
and development of large strategic projects of research and innovation related to the
implementation of the Italian Digital Agenda and in conformity to the European program
Horizon 2020.
The Agency supports public administrations in their effective adoption and use of ICT,
improving quality of services and reducing costs, with broad competences in e-Government,
information society and technology innovation, including such areas as new generation
networks, security, open standards, e-health, digital literacy, open data, online education,
digital inclusion, and smart communities.
It identifies and promotes the main principles and rules on interoperability, usability,
accessibility, etc. to be carried out by PAs in order to implement and sustain in the long-term
concrete and shared objectives and actions.
It is also in charge of the design and management of IT national strategic projects, such as the
development of the national civil registry, the electronic health record (HER), the electronic
invoicing to Italian PA.
In the health sector, the Italian law confirms AgID the competence of implementing and
evolving the national infrastructure for the interoperability of the national EHRs, in
accordance with the Ministry of Health. In fact, is responsible to design the national
architecturIf the EHR and to define interoperability standards and technical specifications and
is responsible to define the technical structure and the guidelines of the documents a data that
are going to compose the national HER.
https://www.fascicolosanitario.gov.it/
Main tasks in Project
AgID can contribute to analyse, define and improve the general X-eHealth architecture
(Work package 7 “Architecture integration and System specifications”), to define
guidelines of EHRxF domains (work package 6 “Definition of EHRxF implementable
specifications”) and to analyse and to give advice on generic aspects of EHRxF
recommendation (work package 4 “Generic Aspects of EHRxF recommendation”) as
partner.
Relevant expertise and experience of the institution
114
951938 X-eHealth – Part B
AgID represents Italy in the several eHealth Strategy, contributing actively to policy
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
definition and implementation.
The main experience of the institution is provided in:
Publishing guidelines on the Iional EHR;
Defining the national architecture;
Defining standards for the eHealth sector;
Defining technical specifications;
Participating in national working group;
Participating in several eHealth projects.
Key Personnel’s CVs (incl. gender)
Enrica Massella (female) is head of Digital Ecosystems Unit. She is involved as project
manager on several EU projects about the implementation of e-government processes and
digital ecosystems. She is member of several boards about digital transformation for Italian
Digital Agenda in the fields: e-invoicing, e-payments, ANPR (register of the resident
population), documents dematerialization, electronic health records and workflows
management systems.
Ing. Stefano van der Byl (male). Graduated in Management Engineering Senior in 2006 at
the University of Rome “Tor Vergata”; Master degree in ICT, Logistics and Transport at the
University of Salerno. In 2008 he joined the Presidency of the Council of Ministers, where he
worked as Project Manager, implementing and supervising many ICT project, both national
and international, and coordinating e-Government program. He worked for the “Innovation
and Technology Department” on various national and European projects focused on the e-
Government deployment and on the innovation support until 2012. He has been member of
several groups of the European Commission. From 2013 he works for AgID as responsible of
the eHealth sector and for implementing the Electronic Health Record by the national side.
Ing. Chiara Basile (female). Graduated in Biomedical Engineer Senior in 2006 at the
University of Rome “Tor Vergata”; Master degree in “Management of Clinical Engineering”
at the University of Trieste. She joined the San Camillo Forlanini Hospital from 2010, where
she worked as Biomedical Engineer. The main activities in hospital were focused in
Telemedicine, Teleradiology, Management of Electronic Clinical Records, LIS-RIS-PACS
systems. She also involved in Planning and management of technical and administrative
procedures for the testing activities of medical equipment. She is author of over 40
publications (including articles in international journals, national, conference proceedings,
technical reports and contributions in volumes) in the field of e-health and Telemedicine.
From 2017 she works for AgID in the eHealth sector and for implementing the Electronic
Health Record by the national side.
Relevant publications, products, services, or other achievements (max. 5)
National guidelines for implementing the Iional EHR;
Architecture of the National Infrastructure for the Interoperability of Electronic Health
Records;
115
951938 X-eHealth – Part B
Technical specifications for interoperability betweenAssociated with document Ref. Ares(2020)2778062 - 28/05/2020
the regional systems;
Technical specification and procedure to access Iional EHR form a single point.
https://www.fascicolosanitario.gov.it/linee-guida-manuali-documenti-tecnici
Previous projects or activities related to the project subject (max. 5)
Set up the national electronic health record infrastructure;
eSENS;
EpSOS;
Dematerialisation of the electronic prescription;
NCPeH;
Partner Full Name ARI– S.p.A. - Azienda Regionale per l’Innovazione e gli
Acquisti
Short Name ARIA Partner No. 23
Country Italy Website www.ariaspa.it
Type of Private Logo
organisation
Brief Partner Profile
ARI– S.p.A. - Azienda Regionale per l’Innovazione e gli Acquisti is a Company totally
participated by Regione Lombardia within the Regional System (SiReg), created by the
Regional Law 30/2006, modified by the Regional Law 12/2010, in order to contribute to the
implementation of the regional programming objectives. ARIA S.p.A. operates with the
Region according to the Framework Convention and the annual planning, approved by the
Regional Government.
ARIA mission is to innovate services and increase the Regional System’s productivity
through Information Technology. As Regione Lombardia’s IT partner, ARIA designs and
implements ICT Systems for the Regional Government. The company’s main projects are
development and the provision of the eHealth / Electronic Health Record and e-Gov services
within Regione Lombardia.
ARIA operates the Regional Electronic Health Record (SISS: Sistema Informativo Socio
Santario) which gathers the clinical documents of 10 million Lombardy citizens. 95% of the
GPs, all public hospitals and Labs, and most of the private ones are integrated in SISS. The
Lombardy Iional EHR is connected to the Lombardy citizens’ PHR, where trusted clinical
data are stored through qualified Apps or formally published documents. These services will
be extended by including patients’ provided information.
116
951938 X-eHealth – Part B
The Data Warehouse connecteIo the EHR is the Big Data historical source for analytical
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
analysis for Public Health statistics. Artificial Intelligence based predictive tools are in use to
forecast healthcare needs.
Since epSOS LISPA (the previous company name of ARIA) operated the Italian National
Contact Point for eHealth. In CEF eHDSI, where new regions are included, the Italian
NCPeH has been transferred to the Italian Ministry of Economy and Finance. The Ibardy
EHR is connected to the other Iional EHR system through the NationalIntral EHR
Interoperability System (INI). INI is connected to the NCPeH to allow the provision of Cross-
Border eHealth Services.
Main tasks in Project
ARIA will be the WP4 leader Generic Aspects. In addition, ARIA will be Task Leader of
T4.1 Electronic Identification implementation,
ARIA will contribute to WP5 – “Definition of EHRxF functional specifications”, as T5.2
“EHRxF and its relationship with clinical guidelines” leader.
ARIA will be the WP7 Leader – “Architecture integration and System specifications”,
Task T7.1 Leader. and WP9 – “Proof of concept to the adoption of EHRxF by eHealth
service” as Co-leader and T7.1 Leader, to demonstrate the application and generalisation
of the guidelines to Rare Diseases.
ARIA will also contribute to WP3 and WP6.
Relevant expertise and experience of the institution
ARIA will bring the experience and the use of the Lombardy highlyIcured EHR (FSR
Fascicolo Sanitario Elettronico, operated over the Infrastructure “Sistema Informativo Socio
Sanitario” (SISS)) for 10 million citizens, which integrates all GPs, Public and Private
Hospitals and labs. The SISS is connected to theIalian EHR Interoperability System (INI) and
to the Italian NCPeH to interoperate PS and eP as Country of Affiliation and Country of
Service.
Key Personnel’s CVs (incl. gender)
Dr. Marcello Melgara (male) Degree in Electronic Engineer (1980), 36 years’ experience in
ICT based EU projects (18 years in healthcare sector). Previous experience in Telecom Italia
(1979-2001), ATOS Origin (2001-2008). Since 2008 Senior consultant at ARIA. Reviewer of
several EC projects on eHealth and Semantic Interoperability. epSOS skills: WP manager for
Implementation and Testing, semantic interoperability, sustainability, testing and piloting,
system architecture. epSOS responsible for Implementation, testing, Semantic Services and
National Pilot. Italian e-SENS eHealth pilot responsible. Trillium Bridge: WP Specification
leader. EXPAND responsible for epSOS asset maintenance and relation with Institutions.
H2020 PHC 34 eStandards, openMedicine, ASSESS-CT, VALUeHEALTH WP leader and
contributor. He is the appointed Italian member of the eHMSEG – Semantic Task Force and
WP Organisation Leader within that Task Force. He is leading tasks in the CEF eHealth Italy
117
951938 X-eHealth – Part B
Preparation and Implementation. H2020 Trillium II: responsible for Pilot implementation and
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Validation. CEF HEALTHeID: responsible for validation and handing over to CEF eHDSI.
Dr. Livio De Nardi (male) Degree in management Engineer (2008), Executive Course in
Digital Innovation Management (2015), 8 years’ experience in healthcare sector (which 1
year in healthcare EU projects). Since 2015 Program Manager and Demand Manager at ARIA
in the role of International R&D and Prevention Service Manager. Principal eHealth Skills:
Strategy management, Program management, Business Analysis, contracts procurement.
Dr. Alberto Zanini (male), Degree in Electronic Engineering (1997), PMP® certified (2011),
20 years’ experience in ICT with a strong background on security, identity management, e-
payments, e-health, and innovative technologies. Dr. Zanini is a Senior Project Manager in
ARIA since 2003, and also covers the role of independent expert and reviewer for the
European Commission since 2017. He was involved in several EU-funded projects on behalf
of ARIA, like CREDENTIAL (H2020, Grant Agreement no. 653454), with the responsibility
of the lead architect and project manager of the eGovernment pilot, and HEALTHeID (CEF,
Grant Agreement no. 1444644), with the role of interoperability and cross-border identity
expert.
Dr. Francesca Fecchio (female): management engineer (2002), 11-years working experience in
health informatics at regional and national level as Demand Manager at ARIA. She has been
involved in the e-Prescription implementation, in Pharmaceutical process controls management,
Iional EHR system interoperability, clinical documents standardization and regional chronic-
care model implementation.
Dr. Luca Augello: (male): Biomedical engineer (2001), post-graduate master degree in Health
Technology Assessment (2005), 17-years working experience in health informatics both at
hospital, regional, national & international level. Has been Involved in Iional EHR system
development, chronic-care models implementation, clinical documents standardization,
semantic interoperability at national & European level (CEF ehealth DSI), open data & data
governance.
Dr. Francesca Sapio (female) has a Master’s Degree in Natural Science and has attended the
Post-Graduate Course in Remote Sensing and Natural Resources Evaluation starting her
experience in GIS and Remote sensing applied to environmental and natural resource
management in Europe and in developing countries (the final project has been development in
Eritrea). Her educational and training experience has been completed with a Master in
Environmental Management organized by EAME (European Association Environment
Management Education), financed by EU and developed in Athens. She worked at the
European Institute of Research and Development at JRC Ispra Environmental Department
where she carried out technical activities for RSDE companies within European projects funded
by V and VI Framework Programme (ALPMON, AWARE) and other large-scale projects as
LACOAST, Corine land cover, MURBANDY managed in collaboration with national and
European working groups. Since 2008, in GeneGIS GI she acts as a technical manager in the
working groups for activities related to the management of gas transportation network of
leading Italian operator. From 2012 the work in GeneGIS GI has been focused and specialized
118
951938 X-eHealth – Part B
in the proposal preparation and management of researchAssociated
and development projects (at national,
with document Ref. Ares(2020)2778062 - 28/05/2020
European and international level), related to the management of networks, transport and critical
infrastructure based on geospatial information.
Relevant publications, products, services, or other achievements (max. 5)
- M. Melgara: eHealth Interoperability – What is the future? Keynotes at Lisbon eHealth
Summit 2019
- M. Melgara: The Challenges of Managing Healthcare Systems, Lisbon eHealth Summit
2019
- M. Melgara et al: Converging Patient Summaries: finding the common denominator
between the European Patient Summary and the US-based Continuity of Care Document,
European Journal for Biomedical Informatics. Special issue 15th International HL7
Interoperability Conference (IHIC 2015)
- M. Melgara: Are there business opportunities in the transatlantic exchange of electronic
records by providers and patients? 5th EU-US eHealth Marketplace. Boston, MA, 21-22
October 2014
- A. Zanini et al: Secure and Privacy-Friendly Storage and Data Processing in the Cloud,
publication, 2017
Previous projects or activities related to the project subject (max. 5)
- CEF eHDSI Italy: Implement the ePrescription and Patient Summary Cross-Border
services for Euripean Citizens, CEF 2017-2020
- CEF HEALTHeID: connecting eIDAS and eHDSI to authenticate citizens seeking for
eHealth Services while abroad. CEF 2018-2019.
- UNICOM: Up-scaling the global univocal identification of medicines, H2020 SC1-DTH-
09-20–9, 2020 - 2023
- epSOS: Smart Open Services for European –atients - Open eHealth initiative for a
European large scale pilot of patient summary and electronic prescription CIP PSP 2008 –
2014
- CREDENTIAL: Innovative cloud-based services for Digital Identity, secure authentication
and cyber-security, 2015-2017
119
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Partner Full Name MINISTERO DELLA SALUTE
Short Name MIN SAL Partner 24
No.
Country Italy Website http://www.salute.gov.it/portale/home.html
Type of Public Logo
organisation organisation
Brief Partner Profile
The Italian Ministry of Health is the central body of the National Health Services; it is on
charge of health care policies definition, health planning and provision to all citizens across
the country to ensure fundamental levels of assistance, in terms of universal access and high
quality of health services. Within the scope and purpose of protection and integrated
management of health and social services and the protection of constitutional rights to human
dignity and health, the Ministry of Health performs the functions due to the State in the
following subjects: Protection of human health, coordination of the national health system,
veterinary health, protection of health in the workplace and hygiene and food safety.
Furthermore, the Ministry of Health is the Italian representative at EU level, in the subjects of
its competence. The Italian Ministry of Health is the official government authority in Italy for
health and the link with international and European institutions on all health-related topics.
The Ministry of Health guarantees the respect of the national socio-economic planning in
consideration of health protection objectives, identified at international level and in
accordance with funding entities reserved for the National Health System.
It prepares the National Health Plan that outlines the strategic actions of healthcare for Italy
that have to be implemented by regions.
- priority areas of intervention
- Essential levels of healthcare assistance (minimum threshold of health services paid by the
NHS guaranteed to citizens)
- per capita amount of financing secured to the Regions for each year of validity of the plan
- needs and guidelines for staff training
- guidelines for diagnostic-therapeutic pathways
- criteria and indicators for verifying effective levels of assistance compared to what was
expected
The Ministry of Health monitors the use of resources, promotes research and training
Main tasks in Project
120
951938 X-eHealth – Part B
MIN SAL will participate as a partner in the following Associated
WP andwith ta–ks:
document Ref. Ares(2020)2778062 - 28/05/2020
WP1 - Project coordination
T1.4: Mapping national challenges for EHRxF adoption
WP5– Definition of EHRxF functional specifications
T5.3: Laboratory Results guideline and functional specifications
T5.4: Medical Imaging and Reports guideline and functional specs
T5.5: Hospital Discharge Reports guideline and functional specs
WP6 – Definition of EHRxF implementable specifications
T6.1: Laboratory Results technical specifications
T6.2: Medical Imaging and Reports technical specifications
T6.3: Hospital Discharge Reports technical specifications
T6.6 Publication and maintenance of the X-eHealth Implementation Guide (content)
Relevant expertise and experience of the institution
MIN SAL represents Italy in the several eHealth Strategy, contributing actively to policy
definition and implementation. It represents Italy in the eHealth network (eHN), the voluntary
network of national authorities of Member States responsible for eHealth, with a view to
enhance cooperation, knowledge sharing and good practices between member States.
MIN SAL is also engaged in the 3rd Joint Action, the eHAction supporting the eHealth
Network (June 2018 – June 2021) and is involved i– WP 6.1 - Roadmap on future eHDSI use
cases and features and i– WP 8.1 - National eHealth strategies.
MIN SAL is also fully engaged with the OpenNCP Community for development (see
https://openncp.atlassian.net/wiki/display/ncp/OpenNCP+Community+Home). Through the
representative of Regione Lombardia and its affiliated entities LISPA, Italy was among the
founders of the OpenNCP Community, has adopted Open NCP Solution in the framework
121nalyseOS poject (see section “previous projects” for more details).
The Ministry of Health has been financed by the Connecting Europe Facility (CEF) to
implement the Italian National Contact Point for eHealth (NCPeH). The project is aimed to
prepare, test and deploy the cross-border Patient Summary and the ePrescription taking into
account the already existing national infrastructure. Italy intends to implement cross-border
Patient Summary and ePrescription during the third quarter of 2021. The consortium involved
in NCPeH project implementation is composed of the Italian Ministry of Health as
Coordinator, Digital Italy Agency (AgID), Emilia Romagna, Lombardy and Veneto; an
amendment request was recently submitted to introduce the Ministry of Economics and
Finance as new partner.
At national level, MIN SAL is a National eHealth System owner and contribute to design
eHealth regulation and strategy. Indeed, it has identified eHealth as one of the strategic goals
to be reached since 2008. Furthermore, eHealth is one of the areas for the digital growth listed
by the Italian Government in its “ocument "Strategy for digital growth ”014-2020". On 2019,
121
951938 X-eHealth – Part B
MIN SAL has approved The Digital Healthcare Pact that represents the strategic plan aimed
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
to achieve efficiency, transparency and sustainability of the NHS, through digital innovation
in healthcare.
The pact proposes to implement actions aimed at:
- use of new technologies that allow information to be networked and ensure transparency
- collection of performance data in order to guarantee investments
- control and validation of the protocols to be tested and / or inserted into the system in terms
of economy, validity, efficiency and measurability of the effects for the purpose of
replicability
- complete and certified collection of NHS information for
a) the construction of databases with strong governance (addresses, standardization,
interoperability)
b) guarantee a continuous comparison of activity and economic data between the various
actors and levels of the NHS
Since 2008, the Ministry of Health has been implementing many different eHealth initiatives
nation-wide in collaboration with Regions.
MIN SAL create the New Health Information System (NSIS) that is the reference tool for the
quality, efficiency and appropriateness of the National Health Service (SSN), through the
availability of information, which, for completeness, consistency and timeliness, supports the
Regions and the Ministry in the exercise of their duties. NSIS was born, therefore, with the
aim of making available, nationally and regionally, a wealth of data, rules and methodologies
for quality, efficiency, appropriateness and cost measures to support the NHS government,
monitoring and control of health expenditure, shared among the various institutional levels
and centred on the citizen.
The objectives of NSIS objectives are:
• monitoring the health status of the population;
• monitoring the effectiveness / efficiency of the health system;
• monitoring the appropriateness of the provision of benefits in relation to the demand for
health;
• monitoring of health expenditure;
• availability at national level of an integrated system of individual health information;
• facilitating user access to facilities and services through IT tools;
• promotion of the globalization of service ”fferings"
MIN SAL is responsible of the Electronic Health Record in Italy, a set of digital data and
documents, related to health and social aspects of the patient and generated from present and
past clinical events.
122
951938 X-eHealth – Part B
The data collIed in EHR can be used for purposes of care, research and governance.
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Key Personnel’s CVs (incl. gender)
Serena Battilomo (female), Graduated in Statistical and Economic Sciences with 110/110
cum laude, she earned an Executive Master in Public Administration Management at SDA
Bocconi. In March 2019, she was appointed as Director of Office 3 of the Directorate General
for the Digitalization, of the Health Information System and Statistics. In particular, it deals
with the identification of the information needs of the NHS (National Health System) in
conjunction with the other general directorates. The Directorate is in charge of the
coordination of the NHS computerization through the planning, design, development and
management of the systems and information flows. She handles the proposals on the national
e-health strategy and its implementation as well as the integration of technological innovation
in healthcare processes. It provides support to the functions of the control room of the New
Health Information System and coordinates, with MEF and AGID, the implementation
process of the Electronic HealthIcord (EHR) and the digitization of health documentation.
She participate in European projects for e-health, as representative of Italy. Previously, within
the competences of the Office for the health of migrants, she was the Italian focal point of the
Equi-health project coordinated by the International Organization for Migration (IOM). She
collaborates with the Ministry of the Interior as part of initiatives inter-institutional financed
with FAMI funds. She coordinated the work for the drafting of national guidelines for
assistance to refugees who are victims of torture, rape and intentional violence. In July 2013,
she has the role of office manager at the General Directorate of Health Prevention in the
context of the protection’of women's health, developmental age and all vulnerable subjects,
including migrants, disabled, elderly and LGBTI. In 2008, she was awarded the “onor of
"Knight of Merit of the Italian”Republic".
Valeria Proietti (female) Graduated in Physics, she works in the National Healthcare
Information System (SISN) Unit of the Directorate General of Digitization, Health
Information System and Statistic of the Ministry of Health. Work experience: implementation
of e-health solutions; project manager for design and development of healthcare information
systems; expert in exchange data relating patients international mobility, referent for the
establishment of the National Contact Point. Previously she was in charge of planning,
designing, monitoring development and managing the systems of the Ministry of Health and
the Italian Drug Agency for medical devices, human and veterinary drugs. From 1994 to 1999
she works as contractor at the European Space Agency, taking care of the testing and
validatio123nalyse123 european environmental satellites data processing systems. She was a
scholarship holder and scientific consultant for Thales Alenia Space Italia Spa, dealing with
the development of decision support systems for environmental risk management and land
protection.
Sergio Tedeschi (male), graduated in Information Technology Engineering at University of
Naples Federico II, with post-graduation in Information Systems Government at Roma Tre
University. He worked as IT specialist at National Institute of Statistics of Italy (Istat) in an
123
951938 X-eHealth – Part B
environmental project. He has been working at MinistryAssociated
of Health of Italy since 2005, holding
with document Ref. Ares(2020)2778062 - 28/05/2020
positions in the statistics office and in the IT infrastructure office. Recently he had a two-
years job experience at European Commission (DG ESTAT), working on the validation of
social protection and health data. Now he is working in the National Health Information
System office, following several eHealth projects funded by European Commission,
specifically at the Cross Border project of the National Contact Point of ePrescription and
eDispensation at the level of the Connecting Europe Facility.
Relevant publications, products, services, or other achievements (max. 5)
MIN SAL is involved and committed to generate scientific material and to publish it in
dedicated magazines as for example:
Article on Integrated use of healthcare utilization databases: the Italian Legislative
Decree on the interconnection of information flows Epidemiol Prev 2019; 43 (1): 106-108
Several projects with high visibility were developed internally as the New National Health
Information System that manage several flux of dates such as:
Information system for home care monitoring
Information system for emergency assistance monitoring
Information system for Hospices assistance monitoring
Residential and semi-residential assistance
Addictions Information System
Errors in healthcare monitoring
Service network monitoring
Public investment in healthcare observatory
Information System for the monitoring and protection of Mental Health
Se Parto Per Guide
MIN SAL develop an interactive guide, called “Se parto per” that allows all assisted (all those
who are registered and are dependent by the National Health–Service - SSN) and all health
workers to have information on the health care system during their permanence in any
country in the world. In particular they can have information on:
how to get healthcare in any country in the world
who are the healthcare contact
how to request any refunds
To use the guide you will need to answer three questions:
Where are you going? For what reason? What category do you belong to?
All your choices will be guided and you will have the list of all the countries of the world
available; the list of all the possible reasons for the trip and the list of all the types of users
envisaged (worker, student, etc.).
Previous projects or activities related to the project subject (max. 5)
The MIN SAL participate in different projects relative to eHealt–:
124
951938 X-eHealth – Part B
EPSOS - European Patients Smart Open Services (J–ly 2008 - June 2014)
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
The Ministry of Health, through delegation to the Lombardia region, participated in the Smart
Open Services project for European Patients (epSOS).
Scope: a European large-scale pilot testing the cross-border sharing of certain health data: a
summary of ’ patient's most important health data in case of unplanned care (the patient
summary) and the electronic prescription (ePrescription).
At the end of the epSOS, within the eHN, a sub-group has been set up to preserve the
functionality of the developed services and to pursue the implementation of the same large-
scale services within“the CEF "Connecting Europe”Facility"–
PARENT - Cross-Border pAtient REgistries iNiTiative. (J–ly 2008 - June 2014)
Scope: Support member states in developing comparable and coherent patient registries in
fields of identified importance with the aim to rationalize and harmonize the development and
governance of patient registries
Products: Guidelines on Patient Registries (November 2015)–
ProMIS - International Health Brick Program (national project – 2011 onwards)
The Italian Ministry of Health supports the 21 Italian Autonomous Regions in their
internationalization processes connected with the health and social dimensions through
participation in ProMIS.
ProMIS stands for Programma Mattone Internazional– Salute - International Health Brick
Program: the building blocks of the New National Health System are called Mattoni (bricks),
they define the contents and the methodology on which the serv“ces a”e "built".
Since its establishment in 2011, ProMIS has been promoting opportunities of cooperation
among the Italian regions about themes identified as main topics for a common approach;
they are jointly developed and implemented by the central, regional and local administrations.
eHGI – eHealth Governance Initiative, (Feb 2011 – Jan 2014)
Products:
Guidelines on Patient summary (Nov 2013)
Guidelines on ePrescription (Nov 2014)
JAseHN – Joint Action to support the eHealth Network (May 2015; May 2018)
MIN SAL was partner to the JAseHN, ensuring participation in this project; JAseHN has as
objectives to ensure the regular production of instruments and recommendations to be
presented to the eHN.
Products:
Guideline on the electronic exchange of health data under Directive 2011/24/EU (Nov 2016)
125
951938 X-eHealth – Part B
eHDSI governance model (Nov 2016) Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Raccomandation and Paper on implementation of eHDSI (2016-2018)
Partner Full Regione Lombardia
Name
Short Name REGLOMB Partner No. 25
Country Italy Website www.regione.lombardia.it
Type of Public Logo
organisation
Brief Partner Profile
Regione Lombardia General Directorate for Welfare is responsible for healthcare policy
design, implementation and delivery to its 10 million citizens. The General Directorate for
Health holds the regulatory and administrative competencies in the healthcare domain,
including planning and supplying, quality monitoring and control, appropriateness and
efficiency of services. As regional governing authority Lombardy plans its own programming
and strategies in prevention area based on efficacy, effectiveness and sustainability criteria
and multi-stakeholders’approach.
Main tasks in Project
Since epSOS Large Scale Pilot, Regione Lombardia acted as National Contact Point for
eHealth
The Lombardy Department participating to X-eHealth is in charge of managing the policies
and the guidelines Hospitals in Lombardy, and related clinical data exchange. It is also
managing the European Projects for DG Welfare.
In X-eHealth, Regione Lombardia will co-operate in:
WP3 – Evaluation
T3.1: Establish evaluation strategy
T3.2: Evaluation of results for the new services
WP7 – Architecture integration and System specification.
T7.4: Guidance for the new EHRxF domains
and provide support to Istituto Nazionale Tumori (INT), its Linked Third Party.
Relevant expertise and experience of the institution
126
951938 X-eHealth – Part B
Regione Lombardia will bring its experience in defining, governing and managing the
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
healthcare services for the Lombardy citizen, together with the clinical knowledge from the
19 Research Hospitals, also members of the ERN, the Public/Private network of Primary and
Secondary Healthcare Providers. All these entities are connected through the Iional EHR
(SISS: Sistema Informativo Socio-Sanitario), also accessible to citizens, and connected to the
Iional EHR and, through it in future, to the CEF eHealth Digital Service Infrastructure for
Cross-border Services.
ePrescriptions/eDispensations, Hospital Discharge Letters, Laboratory Test Reports,
Encounter Reports, Rare Disease Patient Records and Repository, Continuity of Care Plans
for chronic patients are the most relevant among the clinical documents managed by the
Iional EHR. The Personal Health Record (called Taccuino) is connected to the Iional EHR. A
new September 2019 Regional Law has established the creation of a centralised repository for
Clinical Images and reports, included in the Iional EHR.
Lombardy Region started collecting structured data on healthcare events, resources & costs
(leveraging on Lombardia Informatica (currently ARIA) technological expertise) around year
2000, mainly to support health care system governance & evaluation, within a regional data
ware-house (DWH) ecosystem that has progressively grown up in features offered.
With 10 million inhabitants & about 3,2 million chronic population, progressively ageing and
developing comorbidities, it was earlier recognized that data governance could strongly
support the required changes in chronic care management.
In 2012 it was launched an experimental chronic care model reform targeted at more than
100.000 citizens, that ended in 2017 and was overcome by a new larger implementation
targeted at all chronic conditions (up to 3.2 million people), started in January 2018.
Key Personnel’s CVs (incl. gender)
Dr. Alessandra Piatti (female). Medical Doctor and PhD, specialised in Hygiene and
Prevention Medicine (University of Milan and London School of Hygiene). Manager, Head
of the Unit “Planning and Projects”, under the General Directorate “Welfare”, Regione
Lombardia, with mandate on the definition and assessment Health & Social Support Plans,
the promotion of the creation of Network of Pathologies (chronicity, frailty, rare diseases,
transplant networks), to guarantee homogeneity over the territory and the compliance with
National / International Guidelines in particular for high complexity pathologies, the
management of International projects on Health. She covered several relevant roles in
different Lombardy healthcare institutions (Preventive Medicine, Italian Cancer Registry,
Disaster Management Unit).
Dr. Annalisa Bodina (female). Medical Doctor and PhD, specialised in Hygiene and
Prevention Medicine (University of Milan) and doctor on Public Administration (University
Bocconi), Manager of Network of Pathologies and Rare Diseases, Unit Clinical Research and
Organisation, under the General Directorate “Welfare”, Regione Lombardia. She was
responsible for the ISO 9001-2015 Quality Certification of Lombardy Territorial Healthcare
127
951938 X-eHealth – Part B
Institutions. Responsible for appropriateness KPI monitoring of the Discharge Letters for the
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
DG Welfare.
Relevant publications, products, services, or other achievements (max. 5)
For Lombardy Region:
- L Moja, A Piatti, V Pecoraro, C Ricci, G Virgili, G Salanti, L Germagnoli et al.: Timing
matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A
meta-analysis and meta-regression of over 190,000 patients. PloS one 7 (10), e46175
- Benedetti G, Radice C, Schieppati S, Bodina A, et al. : Telemedicine System for the
management of patient affected by Acute Stroke. Tecnica Ospedaliera, novembre 2017:
44-46.
- Tagliabue L, Banzi R, Bertizzolo L, Bodina A, Piatti A, et al.: Horizon for Public Health
within the Cochrane Collaboration. Ann Ig 2013; 25 (Suppl. 1): 401-410.
- Carlotta Franchi, Ida Fortino, Angela Bortolotti, Luca Merlino, Alessandro Nobili: Rapid
response: How to move to a palliative approach to care for people with multimorbidity. 8
January 2013 – BMJ N.1840
- Gianni M, Terao M, Fortino I, LiCalzi M, Viggiano V, Barbui T, Rambaldi A, Garattini
E.: Stat1 is induced and activated by all-trans retinoic acid in acute promyelocytic
leukemia cells. Blood. 1997 Feb 1;89(3):1001-12.
For Istituto Nazionale Tumori (INT), Linked Third Party of Lombardy Region:
- Casali PG. Rare cancers: from centralized referral to networking. Ann Oncol. 2019 Jul
1;30(7):1037-1038. doi: 10.1093/annonc/mdz146. No abstract available.
- Frezza AM, Trama A, Blay JY, Casali PG. Networking in rare cancers: What was d’ne,
what's next. Eur J Surg Oncol. 2019 Jan;45(1):16-18. doi: 10.1016/j.ejso.2018.03.030.
Epub 2018 Apr 12.
- Pasquali S, Bonvalot S, Tzanis D, Casali PG, Trama A, Gronchi A; RARECARENet
Working Group. Treatment challenges in and outside a network setting: Soft tissue
sarcomas. Eur J Surg Oncol. 2019 Jan;45(1):31-39. doi: 10.1016/j.ejso.2017.09.015. Epub
2017 Sep 19.
- Casali PG, Bruzzi P, Bogaerts J, Blay JY; Rare Cancers Europe (RCE) Consensus
Panel.Rare Cancers Europe (RCE) methodological recommendations for clinical studies in
rare cancers: a European consensus position paper. Ann Oncol. 2015 Feb;26(2):300-6. doi:
10.1093/annonc/mdu459. Epub 2014 Oct 1.
- Casali PG. Rare cancers: work in progress in Europe. Ann Oncol. 2014 Apr;25(4):914.
doi: 10.1093/annonc/mdu033. No abstract available.
Previous projects or activities related to the project subject (max. 5)
128
951938 X-eHealth – Part B
- CEF eHDSI Italy: Implement the ePrescription andAssociated
Patientwith
Summary Cross-Border
document Ref. Ares(2020)2778062 - 28/05/2020
services for Euripean Citizens, CEF 2017-2020
- VALUeHEALTH: Establishing the value and business model for sustainable eHealth
services in Europe, H2020 CSA, 2015-2017
- ALIAS: Alpine Hospitals Networking for Improved Access to Telemedicine Services,
Alpine Space 2009 – 2012
- NATHCARE: Networking Alpine Health for Continuity of Care, Alpine Space 2012 –
2015
- epSOS: Smart Open Services for European –atients - Open eHealth initiative for a
European large scale pilot of patient summary and electronic prescription CIP PSP 2008 –
2014
Partner Full National Health Service of the Republic of Latvia
Name
Short Name NVD Partner 26
No.
Country Latvia Website http://www.vmnvd.gov.lv/en
Type of Public Logo
organisation organisation
Brief Partner Profile
NVD is a subordinate institution of the Ministry of Health. It is a public enterprise created in
2011. Its aim is to implement State policy for availability of health care services,
administrate the State budgetary funds prescribed for health care, implement State policy in the
planning of health care services, ensure rational and the most effective use of State budget,
implement the e-Health program according to the policy decided by the State.
Main tasks in Project
NVD will participate in this CSA project and will share expertise and will work on the
development of deliverables in WP4 in cybersecurity task T4.3, as well as in WP6 working
on laboratory results domain’s technical specification and rare diseases adding to
129
951938 X-eHealth – Part B
patient summary, and in WP8 tasks on deliverables inAssociated
rare disease as well as in tasks 8.4 till
with document Ref. Ares(2020)2778062 - 28/05/2020
8.6.
Relevant expertise and experience of the institution
Being Latvian National authority for cooperation matters in the field of eHealth, NVD
together with the Ministry of Health represents Latvia in the eHealth Network (eHN).
Currently NVD is participating in Electronic Exchange of Social Security Information project
and is planning to apply for Connecting Europe Facility eHealth project (Call CEF-TC-2019-
2) in order to join ePrescription and Patient Summary exchange platform.
Key Personnel’s CVs (incl. gender)
Edg–rs Goba - Deputy Director of National Health Service, responsible for information and
communication technology field, , graduated in Information Technology. He obtained his
Master degree in Riga Technical University. Currently he is responsible for implementation
the e-Health program in the State, participation in international projects in the field of
eHealth, for planning and organization of IT resources in National Health Service. In total, he
possesses 20 years’ experience in the field of IT management in public sector.
Vera Gubernatorova – Project Manager in Information Technology Projects Development
Unit, National Health Service, , graduated in Analytical Economics. Since the beginning of
2019 she is responsible for such areas in eHealth ’s People's Recovery Empowerment
Development Assistance IS, eReferral&eBooking system, eResults (including Hospital
Discharge, Visual Diagnostics, outpatient eResults), system of classifiers (including ORPHA
code classification), as well as exchange process with external systems.
Relevant publications, products, services, or other achievements (max. 5)
NVD has more than 10 years’ experience in implementation of IT solutions in Health
Industry at both local and European level. As organization responsible for eHealth
management in Latvia, NVD has developed and already introduced in production Visual
Diagnostics result and image, as well as Hospital Discharge. Laboratory results are to be
implemented by the end of 2021.
Previous projects or activities related to the project subject (max. 5)
Within EU funding (ERDF) NVD by the end of 2014 has developed eHealth Integration
platform. Based on the platform several major projects have been carried out: for the purpose
of centralized gathering of patients’ data Electronic Health Record was implemented;
furthermore NVD developed Patient Summary for representation of main health information;
the most popular systems introduced by NVD since the beginning of eHealth in Latvia have
been ePrescription IS and system of eSick Leave Certificates.
Partner Full Name Ministry of Health of The Republic of Lithuania
130
951938 X-eHealth – Part B
Short Name SAM Partner No. 27
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Country Lithuania Website http://sam.lrv.lt/en/
Type of Ministry of Logo
organisation Health
Brief Partner Profile
The Ministry of Health of the Republic of Lithuania (Sveikatos apsaugos ministerija – SAM)
is an institution that exercises executive powers, carries out State administration functions
established by the laws and other legal acts in the health care sector, and implements State
policy in the health care sector. Mission of Ministry of Health is to form and implement
health policy that ensures public health, high quality health promotion activities, and rational
use of resources.
Main tasks in Project
SAM will participate in this X-eHealth project and will share expertise in WP4, WP5, WP6
and WP8 at the required extent.
Relevant expertise and experience of the institution
Ministry of Health leads digital health strategy in Lithuania and represents Lithuania various
European and Global eHealth events and networks, for instance European eHealth network
(eHN), the voluntary network of national authorities of Member States responsible for
eHealth, with a view to enhance cooperation, knowledge sharing and good practices between
member States.
Currently, Ministry of Health is involved in CEF project and is planning to test cross border
exchange of ePrescription/eDispensation.
In addition, Ministry of Health is actively involved in the Joint Action of the third Health
Programme (eHAction – Joint Action supporting the eHealth Network).
Key Personnel’s CVs (incl. gender)
Linas Kavolius - , Advisor for eHealth information technology coordination and
implementation in the Ministry of Health of the Republic of Lithuania. Holds a master’s degree
in informatics and a bachelor’s degree in international business from Vilnius university. Linas
has 20-year experience in information technology project analysis, specification, development
and project management. Worked in these areas: state registers and information systems,
insurance, leasing, risk management, customer relationship management, finance.
Lukas Galkus - , Chief Specialist at Electronic Health System and Informational Resources
Division. Lukas has graduated Lithuanian University of Health Sciences in 2018 and holds a
degree of medical doctor. He has experience in other European projects in the public health
field. His current responsibilities include surveillance of central eHealth System (ESPBI IS),
131
951938 X-eHealth – Part B
consulting health care providers on eHealth topics and implementing development plan of
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
eHealth.
Justas Trinkunas - , Information systems project manager in Informatics and Development
Centre at Vilnius University Hospital Santariskiu Klinikos (VULSK). He is responsible for the
development of the Hospital Information Systems. He has more than 10 years’ experience
working with e-health information systems. He participated in Joint action to support the
eHealth network (JAseHN) project in 2015-2019. In 2010 he become Doctor of Science
(Sciences of technology, informatics engineering, Vilnius Gediminas University). He has
experience as a lecturer and researcher in Vilnius Gediminas University from 2006. He wrote
more than 20 scientific papers on information systems development and lectured in universities
in Europe, Africa and Asia.
Simona Cirtautaite-Kaminskiene – ♀ Chief Specialist at Electronic Health System and
Informational Resources Division. Simona has graduated Vilnius University Faculty of Law in
2004 and holds a master ‘s degree in Laws. She has experience as lecturer in Vilnius University
since 2004 and is a member of Science Centre of Labour Law at Vilnius University Faculty of
Law. His current responsibilities include surveillance of central eHealth System (ESPBI IS),
consulting health care providers on eHealth legislative topics and implementing development
plan of eHealth
Relevant publications, products, services, or other achievements (max. 5)
SAM is an active participant in present EC projects (eHAction, engaged in topics as
empowering people, enhancing continuity of care and innovative use of health data);
SAM has more than 10 years’ experience in development and implementation of IT solutions
in healthcare sector. As governor of eHealth system, SAM has implemented an excIge of
EHR, medical images, ePrescriptions, etc.
Successful deployment of Iional EHR platform, comprising of documentaIn and EHR records
(> 1,3 million records monthly);
Successful deployment of ePrescription. A fully deployed system (>95% of all reimbursed
drugs prescriptions, > 99 % HC providers, > 95% of the population);
Successful implementation of patient portal.
Previous projects or activities related to the project subject (max. 5)
Ministry of Health is the main manager of ESPBI IS (central eHealth system) after its launch
in 2015.
The Lithuanian e-health system consists of:
The central IS (ESPBI IS), which contains the storage of electronic medical history, as well as
its sub-systems: e-recipe and Medical Images;
The main IS / registers of the health sector: IS of medical terms (SNOMED CT), Register of
medical licenses of healthcare and pharmaceutical professionals, IS of medicinal products, IS
of institution licensing;
132
951938 X-eHealth – Part B
23 HIS. Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ESPBI IS ensures a unified access to e-health services for both citizens, and healthcare
professionals. The patient health data (history, analyses, diagnoses, recipes, referrals, x-rays,
certificates, etc.) is submitted to said system by the healthcare institutions who participated in
eHealth projects via the e-health portal www.esveikata.lt. PHIs that do not have electronic
systems can also submit data to the central IS via said portal. 150 PHIs took part in the e-
health system’s development programme.
Partner Full Nationaal ICT Instituut in de Zorg
Name
Short Name Nictiz Partner 28
No.
Country Netherlands Website https://www.nictiz.nl/
Type of National Logo
organisation Competence
Centre
Brief Partner Profile
Nictiz (National IT institute for Healthcare) is the national Dutch competence centre for eHealth,
interoperability and standardization. It is an independent, not for profit, organization and has an
intermediary position between healthcare, industry, and government. Nictiz is an adviser for the
Ministry of Health of the Netherlands on national and international affairs, such as the eHealth
Network. Nictiz supports the development of national interoperability standards and profiles. To this
end Nictiz maintains close cooperation with the international Standardization Organizations: IHE, HL7,
SNOMED International, PCH Alliance, CEN/NEN. Nictiz is the National Release Center for
SNOMED CT. Nictiz is a member of EHTEL and participates in the network for European competence
centers (EHTEL/ELO).
Main tasks in Project
WP1: Nictiz will be co-lead for WP1 and task lead for tasks 1.3 and 1.4
WP5: Nictiz will be work package leader for WP5 together with MZCR (Czech Republic). In this WP
Nictiz will be task lead for tasks 5.4 and 5.7.
Relevant expertise and experience of the institution
Nictiz is the national competence centre for eHealth
Nictiz is an independent liaison between healthcare, industry and government
Nictiz works on the development of interoperability standards and profiles
Nictiz is involved in several national programs working on information exchange
Nictiz was part of epSOS, Antilope, JAseHN and is part of eHAction and eHDSI
Nictiz is member of IHE and HL7, SNOMED, PCH Alliance and CEN/NEN
133
951938 X-eHealth – Part B
Key Personnel’s CVs (incl. gender) Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Elise Peters (female) works at Nictiz since 2016 as eHealth adviser international. She did her
masters in business communication & digital media and public information management.
Before Nictiz she did a traineeship in information management and worked at the Erasmus
Medical Centre in Rotterdam. As eHealth adviser at Nictiz she was involved in JAseHN and
currently she is involved in eHDSI (use case PS-B) and eHAction (WP4 lead).
Maayke Klinkenberg (female) has worked since 1981 in informatics in different sectors .
Since 2007 she has worked as an information analyst and IT consultant in several hospitals,
most recently at an Academic Medical Centre (Amsterdam UMC). She has a PDEng in
Clinical Informatics. She joined Nictiz in 2019 as senior advisor and is currently involved in
various international interoperability projects.
Vincent van Pelt (male) is a senior advisor at Nictiz, the Dutch healthcare ICT competence
centre. He is a physician with a drive to improve information exchange and cooperation
between all relevant parties concerning the health issues of citizens. He has worked in many
fields of healthcare ICT and has a broad knowledge of healthcare ICT related topics. He is a
member of IHE Netherlands, IHE international and HL7 Netherlands. He is or has been
involved in a number of European projects, such as Antilope, eStandards and CEN IPS
(International Patient Summary). In the Netherlands, he is one of the architects of a standards-
based set of rules defining the national Personal Health Environment (MedMij). In the context
of an Implementation Guide to interoperability between XDS Affinity Domains he is
currently part of a taskforce that focuses on a multi-country harmonization of national
definitions for an interoperable cross-community exchange of XDS metadata.
Pim Volkert (male) joined Nictiz in 2012 and is the coordinator of the Terminology Centre
and the SNOMED National Release Centre. Pim is also one of the managers of the Clinical
Informatics study at the Technical University Eindhoven. Before that he worked 3 years for
an interIional EHR vendor and 11 years in a hospital. Pim started his career as an Agricultural
Economist and worked for the Netherlands Ministry of Foreign Affairs and the United
Nations World Food Program in several African Countries.
Relevant publications, products, services, or other achievements (max. 5)
Nictiz does not publish scientific papers. However, with the involvement in European and
national standardisation, Nictiz publishes many communication materials and papers. Nictiz
is involved in the national program and the development of the framework MedMij
(https://www.medmij.nl/en/personal-health-environment/). In addition, Nictiz has a national
release center in zibs (health and care information models)
(https://zibs.nl/wiki/HCIM_Mainpage), a Terminology Centre and the SNOMED National
Release Centre. Nictiz was involved in introducing the ReEIF to the eHN
134
951938 X-eHealth – Part B
(https://ec.europa.eu/health/sites/health/files/ehealth/docs/ev_20151123_co03_en.pdf). A
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
program running in the Netherlands currently is Twiin with one of the objective to share
images between health professionals (information on website only in Dutch).
Previous projects or activities related to the project subject (max. 5)
Nictiz is an active participant in present and past EC projects (eHAction, ASSESS CT, eStandards,
JAseHN, Antilope, epSOS and CEN IPS).
Within CEN IPS Nictiz worked on creating the international patient summary.
Within JAseHn and eHAction Nictiz was and is WP leader and engaged in topics as
interoperbality and empowering people
Within eHDSI Nictiz works on use case PS-B; retrieving PS from other EU countries and is
involved in eHMSEG, PS WG and Semantic Task Force
Partner Full NCZI - National Health Information Centre
N–me
Short Name NCZI Partner 29
No.
Country Slovak Website www.nczisk.sk
Republic
Type of Public sector Logo
organisation undertaking
Brief Partner Profile
The mission and the subject of the activities of NCZI in the Slovak Republic is to promote the
use of IT systems in healthcare, to support and ensure the operation of implemented eHealth
solutions, and to ensure a flexible information base for authorized persons. Because of that,
NCZI also supports the introduction of ITC standards into the healthcare arena.
NCZI is a state-funded organization founded by the Ministry of Health of the Slovak Republic.
NCZI performs tasks in the following areas:
- informatization of health services, administration of the National Health Information System
- standardization of health informatics
- health statistics
- administration of National Health Administrative Registries and National Health Registries
135
951938 X-eHealth – Part B
- provision of library and information services in the fieldAssociated
of medical sciences and healthcare
with document Ref. Ares(2020)2778062 - 28/05/2020
services
NCZI collaborates with institutions such as the Statistical Office of the Slovak Republic, the
Healthcare Surveillance Authority, the Public Health Authority of the Slovak Republic, the
State Institute for Drug Control, institutes of the Slovak Academy of Sciences, healthcare
providers, chambers and health professional organisations, health insurance companies and
medical faculties.
At international level, NCZI collaborates with WHO, EOCD, EUROSTAT and EMCDDA.
Main tasks in Project
NCZI will participate in WPs 5 and 6 and in both packages hande t–e topic - Hospital
Discharge Reports.
Relevant expertise and experience of the institution
NCZI has experience in operating national eHealth services.
Since the 1.1.2018 medical documentation exchange in the Slovak Republic occurs on a central level
and the Information System of NCZI is the unique central system for medical documentation storage
and exchange. Since than more than 83 million ePrescriptions and about 27 million medical records
have been saved into the Slovak National eHealth System.
At the same time, as member of the eHMSEG, NCZI follows the implementation, deployment and
operations processes of other Members States which have already undergone this process.
Key Personnel’s CVs (incl. gender)
Pavol Rieger, , Ing., currently in NCZI responsible for International Projects and International
Cooperation. He is a deputy representative of the Slovak Republic in eHN, member of eHMSEG,
member of general assembly of Snomed CT.
In the past, he participated in epSOS project and ANTILOPE project.
Eva Sabajova, , Mag., studied Economics and Linguistics at Comenius University of
Bratislava (Slovakia) and University of Bremen (Germany). Since 2017, she works at NCZI,
where she established Call Centre for the purpose of performing the support for health
professionals regarding eHealth services. Nowadays, she performs analytical functions in the
area of cross-border health data exchange, primary at the semantic level.
She actively collaborates on actual and planned European projects, specifically at the cross-
border health data exchange project of the National Contact Point of ePatient Summary.
Relevant publications, products, services, or other achievements (max. 5)
136
951938 X-eHealth – Part B
- NCZI is a national correspondent for OECD in field of Associated
healthcare since 2001. NCZI contributes
with document Ref. Ares(2020)2778062 - 28/05/2020
annually to upload and update OECD databases according to established methods
- NCZI provides statistical health data to WHO database named HFA – European Health for All
Previous projects or activities related to the project subject (max. 5)
In past, NCZI participated in the epSOS project, piloted cross border Patient Summary
(country A and country B) and ePrescription (country A and country B), and gained experience
in deploying operational solutions (real patient data) for cross border Patient Summary (country
A and country B) and ePrescription (country A and country B). Later on, NCZI took part in the
EXPAND project and contributed to maintain and sustain key cross-border eHealth
Interoperability assets. NCZI also participated in the e-SENS eHealth pilot where technological
assets were refined and upgraded to adopt CEF Building Blocks and elevated to Technology
Readiness–Level 9 - Actual system proven in operational environment.
Partner Full Name SI: Nacionalni inštitut za javno zdravje, NIJZ
EN: National Institute of Public Health, NIPH
Short Name NIJZ Partner No. 30
Country Slovenia Website www.nijz.si
Type of organisation Public institution/ Logo
Publich health, eHealth
Brief Partner Profile
The National Institute of Public Health (NIJZ) is the central Slovenian institution for public
health practice, research and education. Its academic staff work on various tasks covering the
areas of epidemiology of communicable and non-communicable diseases, health promotion,
health protection, health system research and national coordination of preventive
programmes in primary health care Although public health practice is not in the exclusive
domain of a single type of organisation or profession, the majority of important public health
functions and services in Slovenia are provided by NIJZ. Furthermore, NIJZ functions as the
central statistical authority in health sector and is responsible for the governance of the
national eHealth system. The main function of NIJZ is to provide research in the field of
health, protect and increase the level of health of the population by raising the awareness of
population and carrying out other preventive measu’es. NIJZ's activities include national
health statistics and research in the field of public health, health care systems; identification
and control of health threats; designing and providing health promotion programmes and
preparing a scientific background for health-friendly policies, programmes and measures for
disease prevention. As of 2015 NIJZ is appointed for governance of national eHealth services.
Main tasks in Project
137
951938 X-eHealth – Part B
NIJZ will be a contributing participant in the work packages/ta–ks:
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
WP4 - Generic Aspects of EHRxF recommendation
T4.1: Electronic Identification implementation
T 4.2. Legal aspects & enable–s;
WP 5 - Definition of EHRxF functional specifications
T5.3 Laboratory Requests and Reports guideline and functional specification–;
WP 7 - Architecture integration and System specifications
T7.1 Global architecture for EHRxF Domains us;
Relevant expertise and experience of the institution
NIJZ is engaged in numerous activities covering the areas of epidemiology, health promotion,
statistics, and national coordination of preventive health programmes.
In accordance with Healthcare Databases Act, NIJZ is controller of various healthcare
databases and is an authority for terminologies, coding standards and classifications in the
Slovenian healthcare sector. Furthermore, NIJZ is lawfully authorised entity for national
eHealth governance, responsible for design, development, implementation, deployment and
maintenance of eHealth services. Slovenia has a mature and widely deployed eHealth system,
providing valuable services such as ePrescription, eAppointment, eReferral, Central Registry
of Patients Data (Iional EHR platform) and Patient Portal.
NIJZ has successfully coordinated and participated in many international collaborative
projects. Being competent on all aspects of the public health, NIJZ presents a capable partner
in any health-related projects.
Key Personnel’s CVs (incl. gender)
The following persons are envisaged for carrying out the proposed activities:
Dalibor Stanimirović, PhD, is a researcher and Head of Centre for health care informatics at
the National Institute of Public Health of the Republic of Slovenia (NIJZ). He is an Assistant
Professor of informatics at the University of Ljubljana. His research work has been published
in high-ranked scientific journals and presented at leading conferences and seminars. His
general research interests include ICT policies and projects in health care, evaluation metrics
and models, government enterprise architectures, and health information systems. In the last
years, he has been actively involved in several research projects: Development of Pan-
European information society services in Slovenia (EuPAN), Development of an integrated
model of indicators for monitoring and evaluation of e-government policies (KRONOS),
Deploying sustainable cross-border eHealth services in the EU (EXPAND), e-Certification of
Causes of Deaths (e-DC), Analysis and development in the field of rare diseases in Slovenia,
Cro–dHEALTH - Collective wisdom driving public health policies, etc.
Vedrana Matetić is an IT professional with extensive experience in analysis, development
and management of various IT projects. She is currently a member of eHealth team at Centre
138
951938 X-eHealth – Part B
for health care informatics at the National Institute of Public Health of the Republic of
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Slovenia (NIJZ), where she is in charge of the national ePrescription solution. She has been
actively involved in several research and development projects, including EU funded
Assistance for the blind and visually impaired (ALICE), Humane technology for enhanced
user experience (Emphatic Products), etc.
Nina Zenkovič, graduated in Computer and Information Science from the University of
Ljubljana. She has worked as a member of Centre for Healthcare Informatics at the National
Institute of Public Health of the Republic of Slovenia (NIJZ) since 2017 and joined their
eHealth team in 2018. She has been involved in the eAppointment segment of the national
eHealth platform, as well as research and development projects regarding telehealth. The
focus of her previous work experience was complex data analysis in the field of spatial
informatics.
Alen Vrečko, MSc, is currently employed as a health care informatician and researcher at the
National Institute of Public Health of the Republic of Slovenia (NIJZ). In 2014-2015, he was
actively involved in EU funded cross-border projects PARENT (Cross-border patient
registries initiative) and EXPAND (Expanding health data interoperability services). His past
research interests include cognitive systems, robotics, computer vision and artificial
intelligence. As a member of the Visual Cognitive Systems Laboratory at the University of
Ljubljana, he participated in EU FP6 and FP7 proje–ts Cosy - Cognitive systems for cognitive
assistants (2007-2008) –nd CogX - Cognitive systems that Self-Understand and Self-Extend
(2008-2012). He authored and contributed to several scientific publications from the fields of
artificial intelligence, cognitive systems and ”obotics."
Lucija Tepej Jočić, graduated in physics at the University of Mathematics and Physics in
Ljubljana. She is a member of Centre for healthcare informatics team at the National Institute
of Public Health of the Republic of Slovenia (NIJZ). She is currently working as business
analyst and project coordinator in the field of national eHealth solutions. She is actively
involved in different activities on many viewpoints of the Electronic Health Record in
Slovenia. Her previous work experience includes management of complex ICT projects in the
field of telecommunication.
Relevant publications, products, services, or other achievements (max. 5)
Publications:
Stanimirović, Dalibor, Murko, Eva, Battelino, Tadej, Grošelj, Urh. Development of a pilot rare
disease registry : a focus group study of initial steps towards the establishment of a rare disease
ecosystem in Slovenia. Orphanet journal of rare diseases, ISSN 1750-1172, 9 Jul. 2019, vol. 14,
no. 172, str. 1-13, ilustr. https://ojrd.biomedcentral.com/track/pdf/10.1186/s13023-019-1146-x,
doi: 10.1186/s13023-019-1146-x.
Beštek, Mate, Stanimirović, Dalibor. Special topic interoperabiIy and EHR : combining
openEHR, SNOMED, IHE, and continua as approaches to interoperability on national eHealth.
Applied clinical informatics, 2017, vol. 8, iss. 3, ilustr.
https://aci.schattauer.de/en/contents/archive/issue/2503/issue/special/manuscript/27811/show.html
, doi: 10.4338/ACI-2017-01-RA-0011.
139
951938 X-eHealth – Part B
Other achievements: Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Successful deployment of Cental Registry of Patients Data – Iional EHR platform, including
OpenEHR based Patient summary Records. > 2,5 mio records monthly, > 90 % of the population
has a record;
Successful deployment of ePrescription. A fully deployed system;
Successful implementation of patient portal accessing Iional EHR
Previous projects or activities related to the project subject (max. 5)
NIJZ has taken on the role of lead partner in PARENT – Cross-border Patients’ Registries
Initiative.
NIJZ participated in epSOS project, implementing Patient Summary and piloting its cross border
exchange (country A and country B).
NIJZ has recently implemented “Slovenian eIDAS Node and Integrated –ervices ” SI-PASS",
action number 2017-SI-IA-0037
NIJZ is an active partner in eHAction project, participating in WP4, WP5, WP6, WP7 and WP8.
Partner Full Name FUNDACIÓ TICSALUT
Short Name FTSS Partner No. 31
Country Spain Website www.ticsalutsocial.cat
Type of Public Logo
organisation organisation
Brief Partner Profile
Fundació TIC Salut Social is a public agency within the Catalan Ministry of Health founded
in 2006 whose aim is to facilitate and promote the development and transformation of health
and social care models fostering innovation in the use of ICT. The agency acts as an
observatory for trends, innovations and emerging initiatives in the health and social care and
provides services for the standardization and accreditation of products.
FTSS’s strategy is focused on e-Health and m-Health to improve healthcare processes, in
order to ensure conformity with current standards to guarantee interoperability and
standardization in IT systems. The Foundation has also the role of “Observatory for e-Health”
for the Catalan region, exploring and disseminating e-Health-related projects and use of ICT
in the health and social care sectors at both national and international level. TIC Salut Social
team has international expertise in semantics and syntactic medical information standards.
Thus, the Foundation is involved in several national, European and international initiatives
that define standards that ensure interoperability and that allow integration with the existing
IT systems.
140
951938 X-eHealth – Part B
The TIC Salut Social’s Foundation’s Standards and Interoperability Office works on behalf of
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
the Catalan Ministry of Health and the Ministry of Work, Social Affairs and Families to
identify and define interoperability standards between information systems. Interoperability is
the capacity of components, such as systems and devices, to exchange information coherently,
without altering its meaning. It has different layers or dimensions: technical, syntactic, legal,
and organizational. The Standards and Interoperability Office analyses SISCAT’s needs. It
identifies and changes the various standards as a result; it also helps to the implementation of
standards in the social sector, managing pioneering projects at the international level. The
Standards and Interoperability Office also heads integrations and standardization in the
mHealth and mSocial fields, defining controlled vocabularies and communication interfaces.
The goal of interoperability is to ensure that all relevant, necessary information is made
available for decision making.
Main tasks in Project
FTSS will bring in expertise in the area of interoperability frameworks definition and
implementation and the public health system in Catalonia region. As a participant of EPSOS
project and CEF Telecom project coordinator for Catalonia, FTSS will also ensure that all
future planning and activities foreseen in the project are in line with the current CEF wave
implementation plan. Besides, FTSS will bring its expertise in Laboratories (LOINC),
medical imaging (DICOM) and FHIR.
FTSS will take part in the following WP/Tasks:
WP1 – Task 1.4
WP5 – Task 5.1, 5.3, 5.4, 5.5 and 5.6: As the entity in charge of ensure the interoperability
in the Public Health System in Catalonia, FTSS will provide its expertise in system definition
and architecture: TIC Salut Social team has international expertise in semantics and syntactic
medical information standards like HL7, DICOM, LOINC, IHE, FHIR and cross-border
exchange of health Data (patient summary and ePrescription).
WP6 – Task 6.1, 6.2, 6.3, 6.4 and 6.6. FTSS will provide its expertise in Lab (LOINC) ,
medical imaging (DICOM), Patient Summary and ePrescription.
WP7 – Tasks 7.1, 7.2 and 7.3. As CEF Catalonia project coordinator, FTSS will contribute
in the whole integration strategy definition.
Relevant expertise and experience of the institution
Promotion in the use of ICT standards in the healthcare sector, as the key element to ensure a
coherent exchange of information at an international level.
Definition and implementation of the interoperability framework for the public health system
of the Catalonian Government.
TIC Salut Social acts as an observatory for trends innovations and emerging initiatives in the
health and social care and provides services for the standardization and accreditation of
products.
141
951938 X-eHealth – Part B
Key Personnel’s CVs (incl. gender) Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Josuè Sallent Ribes (M), PhD, is the director of Fundació TIC Salut Social (FTSS). He studied
Physics at the University of Barcelona and studied Business at the UOC in Barcelona. Josuè
has a strong background in development and strategic implementation of technological
solutions such as IoT, 5G in the context of Smart Cities and Industry. Before becoming director
of FTSS, he was strategic director of the Centre for Telecommunications and Technology
(CTTI) that delivers all digital services for the Catalan central government. He has also been
the CEO of the Societat de la Informacio at the Generalitat and Director at the Fundació
Observatori per a la Societat de la informacio de Catalunya (FOBSIC). As a director his main
focus is to boost the ICT innovation and its adoption in the Health and social services providers
Ariadna Rius (F) is the Manager of the Office of Standards and Interoperability (OFSTI) at
Fundació TIC Salut Social. She holds a degree in Computing Engineering, a master’s degree in
Computing Engineering and is currently doing a master in Advanced Artificial Intelligence.
She worked as a web developer in insurances and marketing sectors. Since 2010, she has been
working on semantic interoperability and standards issues. She is specialized in the clinical
terminology SNOMED CT and in the definition of terminology services. Ariadna participates
in the managing and the execution of the “Clinical Dictionary for e-Health”, and also provides
support to healthcare providers, private companies and public agencies, as well as in different
European projects and national initiatives.
David Rodríguez (M) is Project manager at the Office of Standards and Interoperability
(OFSTI) of Fundació TIC Salut Social. He holds a degree in a Technical Engineering in
Computer Management. He has advanced knowledge of medical information standards like
DICOM, HL7 FHIR, HL7 messaging (V2.7 certified in 2013) and HL7 CDA R2 (certified in
2011), as well as IHE interoperability frameworks and Continua guidelines. He works since
2010 in integration projects to facilitate interoperability between information systems,
applications and medical devices, applying medical standards using integration engines like
Mirth Connect as well as teaching training courses (DICOM, HL7, IHE, etc) in the field of
ICT health.
Juan Antonio De los Cobos (M) is a technical computer engineer and graduated computer
engineering at UOC. Juan Antonio has more than 20 years of experience working as a program
analyst of clinical data in healthcare research projects. He worked as a functional consultant in
the Health information system obtaining functional requirements, test data and system
validation. Later on he worked to optimize service delivery processes in insurance and
healthcare companies. Currently Juan Antonio is coordinating technical tasks using different
interoperability standards like FHIR or HL7 or terminologies like SNOMED related to analysis
and design of standards and terminology in projects such as the European Patient summary
sharing and interregional Databases. He is currently an associate teacher at the faculty of social
sciences and wellbeing at the UVIC for e-health.
142
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Joan Solans Puig (M) is a technical computer engineer at Tecnocampus (UPF). He is working
on different projects using different interoperability standards like FHIR or HL7 or
terminologies like SNOMED. He has developed a mobile application for a project called IPS
(International Patient Summary). This app has been tested in a real simulation exercise of a
tsunami (EUMODEX) in Estonia. Joan is providing support to others healthcare projects to
facilitate interoperability between information systems.
Relevant publications, products, services, or other achievements (max. 5)
Digital Medical Image Observatory. FTSS, in collaboration with the Ministry of Health in
Catalonia, created the Digital Medical Image Observatory; a new body that aims to become a
search space and a meeting point in the sector to share knowledge and experiences, and at the
same time, developed a 143nalyseo analyze the viability of the innovative services proposed
to be incorporated into the SIMDCAT project.
Clinical Dictionary for iHealth – Ministry of Health (Generalitat de Catalunya): This
project aims to standardize the controlled vocabulary used in the Catalan Health System to
exchange information between IT systems. It includes different vocabularies like LOINC,
ICD-10, ATC, ICPC-2, etc. but uses SNOMED CT as reference terminology and ontology of
representation. This project includes the management of the Catalan Extension of SNOMED
CT that was created in 2011 by the OFSTI. In the project we also use a standard methodology
developed by the OFSTI to create refsets of SNOMED CT.
Publication of laboratory results in HC3. The Health Shared Folder in Catalonia (HC3) is
the Electronic Health record model that allows all public healthcare centers to share millions
of clinical documents to facilitate the work of healthcare professionals and improve care for
citizens. FTSS has given and is currently supporting the definition and standardization of
various types of documents currently available in the HER, as for example, the laboratory
results.
Relevant publications:
1. Sanz, X. et al. Definition of a SNOMED CT pathology subset and microglossary, based on
1.17 million biological samples from the Catalan Pathology Registry. J. Biomed. Inform. 78,
167-176 (2018)
2. Lamine, E. et al. An inventory of interoperability in healthcare ecosystems: Characterization
and challenges in Enterprise Interoperability: INTEROP-PGSO Vision 167-198 (2017).
Previous projects or activities related to the project subject (max. 5)
TRILLIUM BRIDGE II, H2020, 2 years, https://trillium2.eu/: International patient
summary (IPS) standards consistently adapted and localized to serve the needs of specific use
cases are essential to attaining of vision of the patient summary as a social good and human
right. The Trillium Bridge project (2013-2015) compared patient summary standards and
specification in Europe and the United States and demonstrated the technical feasibility of
143
951938 X-eHealth – Part B
exchanging electronic health record summaries across the Atlantic in the context of
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
emergency or unplanned care abroad. Reflecting on its results, the Trillium Bridge
consortium reached a broadly endorsed recommendation: “Advance an International Patient
Summary standard to enable people to access and share their health information for
emergency or unplanned care anywhere and as needed starting with immunizations, allergies,
medications, clinical problems, past operations and implants.”
Trillium II builds on the recommendations of Trillium Bridge and places IPS standards at the
core of a global community for digital health innovation with the aim to advance patient
safety & trust by bridging the gap between strategic intent and capability to deliver
interoperability at a global scale.
IS3 WiFIS – Ministry of Health (Generalitat de Catalunya): IS3 WiFIS is the project to
coordinate and integrate different assistance levels like primary care and specialized care. It
covers the workflows for referrals, appointments, laboratory, notifications and patient data
queries. In the project, HL7 2.x messaging is used as the protocol of communication. The
project IS3 aims to include the process management layer to the ICT strategy of Catalonia. It
includes an interoperability platform that implements the messaging protocols of the WiFIS
project, with the encoded content using the semantic standards of the Clinical Dictionary. IS3
includes the development of a Terminology Server and the OFSTI is collaborating in its
design and development.
Deployment of Generic Cross Border eHealth Services in Spain (Project Coordinator in
the Catalan Region), CEF TELECOM, Spain: The main objective of this Connecting
Europe Facility project (2017-ES-IA-0068) is to support Spain’s effort to be part of a secure
peer-to-peer network allowing the exchange of Patient Summaries and ePrescriptions, which
will pave the way to enable seamless cross-border care and secure access to patient health
information between European
EpSOS (I and II, ICT PSP, 6 years, www.epsos.eu) (Project Coordinator in the Catalan
region): epSOS is focused on improving medical treatment of citizens while abroad by
providing health professionals with the necessary patient data in a secure electronic format,
epSOS aimed to offer seamless healthcare to European citizens by building and evaluating a
service infrastructure. epSOS was a six years project with 25 different countries involved with
the common goal to design, build and a service infrastructure to demonstrate cross-border
interoperability between electronic health record systems in Europe.
Partner Full Name Equalis AB
Short Name Equalis Partner No. 32
Country Sweden Website www.equalis.se
144
951938 X-eHealth – Part B
Type of Not for profit Logo Associated with document Ref. Ares(2020)2778062 - 28/05/2020
organisation private company
Brief Partner Profile
Equalis is not-for-property private company owned by the Swedish Association of Local
Authorities and Regions (SKL), the Swedish Medical Association and the Swedish Institute
of Biomedical Laboratory Science. The core activity is External Quality Assurance (EQA) for
laboratory medicine with focus on the Swedish health care system. The EQA activities cover
a broad range of activities within clinical microbiology, immunology, clinical chemistry,
haematology, haemostasis, morphological pathology, clinical physiology, nuclear medicine
and radiology.
Equalis also act as the national release centre for the NPU-terminology (http://www.npu-
terminology.org/). NPU is the terminology recommended for the unique coding and
identification of laboratory results used in electronic communication in Denmark, Norway
and Sweden.
Equalis is an active expert partner in the national “Laboratory medicine project” coordinated
by Inera (managing joint digital solutions in Sweden). The aim of the project is to extend the
current information model for laboratory medicine results to enable exchange of more
complex data with the national service platform. To this end, the general public and
authorised health care staff will be able to see laboratory results from additional areas e.g.,
microbiology and immunology.
Main tasks in Project
Equalis is an active partner in the following WPs:
WP5 (Tasks 5.2 and 5.3)
WP6 (Task 6.1, 6.2 and 6.6)
WP7 (Tasks. 7.1 and 7.4)
Relevant expertise and experience of the institution
Broad competence of quality assessment and interpretation of results of laboratory
investigations of different types.
Responsible for the NPU-terminology used by the Swedish laboratories for the identification
of laboratory results.
Active involvement in IUPAC, IFCC and JCGM working groups on topics related
standardization and laboratory medicine.
Engaged in the work for an extended information model for exchange of laboratory results on
a national level in Sweden.
Available network of expert groups for the relevant fields of laboratory medicine.
Key Personnel’s CVs (incl. gender)
145
951938 X-eHealth – Part B
Gunnar Nordin, senior advisor, ♂, MD. Specialist in clinical chemistry. 10-year experience
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
(5 as head of department) from hospital laboratory with clinical chemistry, clinical
microbiology and transfusion medicine services). 17 years’ experience as CEO for Equalis.
General interest in informatics, especially for laboratory test results. Member of the IFCC and
IUPAC committee on nomenclature, and in the JCGM WG2 for the revision of VIM.
Rebecca Ceder,♀, health informatician at Equalis. Holds a MSc in Biomedicine (2006) and
PhD in Medical Science (2011) from Karolinska Institutet, Stockholm. Doctoral and post-
doctoral work included application of computational biology approaches for biomarker
discovery and toxicological endpoints, with several publications in the area. She has also
worked in the Data Science team at the pharmaceutical company Roche in Basel, Switzerland,
supporting scientist with literature and business information in early drug discovery. In 2016,
she joined Equalis with responsibility for the terminology work and serving as a project
member in national e-health projects for laboratory medicine. Current engagements also
include IFCC and IUPAC projects on nomenclature for laboratory medicine, in particular,
genomics and molecular biology.
Relevant publications, products, services, or other achievements (max. 5)
Helmersson-Karlqvist, J., Ridefelt, P., Boija, E.E, Nordin, G.“(2019). "Lower creatinine
concentration values and lower inter-laboratory variation among Swedish hospital laboratories
in 2014 compared to 1996: results from the Equalis external quality assessment”program."
Clin Chem Lab Med. 57(6): 838-844.
Nordin, G., R. Dybkaer, U. Forsum, X. Fuentes-Arderiu“(2018). "Vocabulary on nominal
property, examination, and related concepts for clinical laboratory sciences (IFCC-IUPAC
Recommendatio”s 2017)." Pure Appl. Chem. 90(5): 913-935.
Nordin, G.“(2018). "Accuracy of HbA1c as Monitored by External Quality Assessment and
Compared with Patient Mea” Values." Journal of Diabetes Science and Technology 12(4):
771-779.
Kohonen, P., Parkkinen, J.A., Willighagen, E.L., Ceder, R., Wennerberg, K., Kaski, S.,
Grafström, R.C. (2017). ”A transcriptomics data-driven gene space accurately predicts liver
cytopathology and drug-induced liver injury.” Nat Commun. (8):15932.
Nordin, G.“(2017). "Cystatin C-Incremental Improvement in Measurement and Understanding
of”Results." Clin Chem 63(4): 802-803.
Previous projects or activities related to the project subject (max. 5)
The laboratory terminology expert in the national “Laboratory medicine” project. Application
of terminologies is central in this project.
Works actively with the clinical laboratories in Sweden to increase the implementation of
coding and structured reporting.
Was a partner in the national project DigiPat3 (2014-2017, Vinnova 2014-04257) with the aim
to implement digital pathology in Sweden. Within the project a hub was developed, providing
forms for synoptic reporting and for quality assessment of pathology using digital images.
146
951938 X-eHealth – Part B
Partner Full Swedish eHealth Agency (E-hälsomyndigheten)
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Name
Short Name SEHA Partner 33
No.
Country Sweden Website https://www.ehalsomyndigheten.se
Type of Governmental Logo
organisation body
Brief Partner Profile
The Swedish eHealth Agency (E-hälsomyndigheten) is a governmental authority responsible
for coordinating the G’vernment's initiatives and efforts in eHealth and for overall monitoring
the development of eHealth.
The Agency is also responsible for registries and IT functions which outpatient pharmacies and
healthcare providers need access to, for a patient-safe and cost-effective drug management. The
Agency is responsible for the Swedish e-prescription infrastructure and is designated as
National Contact Point for eHealth (NCPeH) in accordance with the directive on patients’
rights in cross-border healthcare. The Agency also gathers and supplies statistics about
pharmaceutical sales from pharmacies, retailers and wholesalers.
The Agency provides several services such as:
- The medicine check
- My issued prescriptions
- Keep track of medicines via electronic expert support (EES)
In an agreement between the Swedish Government and the Swedish Association of Local
Authorities and Regions (Sveriges Kommuner och Landsting) a goal was stated that in the
year 2025 Sweden shall be world-leading in eHealth – this agreement is called Vision eHealth
2025. The Swedish eHealth Agency coordinates the office for this national multi-party work
and contributes to the Vision by leading, driving and working in partnership, as well as
creating structures and monitoring quality. A crucial part of this work involves international
collaboration and global outlook.
The Swedish eHealth Agency is based in Kalmar with an office in Stockholm.
Main tasks in Project
WP7 Co-Leader: Architecture integration and System specification and active participation in WP5:
Definition of EHRxF functional specifications
T5.3 Active participant: Laboratory Results guideline and functional specifications
T5.4 Active participant: Medical Imaging and Reports guideline and functional specs
T5.5 Active participant: Hospital Discharge Reports guideline and functional specs
147
951938 X-eHealth – Part B
T5.7 Active participant: Final conclusion and recommendations
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
T7.1 Active participant: Global architecture for EHRxF Domains use
T7.3 Leader: Needs for upgrade of CEF eHDSI core and generic services
T7.4 Leader: Guidance for the new EHRxF domains
Relevant expertise and experience of the institution
The Swedish eHealth Agency is a government agency in the specific field of eHealth, with
extensive experience of working with interoperability issues, on a national as well as
international basis.
Key Personnel’s CVs (incl. gender)
Michel Silvestri, ♂, PhD, Reg. Biomedical Scientist. PhD from Karolinska Institutet with a
position for 15 years as Senior lecturer, and for 6 years as Programme Director of Biomedical
Laboratory Science. 2001-2007 President of the Swedish Institute of Biomedical Laboratory
Science and member of the Equalis Board of Directors. 2014-2017 elected Member of
Stockholm County Council with positions such as member of the Board of Healthcare for the
Stockholm Region. 2016-2019 head of the Medical Laboratory Centre of Gotland at Visby
hospital. Experience from procurement of e.g. Laboratory Information Management Systems
(LIMS). From April 2019 Head of Unit, Dept. of Coordination, at the Swedish eHealth
Agency.
Emanuel Andersson, ♂, MSc Computer Science and Electrical Engineering, holds a position as a
senior advisor and enterprise architect. Between 2015 and 2018 he had a position as a work package
leader for interoperability and standardisation in the project JAseHN (Joint Action to Support the
eHealth Network,
https://webgate.ec.europa.eu/chafea_pdb/health/projects/677102/summary).
He has in 2018, as a member of a core team consisting of architects from different authorities, created
the national interoperability framework out of the European interoperability framework, EIF. Recently,
in an assignment from the Swedish government, he investigated what building blocks needs to be
created on a national level to be able to create a secure and efficient information exchange with and
within the Swedish public sector, e.g. eId framework, API-management, different national services.
Emanuel has also been responsible for setting up the architecture for national e-prescription
infrastructure in Sweden and is currently involved in collaboration with various national governmental
and other organizations, including standards development organizations with respect to digitalisation,
standardisation and interoperability in health and social care.
Relevant publications, products, services, or other achievements (max. 5)
Silvestri M. Initiative and project owner of regional e-health service for patients with
anticoagulation treatment, Region of Gotland, Sweden.
148
951938 X-eHealth – Part B
Previous projects or activities related to the project Associated
subject with
(max. 5)
document Ref. Ares(2020)2778062 - 28/05/2020
Andersson, E. Actively involved in JAseHN, primarily interoperability and standardisation.
Member of core team developing the national interoperability framework out of EIF. building blocks
needs to be created on a national level to be able to create a secure and efficient information exchange
with and within the Swedish public sector, e.g. eId framework, API-management, different national
services.
Emanuel has also been responsible for setting up the architecture for national e-prescription
infrastructure in Sweden and is currently involved in collaboration with various national
governmental and other organizations, including standards development organizations with
respect to digitalisation, standardisation and interoperability in health and social care.
Partner Full Name French National Institute of Health and Medical Research
Short Name INSERM Partner No. 34
Country France Website www.orpha.net
Type of organisation Public organisation Logo
Brief Partner Profile
The French National Institute of Health and Medical Research (INSERM), founded in
1964 is a public scientific and technological institute which operates under the joint authority of the
Prime Minister and French Ministry of Research. INSERM has been acting as coordinator of the
Orphanet network since the beginning of the European projects in 2001. The INSERM also acted as co-
ordinator of the Rare Diseases Task Force (2004-2009) and the European Union Committee of Experts
on Rare Diseases (EUCERD)(2010-2013) and of RD-ACTION (2015-2018).
Main tasks in Project
Orphanet will play an active role in X-eHealth in the following ta–ks:
WP5 - Definition of EHRxF functional specifications
T5.6: Refine PS functional specifications to account for eHN Guidelines and rare dise–ses
WP6 - Definition of EHRxF implementable specifications
T6.4: Refinement of Patient Summary (PS) technical specifications for supporting rare dise–
ses
WP8 - EHRxF Communities of Practice: from Proof of Concept to large scale adoption and
Infrastructure for Innovation
149
951938 X-eHealth – Part B
T8.1: Proof of concept: EHRxF in rare diseases Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Relevant expertise and experience of the institution
Promotion in the use of ICT standards in the healthcare sector, as the key element to ensure a
coherent exchange of information at an international level.
Definition and implementation of the interoperability framework for the public health system
of the Catalonian Government.
TIC Salut Social acts as an observatory for trends innovations and emerging initiatives in the
health and social care and provides services for the standardization and accreditation of
products.
Key Personnel’s CVs (incl. gender)
Orphanet Director Dr. Ana Rath (female) is a medical doctor and has a Master degree in Philosophy.
She oriented her career to medical information in 1997 (working in medical information and
terminologies) and joined Orphanet (www.orpha.net) in 2005. In Orphanet she has been in charge
successively of the Orphanet encyclopaedia, the rare diseases database, and of the Scientific Direction.
She became Deputy Director in 2011and is currently acting as Director of Orphanet since May 2014.
She was Rd-ACTION Project coordinator (www.rd-action.eu), HIPBI-RD project coordinator
(www.hipbi-rd.net) and is currently the coordinator of the RD-CODE project (www.rd-code.eu)
Marc Hanauer (male) the Chief Technology officer and Deputy Director has a master’s degree in
Sciences Information & communication. From 2000 to 2009 he worked for different Internet Start-ups.
He is Engineer at INSERM and CTO of Orphanet since 2009. He is Orphanet deputy director since
2017. The Scientific Operating Director
The Director of production and Nomenclature Resposible Annie Olry (female) has a PhD in cellular
biology. She has worked for Orphanet since 2007. First in charge of the literature survey, she has been
in charge of the diseases inventory and classification system for 4 years. She now manages the
scientific team and ensures overall scientific validity of the diseases inventory and classification
system, genes inventory, epidemiological and disability data. She is involved in most of the scientific
partnerships, notably handling the Orphanet rare diseases ontology collaboration.
Relevant publications, products, services, or other achievements (max. 5)
Standard nomenclature and classification of rare diseases: the ORPHAcodes.
ORPHAcodesare at the center of a normalized, manually curated and quality control semantic
system allowing for interoperability between health information systems (i.e. electronic health
records in hospitals at the national level) and other resources (i.e. registries, cohorts,
databases, biobanks) at the transnational level.
The Orphanet Rare Disease ontology (ORDO) was jointly developed by Orphanet and the
European Bioinformatics Institute (EBI) and provides a structured vocabulary for RD,
capturing relationships between diseases, genes and other relevant features, providing a useful
resource for the computational analysis of RD.
150
951938 X-eHealth – Part B
Orphanet provides phenotypic annotations of the rare diseases in the Orphanet nomenclature
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
using the Human Phenotype Ontology (HPO). HOOM is a module that qualifies the
annotation between a clinical entity and phenotypic abnormalities according to a frequency
and by integrating the notion of diagnostic criterion.
Relevant publications:
1. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.
Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, Murphy D, Le Cam
Y, Rath A. Eur J Hum Genet. 2019 Sep 16.
2. Plain-language medical vocabulary for precision diagnosis. Vasilevsky NA, Foster ED, Engelstad
ME, Carmody L, Might M, Chambers C, Dawkins HJS, Lewis J, Della Rocca MG, Snyder M, Boerkoel
CF, Rath A, Terry SF, Kent A, Searle B, Baynam G, Jones E, Gavin P, Bamshad M, Chong J, Groza T,
Adams D, Resnick AC, Heath AP, Mungall C, Holm IA, Rageth K, Brownstein CA, Shefchek K,
McMurry JA, Robinson PN, Köhler S, Haendel MA. Nat Genet. 2018 Apr;50(4):474-476.
Previous projects or activities related to the project subject (max. 5)
RD-CODE (www.rd-code.eu): The project, co-funded by the European Union’s Third
Health Programme, started on January 2019 and it will end in June 2021. The objective of this
project is to support Member States in improving gathering information on rare diseases by
implementation of Orphacodes (rare diseases specific codification system). The
implementation process will be guided by the « Standard procedure and guide for the coding
with Orphacodes » and the « Specification and implementation manual of the Master
file » both developed in the frame of the previous Joint Action on rare Diseases RD-
ACTION (2015-2018). The aim of the RD-CODE project is to promote the use of the
Orphanet nomenclature for implementation into routine coding systems. This enables a
standardised and consistent level of information to be shared at European level. Starting with
countries that have no systematic implementation of the Orpha codification yet, but that are
actively committed already in doing so, this project will provide a sufficient real-world
implementation experience to be captured by other countries in the future.
HIPBI-RD(www.hipbi-rd.net) : This project has built on three resources largely adopted by
the RD community: Orphanet, and its ontology ORDO, HPO and PhenoTips. It is aimed to
provide the community with an integrated, RD-specific informatics ecosystem that will
harmonize the way phenomics information is stored in databases and in patient files worldwide,
and thereby contribute to interoperability. This ecosystem will consist of a suit of tools and
ontologies, optimized to work together, and available to clinicians and scientists through
commonly used software repositories. Additionally, the ecosystem will improve and streamline
the interpretation of variants identified through exome and full genome sequencing by
harmonizing the way phenotypic information is collected.
151
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
152
951938 X-eHealth – Part B
4.2. Third parties involved in the project (including use of third party resources)
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
SPMS
Does the participant plan to subcontract certain tasks (please note that Y
core tasks of the project should not be sub-contracted)
Acting in two domains - coordinator and participant - SPMS requires € 85 000 in
subcontracting to promote the smooth development of the project and support the
working capacity of its internal teams.
In this sense, the breakdown of the required amount for subcontracting attends the
following reasoning: 1.1) at the level of project coordination and aiming at tackling
the barriers that are to arise to develop the specifications for a common framework
for an EHRxF, € 28 000 are directed to function as an operational fund for addressing
the insufficiencies that X-eHealth Consortium may have throughout the project. This
amount is specifically directed for approaching relevant experts and stakeholders of
the sector towards solving the puzzle at issue.
1.2) Since quality management stands as a fundamental element for the quality of the
project's outputs, and since this consortium does not have native English speakers for
content review and Copywrite functions, 12 000 € are foreseen for this aspect.
2) As for the level of effective participation of SPMS' teams in the development of
the project objectives, € 45 000 are designed to subcontract the external expertise
necessary for supporting the advance of the project. Since the participation of SPMS
focuses on work packages WP1, WP2, WP4, WP5, WP6 and WP7, there is a need to
resort to subcontracting to deal with certain technical-functional domains that the
project demands and SPMS lacks. Namely, specific knowledge about medical
specifications such as images and laboratory results.
Does the participant envisage that part of its work is performed by
N
linked third parties9
Does the participant envisage the use of contributions in kind
N
provided by third parties (Articles 11 and 12 of the General Model
Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners10 (Article 14a of the General Model Grant N
Agreement)?
9
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
10
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
153
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ATNA
Does the participant plan to subcontract certain tasks (please note that Y
core tasks of the project should not be sub-contracted)
ATNA plans to subcontract certain activities to third parties such as ELGA GmbH, AGES or
other national organisations in order to ensure involvement of national expertise, in particular
when it comes to contributions to WP5, WP6, WP7. The national expertise for architecture,
functional specifications and definitions of workflows is concentrated in the national competent
authorities that are linked with ATNA. Therefore, ATNA plans to involve relevant experts on
certain topics and key questions the CSA is working on. To ensure the involvement of this
know-how the amount of minimum 20.000 EUR needs to be allocated for subcontracting.
Does the participant envisage that part of its work is performed by
N
linked third parties11
Does the participant envisage the use of contributions in kind provided
by third parties (Articles 11 and 12 of the General Model Grant N
Agreement)
Does the participant envisage that part of the work is performed by
International Partners12 (Article 14a of the General Model Grant N
Agreement)?
GOeG
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties13
Does the participant envisage the use of contributions in kind provided
by third parties (Articles 11 and 12 of the General Model Grant N
Agreement)
11
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
12
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
13
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
154
951938 X-eHealth – Part B
Does the participant envisage that part of the workAssociated
is performed by
with document Ref. Ares(2020)2778062 - 28/05/2020
International Partners14 (Article 14a of the General Model Grant N
Agreement)?
FPS Health
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties15
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners16 (Article 14a of the General Model Grant N
Agreement)?
IHE
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties17
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners18 (Article 14a of the General Model Grant N
Agreement)?
14
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
15
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
16
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
17
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
18
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
155
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
HL7
Does the participant plan to subcontract certain tasks (please note that Y
core tasks of the project should not be sub-contracted)
Part of task 8.3 delivering D8.4 will be subcontracted to Karolinska Institute to contribute to
an exploratory proof of concept study on how to integrate EHRxF into research studies and
specifically citizen-driven health science. This exploratory task links EHRxF to initiatives
assessing and integrating new concepts and tools such as AI, outcomes-based research, clinical
research, clinical trial integration, business analytics, decision aids for patients, and citizen-
driven health-science. The study would result into clear recommendations for incorporating
the EHRxF in these areas taking into account technical, legal, procedural, and other barriers,
engaging also collaborative partners and the community of practice.
The Health Informatics Centre (HIC) at the department of Learning, Informatics,
Management and Ethics (LIME) performs research in the areas of clinical decision
making, integrated patient-centred information systems for collaborative care and patient
e-services with special focus on usability. Our aim is to perform needs driven research
and to enhance clinical practice through informatics, delivering new evidence-based
knowledge into patient care, prevention and self-management. We systematically use
knowledge about care processes, information flows in health and social care, patients’
information and communication needs, usability and health informatics standards to
develop new methods and tools. These are evaluated to create new knowledge about how
to best design and implement eHealth to create benefits for both patients and healthcare
professionals. We apply a sociotechnical approach, combining technical and
methodological research with research on how implementation and use of eHealth affects
roles, relationships and tasks for patients and healthcare professionals.
Does the participant envisage that part of its work is performed by
N
linked third parties19
Does the participant envisage the use of contributions in kind provided
by third parties (Articles 11 and 12 of the General Model Grant N
Agreement)
Does the participant envisage that part of the work is performed by
International Partners20 (Article 14a of the General Model Grant N
Agreement)?
19
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
20
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
156
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
NEN
Does the participant plan to subcontract certain tasks (please note that Y
core tasks of the project should not be sub-contracted)
As one of the 34 formal members of CEN (the European Committee for Standardization), NEN
holds the secretariat of CEN/TC 251 ‘Health informatics’ for which this H2020 project
proposal is of interest for the CEN/TC 251 work programme. CEN as legal entity does not
participate in EU projects and defer to its members (such as NEN) to participate in relevant
projects. Participation in NEN and CEN standardization activities is carried out by nominated
experts that are not employed by NEN. The three nominated experts for this project are the
chairman, vice-chairman and WG-convenor in CEN/TC 251. NEN plans to subcontract the 3
experts to provide the technical expertise from a CEN/ISO standardisation point of view.
The three experts will contribute to T8.6 and their technical expertise will be employed to
evaluate the proof of concept outcomes of T8.1 and T8.2, as well as, to provide input to the
sustainability task of the project (T1.4). They will also contribute to T8.6 linked deliverable.
Does the participant envisage that part of its work is performed by
N
linked third parties21
Does the participant envisage the use of contributions in kind provided
by third parties (Articles 11 and 12 of the General Model Grant N
Agreement)
Does the participant envisage that part of the work is performed by
International Partners22 (Article 14a of the General Model Grant N
Agreement)?
HZZO
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties23
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
21
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
22
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
23
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
157
951938 X-eHealth – Part B
Does the participant envisage that part of the workAssociated
is performed by
with document Ref. Ares(2020)2778062 - 28/05/2020
International Partners24 (Article 14a of the General Model Grant N
Agreement)?
UCY
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by N
linked third parties25
Does the participant envisage the use of contributions in kind provided N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by N
International Partners26 (Article 14a of the General Model Grant
Agreement)?
MZCR
Does the participant plan to subcontract certain tasks (please note that
Y
core tasks of the project should not be sub-contracted)
Participation of the Czech Medical Association of J. E. Purkyně (CMA) is envisaged in area of
the clinical aspects of the project. Czech Medical association is a professional association of
medical, biomedical and healthcare IT experts and valuable partner of the Czech MoH. CMA,
under the lead of its presidency and e-Health workgroup, will bring clinical and healthcare IT
experience and expertise of its leading Czech specialists. CMA will be involved as contributor
and consultative partner in the task T5.1: X-eHealth use cases driven methodology, T5.2: EHRxF
and its relationship with clinical guidelines, T5.3: Laboratory Requests and Reports functional
specifications, T5.4: Imaging and Reports functional specifications and T5.5: Hospital Discharge
Reports functional specifications.
24
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
25
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
26
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
158
951938 X-eHealth – Part B
Does the participant envisage that part of its work is performed by linked
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
27 N
third parties
Does the participant envisage the use of contributions in kind provided
by third parties (Articles 11 and 12 of the General Model Grant N
Agreement)
Does the participant envisage that part of the work is performed by
International Partners28 (Article 14a of the General Model Grant N
Agreement)?
Vysocina
Does the participant plan to subcontract certain tasks (please note that core
N
tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by linked
N
third parties29
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners30 (Article 14a of the General Model Grant N
Agreement)?
MSAE
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties31
27
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
28
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
29
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
30
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
31
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
159
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners32 (Article 14a of the General Model Grant N
Agreement)?
ANS
Does the participant plan to subcontract certain tasks (please note that Y
core tasks of the project should not be sub-contracted)
ANS needs to subcontract external expertise because, as a national public organization, the law
imposes a cap on the number of employees and subcontracting is the usual way to mobilize resources.
ANS’s internal experts will be in charge of the clinical, functional and technical activities of the
project. Namely, T5.3 (Laboratory functional specifications), T6.1 (laboratory technical specifications),
T6.3 (Discharge letters technical specifications) and T7.3 (Needs for upgrade of CEF eHDSI core and
generic services). The internal experts will also focus on strategic tasks, in particular those related to
governance issues. The amount requested is allocated proporcionally among the tasks.
In this context, subcontractors – under the auspices of ANS – will provide support, contributing to the
creation of content for the deliverables, as well as participate in meetings and phone calls, in close
collaboration with internal experts.
Does the participant envisage that part of its work is performed by
N
linked third parties33
Does the participant envisage the use of contributions in kind provided
by third parties (Articles 11 and 12 of the General Model Grant N
Agreement)
Does the participant envisage that part of the work is performed by
International Partners34 (Article 14a of the General Model Grant N
Agreement)?
32
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
33
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
34
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
160
951938 X-eHealth – Part B
MoH France Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties35
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners36 (Article 14a of the General Model Grant N
Agreement)?
DIMDI
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties37
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners38 (Article 14a of the General Model Grant N
Agreement)?
Gematik
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
35
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
36
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
37
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
38
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
161
951938 X-eHealth – Part B
Does the participant envisage that part of its work is performed by
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
39
N
linked third parties
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners40 (Article 14a of the General Model Grant N
Agreement)?
TMF
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties41
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners42 (Article 14a of the General Model Grant N
Agreement)?
MoH Greece
Does the participant plan to subcontract certain tasks (please note that Y
core tasks of the project should not be sub-contracted)
39
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
40
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
41
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
42
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
162
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
MOHGR plans to subcontract specific tasks to HL7 Hellas, the Greek affiliate of HL7
International.
Tasks proposed to be subcontracted will be part of WP 5, 6, 7, and 8.
HL7 Hellas will perform the following tasks for MoHGR
1. organise consensus building local stakeholders’ meetings
2. organise national technical committees and provide technical support on the specifications and
deliverables in WP 5-6-7
3. Review deliverables and provide expert comments on recommendations especially concerning the
proper use of HL7 standards within EHRxF and integration profiles and implementation guide
4. Localise final technical documents to the Greek environment and support the ministry to create
national standards in Greece for EHRxF
5. Assist MOHGR in performing proof of concept demonstration in Greece (WP8).
6. Provide recommendations to MOHGR on the WP8 community of practice
Does the participant envisage that part of its work is performed by
N
linked third parties43
Does the participant envisage the use of contributions in kind provided
by third parties (Articles 11 and 12 of the General Model Grant N
Agreement)
Does the participant envisage that part of the work is performed by
International Partners44 (Article 14a of the General Model Grant N
Agreement)?
AEEK
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties45
43
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
44
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
45
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
163
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners46 (Article 14a of the General Model Grant N
Agreement)?
SE
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties47
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners48 (Article 14a of the General Model Grant N
Agreement)?
DoH
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties49
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
46
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
47
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
48
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
49
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
164
951938 X-eHealth – Part B
Does the participant envisage that part of the workAssociated
is performed by
with document Ref. Ares(2020)2778062 - 28/05/2020
International Partners50 (Article 14a of the General Model Grant N
Agreement)?
AGiD
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties51
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners52 (Article 14a of the General Model Grant N
Agreement)?
ARIA
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties53
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
50
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
51
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
52
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
53
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
165
951938 X-eHealth – Part B
Does the participant envisage that part of the workAssociated
is performed by
with document Ref. Ares(2020)2778062 - 28/05/2020
International Partners54 (Article 14a of the General Model Grant N
Agreement)?
MIN SAL
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties55
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners56 (Article 14a of the General Model Grant N
Agreement)?
RegLomb
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
Y
linked third parties57
Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy (INT) is the largest
comprehensive cancer centre in Italy. Since its establishment (1928), it has aimed to provide
the highest standards of cancer care and to pursue pre-clinical and clinical research in such a
way as to swiftly translate innovation into better prevention, diagnosis, therapy and
rehabilitation for Italian cancer patients. INT has a long-standing record on rare cancers,
serving as one of the Italian reference centres for several rare cancers, including childhood
54
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
55
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
56
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
57
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
166
951938 X-eHealth – Part B
cancers, sarcomas, head & neck cancers, peritoneal andAssociated
pleuralwith
mesothelioma and thymoma,
document Ref. Ares(2020)2778062 - 28/05/2020
neuroendocrine tumours, male genital tumours, rare female genital cancers, lymphomas and
myeloma.
Three units of INT will contribute to this project: Medical Oncology Unit 2, Medical Oncology
Unit 3 and Evaluative Epidemiology Unit. Medical Oncology Units 2 and 3 are medical
oncology facilities exclusively devoted to families of rare adult cancers, i.e., sarcomas and head
and neck cancers, respectively. Medical Oncology Units 2 coordinates the Italian Rare Cancer
Network. The Evaluative Epidemiology Unit coordinated the RARECARE and
RARECAREnet projects, in addition to national project dedicated to rare cancers. This Unit is
also involved in the evaluation of public health activities related to cancer in Italy, Europe and
extra-European countries. The unit is involved in several national and international projects
estimating cancers indicators and comparing them across EU and extra EU countries. The
Medical Oncology Units 2 and the Evaluative Epidemiology Unit coordinated the Joint Action
on Rare Cancers (JARC). Finally, INT hosts and coordinates the project “State-of-the-art
oncology in Europe” (START). START is intended as a state-of-the-art knowledge base to
support oncologists in their clinical decisions and is currently devoting its efforts completely to
rare cancers.
Two medical oncologists will also contribute. Prof. Paolo Casali (male) is chairing INT’s
Medical Oncology Unit 2, on mesenchymal tumours; coordinating the Italian Rare Cancer
Network; chairing the steering committee of Rare Cancers Europe (a multi-stakeholder
European effort on rare cancers); serving as the secretary of the Italian Sarcoma Group (the
Italian collaborative research group on sarcomas); chairing the EU Policy Committee of the
European Society for Medical Oncology (ESMO), coordinating the EURACAN domain on
sarcomas and involved in the knowledge generation WG of the ERN.
Dr. Lisa Licitra (female) is a senior medical oncologist chairing INT’s Medical Oncology Unit
3, exclusively devoted to head & neck cancers; serving as the coordinator of Clinical Practice
Guidelines on head & neck cancers of the European Society for Medical Oncology (ESMO);
serving as co-opted Board member of the Organisation of European Cancer Institutes (OECI);
serving as Board member of the European Organisation for Research and Treatment of Cancer
(EORTC) and, coordinating START. She is the domain leader of the EURACAN domain on
rare head and neck cancers. Annalisa Trama, epidemiologist, with a Master’s in health
services/system research and a PhD in Public Health. She has important experience in cancer
and rare cancer registration. She has experience in pattern of care study, evaluation of health
care system and, use of different data sources. She has experience also on rare diseases since
she worked at the National centre for rare diseases (ISS, Italy) and was a member of the EU
task force on rare diseases (Monitoring & Evaluation) WG. Knowing rare diseases and rare
cancers community, she is well placed to support collaboration with cancer and rare diseases
dedicated ERNs.
Within X-eHealth, the Istituto Nazionale Tumori will bring its relevant clinical knowledge both
on Rare Diseases, as member and responsible for ERN and on International Clinical Guidelines
driven Clinical Model definition.
167
951938 X-eHealth – Part B
IST will support Regione Lombardia in Task T5.2: “EHRxF and its relationship with clinical
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
guidelines” and T5.6: “Refine PS guideline and functional specifications to account for rare
diseases”. It will also participate to WP8.
Does the participant envisage the use of contributions in kind provided
by third parties (Articles 11 and 12 of the General Model Grant N
Agreement)
Does the participant envisage that part of the work is performed by
International Partners58 (Article 14a of the General Model Grant N
Agreement)?
NVD
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties59
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners60 (Article 14a of the General Model Grant N
Agreement)?
SAM
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
58
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
59
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
60
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
168
951938 X-eHealth – Part B
Does the participant envisage that part of its work is performed by
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
61
N
linked third parties
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners62 (Article 14a of the General Model Grant N
Agreement)?
NICTIZ
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties63
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners64 (Article 14a of the General Model Grant N
Agreement)?
NCZI
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties65
61
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
62
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
63
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
64
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
65
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
169
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners66 (Article 14a of the General Model Grant N
Agreement)?
NIJZ
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties67
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners68 (Article 14a of the General Model Grant N
Agreement)?
TIC Salut
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by linked
N
third parties69
Does the participant envisage the use of contributions in kind provided by
N
third parties (Articles 11 and 12 of the General Model Grant Agreement)
66
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
67
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
68
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
69
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
170
951938 X-eHealth – Part B
Does the participant envisage that part of the workAssociated
is performed by
with document Ref. Ares(2020)2778062 - 28/05/2020
International Partners70 (Article 14a of the General Model Grant N
Agreement)?
Equalis
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties71
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners72 (Article 14a of the General Model Grant N
Agreement)?
SEHA
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties73
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
70
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
71
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
72
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
73
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
171
951938 X-eHealth – Part B
Does the participant envisage that part of the workAssociated
is performed by
with document Ref. Ares(2020)2778062 - 28/05/2020
International Partners74 (Article 14a of the General Model Grant N
Agreement)?
Inserm
Does the participant plan to subcontract certain tasks (please note that N
core tasks of the project should not be sub-contracted)
Does the participant envisage that part of its work is performed by
N
linked third parties75
Does the participant envisage the use of contributions in kind provided
N
by third parties (Articles 11 and 12 of the General Model Grant Agreement)
Does the participant envisage that part of the work is performed by
International Partners76 (Article 14a of the General Model Grant N
Agreement)?
74
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
75
A third party that is an affiliated entity or has a legal link to a participant implying a collaboration not limited to the action.
(Article 14 of the Model Grant Agreement).
76
‘International Partner’ is any legal entity established in a non-associated third country which is not eligible for funding
under Article 10 of the Rules for Participation Regulation No 1290/2013.
172
951938 X-eHealth – Part B
4.3. Financial support to third parties Associated with document Ref. Ares(2020)2778062 - 28/05/2020
SPMS
N/A
ATnA
N/A
GOeG
N/A
FPS Health
N/A
IHE
N/A
HL7
N/A
NEN
N/A
HZZO
N/A
UCY
N/A
NCEZ
N/A
173
951938 X-eHealth – Part B
Vysocina Associated with document Ref. Ares(2020)2778062 - 28/05/2020
N/A
MSAE
N/A
ANS
N/A
MoH France
N/A
DIMDI
N/A
Gematik
N/A
TMF
N/A
MoH GR
N/A
AEEK
N/A
SE
N/A
DoH
174
951938 X-eHealth – Part B
N/A Associated with document Ref. Ares(2020)2778062 - 28/05/2020
AGiD
N/A
ARIA
N/A
MIN SAL
N/A
REgLomb
N/A
NVD
N/A
SAM
N/A
NICTIZ
N/A
NCZI
N/A
NIJZ
N/A
TIC Salut
N/A
175
951938 X-eHealth – Part B
Equalis Associated with document Ref. Ares(2020)2778062 - 28/05/2020
N/A
SEHA
N/A
Inserm
N/A
176
951938 X-eHealth – Part B
5. Ethics and Security Associated with document Ref. Ares(2020)2778062 - 28/05/2020
5.1 Ethics
Being the protection of personal data a crucial element that must be safeguarded, X-eHealth sets out in this section
how does the project intend to safeguard the rights and freedoms of the data subjects / research participants.
Following a self-assessment of the ethical assumptions that the project must comply with, the subsequent main issues
shall be considered:
Will X-eHealth have workshops?
o Yes
Does this research involve personal data collection and/or processing?
o Yes, limited to the workshops' attendance
Will the project collect information about the registered participants?
o Yes, yet, they will be acting on behalf of their institution and role
Does it involve the collection and/or processing of sensitive personal data (e.g. health, sexual lifestyle,
ethnicity, political opinion, religious or philosophical conviction)?
o No, no real sensitive personal data will be collected or processed in X-eHealth
Will X-eHealth ask participants about their health status?
o No
Will X-eHealth ask their "consent" to openly include their names in the Deliverable?
o Yes
Since the project intends to carry out several workshops and surveys, the participation of stakeholders stands as a
meaningful element for these activities' productiveness. This way, even though collection and/or processing of
personal data does not act as relevant for X-eHealth goals, in order to safeguard data protection for any purpose other
than the ones stipulated by the project, a task named T1.5 Ethics requirements was created to address the way personal
data will be handled within the confines of the project itself, i.e. how personal data of project members, workshop
participants, et cetera, will be used by the project coordinator and the respective working packages during the project
timeline.
On this basis, feature by the project coordination work package (WP1), task T1.5 was specifically designed to cover
the project-related aspects for safeguarding participants and stakeholders' personal data towards ensuring its ethical
compliance. To do so, T1.5 objectives are: to ensure compliance with the ethics requirements established by the
General Data Protection Regulation (i), to set out the ethics requirements that the project must comply with (ii), and
to produce a deliverable clearly stating that the personal data from stakeholder and survey participants will be handled
in a GDPR compliant manner, therefore in accordance with the ‘data minimisation' principle (iii).
In order to operationalize these abovementioned objectives, two measures have been established: 1) The first, already
referenced, is a deliverable named D1.6 - Ethics Requirements (due month 3) stating how the personal data collected
from stakeholders will be dealt with in a GDPR compliant way; 2) The second measure is that every single deliverable
submitted by X-eHealth will include an ethics section in order to particularly address the issue at stake within a
specific context and from an ethical perspective.
177
951938 X-eHealth – Part B
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
In parallel, a content-related task essential for structural cooperation was also designed to address the fundamental
legal and ethical provisions for the exchange of cross-border data. Namely, the sub-tasks T4.2.1 (Legal and ethical
aspects of cross-border exchange of data) and T4.2.2 (Legal and ethical enablers for cross-border interoperability
of personal data), will strive to develop the ethical guidelines to safeguard EU citizens on how their data will be
treated.
Concerning the proof of concept tasks (T8.1 and T8.2) to be carried out by WP8, it should be noted that these activities
will be tested with dummy data. In other words, all data to be used during these tests will always be fictitious,
therefore, focusing specifically on the operationalization of the concept, without using or endangering real-life data.
Since the data to be used to test the interoperability of the concepts is fictitious and formulated specifically for that
purpose, the project will not process any data, thus it will not consider a data management plan.
5.2 Security
Activities or results raising security issues: NO
‘EU-classified information’ as background or results: NO
178
951938 X-eHealth – Part B
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
ESTIMATED BUDGET FOR THE ACTION Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Estimated eligible1 costs (per budget category) EU contribution Additional information
B. Direct costs of [C. Direct costs Reimbursement Maximum EU Maximum Information for Information Other
A. Direct personnel costs D. Other direct costs E. Indirect costs2 Total costs
subcontracting of fin. support] rate % contribution3 grant amount4 indirect costs for auditors information:
A.1 Employees (or equivalent) A.4 SME owners without salary D.1 Travel D.5 Costs Estimated Declaration of Estimated costs
of internally costs of in-kind costs under Point of beneficiaries/
A.2 Natural persons under direct A.5 Beneficiaries that are natural D.2 Equipment invoiced goods contributions not D.4 linked third
contract persons without salary and services used on premises parties not
D.3 Other goods receiving
A.3 Seconded persons and services funding/
international
[A.6 Personnel for providing access [D.4 Costs of partners
to research infrastructure] large research
infrastructure]
Flat-rate10
Form of costs6 Actual Unit7 Unit8 Actual Actual Actual Unit9
25%
h = 0,25 x (a j = a+b+c+d
a Total b No hours Total c d [e] f Total g +b+c+f+g +[e]+f+g+h k l m n Yes/No
+[i1]13+[i2]13-n) +[i1]+[i2]
1. SPMS 276 000.00 0.00 0.00 0.00 85 000.00 0.00 117 499.00 0.00 98 374.75 576 873.75 100.00 576 873.75 576 873.75 0.00 No n/a
2. ATNA 21 250.00 0.00 0.00 0.00 20 000.00 0.00 9 100.00 0.00 7 587.50 57 937.50 100.00 57 937.50 57 937.50 0.00 No n/a
3. GÖG 57 400.00 0.00 0.00 0.00 0.00 0.00 18 200.00 0.00 18 900.00 94 500.00 100.00 94 500.00 94 500.00 0.00 No n/a
4. FPS Health Be 17 400.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 6 625.00 33 125.00 100.00 33 125.00 33 125.00 0.00 No n/a
5. IHE-EUR 149 500.00 0.00 0.00 0.00 0.00 0.00 18 200.00 0.00 41 925.00 209 625.00 100.00 209 625.00 209 625.00 0.00 No n/a
6. HL7 Europe 142 500.00 0.00 0.00 0.00 25 000.00 0.00 18 200.00 0.00 40 175.00 225 875.00 100.00 225 875.00 225 875.00 0.00 No n/a
7. NEN 8 100.00 0.00 0.00 0.00 50 000.00 0.00 9 100.00 0.00 4 300.00 71 500.00 100.00 71 500.00 71 500.00 0.00 No n/a
8. HZZO 8 925.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 4 506.25 22 531.25 100.00 22 531.25 22 531.25 0.00 No n/a
9. UCY 32 500.00 0.00 0.00 0.00 0.00 0.00 18 200.00 0.00 12 675.00 63 375.00 100.00 63 375.00 63 375.00 0.00 No n/a
10. MZCR 45 000.00 0.00 0.00 0.00 15 000.00 0.00 18 200.00 0.00 15 800.00 94 000.00 100.00 94 000.00 94 000.00 0.00 No n/a
11. Kraj Vysočina 40 285.00 0.00 0.00 0.00 0.00 0.00 27 300.00 0.00 16 896.25 84 481.25 100.00 84 481.25 84 481.25 0.00 No n/a
12. MSAE 26 250.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 8 837.50 44 187.50 100.00 44 187.50 44 187.50 0.00 No n/a
13. ANS 36 000.00 0.00 0.00 0.00 10 000.00 0.00 9 100.00 0.00 11 275.00 66 375.00 100.00 66 375.00 66 375.00 0.00 No n/a
14. MoH-FR 36 000.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 11 275.00 56 375.00 100.00 56 375.00 56 375.00 0.00 No n/a
15. DIMDI 6 500.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 3 900.00 19 500.00 100.00 19 500.00 19 500.00 0.00 No n/a
16. GEMATIK 43 500.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 13 150.00 65 750.00 100.00 65 750.00 65 750.00 0.00 No n/a
17. TMF 16 000.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 6 275.00 31 375.00 100.00 31 375.00 31 375.00 0.00 No n/a
18. MoHGR 63 000.00 0.00 0.00 0.00 45 000.00 0.00 18 200.00 0.00 20 300.00 146 500.00 100.00 146 500.00 146 500.00 0.00 No n/a
19. AEEK 4 950.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 3 512.50 17 562.50 100.00 17 562.50 17 562.50 0.00 No n/a
20. SE 23 100.00 0.00 0.00 0.00 0.00 0.00 18 200.00 0.00 10 325.00 51 625.00 100.00 51 625.00 51 625.00 0.00 No n/a
21. DoH 28 050.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 9 287.50 46 437.50 100.00 46 437.50 46 437.50 0.00 No n/a
22. AGID 30 000.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 9 775.00 48 875.00 100.00 48 875.00 48 875.00 0.00 No n/a
23. ARIA 134 000.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 35 775.00 178 875.00 100.00 178 875.00 178 875.00 0.00 No n/a
24. MIN SAL 14 000.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 5 775.00 28 875.00 100.00 28 875.00 28 875.00 0.00 No n/a
25. REGLOMB 20 100.00 0.00 0.00 0.00 0.00 0.00 4 000.00 0.00 6 025.00 30 125.00 100.00 30 125.00 30 125.00 0.00 No n/a
- INT 30 150.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 9 812.50 49 062.50 100.00 49 062.50 49 062.50 0.00 No n/a
Total beneficiary 50 250.00 0.00 0.00 0.00 13 100.00 0.00 15 837.50 79 187.50 79 187.50 79 187.50 n/a n/a 0.00
26. NVD 20 000.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 7 275.00 36 375.00 100.00 36 375.00 36 375.00 0.00 No n/a
27. SAM 18 000.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 6 775.00 33 875.00 100.00 33 875.00 33 875.00 0.00 No n/a
28. NICTIZ 193 575.00 0.00 0.00 0.00 0.00 0.00 18 200.00 0.00 52 943.75 264 718.75 100.00 264 718.75 264 718.75 0.00 No n/a
29. NCZI 13 750.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 5 712.50 28 562.50 100.00 28 562.50 28 562.50 0.00 No n/a
30. NIJZ 17 500.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 6 650.00 33 250.00 100.00 33 250.00 33 250.00 0.00 No n/a
31. TICSALUT 40 800.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 12 475.00 62 375.00 100.00 62 375.00 62 375.00 0.00 No n/a
Page 1 of 2
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
ESTIMATED BUDGET FOR THE ACTION Associated with document Ref. Ares(2020)2778062 - 28/05/2020
Estimated eligible1 costs (per budget category) EU contribution Additional information
B. Direct costs of [C. Direct costs Reimbursement Maximum EU Maximum Information for Information Other
A. Direct personnel costs D. Other direct costs E. Indirect costs2 Total costs
subcontracting of fin. support] rate % contribution3 grant amount4 indirect costs for auditors information:
A.1 Employees (or equivalent) A.4 SME owners without salary D.1 Travel D.5 Costs Estimated Declaration of Estimated costs
of internally costs of in-kind costs under Point of beneficiaries/
A.2 Natural persons under direct A.5 Beneficiaries that are natural D.2 Equipment invoiced goods contributions not D.4 linked third
contract persons without salary and services used on premises parties not
D.3 Other goods receiving
A.3 Seconded persons and services funding/
international
[A.6 Personnel for providing access [D.4 Costs of partners
to research infrastructure] large research
infrastructure]
Flat-rate10
Form of costs6 Actual Unit7 Unit8 Actual Actual Actual Unit9
25%
h = 0,25 x (a j = a+b+c+d
a Total b No hours Total c d [e] f Total g +b+c+f+g +[e]+f+g+h k l m n Yes/No
+[i1]13+[i2]13-n) +[i1]+[i2]
32. Equalis AB 40 000.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 12 275.00 61 375.00 100.00 61 375.00 61 375.00 0.00 No n/a
33. SEHA 0.00 0.00 0.00 0.00 0.00 0.00 18 200.00 0.00 4 550.00 22 750.00 100.00 22 750.00 22 750.00 0.00 No n/a
34. INSERM 24 000.00 0.00 0.00 0.00 0.00 0.00 9 100.00 0.00 8 275.00 41 375.00 100.00 41 375.00 41 375.00 0.00 No n/a
Total consortium 1 678 085.00 0.00 250 000.00 0.00 521 899.00 0.00 549 996.00 2 999 980.00 2 999 980.00 2 999 980.00 0.00
1 See Article 6 for the eligibility conditions.
2 Indirect costs already covered by an operating grant (received under any EU or Euratom funding programme; see Article 6.5.(b)) are ineligible under the GA. Therefore, a beneficiary/linked third party that receives an operating grant during the action's duration cannot declare indirect costs for the year(s)/reporting period(s) covered by the
operating grant, unless it can demonstrate that the operating grant does not cover any costs of the action (see Article 6.2.E).
3 This is the theoretical amount of EU contribution that the system calculates automatically (by multiplying all the budgeted costs by the reimbursement rate). This theoretical amount is capped by the 'maximum grant amount' (that the Commission decided to grant for the action) (see Article 5.1).
4 The 'maximum grant amount' is the maximum grant amount decided by the Commission. It normally corresponds to the requested grant, but may be lower.
5 Depending on its type, this specific cost category will or will not cover indirect costs. Specific unit costs that include indirect costs are: costs for energy efficiency measures in buildings, access costs for providing trans-national access to research infrastructure and costs for clinical studies.
6 See Article 5 for the forms of costs.
7 Unit : hours worked on the action; costs per unit (hourly rate) : calculated according to the beneficiary's usual accounting practice.
8 See Annex 2a 'Additional information on the estimated budget' for the details (costs per hour (hourly rate)).
9 Unit and costs per unit : calculated according to the beneficiary's usual accounting practices.
10 Flat rate : 25% of eligible direct costs, from which are excluded: direct costs of subcontracting, costs of in-kind contributions not used on premises, direct costs of financial support, and unit costs declared under budget category F if they include indirect costs (see Article 6.2.E).
11 See Annex 2a 'Additional information on the estimated budget' for the details (units, costs per unit).
12 See Annex 2a 'Additional information on the estimated budget' for the details (units, costs per unit, estimated number of units, etc).
13 Only specific unit costs that do not include indirect costs.
14 See Article 9 for beneficiaries not receiving funding.
15 Only for linked third parties that receive funding.
Page 2 of 2
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Templates: Annex 2a (Additional information on the estimated budget)
ANNEX 2a
ADDITIONAL INFORMATION ON THE ESTIMATED BUDGET
Instructions and footnotes in blue will not appear in the text generated by the IT system (since they
are internal instructions only).
For options [in square brackets]: the applicable option will be chosen by the IT system. Options not
chosen will automatically not appear.
For fields in [grey in square brackets] (even if they are part of an option as specified in the previous
item): IT system will enter the appropriate data.
Transitory period: Until SyGMa fully supports Annex 2a, you must prepare it manually (using this
template by choosing and deleting the options/entering the appropriate data).
For the ‘unit cost tables’: either fill them out manually or use currently existing tables from Annex 1 or
the proposal.
The document can then be uploaded in SyGMa and attached to the grant agreement.
Unit cost for SME owners/natural beneficiaries without salary
1. Costs for a [SME owner][beneficiary that is a natural person] not receiving a salary
Units: hours worked on the action
Amount per unit (‘hourly rate’): calculated according to the following formula:
{the monthly living allowance for researchers in MSCA-IF actions / 143 hours}
multiplied by
{country-specific correction coefficient of the country where the beneficiary is established}
The monthly living allowance and the country-specific correction coefficients are set out in the Work
Programme (section 3 MSCA) in force at the time of the call:
- for calls before Work Programme 2018-2020:
- for the monthly living allowance: EUR 4 650
- for the country-specific correction coefficients: see Work Programme 2014-2015 and Work
Programme 2016-2017 (available on the Participant Portal Reference Documents page)
- for calls under Work Programme 2018-2020:
- for the monthly living allowance: EUR 4 880
- for the country-specific correction coefficients: see Work Programme 2018-2020 (available on the
Participant Portal Reference Documents page)
[additional OPTION for beneficiaries/linked third parties that have opted to use the unit cost (in the
proposal/with an amendment): For the following beneficiaries/linked third parties, the amounts per unit
(hourly rate) are fixed as follows:
- beneficiary/linked third party [short name]: EUR [insert amount]
- beneficiary/linked third party [short name]: EUR [insert amount]
[same for other beneficiaries/linked third parties, if necessary] ]
Estimated number of units: see Annex 2
1
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Templates: Annex 2a (Additional information on the estimated budget)
Energy efficiency measures unit cost
2. Costs for energy efficiency measures in buildings
Unit: m2 of eligible ‘conditioned’ (i.e. built or refurbished) floor area
Amount per unit*: see (for each beneficiary/linked third party and BEST table) the ‘unit cost table’ attached
* Amount calculated as follows:
{EUR 0.1 x estimated total kWh saved per m² per year x 10}
Estimated number of units: see (for each beneficiary/linked third party and BEST table) the ‘unit cost table’
attached
Unit cost table (energy efficiency measures unit cost)1
Short name beneficiary/linked BEST No Amount per unit Estimated No of Total unit cost
third party units (cost per unit x
estimated no of units)
1
Data from the ‘building energy specification table (BEST)’ that is part of the proposal and Annex 1.
2
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Templates: Annex 2a (Additional information on the estimated budget)
Research infrastructure unit cost
3. Access costs for providing trans-national access to research infrastructure
Units2: see (for each access provider and installation) the ‘unit cost table’ attached
Amount per unit*: see (for each access provider and installation) the ‘unit cost table’ attached
* Amount calculated as follows:
average annual total access cost to the installation (over past two years 3)
________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
average annual total quantity of access to the installation (over past two years4)
Estimated number of units: see (for each access provider and installation) the ‘unit cost table’ attached
Unit cost table (access to research infrastructure unit cost)5
Short name Short Installation Unit of Amount per Estimated No Total unit
access name access unit of units cost (cost per
provider infrastru unit x estimated
No Short name no of units)
cture
Clinical studies unit cost
4. Costs for clinical studies
Units: patients/subjects that participate in the clinical study
Amount per unit*: see (for each sequence (if any), clinical study and beneficiary/linked third party) the ‘unit
cost table’ attached
* Amount calculated, for the cost components of each task, as follows:
For personnel costs:
For personnel costs of doctors: ‘average hourly cost for doctors’, i.e.:
{certified or auditable total personnel costs for doctors for year N-1
_____________________________________________________________________________________________________________________________ ____________________________________________________
{1720 * number of full-time-equivalent for doctors for year N-1}
multiplied by
estimated number of hours to be worked by doctors for the task (per participant)}
For personnel costs of other medical personnel: ‘average hourly cost for other medical personnel’, i.e.:
{certified or auditable total personnel costs for other medical personnel for year N-1
_____________________________________________________________________________________________________________________________ _______________________________________________________
_
{1720 * number of full-time-equivalent for other medical personnel for year N-1}
2
Unit of access (e.g. beam hours, weeks of access, sample analysis) fixed by the access provider in proposal.
3
In exceptional and duly justified cases, the Commission/Agency may agree to a different reference period.
4
In exceptional and duly justified cases, the Commission/Agency may agree to a different reference period.
5
Data from the ‘table on estimated costs/quantity of access to be provided’ that is part of the proposal and
Annex 1.
3
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Templates: Annex 2a (Additional information on the estimated budget)
multiplied by
estimated number of hours to be worked by other medical personnel for the task (per participant)}
For personnel costs of technical personnel: ‘average hourly cost for technical personnel’, i.e.:
{certified or auditable total personnel costs for technical personnel for year N-1
____________________________________________________________________________________________________________________________ ________________________________________________________
_
{1720 * number of full-time-equivalent for technical personnel for year N-1}
multiplied by
estimated number of hours to be worked by technical personnel for the task (per participant)}
‘total personnel costs’ means actual salaries + actual social security contributions + actual taxes and other
costs included in the remuneration, provided they arise from national law or the employment
contract/equivalent appointing act
For consumables:
For each cost item: ‘average price of the consumable’, i.e.:
{{certified or auditable total costs of purchase of the consumable in year N-1
___________________________________________________________________________________________________________________ ____________________________________
total number of items purchased in year N-1}
multiplied by
estimated number of items to be used for the task (per participant)}
‘total costs of purchase of the consumable’ means total value of the supply contracts (including
related duties, taxes and charges such as non-deductible VAT) concluded by the beneficiary
for the consumable delivered in year N-1, provided the contracts were awarded according to
the principle of best value- for-money and without any conflict of interests
For medical equipment:
For each cost item: ‘average cost of depreciation and directly related services per unit of use’, i.e.:
{{ certified or auditable total depreciation costs in year N-1 + certified or auditable total costs of
purchase of services in year N-1 for the category of equipment concerned}
_____________________________________________________________________________________________________________________________ _______________________
total capacity in year N-1
multiplied by
estimated number of units of use of the equipment for the task (per participant)}
‘total depreciation costs’ means total depreciation allowances as recorded in the beneficiary’s
accounts of year N-1 for the category of equipment concerned, provided the equipment was
purchased according to the principle of best value for money and without any conflict of
interests + total costs of renting or leasing contracts (including related duties, taxes and charges
such as non-deductible VAT) in year N-1 for the category of equipment concerned, provided
they do not exceed the depreciation costs of similar equipment and do not include finance fees
For services:
For each cost item: ‘average cost of the service per study participant’, i.e.:
{certified or auditable total costs of purchase of the service in year N-1
______________________________________________________________________________________________________________________________________________________
total number of patients or subjects included in the clinical studies for which the service was
delivered in year N-1}
‘total costs of purchase of the service’ means total value of the contracts concluded by the
beneficiary (including related duties, taxes and charges such as non-deductible VAT) for the
specific service delivered in year N-1 for the conduct of clinical studies, provided the contracts
were awarded according to the principle of best value for money and without any conflict of
interests
For indirect costs:
{{{cost component ‘personnel costs’ + cost component ‘consumables’ + cost component ‘medical
equipment’}
minus
{costs of in-kind contributions provided by third parties which are not used on the beneficiary’s premises
+ costs of providing financial support to third parties (if any)}}
multiplied by
25%}
4
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Templates: Annex 2a (Additional information on the estimated budget)
The estimation of the resources to be used must be done on the basis of the study protocol and must be the
same for all beneficiaries/linked third parties/third parties involved.
The year N-1 to be used is the last closed financial year at the time of submission of the grant application.
Estimated number of units: see (for each clinical study and beneficiary/linked third party) the ‘unit cost table’
attached
Unit cost table: clinical studies unit cost6
Costs year Costs year Costs year Costs year Costs
N-1 N-1 N-1 N-1 year N-1
Task, Direct cost Resource per Beneficiary Linked Beneficiary Linked Third
categories patient 1 third party 2 third party party
[short 1a [short 2a giving in-
name] [short name] [short kind
name] name] contributi
ons 1
[short
name]
Sequence No. 1
Task No. 1
Blood sample
(a) Personnel costs:
- Doctors
n/a
- Other Medical Phlebotomy 8,33 EUR 11,59 EUR 10,30 EUR 11,00 EUR 9,49 EUR
Personnel (nurse), 10
minutes
- Technical Personnel Sample 9,51 EUR 15,68 EUR 14,60 EUR 15,23 EUR 10,78
Processing (lab EUR
technician), 15
minutes
(b) Costs of Syringe XX EUR XX EUR XX EUR XX EUR XX EUR
consumables:
Cannula XX EUR XX EUR XX EUR XX EUR XX EUR
Blood container XX EUR XX EUR XX EUR XX EUR XX EUR
(c) Costs of medical Use of -80° deep XX EUR XX EUR XX EUR XX EUR XX EUR
equipment: freezer, 60 days
Use of centrifuge, XX EUR XX EUR XX EUR XX EUR XX EUR
15 minutes
(d) Costs of services Cleaning of XXX XX EUR XX EUR XX EUR XX EUR XX EUR
(e) Indirect costs (25% flat-rate) XX EUR XX EUR XX EUR XX EUR XX EUR
Task No. 2
…
Amount per unit (unit cost sequence 1): XX EUR XX EUR XX EUR XX EUR XX EUR
Sequence No. 2
Task No. 1
6
Same table as in proposal and Annex 1.
5
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Templates: Annex 2a (Additional information on the estimated budget)
XXX
(a) Personnel costs:
- Doctors
XXX XX EUR XX EUR XX EUR XX EUR XX EUR
- Other Medical XXX XX EUR XX EUR XX EUR XX EUR XX EUR
Personnel
- Technical Personnel XXX XX EUR XX EUR XX EUR XX EUR XX EUR
(b) Costs of XXX XX EUR XX EUR XX EUR XX EUR XX EUR
consumables:
XXX XX EUR XX EUR XX EUR XX EUR XX EUR
XXX XX EUR XX EUR XX EUR XX EUR XX EUR
(c) Costs of medical XXX XX EUR XX EUR XX EUR XX EUR XX EUR
equipment:
XXX XX EUR XX EUR XX EUR XX EUR XX EUR
(d) Costs of services XXX XX EUR XX EUR XX EUR XX EUR XX EUR
(e) Indirect costs (25% flat-rate) XX EUR XX EUR XX EUR XX EUR XX EUR
Task No. 2
…
Amount per unit (unit cost sequence 2): XX EUR XX EUR XX EUR XX EUR XX EUR
…
Amount per unit (unit cost entire study): XX EUR XX EUR XX EUR XX EUR XX EUR
]
6
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
BUNDESMINISTERIUM FUER ARBEIT, SOZIALES, GESUNDHEIT UND
KONSUMENTENSCHUTZ (ATNA), established in Radetzkystrasse 2, WIEN 1030, Austria, (‘the
beneficiary’), represented for the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘2’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-999467243_75_210--]
Robert SCHARINGER with ECAS id nshariro signed in the
Participant Portal on 08/06/2020 at 08:16:42 (transaction id SigId-
6367-
PRC0cExzGoriAWfwE7kvEBP9Z6JuEAy9Zp2cTvQDULCu7lUYNE
c0BSKK6IDMTFpc1O3STfsRApXyv8MDZtsOIa-
rS0vSrmBGYCubIhZmPp76e-
jgHat66bjgpAfFrnYT43PAEbGvDNzv8CcyTkNAj3hE7t6K3a88At7j
R3WlA3zcSm4BXv2WwOOaZgYc4uBTvU9x). Timestamp by third
party at
Mon Jun 08 09:16:52 CEST 2020
1
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
GESUNDHEIT OSTERREICH GMBH (GÖG), established in STUBENRING 6, WIEN 1010,
Austria, VAT number: ATU62777178, (‘the beneficiary’), represented for the purpose of signing this
Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘3’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-928836208_75_210--]
Claudia HABL with ECAS id nhablhcl signed in the Participant
Portal on 04/06/2020 at 19:34:30 (transaction id SigId-346-
NnvMGssww9PGF8GC9b1k2yvp4bPQiU4ZHKyqjq0AkyuiPU
C3wLCuoIdfXvGAhfdVwlTV6QGAzVroKi1UzVYQKc-
rS0vSrmBGYCdSIzzSbUCdZm-
SAIlcFZwqBkyr4K5a0cuYazHU5gA4bec1wi5evxFZFIbzhsBM
S38UzwG4V9wyxhHR1xbD2040NurIwzOpJRdhRO).
Timestamp by third party at
Thu Jun 04 20:34:41 CEST 2020
2
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
SERVICE PUBLIC FEDERAL SANTE PUBLIQUE, SECURITE DE LA CHAINE
ALIMENTAIRE ET ENVIRONNEMENT (FPS Health Be), established in SQUARE VICTOR
HORTA 40 BUR 1D 1G, BRUSSELS 1060, Belgium, VAT number: N/A, (‘the beneficiary’),
represented for the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘4’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-998853815_75_210--]
Els EEMAN with ECAS id neemanel signed in the Participant
Portal on 04/06/2020 at 09:08:16 (transaction id SigId-73192-
MQOR7O8dueywpeaZYcyGLIOVvfio0qXO4HRE0BuqQMCq
RPbtigYqfzut0MBmOcHKp0TN9WKzxiBeQsPlweibqZ-
jpJZscgsw0K73X2i3UbBsu-
tvGrfIW92sd9guQqj4uqeRxBUUcohukuRmZK6K1q38QBpsh
IXNwSWe1memrVzGbhtZiFHrjlwyzgnuRaP6Lxgd).
Timestamp by third party at
Thu Jun 04 10:08:22 CEST 2020
3
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
INTEGRATING THE HEALTHCARE ENTERPRISE-EUROPE AISBL (IHE-EUR),
established in BOULEVARD AUGUSTE REYERS 80, BRUXELLES 1030, Belgium, (‘the
beneficiary’), represented for the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘5’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-998727133_75_210--]
Els Kooij with ECAS id n001yyfq signed in the Participant
Portal on 09/06/2020 at 10:39:05 (transaction id SigId-9991-
HbFxYEcL8SoTjr2puzKyKJ96BstckuuUls1W2tvwM4SzU7N
BcNzHnuELYXmZzVsyyqijx9uvZLtA9gOsUFOM4oi-
rS0vSrmBGYC6zl2UmTgCaa-
eJulANaerzM5YwQKqYTpUxzypHIEkAw2slDkBaHcAhMdY
NQlygb7CvShjgwJhiczrBjSfVbY9mGZChqPlB7f5BW).
Timestamp by third party at
Tue Jun 09 11:39:12 CEST 2020
4
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
HL7 INTERNATIONAL FONDATION (HL7 Europe), established in SQUARE DE MEEUS
38-40, BRUSSELS 1000, Belgium, (‘the beneficiary’), represented for the purpose of signing this
Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘6’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-974224448_75_210--]
Catherine CHRONAKI with ECAS id nchroncn signed in the
Participant Portal on 04/06/2020 at 08:14:08 (transaction id SigId-
72400-
sczU6T1an8YrEK3qQDVTzZWKdZrX110iuzPEG2HG1Zo4nY0do
ODrG3HDrJcigMF0B6vP8nYVY5NLbzMm206thoS-
jpJZscgsw0K73X2i3UbBsu-
i9x63pMUizZuJLaTyooQ9LtgXFw7HCukTCc1gcnV20MeL1FBnn0
XffriBtq8lEzhYgp85BtZ9YQgSTWZHX2BzQm). Timestamp by
third party at
Thu Jun 04 09:14:13 CEST 2020
5
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
STICHTING KONINKLIJK NEDERLANDS NORMALISATIE INSTITUUT (NEN),
established in VLINDERWEG 6, DELFT 2623 AX, Netherlands, VAT number: NL002814237B01,
(‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘7’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-999631755_75_210--]
Rik van Terwisga with ECAS id n00219i0 signed in the Participant
Portal on 10/06/2020 at 10:44:26 (transaction id SigId-20716-
0LuVcLj9D9gRdGWx8h9IRmVaVckmp4kZyjpZ9MeniARzsAwszKL
kmX2liqCJS3oL32pSet7h2lsF3N7zqvgO2mm-
rS0vSrmBGYC6zl2UmTgCaa-
QsLIbCHUFHgAQbNyioKsCFMF2Yait3KlIqe9JCF64agRzZcm75R
FhVMemncYzmGDxwOzeB2Pl8jrjLd1Whg0ONm). Timestamp by
third party at
Wed Jun 10 11:44:33 CEST 2020
6
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
HRVATSKI ZAVOD ZA ZDRAVSTVENO OSIGURANJE (HZZO), established in
MARGARETSKA 3, ZAGREB 10000, Croatia, VAT number: HR3580261, (‘the beneficiary’),
represented for the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘8’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-952813541_75_210--]
Lucian Vukelić with ECAS id n00292h5 signed in the Participant
Portal on 05/06/2020 at 12:18:46 (transaction id SigId-82607-
xzUzyisTKYm6Ky57RnDclf6nqvR25XmD88zsDcq1ha16xhPSS
QzxYRabADXWpzRH17gKL5LykQlCZFco5MMMK8P-
jpJZscgsw0K73X2i3UbBsu-
SN8zPRDoszxZKCNQbiGGKlMW5zY3zdzdPhDVPy1gQCDozTj
4H60L52k8200Sq3lKx6xdpHwBZ2NiDXCMUMzviOpG).
Timestamp by third party at
Fri Jun 05 13:18:56 CEST 2020
7
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
UNIVERSITY OF CYPRUS (UCY), established in KALLIPOLEOS STREET 75, NICOSIA 1678,
Cyprus, VAT number: CY90001673W, (‘the beneficiary’), represented for the purpose of signing this
Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘9’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-999835843_75_210--]
Marios DEMETRIADES with ECAS id ndmemari signed in the
Participant Portal on 04/06/2020 at 08:22:50 (transaction id SigId-
72528-
IYZFnLqLjbIolYzYLhJ8O0lioR9loesL0l4evD5H1aJgbE2lM6Yc4bPl
c03ZDJkNX1NlR7N4QuJG4fQ60sInzR-
jpJZscgsw0K73X2i3UbBsu-
MNuFPytDfJj2JSTAAcmA3gzI1owv6WtD5WIafXrugnhIzITk601ZF
MBQKi9rKKcJhN9dQdUPLIWxp4SYDGiB0U). Timestamp by third
party at
Thu Jun 04 09:22:58 CEST 2020
8
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
MINISTERSTVO ZDRAVOTNICTVI CESKE REPUBLIKY (MZCR), established in
PALACKEHO NAMESTI 375/4, PRAHA 12801, Czech Republic, (‘the beneficiary’), represented
for the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘10’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-924144512_75_210--]
Adam Vojtěch with ECAS id n003f2zf signed in the Participant
Portal on 30/06/2020 at 09:46:05 (transaction id SigId-8574-
bdozmBfDDezexbbWcCzvvqa2l6Vfmx5kt28gsrRzsA3oFWFD
gfzMYvQHzU2tOkDiZWSSzYtD5p3zizNzarvouRtuS-
rS0vSrmBGYCccyzjTUxfs7-
ILSgAxMErl3PDI3mKFP9w4yxJZIuxZumo0Gkps2m4D7CJNf
L6wBEGpsTls43zn2ADGjkTB6yYiK7sYrCNWUgHa).
Timestamp by third party at
Tue Jun 30 10:46:14 CEST 2020
9
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
VYSOCINA KRAJ (Kraj Vysočina), established in ZIZKOVA 57, JIHLAVA 587 33, Czech
Republic, VAT number: CZ70890749, (‘the beneficiary’), represented for the purpose of signing this
Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘11’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-997519289_75_210--]
Jiri Behounek with ECAS id n003ad0q signed in the Participant
Portal on 22/06/2020 at 13:08:04 (transaction id SigId-105828-
5kvgR17Afqafwf86Knr6CXGxZ3FuDPzuF0ANMUMS0tbd04zq
mZLk4Axu6jbajjrtxkVA1wchJQIHAo8XvvszIKW-
rS0vSrmBGYC6zl2UmTgCaa-
88JiatddJUBzpsTTSPqXcbkt3zNNGkZD0KcpI0fg8y6SqFQAzf
Rv1uHUjjP2fRo8zotsHp1TUzzs2ybVJKBo7xTm). Timestamp
by third party at
Mon Jun 22 14:08:14 CEST 2020
10
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
SOTSIAALMINISTEERIUM (MSAE), established in Suur-Ameerika 1, TALLINN 10122,
Estonia, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the
undersigned,
hereby agrees
to become beneficiary No (‘12’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-998429731_75_210--]
Marika PRISKE with ECAS id nprmaika signed in the Participant
Portal on 22/06/2020 at 05:52:52 (transaction id SigId-101361-
fzNSuUO3Qn25Mb7bPewjAChMat72DocVG6jsRNE9ATbSNnO
G8uTlTqigTaQrzrNEme6Ot5enzdg92IhLXGbyNs0-
rS0vSrmBGYC6zl2UmTgCaa-
IMAdGiByOHQk9ihNAflYzhpgQqHKVzZVS5zPmVmapNhYDXC
0aVsqkF3pZ7FXyGKPp0ND5CyG2YzdoFc6VUl1Rn4).
Timestamp by third party at
Mon Jun 22 06:53:05 CEST 2020
11
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
AGENCE DU NUMÉRIQUE EN SANTÉ (ANS), established in RUE GEORGES PITARD 9,
PARIS 75015, France, (‘the beneficiary’), represented for the purpose of signing this Accession Form
by the undersigned,
hereby agrees
to become beneficiary No (‘13’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-998944025_75_210--]
Pascale SAUVAGE with ECAS id nsauvpas signed in the
Participant Portal on 12/06/2020 at 08:56:53 (transaction id SigId-
39459-
fxmMwPwyJs3JXKO3NIJIXe5FjNqqEHzMjCMhDkL6zL8Iepg5cKR
N1zzjEn07cK0G1toKGUtolRXIPiK3walICQi-
rS0vSrmBGYC6zl2UmTgCaa-
zpPd8GzcVemZfIoiMX3620NZzs779CfiKJ4MGzzkIcYsx5TG5zeOI
ALxOWt1T9rWTziWb0UyjNzpPOXNkozuWmT6m). Timestamp by
third party at
Fri Jun 12 09:57:02 CEST 2020
12
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
MINISTERE DES AFFAIRES SOCIALES ET DE LA SANTE (MoH-FR), established in
AVENUE DUQUESNE 14, PARIS CEDEX 75350, France, VAT number: N/A, (‘the beneficiary’),
represented for the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘14’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-998887377_75_210--]
Laura Létourneau with ECAS id n003aews signed in the
Participant Portal on 23/06/2020 at 18:12:50 (transaction id SigId-
119974-
QxzoKB1XQoqqCymD5vPuYt8FfSb0i4SeaAG4YOQIPIXmjDPAQz
JHdzZmcIXdYn0gOlu24fIQiwk2w18Phw6ddBW-
rS0vSrmBGYC6zl2UmTgCaa-
1K16mzqoog9dMHrs8sM9sAff8KQc6otqSOTxespkzuyPG4LcBoge
WwFdKc1zzzdmftcf625HzRGOzmzuhI8cfWg6). Timestamp by
third party at
Tue Jun 23 20:13:05 CEST 2020
13
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
DEUTSCHES INSTITUT FUR MEDIZINISCHE DOKUMENTATION UND INFORMATION
(DIMDI) (DIMDI), established in WAISENHAUSGASSE 36-38A, KOLN 50676, Germany, VAT
number: DE123052538, (‘the beneficiary’), represented for the purpose of signing this Accession
Form by the undersigned,
hereby agrees
to become beneficiary No (‘15’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-929135065_75_210--]
Weber STEFANIE with ECAS id nstefweb signed in the Participant
Portal on 30/06/2020 at 08:55:21 (transaction id SigId-7569-
TuBOzRvw5g52y9VQsFD4R3VDSbfHKXenBzGHicL6IZafcVTzgU
qMiqr5JFUdQubqhRgizJwNaPwB4YgpREJzpLf-
rS0vSrmBGYCccyzjTUxfs7-
rwhwlgk0MET6ZXzjXtHdq6157HdCDsHNoO8TcnAGjirfHBkF0l2u8
9Nv8I5gzqnvBT0gudAQUouhNXq6xpN0bzm). Timestamp by third
party at
Tue Jun 30 09:55:30 CEST 2020
14
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
GEMATIK GMBH (GEMATIK), established in FRIEDRICHSTRASSE 136, BERLIN 10117,
Germany, VAT number: DE241843684, (‘the beneficiary’), represented for the purpose of signing
this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘16’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-998915022_75_210--]
Stefan Höcherl with ECAS id n003eubh signed in the Participant
Portal on 25/06/2020 at 16:13:39 (transaction id SigId-19701-
yPV0zbliDhUOSi1W5e1OzrzJ9QZqL19Hl2VIJ6FGdcsXI1zrzfZV
3jN50f0xBxVnSGJIMCqFyLWLV5Aql4oI7R5-
jpJZscgsw0KNihoCvhiTby-
4cFpejPWRJ8ZoYVPR8WfZjA1I3JsH7HR5f6rkbkgfTjcRlp7wTu
3qjUGNGDesxWqo56pCUTXEZv3vek9PF8DMW). Timestamp
by third party at
Thu Jun 25 17:13:46 CEST 2020
15
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE
MEDIZINISCHE FORSCHUNG EV (TMF), established in CHARLOTTENSTRASSE 42
ECKE DOROTHEENSTRASSE, BERLIN 10117, Germany, VAT number: DE244871253, (‘the
beneficiary’), represented for the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘17’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-984108457_75_210--]
Karoline Buckow with ECAS id n002zuwf signed in the Participant
Portal on 30/06/2020 at 11:37:17 (transaction id SigId-10805-
5szwCDPL7yvGLLqBzkHANY6fzLqW4zhoRI4FbEjJlzPmJZ3tWhN
9zR5IVAip66IVyv07qgCNdwJRnx8JxHJXnvZm-
rS0vSrmBGYCccyzjTUxfs7-
t53ID7Fb5CyDpFctmIuzfHvzHU5JrA4i3p7i4ghIib3uztlCK6KMzQm
43k3aZOcyfzkwQtYTuA1A9HpcRr3be3H). Timestamp by third
party at
Tue Jun 30 12:37:24 CEST 2020
16
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
MINISTRY OF HEALTH (MoHGR), established in ARISTOTELOUS STREET 17, ATHINA,
Greece, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the
undersigned,
hereby agrees
to become beneficiary No (‘18’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-950261665_75_210--]
Konstantinos Gogosis with ECAS id n0027t8y signed in the
Participant Portal on 09/06/2020 at 17:31:58 (transaction id SigId-
16107-
owROZLQzUgp55UnoqKoRjX8EObYusLNrHpSEdB651azZBKNb
GlRtUCtWh9kzbIJqSi17zPNDYJr0DacP3zq7YVf-
rS0vSrmBGYC6zl2UmTgCaa-
zaL7GkvIGA0tSAzkc4lUyh7K2wPC2fb6SshmALlVIBUzNRzG4Y8
BVvMS9SBrYLUxrGogmMUXfuNX5UB2tqKa1GO). Timestamp by
third party at
Tue Jun 09 18:32:07 CEST 2020
17
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
ALLAMI EGESZSEGUGYI ELLATO KOZPONT (AEEK), established in DIOS AROK 3,
BUDAPEST 1125, Hungary, VAT number: HU15324683, (‘the beneficiary’), represented for the
purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘19’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-955290242_75_210--]
Miklós GONDOS DR. with ECAS id n00298lv signed in the
Participant Portal on 29/06/2020 at 15:09:04 (transaction id SigId-
2518-
gFvqhIXCUeZiBzOdQ0uADaRE2IzlU1GtkIRimARTJFBj1HY2mDfg
Gh6heczKQw47zUNHw7vVJejhY6aURVu9yH4-
rS0vSrmBGYCccyzjTUxfs7-
ImSVaBrLLKY4v79sQzHOlWzSvAtO3HdgtPltxT1p5FMErrwD2zM
VSzG6bW46hdA62YWJOvv9kofzOX0g6O8a11R). Timestamp by
third party at
Mon Jun 29 16:09:15 CEST 2020
18
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
SEMMELWEIS EGYETEM (SE), established in ULLOI UTCA 26, BUDAPEST 1085, Hungary,
VAT number: HU15329808, (‘the beneficiary’), represented for the purpose of signing this Accession
Form by the undersigned,
hereby agrees
to become beneficiary No (‘20’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-999860675_75_210--]
Béla Dr. Merkely with ECAS id n002coer signed in the Participant
Portal on 17/06/2020 at 14:17:22 (transaction id SigId-76552-
uM86fWVZB06HfgXdHjouERCBDFblDnSjhaMdp4FzPyL2lbPtjnb
P6sLkel3QS51TeDsN55ipSbrh8qU7bC3Fi0-
rS0vSrmBGYC6zl2UmTgCaa-
XpYCJXj0XY6zxB6n9eALhLm7WLWK80k48IHB6AcazaS4F1Q2
p1Z1WE5XxfTCqgibgdaPJIbZ6G3YuRYd8mNzxp0). Timestamp
by third party at
Wed Jun 17 15:17:32 CEST 2020
19
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
DEPARTMENT OF HEALTH (DoH), established in Block 1, Miesian Plaza, 50 – 58 Lower Baggot
Street, Dublin D02 XW14, Ireland, (‘the beneficiary’), represented for the purpose of signing this
Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘21’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-972459824_75_210--]
Sarah Murphy with ECAS id n0028css signed in the Participant
Portal on 04/06/2020 at 10:27:56 (transaction id SigId-74711-
db0V9DLP3zzOtDStkbTjt2uMRtHDKlXxipN10RQlovPnKK0fCs
0nnud5fJwOebZoWIJV59jT0fpBmPQFx46I8Q-
jpJZscgsw0K73X2i3UbBsu-
iD2Ch8SKU4kCxwTmmKt2RGiUUyXDDT5lxJm32Sx97yvNn32
1uRpYo4DhoziSXmZqApvO4zm3zzIkJqxgknU5OXW).
Timestamp by third party at
Thu Jun 04 11:28:11 CEST 2020
20
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
AGENZIA PER L'ITALIA DIGITALE (AGID), established in VIA LISZT 21, ROMA 00144,
Italy, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the
undersigned,
hereby agrees
to become beneficiary No (‘22’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-950972578_75_210--]
Francesco Paorici with ECAS id n0038zfv signed in the Participant
Portal on 30/06/2020 at 17:36:13 (transaction id SigId-15990-
XNBKfy4MIXy3TpPZJBT39wDVCuzUrlysSXhEjGKhPzk7Rj31zUc
CsbuSI9NsN6ATl1TQ0UgpdYUePAbRaG2r7e0-
rS0vSrmBGYCccyzjTUxfs7-
wuO3iQD93bfA8TX6NJHIeR9DLnKZP10esg6RzJ5WVHKcj1PbSX
Et8L1TRAg3cdBW2rQ1MwIqsyeLqgMCAzU6Nv). Timestamp by
third party at
Tue Jun 30 18:36:28 CEST 2020
21
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
AZIENDA REGIONALE PER L'INNOVAZIONEE GLI ACQUISTI S.P.A. (ARIA), established
in VIA TORQUATO TARAMELLI 26, MILANO 20124, Italy, VAT number: IT05017630152, (‘the
beneficiary’), represented for the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘23’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-985380127_75_210--]
Francesco Ferri with ECAS id n0030re3 signed in the Participant
Portal on 04/06/2020 at 08:11:45 (transaction id SigId-72359-
pCaacVKdvBgGhgbUBQPRGpK5RiU3H192obcqiD10r0dA30W3
sSgCDihUN0yylLK20zo97wAQTYgbUW1EvtaOu0-
jpJZscgsw0K73X2i3UbBsu-
rcfUgczoTPituUHkC5IOcLw9Grzcaoixpfh6CNMCwvS2WT7fVVr
gYaDaqTK1DM2aY6JG2uBaEM9ZLYH3qENtpn). Timestamp by
third party at
Thu Jun 04 09:11:51 CEST 2020
22
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
MINISTERO DELLA SALUTE (MIN SAL), established in Via Giorgio Ribotta 5, ROMA 00144,
Italy, VAT number: N/A, (‘the beneficiary’), represented for the purpose of signing this Accession
Form by the undersigned,
hereby agrees
to become beneficiary No (‘24’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-999531942_75_210--]
Giuseppe Viggiano with ECAS id n001zb0n signed in the
Participant Portal on 10/06/2020 at 10:56:08 (transaction id SigId-
20911-
3yaEk3bl3PpCJusainSAE7S80PPQUR1eMijUJ5JO0zTwhx4l56D2
P6JnERGhefziMn4e88AfMFUUKgSzt7XAunG-
rS0vSrmBGYC6zl2UmTgCaa-
PRwZD9kiN4w9ms0uLZaiSQXR3zIzzh58kuxD9kbdnqotKBnWzWI
4BgLje4uB0dL3Hy7QJ75dPvsXJWFzQTLKjIo). Timestamp by
third party at
Wed Jun 10 11:56:14 CEST 2020
23
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
REGIONE LOMBARDIA (REGLOMB), established in PIAZZA CITTA DI LOMBARDIA 1,
MILANO 20124, Italy, VAT number: IT12874720159, (‘the beneficiary’), represented for the purpose
of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘25’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-999654065_75_210--]
Marco Trivelli with ECAS id n003enuf signed in the Participant
Portal on 10/07/2020 at 14:14:11 (transaction id SigId-69417-
N42bDlnV2GaPRzQ85OiWZ2tXMiTyo3L00cIa70kPsgLs39Vw
0KwBcs0zifi9zQg5kNPcPWSVu2kVkCTdJBlDFzq-
jpJZscgsw0KmE9q55QdRE4-
Thlzq7ni6f0jMjoGEaS91gt6ScdiiIQr49ZszhhzjuXLfrSZ4rVDP
UzXot9Nya0jRUOg93s86sRwIpIrze5TUfp). Timestamp by
third party at
Fri Jul 10 15:14:18 CEST 2020
24
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
NACIONALAIS VESELIBAS DIENESTS (NVD), established in 31 Cēsu str., k-3, 6.entrance,
Riga LV-1012, Latvia, VAT number: 90009649337, (‘the beneficiary’), represented for the purpose
of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘26’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-952594224_75_210--]
Inga MILAŠEVIČA with ECAS id nmilasin signed in the Participant
Portal on 04/06/2020 at 11:48:31 (transaction id SigId-76100-
ZpIyn0B0F34xoHxOLmbwBc1kIQfRdTZNVwrRv7TrmRszazMQs4
8o8Yq6HTzbc5PHaPhbP434nozRQu97u97eQ2S-
jpJZscgsw0K73X2i3UbBsu-
hYDJcUnOWkT4gP9MIyMzOKaziCNEhVYtF4MK2PX44zIyE4k0e
MGbANcs7ZSOKfMmHfx8EzSf9rjOazzZ9ow415cG). Timestamp
by third party at
Thu Jun 04 12:48:41 CEST 2020
25
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (SAM), established in
VILNIAUS G 33, VILNIUS LT 01506, Lithuania, (‘the beneficiary’), represented for the purpose of
signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘27’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-933839468_75_210--]
Audrone ASTRAUSKIENE with ECAS id nastraau signed in the
Participant Portal on 08/06/2020 at 15:14:06 (transaction id SigId-
2776-
egHZD1GwDDOwRAtsZOszppSF4BVFTshoU8zKjZEXXIOuzWzL
QCAgLAZzyFdXXJv10iyDiDKziSIEt26zUgYjCx4S-
rS0vSrmBGYC6zl2UmTgCaa-
xxnklHbrPrBG7iQwfkaShzkjeBWIwktaTEjzLaSUuzdhcPVmwzlFe0
CVrn1cvteUea01Qdzyn0GU4ZdTfhqLNO6). Timestamp by third
party at
Mon Jun 08 16:14:13 CEST 2020
26
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
STICHTING NATIONAAL ICT INSTITUUT IN DE ZORG (NICTIZ), established in Oude
Middenweg 55, Den Haag 2491AC, Netherlands, (‘the beneficiary’), represented for the purpose of
signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘28’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-998830147_75_210--]
Leonique Niessen with ECAS id n002yny8 signed in the Participant
Portal on 22/06/2020 at 11:34:52 (transaction id SigId-104727-
jwLlWBqdI1FnU3ThahVdeY6dPp6zrKVzfzzRkUwaojzjBJ7Qoi6SK
LEuzrbmaJ159QrxE773JrRRNUEKgcamzc5i-
rS0vSrmBGYC6zl2UmTgCaa-
q7etizi8A2LMsnQN7rsSzqctRe6RuMT6vLd8eJUgkYdD7XlRrEPU
M6oQ0Y3NXSUdCJFoitLNmS2cBRpUGMMd2H). Timestamp by
third party at
Mon Jun 22 12:35:02 CEST 2020
27
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
NARODNE CENTRUM ZDRAVOTNICKYCH INFORMACII (NCZI), established in
LAZARETSKA 26, BRATISLAVA 811 09, Slovakia, VAT number: SK2020830119, (‘the
beneficiary’), represented for the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘29’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-998884370_75_210--]
Peter Bielik with ECAS id n003dmkt signed in the Participant
Portal on 18/06/2020 at 11:55:01 (transaction id SigId-85440-
Kgx25IFqzKodHXYyOeOOM2bVwGLDrtSx5BLElpeIRPfbzIb
n4iunzkrFzzHWGej9ycUqczmswttHYhVasbWmHNl0-
rS0vSrmBGYC6zl2UmTgCaa-
emOobHezfg7zY3cSEd5BDbw7PlwG8hYVRE6WT4yiAhYPv
USGXjbzPU7n1VKUv9XkiXESY7nSgeK9RisnmtaksRm).
Timestamp by third party at
Thu Jun 18 12:55:12 CEST 2020
28
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
NACIONALNI INSTITUT ZA JAVNO ZDRAVJE (NIJZ), established in TRUBARJEVA CESTA
2, LJUBLJANA 1000, Slovenia, VAT number: SI44724535, (‘the beneficiary’), represented for the
purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘30’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-948891346_75_210--]
Milan Krek with ECAS id n003bif0 signed in the Participant
Portal on 04/06/2020 at 09:48:48 (transaction id SigId-73913-
DavwADNc0MfWeay5laDdbCasHqyov4I4HjIR1qdMLtzaiPR
OiF5suGX3j3zfleFRUPeVbGtxkktMymX56mq9dF-
jpJZscgsw0K73X2i3UbBsu-
csb2GQsFprQ0alM2hqcKUK2eJSqV1J3zp2iLClAaUIlRYqRz
pcuodUjCqJQ6ypFw1nwdNoLCT8Ks7txr6vzd6i0).
Timestamp by third party at
Thu Jun 04 10:48:54 CEST 2020
29
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
FUNDACIO TICSALUT (TICSALUT), established in C ERNEST LLUCH 32 Planta 6 Porta 4
TECNOCAMPUS MATARO MARESME TORRE TCM 3, MATARO BARCELONA 08302, Spain,
VAT number: ESG64350374, (‘the beneficiary’), represented for the purpose of signing this Accession
Form by the undersigned,
hereby agrees
to become beneficiary No (‘31’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-998928408_75_210--]
JOSUE SALLENT RIBES with ECAS id n002am4g signed in the
Participant Portal on 04/06/2020 at 09:24:22 (transaction id SigId-
73515-
3j1OqSjTdmUYX8NmwmQLSTMPPavOoulIgC4wzJZ1f7yuq1Mt1A
rUWoKYip4zhgXLWa9jZ9p9N5DWRZRUTbq4EN-
jpJZscgsw0K73X2i3UbBsu-
uy3u9yyVQMiAImmpxSN1KYzQwjnZfOmnpLmCgdrJ03UoUZxpg
M7hvwnvSZ6B4xNOK37GQX3djbqLxWDlziGzzsC). Timestamp by
third party at
Thu Jun 04 10:24:28 CEST 2020
30
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
EQUALIS AB (Equalis AB), established in KUNGSGATAN 113, UPPSALA 751 09, Sweden, VAT
number: SE556515280701, (‘the beneficiary’), represented for the purpose of signing this Accession
Form by the undersigned,
hereby agrees
to become beneficiary No (‘32’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-898402846_75_210--]
Gunnar Nordin with ECAS id n002wchh signed in the Participant
Portal on 04/06/2020 at 18:44:20 (transaction id SigId-159-
zNqpLQtvtJmQqsq6yoKiTlkFDQxejt8B8De3mmzNWAQx4Bmd
SkUA8sszhsZt58XlIOXo0nBeQzzzt4NdvPU6wwyW-
rS0vSrmBGYCdSIzzSbUCdZm-
1bv15yB4pcMyOsk1bjzH6TvdtavznyaDozzfdCEW7XiKryzG5jzs
QAnyxBajDhR96UUi827Z9UAq1l9ezHRzg7RT). Timestamp by
third party at
Thu Jun 04 19:44:27 CEST 2020
31
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
E-HALSOMYNDIGHETEN (SEHA), established in SANK ERIKSGATAN 117, STOCKHOLM
118 60, Sweden, VAT number: SE202100655201, (‘the beneficiary’), represented for the purpose of
signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘33’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-933263676_75_210--]
Michele Silvestri with ECAS id n002v8z3 signed in the Participant
Portal on 13/06/2020 at 09:01:42 (transaction id SigId-47606-
AYwzWpr3zduOa4uhBNGKBCWp3JMyVlviRNzM0ZhXzfrVxSOr
DJNDFSRVQczSVGnrHI1nVIhSzka6KBnO9gVGznjW-
rS0vSrmBGYC6zl2UmTgCaa-
ezha5Q8eXQrAygcMU1zzkTBd35NJkIYGM45euSMqp1cQM8O
VDLhtcmBLdyjJLaaNc7758kIzhOHjALzV4hqF2cg). Timestamp
by third party at
Sat Jun 13 10:01:53 CEST 2020
32
Grant Agreement number: 951938 — X-eHealth — H2020-SC1-DTH-2018-2020 / H2020-SC1-DTH-2019-2
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),
established in RUE DE TOLBIAC 101, PARIS 75654, France, VAT number: FR31180036048, (‘the
beneficiary’), represented for the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘34’)
in Grant Agreement No 951938 (‘the Agreement’)
between SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE and the
European Union (‘the EU’), represented by the European Commission ('the Commission'),
for the action entitled ‘X-eHealth: eXchanging electronic Health Records in a commom framework
(X-eHealth)’.
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 55.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary
[--TGSMark#signature-999997833_75_210--]
Camille CHAUDONNERET with ECAS id nchaucmi signed in the
Participant Portal on 04/06/2020 at 13:58:41 (transaction id SigId-
78181-
eINtNY4jtIOPJdLIyG78DQdq744ehcWQXUiXeMk32jB7RxhdKW3s
6S1k04BK9umWEuPH4BgxTG30fzLTyIlENm-
jpJZscgsw0K73X2i3UbBsu-
zhDCdp2q00qqD04lKvBLzxTInGoObX8UV1PSMy0FTyXGzHNyu
BfJA0ZjrE4XBKQfOp4zLzJwjarmdmGYI1dFjFj). Timestamp by
third party at
Thu Jun 04 14:58:48 CEST 2020
33
i print format A4
MODEL ANNEX 4 FOR H2020 GENERAL MGA — MULTI Associated with document Ref. Ares(2020)2778062 - 28/05/2020
landscape
FINANCIAL STATEMENT FOR [BENEFICIARY [name]/ LINKED THIRD PARTY [name]] FOR REPORTING PERIOD [reporting period]
1 Additional
Eligible costs (per budget category) Receipts EU contribution
information
B. Direct costs [C. Direct
2 Reimburse Maximum EU Requested EU Information for
A. Direct personnel costs of costs of fin. D. Other direct costs E. Indirect costs [F. Costs of … ] Total costs Receipts
ment rate % contribution3 contribution indirect costs :
subcontracting support]
A.1 Employees (or A.4 SME owners [C.1 Financial D.1 Travel [D.4 Costs of D.5 Costs of [F.1 Costs of …] [F.2 Costs of …] Receipts of the Costs of in-kind
equivalent) without salary support] large research internally action, to be contributions not
infrastructure] invoiced goods reported in the used on premises
A.2 Natural persons under A.5 Beneficiaries that [C.2 Prizes] D.2 Equipment and services last reporting
direct contract are natural persons period, according
without salary to Article 5.3.3
A.3 Seconded persons D.3 Other goods
and services
[A.6 Personnel for providing
access to research
infrastructure]
5
Flat-rate
4 Actual Unit Unit Actual Actual Actual Actual Unit Unit [Unit][Lump sum]
Form of costs
25%
i=0,25 x (a+b+ k=
c+f+[g] + h+ Total a+b+c+d+[e] +f +
a Total b No hours Total c d [e] f [g] Total h No units Total [j2] l m n o p
6 6 [j1] [g] +h+ i +
[j 1 ] +[j2] -p) [j1] +[j2]
[short name
beneficiary/linked third
party]
The beneficiary/linked third party hereby confirms that:
The information provided is complete, reliable and true.
The costs declared are eligible (see Article 6).
The costs can be substantiated by adequate records and supporting documentation that will be produced upon request or in the context of checks, reviews, audits and investigations (see Articles 17, 18 and 22).
For the last reporting period: that all the receipts have been declared (see Article 5.3.3).
i Please declare all eligible costs, even if they exceed the amounts indicated in the estimated budget (see Annex 2). Only amounts that were declared in your individual financial statements can be taken into account lateron, in order to replace other costs that are found to be ineligible.
1
See Article 6 for the eligibility conditions
2
The indirect costs claimed must be free of any amounts covered by an operating grant (received under any EU or Euratom funding programme; see Article 6.2.E). If you have received an operating grant during this reporting period, you cannot claim indirect costs unless you can demonstrate that the operating grant
does not cover any costs of the action.
3
This is the theoretical amount of EU contribution that the system calculates automatically (by multiplying the reimbursement rate by the total costs declared). The amount you request (in the column 'requested EU contribution') may be less,
4
See Article 5 for the forms of costs
5
Flat rate : 25% of eligible direct costs, from which are excluded: direct costs of subcontracting, costs of in-kind contributions not used on premises, direct costs of financial support, and unit costs declared under budget category F if they include indirect costs (see Article 6.2.E)
6
Only specific unit costs that do not include indirect costs
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
ANNEX 5
MODEL FOR THE CERTIFICATE ON THE FINANCIAL STATEMENTS
For options [in italics in square brackets]: choose the applicable option. Options not chosen should
be deleted.
For fields in [grey in square brackets]: enter the appropriate data
TABLE OF CONTENTS
TERMS OF REFERENCE FOR AN INDEPENDENT REPORT OF FACTUAL FINDINGS ON COSTS
DECLARED UNDER A GRANT AGREEMENT FINANCED UNDER THE HORIZON 2020 RESEARCH
FRAMEWORK PROGRAMME
INDEPENDENT REPORT OF FACTUAL FINDINGS ON COSTS DECLARED UNDER A GRANT
AGREEMENT FINANCED UNDER THE HORIZON 2020 RESEARCH FRAMEWORK PROGRAMME
1
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Terms of Reference for an Independent Report of Factual Findings on costs declared
under a Grant Agreement financed under the Horizon 2020 Research and Innovation
Framework Programme
This document sets out the ‘Terms of Reference (ToR)’ under which
[OPTION 1: [insert name of the beneficiary] (‘the Beneficiary’)] [OPTION 2: [insert name of the
linked third party] (‘the Linked Third Party’), third party linked to the Beneficiary [insert name of the
beneficiary] (‘the Beneficiary’)]
agrees to engage
[insert legal name of the auditor] (‘the Auditor’)
to produce an independent report of factual findings (‘the Report’) concerning the Financial
1
Statement(s) drawn up by the [Beneficiary] [Linked Third Party] for the Horizon 2020 grant
agreement [insert number of the grant agreement, title of the action, acronym and duration from/to]
(‘the Agreement’), and
to issue a Certificate on the Financial Statements’ (‘CFS’) referred to in Article 20.4 of the Agreement
based on the compulsory reporting template stipulated by the Commission.
The Agreement has been concluded under the Horizon 2020 Research and Innovation Framework
Programme (H2020) between the Beneficiary and [OPTION 1: the European Union, represented by
the European Commission (‘the Commission’)][ OPTION 2: the European Atomic Energy Community
(Euratom,) represented by the European Commission (‘the Commission’)][OPTION 3: the [Research
Executive Agency (REA)] [European Research Council Executive Agency (ERCEA)] [Innovation and
Networks Executive Agency (INEA)] [Executive Agency for Small and Medium-sized Enterprises
(EASME)] (‘the Agency’), under the powers delegated by the European Commission (‘the
Commission’).]
The [Commission] [Agency] is mentioned as a signatory of the Agreement with the Beneficiary only.
The [European Union][Euratom][Agency] is not a party to this engagement.
1.1 Subject of the engagement
The coordinator must submit to the [Commission][Agency] the final report within 60 days following
the end of the last reporting period which should include, amongst other documents, a CFS for each
beneficiary and for each linked third party that requests a total contribution of EUR 325 000 or more,
as reimbursement of actual costs and unit costs calculated on the basis of its usual cost accounting
practices (see Article 20.4 of the Agreement). The CFS must cover all reporting periods of the
beneficiary or linked third party indicated above.
The Beneficiary must submit to the coordinator the CFS for itself and for its linked third party(ies), if
the CFS must be included in the final report according to Article 20.4 of the Agreement.
The CFS is composed of two separate documents:
- The Terms of Reference (‘the ToR’) to be signed by the [Beneficiary] [Linked Third Party]
and the Auditor;
1
By which costs under the Agreement are declared (see template ‘Model Financial Statements’ in Annex 4 to
the Grant Agreement).
2
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
- The Auditor’s Independent Report of Factual Findings (‘the Report’) to be issued on the
Auditor’s letterhead, dated, stamped and signed by the Auditor (or the competent public
officer) which includes the agreed-upon procedures (‘the Procedures’) to be performed by the
Auditor, and the standard factual findings (‘the Findings’) to be confirmed by the Auditor.
If the CFS must be included in the final report according to Article 20.4 of the Agreement, the request
for payment of the balance relating to the Agreement cannot be made without the CFS. However, the
payment for reimbursement of costs covered by the CFS does not preclude the Commission [ Agency,]
the European Anti-Fraud Office and the European Court of Auditors from carrying out checks,
reviews, audits and investigations in accordance with Article 22 of the Agreement.
1.2 Responsibilities
The [Beneficiary] [Linked Third Party]:
• must draw up the Financial Statement(s) for the action financed by the Agreement in
compliance with the obligations under the Agreement. The Financial Statement(s) must be
drawn up according to the [Beneficiary’s] [Linked Third Party’s] accounting and book-
keeping system and the underlying accounts and records;
• must send the Financial Statement(s) to the Auditor;
• is responsible and liable for the accuracy of the Financial Statement(s);
• is responsible for the completeness and accuracy of the information provided to enable the
Auditor to carry out the Procedures. It must provide the Auditor with a written representation
letter supporting these statements. The written representation letter must state the period
covered by the statements and must be dated;
• accepts that the Auditor cannot carry out the Procedures unless it is given full access to the
[Beneficiary’s] [Linked Third Party’s] staff and accounting as well as any other relevant
records and documentation.
The Auditor:
• [Option 1 by default: is qualified to carry out statutory audits of accounting documents in
accordance with Directive 2006/43/EC of the European Parliament and of the Council of 17
May 2006 on statutory audits of annual accounts and consolidated accounts, amending
Council Directives 78/660/EEC and 83/349/EEC and repealing Council Directive 84/253/EEC
or similar national regulations].
• [Option 2 if the Beneficiary or Linked Third Party has an independent Public Officer: is a
competent and independent Public Officer for which the relevant national authorities have
established the legal capacity to audit the Beneficiary].
• [Option 3 if the Beneficiary or Linked Third Party is an international organisation: is an
[internal] [external] auditor in accordance with the internal financial regulations and
procedures of the international organisation].
The Auditor:
• must be independent from the Beneficiary [and the Linked Third Party], in particular, it must
not have been involved in preparing the [Beneficiary’s] [Linked Third Party’s] Financial
Statement(s);
• must plan work so that the Procedures may be carried out and the Findings may be assessed;
• must adhere to the Procedures laid down and the compulsory report format;
• must carry out the engagement in accordance with this ToR;
• must document matters which are important to support the Report;
• must base its Report on the evidence gathered;
• must submit the Report to the [Beneficiary] [Linked Third Party].
3
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
The Commission sets out the Procedures to be carried out by the Auditor. The Auditor is not
responsible for their suitability or pertinence. As this engagement is not an assurance engagement, the
Auditor does not provide an audit opinion or a statement of assurance.
1.3 Applicable Standards
2
The Auditor must comply with these Terms of Reference and with :
- the International Standard on Related Services (‘ISRS’) 4400 Engagements to perform
Agreed-upon Procedures regarding Financial Information as issued by the International
Auditing and Assurance Standards Board (IAASB);
- the Code of Ethics for Professional Accountants issued by the International Ethics
Standards Board for Accountants (IESBA). Although ISRS 4400 states that independence
is not a requirement for engagements to carry out agreed-upon procedures, the
[Commission][Agency] requires that the Auditor also complies with the Code’s
independence requirements.
The Auditor’s Report must state that there is no conflict of interests in establishing this Report
between the Auditor and the Beneficiary [and the Linked Third Party], and must specify - if the
service is invoiced - the total fee paid to the Auditor for providing the Report.
1.4 Reporting
The Report must be written in the language of the Agreement (see Article 20.7).
Under Article 22 of the Agreement, the Commission[, the Agency], the European Anti-Fraud Office
and the Court of Auditors have the right to audit any work that is carried out under the action and for
which costs are declared from [the European Union] [Euratom] budget. This includes work related to
this engagement. The Auditor must provide access to all working papers (e.g. recalculation of hourly
rates, verification of the time declared for the action) related to this assignment if the Commission [,
the Agency], the European Anti-Fraud Office or the European Court of Auditors requests them.
1.5 Timing
The Report must be provided by [dd Month yyyy].
1.6 Other terms
[The [Beneficiary] [Linked Third Party] and the Auditor can use this section to agree other specific
terms, such as the Auditor’s fees, liability, applicable law, etc. Those specific terms must not
contradict the terms specified above.]
[legal name of the Auditor] [legal name of the [Beneficiary][Linked Third Party]]
[name & function of authorised representative] [name & function of authorised representative]
[dd Month yyyy] [dd Month yyyy]
Signature of the Auditor Signature of the [Beneficiary][Linked Third Party]
2
Supreme Audit Institutions applying INTOSAI-standards may carry out the Procedures according to the
corresponding International Standards of Supreme Audit Institutions and code of ethics issued by INTOSAI
instead of the International Standard on Related Services (‘ISRS’) 4400 and the Code of Ethics for
Professional Accountants issued by the IAASB and the IESBA.
4
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Independent Report of Factual Findings on costs declared
under Horizon 2020 Research and Innovation Framework Programme
(To be printed on the Auditor’s letterhead)
To
[ name of contact person(s)], [Position]
[ [Beneficiary’s] [Linked Third Party’s] name ]
[ Address]
[ dd Month yyyy]
Dear [Name of contact person(s)],
As agreed under the terms of reference dated [dd Month yyyy]
with [OPTION 1: [insert name of the beneficiary] (‘the Beneficiary’)] [OPTION 2: [insert name of
the linked third party] (‘the Linked Third Party’), third party linked to the Beneficiary [insert name of
the beneficiary] (‘the Beneficiary’)],
we
[name of the auditor ] (‘the Auditor’),
established at
[full address/city/state/province/country],
represented by
[name and function of an authorised representative],
have carried out the procedures agreed with you regarding the costs declared in the Financial
Statement(s)3 of the [Beneficiary] [Linked Third Party] concerning the grant agreement
[insert grant agreement reference: number, title of the action and acronym] (‘the Agreement’),
with a total cost declared of
[total amount] EUR,
and a total of actual costs and unit costs calculated in accordance with the [Beneficiary’s] [Linked
Third Party’s] usual cost accounting practices’ declared of
[sum of total actual costs and total direct personnel costs declared as unit costs calculated in
accordance with the [Beneficiary’s] [Linked Third Party’s] usual cost accounting practices] EUR
and hereby provide our Independent Report of Factual Findings (‘the Report’) using the
compulsory report format agreed with you.
The Report
Our engagement was carried out in accordance with the terms of reference (‘the ToR’) appended to
this Report. The Report includes the agreed-upon procedures (‘the Procedures’) carried out and the
standard factual findings (‘the Findings’) examined.
3
By which the Beneficiary declares costs under the Agreement (see template ‘Model Financial Statement’ in
Annex 4 to the Agreement).
5
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
The Procedures were carried out solely to assist the [Commission] [Agency] in evaluating whether the
[Beneficiary’s] [Linked Third Party’s] costs in the accompanying Financial Statement(s) were
declared in accordance with the Agreement. The [Commission] [Agency] draws its own conclusions
from the Report and any additional information it may require.
The scope of the Procedures was defined by the Commission. Therefore, the Auditor is not responsible
for their suitability or pertinence. Since the Procedures carried out constitute neither an audit nor a
review made in accordance with International Standards on Auditing or International Standards on
Review Engagements, the Auditor does not give a statement of assurance on the Financial Statements.
Had the Auditor carried out additional procedures or an audit of the [Beneficiary’s] [Linked Third
Party’s] Financial Statements in accordance with International Standards on Auditing or International
Standards on Review Engagements, other matters might have come to its attention and would have
been included in the Report.
Not applicable Findings
We examined the Financial Statement(s) stated above and considered the following Findings not
applicable:
Explanation (to be removed from the Report):
If a Finding was not applicable, it must be marked as ‘N.A.’ (‘Not applicable’) in the corresponding row on the
right-hand column of the table and means that the Finding did not have to be corroborated by the Auditor and
the related Procedure(s) did not have to be carried out.
The reasons of the non-application of a certain Finding must be obvious i.e.
i) if no cost was declared under a certain category then the related Finding(s) and Procedure(s) are
not applicable;
ii) if the condition set to apply certain Procedure(s) are not met the related Finding(s) and those
Procedure(s) are not applicable. For instance, for ‘beneficiaries with accounts established in a
currency other than euro’ the Procedure and Finding related to ‘beneficiaries with accounts
established in euro’ are not applicable. Similarly, if no additional remuneration is paid, the related
Finding(s) and Procedure(s) for additional remuneration are not applicable.
List here all Findings considered not applicable for the present engagement and explain the
reasons of the non-applicability.
….
Exceptions
Apart from the exceptions listed below, the [Beneficiary] [Linked Third Party] provided the Auditor
all the documentation and accounting information needed by the Auditor to carry out the requested
Procedures and evaluate the Findings.
Explanation (to be removed from the Report):
- If the Auditor was not able to successfully complete a procedure requested, it must be marked as ‘E’
(‘Exception’) in the corresponding row on the right-hand column of the table. The reason such as the
inability to reconcile key information or the unavailability of data that prevents the Auditor from
carrying out the Procedure must be indicated below.
- If the Auditor cannot corroborate a standard finding after having carried out the corresponding
procedure, it must also be marked as ‘E’ (‘Exception’) and, where possible, the reasons why the
Finding was not fulfilled and its possible impact must be explained here below.
List here any exceptions and add any information on the cause and possible consequences of
each exception, if known. If the exception is quantifiable, include the corresponding amount.
….
6
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Example (to be removed from the Report):
1. The Beneficiary was unable to substantiate the Finding number 1 on … because ….
2. Finding number 30 was not fulfilled because the methodology used by the Beneficiary to
calculate unit costs was different from the one approved by the Commission. The differences
were as follows: …
3. After carrying out the agreed procedures to confirm the Finding number 31, the Auditor found a
difference of _____________ EUR. The difference can be explained by …
Further Remarks
In addition to reporting on the results of the specific procedures carried out, the Auditor would like to
make the following general remarks:
Example (to be removed from the Report):
1. Regarding Finding number 8 the conditions for additional remuneration were considered as
fulfilled because …
2. In order to be able to confirm the Finding number 15 we carried out the following additional
procedures: ….
Use of this Report
This Report may be used only for the purpose described in the above objective. It was prepared solely
for the confidential use of the [Beneficiary] [Linked Third Party] and the [Commission] [Agency], and
only to be submitted to the [Commission] [Agency] in connection with the requirements set out in
Article 20.4 of the Agreement. The Report may not be used by the [Beneficiary] [Linked Third Party]
or by the [Commission] [Agency] for any other purpose, nor may it be distributed to any other parties.
The [Commission] [Agency] may only disclose the Report to authorised parties, in particular to the
European Anti-Fraud Office (OLAF) and the European Court of Auditors.
This Report relates only to the Financial Statement(s) submitted to the [Commission] [Agency] by the
[Beneficiary] [Linked Third Party] for the Agreement. Therefore, it does not extend to any other of
the [Beneficiary’s] [Linked Third Party’s] Financial Statement(s).
There was no conflict of interest4 between the Auditor and the Beneficiary [and Linked Third Party]
in establishing this Report. The total fee paid to the Auditor for providing the Report was EUR ______
(including EUR______ of deductible VAT).
We look forward to discussing our Report with you and would be pleased to provide any further
information or assistance.
[legal name of the Auditor]
[name and function of an authorised representative]
[dd Month yyyy]
Signature of the Auditor
4
A conflict of interest arises when the Auditor's objectivity to establish the certificate is compromised in fact
or in appearance when the Auditor for instance:
- was involved in the preparation of the Financial Statements;
- stands to benefit directly should the certificate be accepted;
- has a close relationship with any person representing the beneficiary;
- is a director, trustee or partner of the beneficiary; or
- is in any other situation that compromises his or her independence or ability to establish the certificate
impartially.
7
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Agreed-upon procedures to be performed and standard factual findings to be confirmed by the Auditor
The European Commission reserves the right to i) provide the auditor with additional guidance regarding the procedures to be followed or the facts to be
ascertained and the way in which to present them (this may include sample coverage and findings) or to ii) change the procedures, by notifying the Beneficiary
in writing. The procedures carried out by the auditor to confirm the standard factual finding are listed in the table below.
If this certificate relates to a Linked Third Party, any reference here below to ‘the Beneficiary’ is to be considered as a reference to ‘the Linked Third Party’.
The ‘result’ column has three different options: ‘C’, ‘E’ and ‘N.A.’:
‘C’ stands for ‘confirmed’ and means that the auditor can confirm the ‘standard factual finding’ and, therefore, there is no exception to be reported.
‘E’ stands for ‘exception’ and means that the Auditor carried out the procedures but cannot confirm the ‘standard factual finding’, or that the Auditor
was not able to carry out a specific procedure (e.g. because it was impossible to reconcile key information or data were unavailable),
‘N.A.’ stands for ‘not applicable’ and means that the Finding did not have to be examined by the Auditor and the related Procedure(s) did not have to
be carried out. The reasons of the non-application of a certain Finding must be obvious i.e. i) if no cost was declared under a certain category then the
related Finding(s) and Procedure(s) are not applicable; ii) if the condition set to apply certain Procedure(s) are not met then the related Finding(s) and
Procedure(s) are not applicable. For instance, for ‘beneficiaries with accounts established in a currency other than the euro’ the Procedure related to
‘beneficiaries with accounts established in euro’ is not applicable. Similarly, if no additional remuneration is paid, the related Finding(s) and
Procedure(s) for additional remuneration are not applicable.
Result
Ref Procedures Standard factual finding (C / E /
N.A.)
ACTUAL PERSONNEL COSTS AND UNIT COSTS CALCULATED BY THE BENEFICIARY IN ACCORDANCE WITH ITS USUAL
A
COST ACCOUNTING PRACTICE
The Auditor draws a sample of persons whose costs were declared in the Financial Statement(s)
to carry out the procedures indicated in the consecutive points of this section A.
(The sample should be selected randomly so that it is representative. Full coverage is required if
there are fewer than 10 people (including employees, natural persons working under a direct
contract and personnel seconded by a third party), otherwise the sample should have a minimum
of 10 people, or 10% of the total, whichever number is the highest)
The Auditor sampled ______ people out of the total of ______ people.
8
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Result
Ref Procedures Standard factual finding (C / E /
N.A.)
A.1 PERSONNEL COSTS
1) The employees were i) directly
For the persons included in the sample and working under an employment contract or equivalent hired by the Beneficiary in
act (general procedures for individual actual personnel costs and personnel costs declared as unit accordance with its national
costs) legislation, ii) under the
Beneficiary’s sole technical
To confirm standard factual findings 1-5 listed in the next column, the Auditor reviewed
supervision and responsibility
following information/documents provided by the Beneficiary:
and iii) remunerated in
o a list of the persons included in the sample indicating the period(s) during which they accordance with the
worked for the action, their position (classification or category) and type of contract; Beneficiary’s usual practices.
o the payslips of the employees included in the sample;
o reconciliation of the personnel costs declared in the Financial Statement(s) with the 2) Personnel costs were recorded in
the Beneficiary's
accounting system (project accounting and general ledger) and payroll system;
accounts/payroll system.
o information concerning the employment status and employment conditions of personnel
included in the sample, in particular their employment contracts or equivalent;
3) Costs were adequately supported
o the Beneficiary’s usual policy regarding payroll matters (e.g. salary policy, overtime
and reconciled with the accounts
policy, variable pay);
and payroll records.
o applicable national law on taxes, labour and social security and
o any other document that supports the personnel costs declared. 4) Personnel costs did not contain
The Auditor also verified the eligibility of all components of the retribution (see Article 6 GA) any ineligible elements.
and recalculated the personnel costs for employees included in the sample.
5) There were no discrepancies
between the personnel costs
charged to the action and the
costs recalculated by the
Auditor.
Further procedures if ‘additional remuneration’ is paid 6) The Beneficiary paying
To confirm standard factual findings 6-9 listed in the next column, the Auditor: “additional remuneration” was a
non-profit legal entity.
o reviewed relevant documents provided by the Beneficiary (legal form, legal/statutory
9
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Result
Ref Procedures Standard factual finding (C / E /
N.A.)
obligations, the Beneficiary’s usual policy on additional remuneration, criteria used for
7) The amount of additional
its calculation, the Beneficiary's usual remuneration practice for projects funded under
remuneration paid corresponded
national funding schemes…);
to the Beneficiary’s usual
o recalculated the amount of additional remuneration eligible for the action based on the remuneration practices and was
supporting documents received (full-time or part-time work, exclusive or non-exclusive consistently paid whenever the
dedication to the action, usual remuneration paid for projects funded by national same kind of work or expertise
schemes) to arrive at the applicable FTE/year and pro-rata rate (see data collected in the was required.
course of carrying out the procedures under A.2 ‘Productive hours’ and A.4 ‘Time
recording system’). 8) The criteria used to calculate the
additional remuneration were
‘ADDITIONAL REMUNERATION’ MEANS ANY PART OF THE REMUNERATION WHICH EXCEEDS WHAT THE
objective and generally applied
PERSON WOULD BE PAID FOR TIME WORKED IN PROJECTS FUNDED BY NATIONAL SCHEMES.
by the Beneficiary regardless of
IF ANY PART OF THE REMUNERATION PAID TO THE EMPLOYEE QUALIFIES AS "ADDITIONAL the source of funding used.
REMUNERATION" AND IS ELIGIBLE UNDER THE PROVISIONS OF ARTICLE 6.2.A.1, THIS CAN BE
CHARGED AS ELIGIBLE COST TO THE ACTION UP TO THE FOLLOWING AMOUNT: 9) The amount of additional
remuneration included in the
(A) IF THE PERSON WORKS FULL TIME AND EXCLUSIVELY ON THE ACTION DURING THE FULL
personnel costs charged to the
YEAR: UP TO EUR 8 000/YEAR;
action was capped at EUR 8,000
(B) IF THE PERSON WORKS EXCLUSIVELY ON THE ACTION BUT NOT FULL-TIME OR NOT FOR THE per FTE/year (up to the
FULL YEAR: UP TO THE CORRESPONDING PRO-RATA AMOUNT OF EUR 8 000, OR equivalent pro-rata amount if the
(C) IF THE PERSON DOES NOT WORK EXCLUSIVELY ON THE ACTION: UP TO A PRO-RATA AMOUNT
person did not work on the
CALCULATED IN ACCORDANCE TO ARTICLE 6.2.A.1.
action full-time during the year
or did not work exclusively on
the action).
10) The personnel costs included in
Additional procedures in case “unit costs calculated by the Beneficiary in accordance with its
the Financial Statement were
usual cost accounting practices” is applied:
calculated in accordance with
Apart from carrying out the procedures indicated above to confirm standard factual findings 1-5 the Beneficiary's usual cost
and, if applicable, also 6-9, the Auditor carried out following procedures to confirm standard accounting practice. This
methodology was consistently
10
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Result
Ref Procedures Standard factual finding (C / E /
N.A.)
factual findings 10-13 listed in the next column: used in all H2020 actions.
o obtained a description of the Beneficiary's usual cost accounting practice to calculate unit 11) The employees were charged
costs;. under the correct category.
o reviewed whether the Beneficiary's usual cost accounting practice was applied for the
12) Total personnel costs used in
Financial Statements subject of the present CFS;
calculating the unit costs were
o verified the employees included in the sample were charged under the correct category consistent with the expenses
(in accordance with the criteria used by the Beneficiary to establish personnel categories) recorded in the statutory
by reviewing the contract/HR-record or analytical accounting records; accounts.
o verified that there is no difference between the total amount of personnel costs used in 13) Any estimated or budgeted
calculating the cost per unit and the total amount of personnel costs recorded in the element used by the
statutory accounts; Beneficiary in its unit-cost
o verified whether actual personnel costs were adjusted on the basis of budgeted or calculation were relevant for
calculating personnel costs and
estimated elements and, if so, verified whether those elements used are actually relevant
for the calculation, objective and supported by documents. corresponded to objective and
verifiable information.
14) The natural persons worked
For natural persons included in the sample and working with the Beneficiary under a direct
under conditions similar to
contract other than an employment contract, such as consultants (no subcontractors).
those of an employee, in
To confirm standard factual findings 14-17 listed in the next column the Auditor reviewed particular regarding the way
following information/documents provided by the Beneficiary: the work is organised, the tasks
o the contracts, especially the cost, contract duration, work description, place of work, that are performed and the
ownership of the results and reporting obligations to the Beneficiary; premises where they are
performed.
o the employment conditions of staff in the same category to compare costs and;
15) The results of work carried out
o any other document that supports the costs declared and its registration (e.g. invoices, belong to the Beneficiary, or, if
accounting records, etc.). not, the Beneficiary has
obtained all necessary rights to
fulfil its obligations as if those
11
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Result
Ref Procedures Standard factual finding (C / E /
N.A.)
results were generated by itself.
16) Their costs were not
significantly different from
those for staff who performed
similar tasks under an
employment contract with the
Beneficiary.
17) The costs were supported by
audit evidence and registered
in the accounts.
For personnel seconded by a third party and included in the sample (not subcontractors) 18) Seconded personnel reported to
the Beneficiary and worked on
To confirm standard factual findings 18-21 listed in the next column, the Auditor reviewed
the Beneficiary’s premises
following information/documents provided by the Beneficiary:
(unless otherwise agreed with
o their secondment contract(s) notably regarding costs, duration, work description, place of the Beneficiary).
work and ownership of the results;
19) The results of work carried out
o if there is reimbursement by the Beneficiary to the third party for the resource made belong to the Beneficiary, or, if
available (in-kind contribution against payment): any documentation that supports the not, the Beneficiary has
costs declared (e.g. contract, invoice, bank payment, and proof of registration in its obtained all necessary rights to
accounting/payroll, etc.) and reconciliation of the Financial Statement(s) with the fulfil its obligations as if those
accounting system (project accounting and general ledger) as well as any proof that the results were generated by
amount invoiced by the third party did not include any profit; itself..
o if there is no reimbursement by the Beneficiary to the third party for the resource made If personnel is seconded against
available (in-kind contribution free of charge): a proof of the actual cost borne by the payment:
Third Party for the resource made available free of charge to the Beneficiary such as a
statement of costs incurred by the Third Party and proof of the registration in the Third 20) The costs declared were
Party's accounting/payroll; supported with documentation
and recorded in the
12
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Result
Ref Procedures Standard factual finding (C / E /
N.A.)
o any other document that supports the costs declared (e.g. invoices, etc.). Beneficiary’s accounts. The
third party did not include any
profit.
If personnel is seconded free of
charge:
21) The costs declared did not
exceed the third party's cost as
recorded in the accounts of the
third party and were supported
with documentation.
A.2 PRODUCTIVE HOURS 22) The Beneficiary applied
method [choose one option and
To confirm standard factual findings 22-27 listed in the next column, the Auditor reviewed delete the others]
relevant documents, especially national legislation, labour agreements and contracts and time
[A: 1720 hours]
records of the persons included in the sample, to verify that:
[B: the ‘total number of hours
o the annual productive hours applied were calculated in accordance with one of the
worked’]
methods described below,
[C: ‘standard annual
o the full-time equivalent (FTEs) ratios for employees not working full-time were correctly
productive hours’ used
calculated.
correspond to usual accounting
If the Beneficiary applied method B, the auditor verified that the correctness in which the total practices]
number of hours worked was calculated and that the contracts specified the annual workable 23) Productive hours were
hours. calculated annually.
If the Beneficiary applied method C, the auditor verified that the ‘annual productive hours’ 24) For employees not working
applied when calculating the hourly rate were equivalent to at least 90 % of the ‘standard annual full-time the full-time
workable hours’. The Auditor can only do this if the calculation of the standard annual workable equivalent (FTE) ratio was
correctly applied.
13
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Result
Ref Procedures Standard factual finding (C / E /
N.A.)
hours can be supported by records, such as national legislation, labour agreements, and contracts. If the Beneficiary applied method
B.
BENEFICIARY'S PRODUCTIVE HOURS' FOR PERSONS WORKING FULL TIME SHALL BE ONE OF THE
25) The calculation of the number
FOLLOWING METHODS:
of ‘annual workable hours’,
A. 1720 ANNUAL PRODUCTIVE HOURS (PRO-RATA FOR PERSONS NOT WORKING FULL-TIME) overtime and absences was
B. THE TOTAL NUMBER OF HOURS WORKED BY THE PERSON FOR THE BENEFICIARY IN THE YEAR
verifiable based on the
(THIS METHOD IS ALSO REFERRED TO AS ‘TOTAL NUMBER OF HOURS WORKED’ IN THE NEXT documents provided by the
COLUMN). THE CALCULATION OF THE TOTAL NUMBER OF HOURS WORKED WAS DONE AS
Beneficiary.
FOLLOWS: ANNUAL WORKABLE HOURS OF THE PERSON ACCORDING TO THE EMPLOYMENT 25.1) The Beneficiary calculates
CONTRACT, APPLICABLE LABOUR AGREEMENT OR NATIONAL LAW PLUS OVERTIME WORKED the hourly rates per full
MINUS ABSENCES (SUCH AS SICK LEAVE OR SPECIAL LEAVE). financial year following
C. THE STANDARD NUMBER OF ANNUAL HOURS GENERALLY APPLIED BY THE BENEFICIARY FOR ITS
procedure A.3 (method B
PERSONNEL IN ACCORDANCE WITH ITS USUAL COST ACCOUNTING PRACTICES (THIS METHOD IS
is not allowed for
ALSO REFERRED TO AS ‘STANDARD ANNUAL PRODUCTIVE HOURS’ IN THE NEXT COLUMN). THIS
beneficiaries calculating
NUMBER MUST BE AT LEAST 90% OF THE STANDARD ANNUAL WORKABLE HOURS.
hourly rates per month).
If the Beneficiary applied method
C.
‘ANNUAL WORKABLE HOURS’ MEANS THE PERIOD DURING WHICH THE PERSONNEL MUST BE
WORKING, AT THE EMPLOYER’S DISPOSAL AND CARRYING OUT HIS/HER ACTIVITY OR DUTIES UNDER
26) The calculation of the number
THE EMPLOYMENT CONTRACT, APPLICABLE COLLECTIVE LABOUR AGREEMENT OR NATIONAL
of ‘standard annual workable
WORKING TIME LEGISLATION.
hours’ was verifiable based on
the documents provided by the
Beneficiary.
14
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Result
Ref Procedures Standard factual finding (C / E /
N.A.)
27) The ‘annual productive hours’
used for calculating the hourly
rate were consistent with the
usual cost accounting practices
of the Beneficiary and were
equivalent to at least 90 % of
the ‘annual workable hours’.
A.3 HOURLY PERSONNEL RATES 28) The Beneficiary applied
[choose one option and delete
I) For unit costs calculated in accordance to the Beneficiary's usual cost accounting practice (unit the other]:
costs):
[Option I: “Unit costs (hourly
If the Beneficiary has a "Certificate on Methodology to calculate unit costs " (CoMUC) approved rates) were calculated in
by the Commission, the Beneficiary provides the Auditor with a description of the approved accordance with the
methodology and the Commission’s letter of acceptance. The Auditor verified that the Beneficiary’s usual cost
Beneficiary has indeed used the methodology approved. If so, no further verification is necessary. accounting practices”]
If the Beneficiary does not have a "Certificate on Methodology" (CoMUC) approved by the [Option II: Individual hourly
Commission, or if the methodology approved was not applied, then the Auditor: rates were applied]
o reviewed the documentation provided by the Beneficiary, including manuals and internal For option I concerning unit costs
guidelines that explain how to calculate hourly rates; and if the Beneficiary applies the
o recalculated the unit costs (hourly rates) of staff included in the sample following the methodology approved by the
results of the procedures carried out in A.1 and A.2. Commission (CoMUC):
29) The Beneficiary used the
II) For individual hourly rates: Commission-approved metho-
The Auditor: dology to calculate hourly
rates. It corresponded to the
o reviewed the documentation provided by the Beneficiary, including manuals and internal organisation's usual cost
guidelines that explain how to calculate hourly rates; accounting practices and was
applied consistently for all
15
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Result
Ref Procedures Standard factual finding (C / E /
N.A.)
o recalculated the hourly rates of staff included in the sample (recalculation of all hourly activities irrespective of the
rates if the Beneficiary uses annual rates, recalculation of three months selected randomly source of funding.
for every year and person if the Beneficiary uses monthly rates) following the results of
the procedures carried out in A.1 and A.2;
o (only in case of monthly rates) confirmed that the time spent on parental leave is not
deducted, and that, if parts of the basic remuneration are generated over a period longer For option I concerning unit costs
than a month, the Beneficiary has included only the share which is generated in the and if the Beneficiary applies a
month. methodology not approved by the
Commission:
“UNIT COSTS CALCULATED BY THE BENEFICIARY IN ACCORDANCE WITH ITS USUAL COST
ACCOUNTING PRACTICES”: 30) The unit costs re-calculated by
IT IS CALCULATED BY DIVIDING THE TOTAL AMOUNT OF PERSONNEL COSTS OF THE CATEGORY TO the Auditor were the same as
WHICH THE EMPLOYEE BELONGS VERIFIED IN LINE WITH PROCEDURE A.1 BY THE NUMBER OF FTE the rates applied by the
AND THE ANNUAL TOTAL PRODUCTIVE HOURS OF THE SAME CATEGORY CALCULATED BY THE Beneficiary.
BENEFICIARY IN ACCORDANCE WITH PROCEDURE A.2. For option II concerning individual
HOURLY RATE FOR INDIVIDUAL ACTUAL PERSONAL COSTS: hourly rates:
IT IS CALCULATED FOLLOWING ONE OF THE TWO OPTIONS BELOW: 31) The individual rates re-
calculated by the Auditor were
A) [OPTION BY DEFAULT] BY DIVIDING THE ACTUAL ANNUAL AMOUNT OF PERSONNEL COSTS OF AN
the same as the rates applied by
EMPLOYEE VERIFIED IN LINE WITH PROCEDURE A.1 BY THE NUMBER OF ANNUAL PRODUCTIVE HOURS
the Beneficiary.
VERIFIED IN LINE WITH PROCEDURE A.2 (FULL FINANCIAL YEAR HOURLY RATE);
31.1) The Beneficiary used only
B) BY DIVIDING THE ACTUAL MONTHLY AMOUNT OF PERSONNEL COSTS OF AN EMPLOYEE VERIFIED IN one option (per full financial
LINE WITH PROCEDURE A.1 BY 1/12 OF THE NUMBER OF ANNUAL PRODUCTIVE HOURS VERIFIED IN year or per month) throughout
LINE WITH PROCEDURE A.2.(MONTHLY HOURLY RATE). each financial year examined.
31.2) The hourly rates do not
include additional
remuneration.
16
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Result
Ref Procedures Standard factual finding (C / E /
N.A.)
A.4 TIME RECORDING SYSTEM
32) All persons recorded their time
To verify that the time recording system ensures the fulfilment of all minimum requirements and dedicated to the action on a
that the hours declared for the action were correct, accurate and properly authorised and daily/ weekly/ monthly basis
supported by documentation, the Auditor made the following checks for the persons included in using a paper/computer-
the sample that declare time as worked for the action on the basis of time records: based system. (delete the
answers that are not
o description of the time recording system provided by the Beneficiary (registration,
applicable)
authorisation, processing in the HR-system);
o its actual implementation; 33) Their time-records were
authorised at least monthly by
o time records were signed at least monthly by the employees (on paper or electronically)
the project manager or other
and authorised by the project manager or another manager;
superior.
o the hours declared were worked within the project period;
o there were no hours declared as worked for the action if HR-records showed absence due 34) Hours declared were worked
to holidays or sickness (further cross-checks with travels are carried out in B.1 below) ; within the project period and
were consistent with the
o the hours charged to the action matched those in the time recording system. presences/absences recorded in
HR-records.
ONLY THE HOURS WORKED ON THE ACTION CAN BE CHARGED. ALL WORKING TIME TO BE CHARGED 35) There were no discrepancies
SHOULD BE RECORDED THROUGHOUT THE DURATION OF THE PROJECT, ADEQUATELY SUPPORTED BY between the number of hours
EVIDENCE OF THEIR REALITY AND RELIABILITY (SEE SPECIFIC PROVISIONS BELOW FOR PERSONS charged to the action and the
WORKING EXCLUSIVELY FOR THE ACTION WITHOUT TIME RECORDS). number of hours recorded.
If the persons are working exclusively for the action and without time records 36) The exclusive dedication is
supported by a declaration
For the persons selected that worked exclusively for the action without time records, the Auditor
signed by the Beneficiary and
verified evidence available demonstrating that they were in reality exclusively dedicated to the
by any other evidence
action and that the Beneficiary signed a declaration confirming that they have worked exclusively
gathered.
for the action.
17
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Result
Ref Procedures Standard factual finding (C / E /
N.A.)
B COSTS OF SUBCONTRACTING
B.1 The Auditor obtained the detail/breakdown of subcontracting costs and sampled ______ 37) The use of claimed
cost items selected randomly (full coverage is required if there are fewer than 10 items, subcontracting costs was
otherwise the sample should have a minimum of 10 item, or 10% of the total, whichever number foreseen in Annex 1 and costs
is highest). were declared in the Financial
Statements under the
To confirm standard factual findings 37-41 listed in the next column, the Auditor reviewed the
subcontracting category.
following for the items included in the sample:
o the use of subcontractors was foreseen in Annex 1; 38) There were documents of
requests to different providers,
o subcontracting costs were declared in the subcontracting category of the Financial different offers and assessment
Statement; of the offers before selection of
o supporting documents on the selection and award procedure were followed; the provider in line with
internal procedures and
o the Beneficiary ensured best value for money (key elements to appreciate the respect of procurement rules.
this principle are the award of the subcontract to the bid offering best price-quality ratio, Subcontracts were awarded in
under conditions of transparency and equal treatment. In case an existing framework accordance with the principle
contract was used the Beneficiary ensured it was established on the basis of the principle of best value for money.
of best value for money under conditions of transparency and equal treatment).
(When different offers were not
In particular, collected the Auditor explains
i. if the Beneficiary acted as a contracting authority within the meaning of Directive the reasons provided by the
2004/18/EC (or 2014/24/EU) or of Directive 2004/17/EC (or 2014/25/EU), the Auditor Beneficiary under the caption
verified that the applicable national law on public procurement was followed and that the “Exceptions” of the Report.
subcontracting complied with the Terms and Conditions of the Agreement. The Commission will analyse
this information to evaluate
ii. if the Beneficiary did not fall under the above-mentioned category the Auditor verified whether these costs might be
that the Beneficiary followed their usual procurement rules and respected the Terms and accepted as eligible)
Conditions of the Agreement..
39) The subcontracts were not
awarded to other Beneficiaries
18
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Result
Ref Procedures Standard factual finding (C / E /
N.A.)
For the items included in the sample the Auditor also verified that: of the consortium.
o the subcontracts were not awarded to other Beneficiaries in the consortium;
o there were signed agreements between the Beneficiary and the subcontractor; 40) All subcontracts were
supported by signed
o there was evidence that the services were provided by subcontractor; agreements between the
Beneficiary and the
subcontractor.
41) There was evidence that the
services were provided by the
subcontractors.
C COSTS OF PROVIDING FINANCIAL SUPPORT TO THIRD PARTIES
C.1 The Auditor obtained the detail/breakdown of the costs of providing financial support to
third parties and sampled ______ cost items selected randomly (full coverage is required if
there are fewer than 10 items, otherwise the sample should have a minimum of 10 item, or 10% of
the total, whichever number is highest).
The Auditor verified that the following minimum conditions were met: 42) All minimum conditions were
met
a) the maximum amount of financial support for each third party did not exceed EUR 60
000, unless explicitly mentioned in Annex 1;
b) the financial support to third parties was agreed in Annex 1 of the Agreement and the
other provisions on financial support to third parties included in Annex 1 were respected.
19
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
D OTHER ACTUAL DIRECT COSTS
D.1 COSTS OF TRAVEL AND RELATED SUBSISTENCE ALLOWANCES 43) Costs were incurred, approved and
reimbursed in line with the
The Auditor sampled ______ cost items selected randomly (full coverage is required if there
Beneficiary's usual policy for
are fewer than 10 items, otherwise the sample should have a minimum of 10 item, or 10% of the
travels.
total, whichever number is the highest).
The Auditor inspected the sample and verified that: 44) There was a link between the trip
o travel and subsistence costs were consistent with the Beneficiary's usual policy for travel. and the action.
In this context, the Beneficiary provided evidence of its normal policy for travel costs
45) The supporting documents were
(e.g. use of first class tickets, reimbursement by the Beneficiary on the basis of actual
consistent with each other regarding
costs, a lump sum or per diem) to enable the Auditor to compare the travel costs charged
subject of the trip, dates, duration
with this policy;
and reconciled with time records
o travel costs are correctly identified and allocated to the action (e.g. trips are directly and accounting.
linked to the action) by reviewing relevant supporting documents such as minutes of
meetings, workshops or conferences, their registration in the correct project account, their
consistency with time records or with the dates/duration of the workshop/conference; 46) No ineligible costs or excessive or
reckless expenditure was declared.
o no ineligible costs or excessive or reckless expenditure was declared (see Article 6.5
MGA).
D.2 DEPRECIATION COSTS FOR EQUIPMENT, INFRASTRUCTURE OR OTHER
ASSETS 47) Procurement rules, principles and
guides were followed.
The Auditor sampled ______ cost items selected randomly (full coverage is required if there
are fewer than 10 items, otherwise the sample should have a minimum of 10 item, or 10% of the
total, whichever number is the highest). 48) There was a link between the grant
agreement and the asset charged to
For “equipment, infrastructure or other assets” [from now on called “asset(s)”] selected in the the action.
sample the Auditor verified that:
49) The asset charged to the action was
o the assets were acquired in conformity with the Beneficiary's internal guidelines and traceable to the accounting records
procedures; and the underlying documents.
20
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
50) The depreciation method used to
o they were correctly allocated to the action (with supporting documents such as delivery
charge the asset to the action was in
note invoice or any other proof demonstrating the link to the action)
line with the applicable rules of the
o they were entered in the accounting system; Beneficiary's country and the
o the extent to which the assets were used for the action (as a percentage) was supported by Beneficiary's usual accounting
reliable documentation (e.g. usage overview table); policy.
51) The amount charged corresponded
The Auditor recalculated the depreciation costs and verified that they were in line with the
to the actual usage for the action.
applicable rules in the Beneficiary’s country and with the Beneficiary’s usual accounting policy
(e.g. depreciation calculated on the acquisition value).
52) No ineligible costs or excessive or
The Auditor verified that no ineligible costs such as deductible VAT, exchange rate losses, reckless expenditure were declared.
excessive or reckless expenditure were declared (see Article 6.5 GA).
D.3 COSTS OF OTHER GOODS AND SERVICES 53) Contracts for works or services did
not cover tasks described in Annex
The Auditor sampled ______ cost items selected randomly (full coverage is required if there
1.
are fewer than 10 items, otherwise the sample should have a minimum of 10 item, or 10% of the
total, whichever number is highest). 54) Costs were allocated to the correct
For the purchase of goods, works or services included in the sample the Auditor verified that: action and the goods were not
placed in the inventory of durable
o the contracts did not cover tasks described in Annex 1; equipment.
o they were correctly identified, allocated to the proper action, entered in the accounting
system (traceable to underlying documents such as purchase orders, invoices and 55) The costs were charged in line with
accounting); the Beneficiary’s accounting policy
and were adequately supported.
o the goods were not placed in the inventory of durable equipment;
o the costs charged to the action were accounted in line with the Beneficiary’s usual 56) No ineligible costs or excessive or
accounting practices; reckless expenditure were declared.
o no ineligible costs or excessive or reckless expenditure were declared (see Article 6 GA). For internal invoices/charges only
the cost element was charged,
In addition, the Auditor verified that these goods and services were acquired in conformity with without any mark-ups.
21
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
the Beneficiary's internal guidelines and procedures, in particular:
o if Beneficiary acted as a contracting authority within the meaning of Directive 57) Procurement rules, principles and
2004/18/EC (or 2014/24/EU) or of Directive 2004/17/EC (or 2014/25/EU), the Auditor guides were followed. There were
verified that the applicable national law on public procurement was followed and that the documents of requests to different
procurement contract complied with the Terms and Conditions of the Agreement. providers, different offers and
assessment of the offers before
o if the Beneficiary did not fall into the category above, the Auditor verified that the selection of the provider in line with
Beneficiary followed their usual procurement rules and respected the Terms and internal procedures and
Conditions of the Agreement. procurement rules. The purchases
For the items included in the sample the Auditor also verified that: were made in accordance with the
principle of best value for money.
o the Beneficiary ensured best value for money (key elements to appreciate the respect of
this principle are the award of the contract to the bid offering best price-quality ratio, (When different offers were not
under conditions of transparency and equal treatment. In case an existing framework collected the Auditor explains the
contract was used the Auditor also verified that the Beneficiary ensured it was established reasons provided by the Beneficiary
on the basis of the principle of best value for money under conditions of transparency and under the caption “Exceptions” of
equal treatment); the Report. The Commission will
analyse this information to evaluate
SUCH GOODS AND SERVICES INCLUDE, FOR INSTANCE, CONSUMABLES AND SUPPLIES, DISSEMINATION whether these costs might be
(INCLUDING OPEN ACCESS), PROTECTION OF RESULTS, SPECIFIC EVALUATION OF THE ACTION IF IT IS accepted as eligible)
REQUIRED BY THE AGREEMENT, CERTIFICATES ON THE FINANCIAL STATEMENTS IF THEY ARE
REQUIRED BY THE AGREEMENT AND CERTIFICATES ON THE METHODOLOGY, TRANSLATIONS,
REPRODUCTION.
D.4 AGGREGATED CAPITALISED AND OPERATING COSTS OF RESEARCH
58) The costs declared as direct costs
INFRASTRUCTURE
for Large Research Infrastructures
The Auditor ensured the existence of a positive ex-ante assessment (issued by the EC Services) of (in the appropriate line of the
the cost accounting methodology of the Beneficiary allowing it to apply the guidelines on direct Financial Statement) comply with
costing for large research infrastructures in Horizon 2020. the methodology described in the
positive ex-ante assessment report.
22
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
In the cases that a positive ex-ante assessment has been issued (see the standard factual findings
59) Any difference between the
58-59 on the next column),
methodology applied and the one
The Auditor ensured that the beneficiary has applied consistently the methodology that is
positively assessed was extensively
explained and approved in the positive ex ante assessment;
described and adjusted accordingly.
In the cases that a positive ex-ante assessment has NOT been issued (see the standard factual
findings 60 on the next column),
The Auditor verified that no costs of Large Research Infrastructure have been charged as
direct costs in any costs category;
60) The direct costs declared were free
from any indirect costs items related
In the cases that a draft ex-ante assessment report has been issued with recommendation for
further changes (see the standard factual findings 60 on the next column), to the Large Research
Infrastructure.
• The Auditor followed the same procedure as above (when a positive ex-ante assessment has
NOT yet been issued) and paid particular attention (testing reinforced) to the cost items for
which the draft ex-ante assessment either rejected the inclusion as direct costs for Large
Research Infrastructures or issued recommendations.
D.5 Costs of internally invoiced goods and services 61) The costs of internally invoiced
goods and services included in the
The Auditor sampled cost items selected randomly (full coverage is required if there are fewer Financial Statement were calculated
than 10 items, otherwise the sample should have a minimum of 10 item, or 10% of the total, in accordance with the Beneficiary's
whichever number is highest). usual cost accounting practice.
62) The cost accounting practices used
To confirm standard factual findings 61-65 listed in the next column, the Auditor: to calculate the costs of internally
o obtained a description of the Beneficiary's usual cost accounting practice to calculate invoiced goods and services were
costs of internally invoiced goods and services (unit costs); applied by the Beneficiary in a
consistent manner based on
o reviewed whether the Beneficiary's usual cost accounting practice was applied for the objective criteria regardless of the
Financial Statements subject of the present CFS; source of funding.
o ensured that the methodology to calculate unit costs is being used in a consistent manner, 63) The unit cost is calculated using the
based on objective criteria, regardless of the source of funding; actual costs for the good or service
o verified that any ineligible items or any costs claimed under other budget categories, in recorded in the Beneficiary’s
particular indirect costs, have not been taken into account when calculating the costs of accounts, excluding any ineligible
cost or costs included in other
23
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
internally invoiced goods and services (see Article 6 GA); budget categories.
o verified whether actual costs of internally invoiced goods and services were adjusted on
the basis of budgeted or estimated elements and, if so, verified whether those elements
used are actually relevant for the calculation, and correspond to objective and verifiable
information. 64) The unit cost excludes any costs of
items which are not directly linked
o verified that any costs of items which are not directly linked to the production of the
to the production of the invoiced
invoiced goods or service (e.g. supporting services like cleaning, general accountancy,
goods or service.
administrative support, etc. not directly used for production of the good or service) have
not been taken into account when calculating the costs of internally invoiced goods and 65) The costs items used for calculating
services. the actual costs of internally
invoiced goods and services were
o verified that any costs of items used for calculating the costs internally invoiced goods
relevant, reasonable and correspond
and services are supported by audit evidence and registered in the accounts.
to objective and verifiable
information.
E USE OF EXCHANGE RATES
E.1 a) For Beneficiaries with accounts established in a currency other than euros
The Auditor sampled ______ cost items selected randomly and verified that the exchange
rates used for converting other currencies into euros were in accordance with the following
rules established in the Agreement ( full coverage is required if there are fewer than 10 items,
otherwise the sample should have a minimum of 10 item, or 10% of the total, whichever number is
highest): 66) The exchange rates used to convert
other currencies into Euros were in
COSTS RECORDED IN THE ACCOUNTS IN A CURRENCY OTHER THAN EURO SHALL BE CONVERTED INTO accordance with the rules
EURO AT THE AVERAGE OF THE DAILY EXCHANGE RATES PUBLISHED IN THE C SERIES OF OFFICIAL established of the Grant Agreement
JOURNAL OF THE EUROPEAN UNION and there was no difference in the
(https://www.ecb.int/stats/exchange/eurofxref/html/index.en.html ), DETERMINED OVER THE final figures.
CORRESPONDING REPORTING PERIOD.
IF NO DAILY EURO EXCHANGE RATE IS PUBLISHED IN THE OFFICIAL JOURNAL OF THE EUROPEAN
UNION FOR THE CURRENCY IN QUESTION, CONVERSION SHALL BE MADE AT THE AVERAGE OF THE
MONTHLY ACCOUNTING RATES ESTABLISHED BY THE COMMISSION AND PUBLISHED ON ITS WEBSITE
(http://ec.europa.eu/budget/contracts_grants/info_contracts/inforeuro/inforeuro_en.cfm ),
24
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
DETERMINED OVER THE CORRESPONDING REPORTING PERIOD.
b) For Beneficiaries with accounts established in euros
The Auditor sampled ______ cost items selected randomly and verified that the exchange
rates used for converting other currencies into euros were in accordance with the following
rules established in the Agreement ( full coverage is required if there are fewer than 10 items, 67) The Beneficiary applied its usual
otherwise the sample should have a minimum of 10 item, or 10% of the total, whichever number is accounting practices.
highest):
COSTS INCURRED IN ANOTHER CURRENCY SHALL BE CONVERTED INTO EURO BY APPLYING THE
BENEFICIARY’S USUAL ACCOUNTING PRACTICES.
[legal name of the audit firm]
[name and function of an authorised representative]
[dd Month yyyy]
<Signature of the Auditor>
25
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
ANNEX 6
MODEL FOR THE CERTIFICATE ON THE METHODOLOGY
For options [in italics in square brackets]: choose the applicable option. Options not chosen
should be deleted.
For fields in [grey in square brackets]: enter the appropriate data.
TABLE OF CONTENTS
TERMS OF REFERENCE FOR AN AUDIT ENGAGEMENT FOR A METHODOLOGY CERTIFICATE IN
CONNECTION WITH ONE OR MORE GRANT AGREEMENTS FINANCED UNDER THE HORIZON 2020
RESEARCH AND INNOVATION FRAMEWORK PROGRAMME
INDEPENDENT REPORT OF FACTUAL FINDINGS ON THE METHODOLOGY CONCERNING GRANT
AGREEMENTS FINANCED UNDER THE HORIZON 2020 RESEARCH AND INNOVATION
FRAMEWORK PROGRAMME
1
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Terms of reference for an audit engagement for a methodology certificate
in connection with one or more grant agreements financed
under the Horizon 2020 Research and Innovation Framework Programme
This document sets out the ‘Terms of Reference (ToR)’ under which
[OPTION 1: [insert name of the beneficiary] (‘the Beneficiary’)] [OPTION 2: [insert name of the
linked third party] (‘the Linked Third Party’), third party linked to the Beneficiary [insert name of the
beneficiary] (‘the Beneficiary’)]
agrees to engage
[insert legal name of the auditor] (‘the Auditor’)
to produce an independent report of factual findings (‘the Report’) concerning the [Beneficiary’s]
[Linked Third Party’s] usual accounting practices for calculating and claiming direct personnel costs
declared as unit costs (‘the Methodology’) in connection with grant agreements financed under the
Horizon 2020 Research and Innovation Framework Programme.
The procedures to be carried out for the assessment of the methodology will be based on the grant
agreement(s) detailed below:
[title and number of the grant agreement(s)] (‘the Agreement(s)’)
The Agreement(s) has(have) been concluded between the Beneficiary and [OPTION 1: the European
Union, represented by the European Commission (‘the Commission’)][ OPTION 2: the European
Atomic Energy Community (Euratom,) represented by the European Commission (‘the
Commission’)][OPTION 3: the [Research Executive Agency (REA)] [European Research Council
Executive Agency (ERCEA)] [Innovation and Networks Executive Agency (INEA)] [Executive Agency
for Small and Medium-sized Enterprises (EASME)] (‘the Agency’), under the powers delegated by the
European Commission (‘the Commission’).].
The [Commission] [Agency] is mentioned as a signatory of the Agreement with the Beneficiary only.
The [European Union] [Euratom] [Agency] is not a party to this engagement.
1.1 Subject of the engagement
According to Article 18.1.2 of the Agreement, beneficiaries [and linked third parties] that declare
direct personnel costs as unit costs calculated in accordance with their usual cost accounting practices
may submit to the [Commission] [Agency], for approval, a certificate on the methodology (‘CoMUC’)
stating that there are adequate records and documentation to prove that their cost accounting practices
used comply with the conditions set out in Point A of Article 6.2.
The subject of this engagement is the CoMUC which is composed of two separate documents:
- the Terms of Reference (‘the ToR’) to be signed by the [Beneficiary] [Linked Third Party]
and the Auditor;
- the Auditor’s Independent Report of Factual Findings (‘the Report’) issued on the Auditor’s
letterhead, dated, stamped and signed by the Auditor which includes; the standard statements
(‘the Statements’) evaluated and signed by the [Beneficiary] [Linked Third Party], the agreed-
upon procedures (‘the Procedures’) performed by the Auditor and the standard factual findings
2
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
(‘the Findings’) assessed by the Auditor. The Statements, Procedures and Findings are
summarised in the table that forms part of the Report.
The information provided through the Statements, the Procedures and the Findings will enable the
Commission to draw conclusions regarding the existence of the [Beneficiary’s] [Linked Third Party’s]
usual cost accounting practice and its suitability to ensure that direct personnel costs claimed on that
basis comply with the provisions of the Agreement. The Commission draws its own conclusions from
the Report and any additional information it may require.
1.2 Responsibilities
The parties to this agreement are the [Beneficiary] [Linked Third Party] and the Auditor.
The [Beneficiary] [Linked Third Party]:
• is responsible for preparing financial statements for the Agreement(s) (‘the Financial
Statements’) in compliance with those Agreements;
• is responsible for providing the Financial Statement(s) to the Auditor and enabling the Auditor
to reconcile them with the [Beneficiary’s] [Linked Third Party’s] accounting and
bookkeeping system and the underlying accounts and records. The Financial Statement(s) will
be used as a basis for the procedures which the Auditor will carry out under this ToR;
• is responsible for its Methodology and liable for the accuracy of the Financial Statement(s);
• is responsible for endorsing or refuting the Statements indicated under the heading
‘Statements to be made by the Beneficiary/ Linked Third Party’ in the first column of the table
that forms part of the Report;
• must provide the Auditor with a signed and dated representation letter;
• accepts that the ability of the Auditor to carry out the Procedures effectively depends upon the
[Beneficiary] [Linked Third Party] providing full and free access to the [Beneficiary’s]
[Linked Third Party’s] staff and to its accounting and other relevant records.
The Auditor:
• [Option 1 by default: is qualified to carry out statutory audits of accounting documents in
accordance with Directive 2006/43/EC of the European Parliament and of the Council of 17
May 2006 on statutory audits of annual accounts and consolidated accounts, amending
Council Directives 78/660/EEC and 83/349/EEC and repealing Council Directive
84/253/EEC or similar national regulations].
• [Option 2 if the Beneficiary or Linked Third Party has an independent Public Officer: is a
competent and independent Public Officer for which the relevant national authorities have
established the legal capacity to audit the Beneficiary].
• [Option 3 if the Beneficiary or Linked Third Party is an international organisation: is an
[internal] [external] auditor in accordance with the internal financial regulations and
procedures of the international organisation].
The Auditor:
• must be independent from the Beneficiary [and the Linked Third Party], in particular, it must
not have been involved in preparing the Beneficiary’s [and Linked Third Party’s] Financial
Statement(s);
• must plan work so that the Procedures may be carried out and the Findings may be assessed;
• must adhere to the Procedures laid down and the compulsory report format;
• must carry out the engagement in accordance with these ToR;
• must document matters which are important to support the Report;
• must base its Report on the evidence gathered;
• must submit the Report to the [Beneficiary] [Linked Third Party].
3
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
The Commission sets out the Procedures to be carried out and the Findings to be endorsed by the
Auditor. The Auditor is not responsible for their suitability or pertinence. As this engagement is not an
assurance engagement the Auditor does not provide an audit opinion or a statement of assurance.
1.3 Applicable Standards
The Auditor must comply with these Terms of Reference and with1:
- the International Standard on Related Services (‘ISRS’) 4400 Engagements to perform
Agreed-upon Procedures regarding Financial Information as issued by the International
Auditing and Assurance Standards Board (IAASB);
- the Code of Ethics for Professional Accountants issued by the International Ethics Standards
Board for Accountants (IESBA). Although ISRS 4400 states that independence is not a
requirement for engagements to carry out agreed-upon procedures, the Commission requires
that the Auditor also complies with the Code’s independence requirements.
The Auditor’s Report must state that there was no conflict of interests in establishing this Report
between the Auditor and the Beneficiary [and the Linked Third Party] that could have a bearing on the
Report, and must specify – if the service is invoiced - the total fee paid to the Auditor for providing the
Report.
1.4 Reporting
The Report must be written in the language of the Agreement (see Article 20.7 of the Agreement).
Under Article 22 of the Agreement, the Commission, [the Agency], the European Anti-Fraud Office
and the Court of Auditors have the right to audit any work that is carried out under the action and for
which costs are declared from [the European Union] [Euratom] budget. This includes work related to
this engagement. The Auditor must provide access to all working papers related to this assignment if
the Commission[, the Agency], the European Anti-Fraud Office or the European Court of Auditors
requests them.
1.5 Timing
The Report must be provided by [dd Month yyyy].
1.6 Other Terms
[The [Beneficiary] [Linked Third Party] and the Auditor can use this section to agree other specific
terms, such as the Auditor’s fees, liability, applicable law, etc. Those specific terms must not
contradict the terms specified above.]
[legal name of the Auditor] [legal name of the [Beneficiary] [Linked Third Party]]
[name & title of authorised representative] [name & title of authorised representative]
[dd Month yyyy] [dd Month yyyy]
Signature of the Auditor Signature of the [Beneficiary] [Linked Third Party]
1
Supreme Audit Institutions applying INTOSAI-standards may carry out the Procedures according to the
corresponding International Standards of Supreme Audit Institutions and code of ethics issued by INTOSAI
instead of the International Standard on Related Services (‘ISRS’) 4400 and the Code of Ethics for
Professional Accountants issued by the IAASB and the IESBA.
4
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Independent report of factual findings on the methodology concerning grant agreements
financed under the Horizon 2020 Research and Innovation Framework Programme
(To be printed on letterhead paper of the auditor)
To
[ name of contact person(s)], [Position]
[[Beneficiary’s] [Linked Third Party’s] name]
[ Address]
[ dd Month yyyy]
Dear [Name of contact person(s)],
As agreed under the terms of reference dated [dd Month yyyy]
with [OPTION 1: [insert name of the beneficiary] (‘the Beneficiary’)] [OPTION 2: [insert name of
the linked third party] (‘the Linked Third Party’), third party linked to the Beneficiary [insert name of
the beneficiary] (‘the Beneficiary’)],
we
[ name of the auditor] (‘the Auditor’),
established at
[full address/city/state/province/country],
represented by
[name and function of an authorised representative],
have carried out the agreed-upon procedures (‘the Procedures’) and provide hereby our Independent
Report of Factual Findings (‘the Report’), concerning the [Beneficiary’s] [Linked Third Party’s] usual
accounting practices for calculating and declaring direct personnel costs declared as unit costs (‘the
Methodology’).
You requested certain procedures to be carried out in connection with the grant(s)
[title and number of the grant agreement(s)] (‘the Agreement(s)’).
The Report
Our engagement was carried out in accordance with the terms of reference (‘the ToR’) appended to
this Report. The Report includes: the standard statements (‘the Statements’) made by the [Beneficiary]
[Linked Third Party], the agreed-upon procedures (‘the Procedures’) carried out and the standard
factual findings (‘the Findings’) confirmed by us.
The engagement involved carrying out the Procedures and assessing the Findings and the
documentation requested appended to this Report, the results of which the Commission uses to draw
conclusions regarding the acceptability of the Methodology applied by the [Beneficiary] [Linked Third
Party].
5
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
The Report covers the methodology used from [dd Month yyyy]. In the event that the [Beneficiary]
[Linked Third Party] changes this methodology, the Report will not be applicable to any Financial
Statement1 submitted thereafter.
The scope of the Procedures and the definition of the standard statements and findings were
determined solely by the Commission. Therefore, the Auditor is not responsible for their suitability or
pertinence.
Since the Procedures carried out constitute neither an audit nor a review made in accordance with
International Standards on Auditing or International Standards on Review Engagements, we do not
give a statement of assurance on the costs declared on the basis of the [Beneficiary’s] [Linked Third
Party’s] Methodology. Had we carried out additional procedures or had we performed an audit or
review in accordance with these standards, other matters might have come to its attention and would
have been included in the Report.
Exceptions
Apart from the exceptions listed below, the [Beneficiary] [Linked Third Party] agreed with the
standard Statements and provided the Auditor all the documentation and accounting information
needed by the Auditor to carry out the requested Procedures and corroborate the standard Findings.
List here any exception and add any information on the cause and possible consequences of each
exception, if known. If the exception is quantifiable, also indicate the corresponding amount.
…..
Explanation of possible exceptions in the form of examples (to be removed from the Report):
i. the [Beneficiary] [Linked Third Party] did not agree with the standard Statement number … because…;
ii. the Auditor could not carry out the procedure … established because …. (e.g. due to the inability to
reconcile key information or the unavailability or inconsistency of data);
iii. the Auditor could not confirm or corroborate the standard Finding number … because ….
Remarks
We would like to add the following remarks relevant for the proper understanding of the Methodology
applied by the [Beneficiary] [Linked Third Party] or the results reported:
Example (to be removed from the Report):
Regarding the methodology applied to calculate hourly rates …
Regarding standard Finding 15 it has to be noted that …
The [Beneficiary] [Linked Third Party] explained the deviation from the benchmark statement XXIV
concerning time recording for personnel with no exclusive dedication to the action in the following manner:
…
Annexes
Please provide the following documents to the auditor and annex them to the report when submitting
this CoMUC to the Commission:
1
Financial Statement in this context refers solely to Annex 4 of the Agreement by which the Beneficiary
declares costs under the Agreement.
6
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
Associated with document Ref. Ares(2020)2778062 - 28/05/2020
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
1. Brief description of the methodology for calculating personnel costs, productive hours and
hourly rates;
2. Brief description of the time recording system in place;
3. An example of the time records used by the [Beneficiary] [Linked Third Party];
4. Description of any budgeted or estimated elements applied, together with an explanation as to
why they are relevant for calculating the personnel costs and how they are based on objective
and verifiable information;
5. A summary sheet with the hourly rate for direct personnel declared by the [Beneficiary]
[Linked Third Party] and recalculated by the Auditor for each staff member included in the
sample (the names do not need to be reported);
6. A comparative table summarising for each person selected in the sample a) the time claimed
by the [Beneficiary] [Linked Third Party] in the Financial Statement(s) and b) the time
according to the time record verified by the Auditor;
7. A copy of the letter of representation provided to the Auditor.
Use of this Report
This Report has been drawn up solely for the purpose given under Point 1.1 Reasons for the
engagement.
The Report:
- is confidential and is intended to be submitted to the Commission by the [Beneficiary] [Linked
Third Party] in connection with Article 18.1.2 of the Agreement;
- may not be used by the [Beneficiary] [Linked Third Party] or by the Commission for any other
purpose, nor distributed to any other parties;
- may be disclosed by the Commission only to authorised parties, in particular the European
Anti-Fraud Office (OLAF) and the European Court of Auditors.
- relates only to the usual cost accounting practices specified above and does not constitute a
report on the Financial Statements of the [Beneficiary] [Linked Third Party].
No conflict of interest2 exists between the Auditor and the Beneficiary [and the Linked Third Party]
that could have a bearing on the Report. The total fee paid to the Auditor for producing the Report was
EUR ______ (including EUR ______ of deductible VAT).
We look forward to discussing our Report with you and would be pleased to provide any further
information or assistance which may be required.
Yours sincerely
[legal name of the Auditor]
[name and title of the authorised representative]
[dd Month yyyy]
Signature of the Auditor
2
A conflict of interest arises when the Auditor's objectivity to establish the certificate is compromised in fact
or in appearance when the Auditor for instance:
- was involved in the preparation of the Financial Statements;
- stands to benefit directly should the certificate be accepted;
- has a close relationship with any person representing the beneficiary;
- is a director, trustee or partner of the beneficiary; or
- is in any other situation that compromises his or her independence or ability to establish the certificate
impartially.
7
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Statements to be made by the Beneficiary/Linked Third Party (‘the Statements’) and Procedures to be carried out by the Auditor (‘the
Procedures’) and standard factual findings (‘the Findings’) to be confirmed by the Auditor
The Commission reserves the right to provide the auditor with guidance regarding the Statements to be made, the Procedures to be carried out or the
Findings to be ascertained and the way in which to present them. The Commission reserves the right to vary the Statements, Procedures or Findings by
written notification to the Beneficiary/Linked Third Party to adapt the procedures to changes in the grant agreement(s) or to any other circumstances.
If this methodology certificate relates to the Linked Third Party’s usual accounting practices for calculating and claiming direct personnel costs declared as
unit costs any reference here below to ‘the Beneficiary’ is to be considered as a reference to ‘the Linked Third Party’.
Please explain any discrepancies in the body of the Report.
Statements to be made by Beneficiary Procedures to be carried out and Findings to be confirmed by the Auditor
A. Use of the Methodology Procedure:
I. The cost accounting practice described below has been in use since [dd The Auditor checked these dates against the documentation the Beneficiary
Month yyyy]. has provided.
II. The next planned alteration to the methodology used by the Beneficiary Factual finding:
will be from [dd Month yyyy].
1. The dates provided by the Beneficiary were consistent with the
documentation.
B. Description of the Methodology Procedure:
III. The methodology to calculate unit costs is being used in a consistent The Auditor reviewed the description, the relevant manuals and/or internal
manner and is reflected in the relevant procedures. guidance documents describing the methodology.
[Please describe the methodology your entity uses to calculate personnel costs, Factual finding:
productive hours and hourly rates, present your description to the Auditor and
annex it to this certificate] 2. The brief description was consistent with the relevant manuals, internal
guidance and/or other documentary evidence the Auditor has reviewed.
[If the statement of section “B. Description of the methodology” cannot be 3. The methodology was generally applied by the Beneficiary as part of its
endorsed by the Beneficiary or there is no written methodology to calculate unit usual costs accounting practices.
costs it should be listed here below and reported as exception by the Auditor in the
main Report of Factual Findings:
- …]
8
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Please explain any discrepancies in the body of the Report.
Statements to be made by Beneficiary Procedures to be carried out and Findings to be confirmed by the Auditor
C. Personnel costs Procedure:
General The Auditor draws a sample of employees to carry out the procedures indicated in
IV. The unit costs (hourly rates) are limited to salaries including during this section C and the following sections D to F.
parental leave, social security contributions, taxes and other costs included [The Auditor has drawn a random sample of 10 employees assigned to Horizon 2020
in the remuneration required under national law and the employment action(s). If fewer than 10 employees are assigned to the Horizon 2020 action(s), the
contract or equivalent appointing act; Auditor has selected all employees assigned to the Horizon 2020 action(s)
V. Employees are hired directly by the Beneficiary in accordance with complemented by other employees irrespective of their assignments until he has
national law, and work under its sole supervision and responsibility; reached 10 employees.]. For this sample:
VI. The Beneficiary remunerates its employees in accordance with its usual the Auditor reviewed all documents relating to personnel costs such as
practices. This means that personnel costs are charged in line with the employment contracts, payslips, payroll policy (e.g. salary policy, overtime
Beneficiary’s usual payroll policy (e.g. salary policy, overtime policy, policy, variable pay policy), accounting and payroll records, applicable
variable pay) and no special conditions exist for employees assigned to national tax , labour and social security law and any other documents
tasks relating to the European Union or Euratom, unless explicitly provided corroborating the personnel costs claimed;
for in the grant agreement(s);
in particular, the Auditor reviewed the employment contracts of the
VII. The Beneficiary allocates its employees to the relevant group/category/cost employees in the sample to verify that:
centre for the purpose of the unit cost calculation in line with the usual cost
accounting practice; i. they were employed directly by the Beneficiary in accordance with
applicable national legislation;
VIII. Personnel costs are based on the payroll system and accounting system.
ii. they were working under the sole technical supervision and
IX. Any exceptional adjustments of actual personnel costs resulted from
responsibility of the latter;
relevant budgeted or estimated elements and were based on objective and
verifiable information. [Please describe the ‘budgeted or estimated iii. they were remunerated in accordance with the Beneficiary’s usual
elements’ and their relevance to personnel costs, and explain how they practices;
were reasonable and based on objective and verifiable information, present iv. they were allocated to the correct group/category/cost centre for the
your explanation to the Auditor and annex it to this certificate]. purposes of calculating the unit cost in line with the Beneficiary’s
X. Personnel costs claimed do not contain any of the following ineligible usual cost accounting practices;
costs: costs related to return on capital; debt and debt service charges; the Auditor verified that any ineligible items or any costs claimed under
provisions for future losses or debts; interest owed; doubtful debts; other costs categories or costs covered by other types of grant or by other
currency exchange losses; bank costs charged by the Beneficiary’s bank for grants financed from the European Union budget have not been taken into
transfers from the Commission/Agency; excessive or reckless expenditure; account when calculating the personnel costs;
deductible VAT or costs incurred during suspension of the implementation the Auditor numerically reconciled the total amount of personnel costs used
of the action. to calculate the unit cost with the total amount of personnel costs recorded
XI. Personnel costs were not declared under another EU or Euratom grant in the statutory accounts and the payroll system.
9
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Please explain any discrepancies in the body of the Report.
Statements to be made by Beneficiary Procedures to be carried out and Findings to be confirmed by the Auditor
(including grants awarded by a Member State and financed by the EU to the extent that actual personnel costs were adjusted on the basis of
budget and grants awarded by bodies other than the Commission/Agency budgeted or estimated elements, the Auditor carefully examined those
for the purpose of implementing the EU or Euratom budget in the same elements and checked the information source to confirm that they
period, unless the Beneficiary can demonstrate that the operating grant correspond to objective and verifiable information;
does not cover any costs of the action).
if additional remuneration has been claimed, the Auditor verified that the
Beneficiary was a non-profit legal entity, that the amount was capped at
If additional remuneration as referred to in the grant agreement(s) is paid EUR 8 000 per full-time equivalent and that it was reduced proportionately
XII. The Beneficiary is a non-profit legal entity; for employees not assigned exclusively to the action(s).
XIII. The additional remuneration is part of the beneficiary’s usual remuneration the Auditor recalculated the personnel costs for the employees in the
practices and paid consistently whenever the relevant work or expertise is sample.
required; Factual finding:
XIV. The criteria used to calculate the additional remuneration are objective and
4. All the components of the remuneration that have been claimed as personnel
generally applied regardless of the source of funding;
costs are supported by underlying documentation.
XV. The additional remuneration included in the personnel costs used to
calculate the hourly rates for the grant agreement(s) is capped at 5. The employees in the sample were employed directly by the Beneficiary in
EUR 8 000 per full-time equivalent (reduced proportionately if the accordance with applicable national law and were working under its sole
employee is not assigned exclusively to the action). supervision and responsibility.
6. Their employment contracts were in line with the Beneficiary’s usual
policy;
7. Personnel costs were duly documented and consisted solely of salaries,
social security contributions (pension contributions, health insurance,
unemployment fund contributions, etc.), taxes and other statutory costs
[If certain statement(s) of section “C. Personnel costs” cannot be endorsed by the included in the remuneration (holiday pay, thirteenth month’s pay, etc.);
Beneficiary they should be listed here below and reported as exception by the 8. The totals used to calculate the personnel unit costs are consistent with those
Auditor in the main Report of Factual Findings: registered in the payroll and accounting records;
- …]
9. To the extent that actual personnel costs were adjusted on the basis of
budgeted or estimated elements, those elements were relevant for
calculating the personnel costs and correspond to objective and verifiable
information. The budgeted or estimated elements used are: — (indicate the
elements and their values).
10. Personnel costs contained no ineligible elements;
11. Specific conditions for eligibility were fulfilled when additional
10
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Please explain any discrepancies in the body of the Report.
Statements to be made by Beneficiary Procedures to be carried out and Findings to be confirmed by the Auditor
remuneration was paid: a) the Beneficiary is registered in the grant
agreements as a non-profit legal entity; b) it was paid according to objective
criteria generally applied regardless of the source of funding used and c)
remuneration was capped at EUR 8 000 per full-time equivalent (or up to up
to the equivalent pro-rata amount if the person did not work on the action
full-time during the year or did not work exclusively on the action).
D. Productive hours Procedure (same sample basis as for Section C: Personnel costs):
XVI. The number of productive hours per full-time employee applied is [delete The Auditor verified that the number of productive hours applied is in
as appropriate]: accordance with method A, B or C.
A. 1720 productive hours per year for a person working full-time The Auditor checked that the number of productive hours per full-time
(corresponding pro-rata for persons not working full time). employee is correct.
B. the total number of hours worked in the year by a person for the If method B is applied the Auditor verified i) the manner in which the total
Beneficiary number of hours worked was done and ii) that the contract specified the
C. the standard number of annual hours generally applied by the annual workable hours by inspecting all the relevant documents, national
beneficiary for its personnel in accordance with its usual cost legislation, labour agreements and contracts.
accounting practices. This number must be at least 90% of the If method C is applied the Auditor reviewed the manner in which the
standard annual workable hours. standard number of working hours per year has been calculated by
If method B is applied inspecting all the relevant documents, national legislation, labour
agreements and contracts and verified that the number of productive hours
XVII. The calculation of the total number of hours worked was done as per year used for these calculations was at least 90 % of the standard number
follows: annual workable hours of the person according to the of working hours per year.
employment contract, applicable labour agreement or national law plus Factual finding:
overtime worked minus absences (such as sick leave and special leave).
General
XVIII. ‘Annual workable hours’ are hours during which the personnel must be
12. The Beneficiary applied a number of productive hours consistent with
working, at the employer’s disposal and carrying out his/her activity or
method A, B or C detailed in the left-hand column.
duties under the employment contract, applicable collective labour
agreement or national working time legislation. 13. The number of productive hours per year per full-time employee was
accurate.
XIX. The contract (applicable collective labour agreement or national
working time legislation) do specify the working time enabling to If method B is applied
calculate the annual workable hours.
14. The number of ‘annual workable hours’, overtime and absences was
11
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Please explain any discrepancies in the body of the Report.
Statements to be made by Beneficiary Procedures to be carried out and Findings to be confirmed by the Auditor
If method C is applied verifiable based on the documents provided by the Beneficiary and the
calculation of the total number of hours worked was accurate.
XX. The standard number of productive hours per year is that of a full-time
15. The contract specified the working time enabling to calculate the annual
equivalent.
workable hours.
XXI. The number of productive hours per year on which the hourly rate is based
i) corresponds to the Beneficiary’s usual accounting practices; ii) is at least If method C is applied
90 % of the standard number of workable (working) hours per year. 16. The calculation of the number of productive hours per year corresponded to
XXII. Standard workable (working) hours are hours during which personnel are at the usual costs accounting practice of the Beneficiary.
the Beneficiary’s disposal preforming the duties described in the relevant 17. The calculation of the standard number of workable (working) hours per
employment contract, collective labour agreement or national labour year was corroborated by the documents presented by the Beneficiary.
legislation. The number of standard annual workable (working) hours that
18. The number of productive hours per year used for the calculation of the
the Beneficiary claims is supported by labour contracts, national legislation
hourly rate was at least 90 % of the number of workable (working) hours per
and other documentary evidence.
year.
[If certain statement(s) of section “D. Productive hours” cannot be endorsed by the
Beneficiary they should be listed here below and reported as exception by the
Auditor:
- …]
E. Hourly rates Procedure
The hourly rates are correct because: The Auditor has obtained a list of all personnel rates calculated by the
Beneficiary in accordance with the methodology used.
XXIII. Hourly rates are correctly calculated since they result from dividing annual The Auditor has obtained a list of all the relevant employees, based on
personnel costs by the productive hours of a given year and group (e.g. which the personnel rate(s) are calculated.
staff category or department or cost centre depending on the methodology
applied) and they are in line with the statements made in section C. and D. For 10 employees selected at random (same sample basis as Section C: Personnel
above. costs):
The Auditor recalculated the hourly rates.
The Auditor verified that the methodology applied corresponds to the usual
accounting practices of the organisation and is applied consistently for all
[If the statement of section ‘E. Hourly rates’ cannot be endorsed by the Beneficiary activities of the organisation on the basis of objective criteria irrespective of
they should be listed here below and reported as exception by the Auditor: the source of funding.
- …] Factual finding:
12
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Please explain any discrepancies in the body of the Report.
Statements to be made by Beneficiary Procedures to be carried out and Findings to be confirmed by the Auditor
19. No differences arose from the recalculation of the hourly rate for the
employees included in the sample.
F. Time recording Procedure
XXIV. Time recording is in place for all persons with no exclusive dedication to The Auditor reviewed the brief description, all relevant manuals and/or
one Horizon 2020 action. At least all hours worked in connection with the internal guidance describing the methodology used to record time.
grant agreement(s) are registered on a daily/weekly/monthly basis [delete
as appropriate] using a paper/computer-based system [delete as
The Auditor reviewed the time records of the random sample of 10 employees
appropriate];
referred to under Section C: Personnel costs, and verified in particular:
XXV. For persons exclusively assigned to one Horizon 2020 activity the
Beneficiary has either signed a declaration to that effect or has put that time records were available for all persons with not exclusive
arrangements in place to record their working time; assignment to the action;
XXVI. Records of time worked have been signed by the person concerned (on that time records were available for persons working exclusively for a
paper or electronically) and approved by the action manager or line Horizon 2020 action, or, alternatively, that a declaration signed by the
manager at least monthly; Beneficiary was available for them certifying that they were working
XXVII. Measures are in place to prevent staff from: exclusively for a Horizon 2020 action;
i. recording the same hours twice, that time records were signed and approved in due time and that all
minimum requirements were fulfilled;
ii. recording working hours during absence periods (e.g. holidays, sick
leave), that the persons worked for the action in the periods claimed;
iii. recording more than the number of productive hours per year used to that no more hours were claimed than the productive hours used to calculate
calculate the hourly rates, and the hourly personnel rates;
iv. recording hours worked outside the action period. that internal controls were in place to prevent that time is recorded twice,
during absences for holidays or sick leave; that more hours are claimed per
XXVIII. No working time was recorded outside the action period; person per year for Horizon 2020 actions than the number of productive
XXIX. No more hours were claimed than the productive hours used to calculate hours per year used to calculate the hourly rates; that working time is
the hourly personnel rates. recorded outside the action period;
the Auditor cross-checked the information with human-resources records to
verify consistency and to ensure that the internal controls have been
effective. In addition, the Auditor has verified that no more hours were
[Please provide a brief description of the time recording system in place together
charged to Horizon 2020 actions per person per year than the number of
with the measures applied to ensure its reliability to the Auditor and annex it to the
productive hours per year used to calculate the hourly rates, and verified that
13
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Please explain any discrepancies in the body of the Report.
Statements to be made by Beneficiary Procedures to be carried out and Findings to be confirmed by the Auditor
present certificate1]. no time worked outside the action period was charged to the action.
Factual finding:
20. The brief description, manuals and/or internal guidance on time recording
[If certain statement(s) of section “F. Time recording” cannot be endorsed by the
provided by the Beneficiary were consistent with management
Beneficiary they should be listed here below and reported as exception by the
reports/records and other documents reviewed and were generally applied
Auditor:
by the Beneficiary to produce the financial statements.
- …]
21. For the random sample time was recorded or, in the case of employees
working exclusively for the action, either a signed declaration or time
records were available;
22. For the random sample the time records were signed by the employee and
the action manager/line manager, at least monthly.
23. Working time claimed for the action occurred in the periods claimed;
24. No more hours were claimed than the number productive hours used to
calculate the hourly personnel rates;
25. There is proof that the Beneficiary has checked that working time has not
been claimed twice, that it is consistent with absence records and the
number of productive hours per year, and that no working time has been
claimed outside the action period.
26. Working time claimed is consistent with that on record at the human-
resources department.
1
The description of the time recording system must state among others information on the content of the time records, its coverage (full or action time-recording, for all
personnel or only for personnel involved in H2020 actions), its degree of detail (whether there is a reference to the particular tasks accomplished), its form, periodicity of
the time registration and authorisation (paper or a computer-based system; on a daily, weekly or monthly basis; signed and countersigned by whom), controls applied to
prevent double-charging of time or ensure consistency with HR-records such as absences and travels as well as it information flow up to its use for the preparation of the
Financial Statements.
14
Grant Agreement number: [insert number] [insert acronym] [insert call identifier]
H2020 Model Grant Agreements: H2020 General MGA — Multi: v5.0 – dd.mm.2017
Please explain any discrepancies in the body of the Report.
Statements to be made by Beneficiary Procedures to be carried out and Findings to be confirmed by the Auditor
[official name of the [Beneficiary] [Linked Third Party]] [official name of the Auditor]
[name and title of authorised representative] [name and title of authorised representative]
[dd Month yyyy] [dd Month yyyy]
<Signature of the [Beneficiary] [Linked Third Party]> <Signature of the Auditor>
15
Digitally sealed by the European Commission
Date: 2020.05.28 17:05:33 CEST
This document is digitally sealed. The digital sealing mechanism uniquely binds the
document to the modules of the Funding & Tenders Portal of the European
Commission, to the transaction for which it was generated and ensures its integrity and
authenticity.
Any attempt to modify the content will lead to a breach of the electronic seal, which can
be verified at any time by clicking on the digital seal validation symbol.
Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË - Tel. +32 22991111